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Abstract 
 
Introduction 
Fragility fractures are common in care home residents. National guidelines recommend risk 
assessment to allow initiation of prophylactic measures. Currently available risk assessment 
tools have been tested in community dwelling adults but not in care home residents. It is 
possible that one or more of the existing tools are also practicable in this population.   
 
Aim 
The aim of this project was to identify fracture risk assessment tools which are usable in care 
home residents and to determine which is the most suitable for use in this population. 
 
Objectives 
1. To conduct a systematic literature review of existing fragility fracture risk assessment 
tools and select those that can be used in care home residents. 
2. To develop a composite questionnaire which can be used to test the identified fragility 
fracture risk assessment tools in a care home population. This will be done by using the 
covariates in each tool to design a questionnaire, the acceptability of which will be 
assessed by consultation visits to two care homes to aid its refinement. 
3. To undertake an observational pilot study of the fragility fracture risk assessment in a 
cohort of care home residents 
4. To design a Clinical Algorithm. 
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 Methods 
1. A literature search was performed by a combination of electronic and manual literature 
searches and studies of assessment tools potentially usable in a care home population 
were selected and assessed based on content and quality criteria. The search was 
updated on 12/08/2019  
2. A questionnaire was designed based on information from the literature review and 
tested by a cross-sectional survey in two care homes in Staffordshire. 
3. A cohort observational study was conducted using the above questionnaire in 18 care 
homes in Boston, Lincolnshire, England. 
 
Results 
1. In the systematic review, 33 fragility tools were identified and four were potentially 
practicable in care home residents. These were: FRAX, QFractureScores, Garvan 
nomogram and Body Mass Index (BMI). The updated search identified a fifth-measure 
micro ribonucleic acid (miRNA). However, this was not implemented. 
2. A composite questionnaire and information leaflet were designed and refined 
following feedback gleaned from the consultation visits.   
3. In the feasibility study 217 (35%) participants out of 618 residents in the 18 care 
homes were enrolled. Out of the 217 participants, 147 (68%) had mental capacity and 
only 70 (32%) did not. This was because there was difficulty in obtaining informed 
consent from the consultees in residents without mental capacity.  
4. Low BMI and history of dementia were identified as the risk factors for falls, fractures 
and combined falls and fractures in the cohort. Charlson Commorbidity Index 
predicted mortality (p= 0.034) and a score of ≥ 36% was identified as the threshold for 
identifying participants who would not benefit from treatment. These three variables 
were used to design a Clinical Algorithm. 
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The fragility tools were easy to use given that the average duration for assessment was 
between 1 and 2 minutes. BMI of 25kg/m² or less had the highest sensitivity of 74.5% for 
falls. The sensitivity and specificity of FRAX and Garvan nomogram were not calculated 
because neither tool predicted falls, fractures or combined falls and fractures. The odds ratios 
for the prediction of the outcomes were as follows: FRAX falls 1.003, SE 0.011 (p=0.813), 
fractures 1.027, SE 0.024 (p=0.267), combined falls and fractures 1.027, SE 0.024 (p=0.267); 
QFractureScores falls 1.007 SE 0.005 (p=.160), fractures  1.024, SE 0.011 (p=0.036), 
combined falls and fractures  1.024, SE 0.011 (p=0.036); Garvan nomogram fall, 1.010, SE 
0.005 (p=0.054), fractures 1.021, SE 0.011 (p=0.0620, combined falls and fractures 1.021, SE 
0.011 (p=0.062); BMI falls 0.952, SE 0.021 (p=0.015), fractures  0.868, SE 0.073 (p=0.024), 
combined falls and fractures 0.868, SE 0.073 (p=0.024). Of the 10 incident fractures, 40% 
occurred in the participants who had dementia. 
 
Conclusions   
The systematic literature review identified many fragility risk assessment tools, but only four 
were potentially practicable in a care home population. Recruitment to the observational study 
was restricted mainly to residents who possessed mental capacity, because it was difficult to 
obtain consultee consent in this setting.   
 
Although the fragility tools were easy to use, generally they had poor screening performance 
for the prediction of falls. BMI of 25kg/m² had the highest sensitivity. BMI was the best 
predictor of falls, fractures and combined falls and fractures but the associations were weak. 
QFractureScores was a predictor of fractures and combined falls and fractures.  Neither FRAX 
nor Garvan nomogram were predictors of these outcomes. Of the 10 incident fractures, 40% 
were observed in participants who had dementia despite the small representation of this group, 
thus dementia is a strong risk factor for fractures in this cohort.  
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A fully powered and representative study is unlikely to be feasible, if individual consent is 
required, as the majority of care home residents do not have mental capacity, and legal 
representative consent is difficult to obtain in this setting. The results of this thesis suggest that 
BMI and dementia are strong predictors of falls and fractures. An algorithm was then designed 
using these to guide selection of suitable residents for treatment.  
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Chapter 1 Introduction and background information 
1.1 Introduction 
Fragility fractures are common in older people. Globally in the year 2000, there were an 
estimated 9 million new fractures (Johnell, Kanis, 2006).  1 in 2 women over 50 years of age 
and 1 in 5 men will sustain a fracture (Van Staa et al., 2001, Kanis et al. on behalf of the 
Scientific Advisory Board of the European Society for Clinical and Economic Aspects of 
Osteoporosis [ESCEO] and the Committee of Scientific Advisors of the International 
Osteoporosis Foundation [IOF], 2012).  In the next two decades, almost half a billion people 
will reach retirement age and as this demographic shift ensues, fragility fractures will be 
expected to increase. Fragility fractures affect many bones in the body but the most frequently 
affected sites are the vertebrae, wrist and hips.  The two determinants of fragility fractures are 
trauma and impaired bone strength, both of which are common in older people. Fragility 
fractures are associated with high morbidity, mortality and the cost associated with managing 
them is substantial (Johnell, Kanis, 2004). Both hip and spinal fractures are associated with a 
higher risk of death; twenty percent or more of those who suffer hip fractures die within 6 
months after the fracture and the burden of care of fragility fractures is increasingly being felt 
in every continent (Johnell, Kanis, 2006).   
 
With the anticipated exponential increase of the ageing population, many older persons will be 
admitted to care homes and fragility fractures will be expected to increase in this cohort. 
Consequently, a well-coordinated, systematic global approach at primary prevention through 
risk assessment is needed because once a fragility fracture has occurred secondary prevention 
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is less effective, thus the identification of high risk older people is a priority (Torgerson, 
Gosden & Reid, 1997).  
 
With the advances in medical research, the scope for reducing fragility fractures has increased 
through collaborative initiatives such as contained in the Blue Book (The British Orthopaedic 
Association, 2007), which provided a summary of current knowledge and evicence based 
treatment recommendations and the National Hip Fracture Database (NHFD) (RCP, 2018), 
both pionnered in the United Kingdom. The NHFD provides a benchmarking care and allows 
units to also monitor their case-mix, outcomes and offer the opportunity to conduct large scale 
multi-centre research in hip fractures. More recent guidance for fragility fracture prevention 
has been published by NICE in 2016 (NICE 2016) and the NHS RightCare (Public Health 
England, National Osteoporosis Society, and the NHS RightCare) in 2017. These include 
recommendations for service organization, pharmaceutical treatments, and therapy 
interventions. The NHS RightCare Pathway recommends that Commissioners responsible for 
Falls and Fragility Fractures for their population should focus on the three priorities for 
optimisation: 
 Falls prevention 
 Detecting and managing Osteoporosis 
 Optimal support after a fragility fracture 
These objectives can be achieved by working across the system to ensure that schemes to 
deliver the higher value interventions are in place by :  
 Targeted case-finding for osteoporosis, fraility and falls risk 
 Strength and balance training for those at low to moderate risk of falls 
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 Multi-factorial intervention for those at higher risk of falls 
 Fracture liaison service for those who have had a fragility fracture 
The document recommend that Commissioners should use the Falls Prevention Consensus and 
Resource Pack especially the implementation checklist 
 
Preventing falls requires a multifactorial approach, including targeted case finding, 
comprehensive assessment of risk factors and implementation of appropriate interventions 
(Close et al 2001). Pharmaceutical treatments for osteoporosis include medications which 
increase bone strength. These drugs offer protection against fractures due to minor trauma and 
include alendronate or risedronate as first line prevention of  fragility fractures for the majority 
of cases. For patients who are intolerant of oral bisphosphonates or in whom they are 
contraindicated, intravenous bisphosphonates or denosumab provide the most appropriate 
alternatives, with raloxifene or hormone replacement therapy as additional options. But these 
are not useful in care home residents many of whom are very old.  The high cost of 
teriparatide restricts its use to those at very high risk, particularly for vertebral fractures 
(NOGG 2017). These measures should be supplemeted with lifestyle and dietary measures. A 
daily calcium intake of between 700 and 1200 mg should be advised through dietary intake if 
possible, with use of supplements if necessary. The recommendations for calcium and vitamin 
D intake for different groups of people are detailed in NICE guidiance of 2016 and this is 
discussed in more details in chapter 6 of this thesis.. Regular weight bearing exercise should 
be advised, tailored according to needs and abilities of the individual patient (NOGG 2017). 
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The most effective healthcare solution to fracture prevention is the Fracture Liaison Service 
(FLS) (McLellan et al., 2003) which is designed to identify and assess patients presenting with 
new fractures. Between half and two thirds of patients with hip fractures would have had a 
prior fracture therefore secondary prevention is important because fracture begets fracture 
(Klotzbuecher et al., 2000, Kanis et al., 2004). The FLS is an integrated service which is 
usually delivered by a Nurse Specialist  supported by a Lead Clinician in Osteoporosis in a 
`one stop` FLS clinic for appropriate patients. In addition to other routine tests, all patients 
who are aged 50 years and over presenting with a fragility fracture should undergo assessment 
of osteoporosis by axial bone densitometry. Appropriate patients are offered bone protection 
therapy as this has shown 50% reduction in fracture incidence during 3 years of treatment. The 
guidance for treatment is detailed in the National Institute for Care Excellence (NICE) 
Technology Appraisal document (NICE 2016) as well as new guidance issued by the National 
Osteoporosis Guideline Group (NOGG 2017); recommendations from the Scottish 
intercollegiate Guidelines Network (SIGN) guideline have been incorporated (SIGN 2015). 
Appropriate patients should be referred to the falls service.   
 
Most fragility fractures result from minor trauma, often falls, but only a minority of these are 
complicated by fractures (Tinetti, Williams, 1997).  To identify people who can potentially 
sustain fractures from falls, risk assessment is a key (The National Falls Prevention 
Coordination Group (NFPCG), 2017).  Almost 40 years ago, the World Health Organization 
(WHO) commissioned a report on screening. The report published in 1968 was entitled 
“Principles and practice of screening for diseases” (Wilson, Jungner, 1968). The criteria 
presented in the report are still upheld today as classics (Hall, Stewart-Brown, 1998), the gold 
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standard of screening assessment (Linnane, Paul & Parry, 1999), having stood the test of time 
(Population cancer screening in Canada, 2002).  
 
The practice of the report relies heavily on screening tools.  With regards to falls and factures, 
there are currently no validated tools exclusively for care home residents.  It is therefore 
important to conduct a study to identify the best fragility tool within the existing pool or to 
create a new tool for use in this cohort. There are inherent difficulties in conducting research 
in care homes and the aims of this research are to conduct a pilot study to determine the 
recruitment rate, identify if the existing scores for fracture risk have relevance for care home 
use in the frail elderly, is it easy to apply the tools and can a clinical algorithm be developed as 
most tools are there for 10 year prediction risk (not relevant in a care home population).  
 
In chapter 1 of this thesis a discussion of the background information relating to the relevant 
aspects of fragility fractures will be presented. Chapter 2 (project 1) is the systematic literature 
review of fragility risk assessment tools. Chapter 3 (project 2) is a report of the consultation 
visit to two care homes to access the acceptability of  the questionnaire designed from the 
results of the systematic review. Chapters 4 and 5 (project 3) are the reports of the 
observational study in care homes in Boston using the questionnaire from project 3 and 
finally, chapter 6 will present the highlights of each chapter and the clinical algorithms which 
were developed from the study. The methodology of each project will be presented in the 
corresponding chapters. 
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1.2 Fragility fractures 
1.2.1 Definition of Fragility Fractures 
A fragility fracture is defined as a fracture that occurs spontaneously or results from low 
energy trauma (low-level trauma) (Kanis et al., 2001).  The World Health Organisation 
(WHO) has quantified this as forces equivalent to a fall from a standing height or less 
(National Institute for Clinical Excellence (NICE), 2012b). In simple terms, fragility fractures 
occur because bones with reduced strength are subjected to critical forces which often arise 
from minor trauma (Pasco et al., 1999). Individuals susceptible to low energy trauma are also 
more likely to sustain fractures following heavy impact injuries. Although the above definition 
is generally accepted, there are views that fragility fractures should now be defined in terms of 
age and bone mineral density (BMD) (Stone et al., 2003, Seeley et al., 1991) because they are 
the two strongest risk factors. 
 
If it is a fragility fracture, the argument is that it should be related to low BMD and or 
advancing age because age and bone mineral density (BMD) are the strongest known risk 
factors. Using these criteria for diagnosis has the merit of eliminating the ‘low energy trauma 
or standing height’ criteria, which are both subjective assessments. Some fractures such as 
skull, facial, ankle and digital fractures are not considered osteoporotic because they are 
neither related to the degree of trauma, BMD or age.  Fragility fracture is used synonymously 
with osteoporotic fracture.  Osteo means `bone` and porosis means `porous`. 
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1.2.2 The Incidence and Prevalence of Fragility Fractures 
Fragility fractures show differences in their patterns of incidence by age, sex, ethnic group, 
geographical area and season, and many of these differences are unexplained (Kanis et al.  
2012). Globally, fragility fractures occur every 3 seconds and a vertebral fracture every 22 
seconds. This translates to about 25,000 fractures daily or 9 million annually (Zanchetta, 
2012). Europe and the Americas accounted for 51% of the fragility fractures, while most of 
the remainder occurred in the Western Pacific region and South East Asia. Worldwide in 
1990, there were about 1.65 million hip fractures; by 2050, it is estimated there will be 6.3 
million with 50% predicted to occur in Asia and Latin America (Cooper, Campion & Melton, 
1992). Osteoporotic fractures occur in about 0.5% of the population per annum in some 
countries such as the United States, European countries and Australia (Access Economics Pty 
Limited, 2001). 
 
The Surgeon General`s report in the United States of America (USA) estimated 1.5 million 
fragility fractures occurred in people over 50 years old in 2004 and over 34 million are at risk 
because of the ageing population (US Department of Health and Human Services., 2004). 
Assuming there is a constant age-specific hip fracture risk and a projected increase of people 
aged 65 years and over, this will result a three-fold increase of hip fractures from 32 million in 
1990 to 69 million by 2050. In 2010, there were 3.5 million new fractures comprising 
approximately 620,000 hip fractures, 520,000 vertebral fractures, 560,000 forearm fractures 
and 1,800,000 other fractures in Europe. This number will rise to 4.8 million by 2025, an 
increase of 28% if no treatment is given.  In Europe, the Scandinavian countries currently have 
the highest prevalence of osteoporotic fractures, which is more than would be expected from 
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the demographic changes in age and sex ratio (Cooper, Campion & Melton, 1992). In the 
United Kingdom in 2010, there were approximately 536,000 new fragility fractures of which 
70,000 were hip fractures; this is predicted to increase to 91,500 in 2015 and 101,000 in 2020 
(British Orthopaedic Association, 2007). 
 
An audit on fragility fractures in South America also showed increased incidence and 
prevalence of fragility fractures in both sexes in most countries (Zanchetta, 2012).  The same 
trends were observed in many countries in Asia. For example in Japan, the incidence of hip 
fracture, which was one of the lowest in the world, has increased 1.6-fold in men and 1.5-fold 
in women between 1980 and 1998. (Mithal, 2013).  Fracture data from the Middle East show a 
similar trajectory (Fuleihan et al 2011).  There are scarce data on fragility fractures from many 
countries in Africa, other social conditions causing more burdens. Less than 3% of the 
population is over 65 years old and the life expectancy is 57 years. However the limited data 
available suggest the same pattern (Zebaze, Seeman, 2003).  
 
The age-standardised hip fracture rates in some countries in different regions of the world, 
Scandinavia, Asia, Middle East, Africa, North & South America and Europe, are shown in 
tables 1 to 6.  These tables are presented separately to highlight the global nature of the 
problem. These tables show that  hip fracture rates are highest in European countries and 
epidemiological data show that hip fractures are most common after the age of 80 years. The 
life span in many developing countries is currently below this.  
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Table 1 shows a transient unexplainable decrease in some Scandinavian countries which have 
the highest incidence of fragility worldwide. Between 1983 and 1984 in Norway, the age-
adjusted rates of hip fractures were 1293 and 561 in females and males respectively, but these 
decreased to 563 and 263 between 1994 and 2008 (Maggi et al., 1991). Similarly, between 
1972 and 1981 in Sweden, the age adjusted rates for hip fractures were 622 and 291 in females 
and males respectively; by 1991, these had decreased to 539 and 247 respectively (Maggi et 
al., 1991, Kanis et al., 2012).  
 
There is no clear reason why the incidences in Sweden and Norway declined over  time, but it 
is in line with the development of several other health problems (Modig et al., 2013 
Karampampa et al., 2014). Socioeconomic and clinical factors could have contributed to the 
change. In Sweden, the age-specific risk for a first and subsequent hospitalisation decreased 
(Karampampa et al., 2014) suggesting that the occurrence of chronic illnessness such as 
cardiovascular disease decreased (Modig et al., 2013, Marks 2010). These well recognised risk 
factors for hip fractures decreased over time; changes in life style factors among the elderly 
such as smoking cessation could also have contributed (Abrahamsen Vestergaard 2010). Also, 
the rising trends of body weight among the elderly, a protective factor for hip fracture 
(Abrahamsen, Vestergaard, 2010) could have played a part (Dey et al., 2001) 
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Table 1: Age-standardised hip fracture rates (per 100,000) in three Scandinavian countries 
 
Country Source Age-adjusted 
rates/100,000 in 
females (1972 – 2005)  
Age-adjusted 
rates/100,000 in males 
(1972 - 2005) 
Norway Finsen et al. 1987 
Emaus et al. 2011 
 
1293 (1983-84) 
563 (1994-08) 
551 (1983-84) 
263 (1994-08) 
Sweden Hedlund et al. 1987 
Kanis et al. 1991 
 
622 (1972-81) 
539 (1991-92) 
291 (1972-81) 
247 (1991-92) 
Denmark Frandsen et al. 1983 
Abrahamson et al. 2010 
620 (1973-79) 
574 (2004-05) 
 
203 (1973-79) 
290 (2004-05) 
Source: adapted from (Kanis et al., 2012)  
 
 Table 1 shows the age-standardised hip fracture rates in three Scandinavian countries. 
Between 1983 and 2008 in Norway, there was a decrease in hip fracture rates in both females 
and males. Between 1972 and 1991 in Sweden, there was a decrease in hip fracture rates in 
both females and males. Between 1973 and 2004 in Demark, there was a decrease in hip 
fracture rates in females but increase in males. These data show there was a consistent 
reduction in hip fracture rates in females and in males (except in Denmark) in these countries 
for over two decades.  
 
Interpretation: The countries are located in the same geographical area and they may have 
had a common and effective strategy to address the problems of hip fractures. The Swedish 
and Norwegian cost estimates indicate that the medical care for osteoporotic fractures 
represent 1 to 2% of the total health expenditure (Christensen, Brixen & Kristiansen, 2003). 
  
11 
 
Table 2: Age-standardised hip fracture rates (per 100,000) in some countries in 
Asia/Australasia  
 
Country Source Age-adjusted 
rates/100,000 in 
females(2007-
2013 
Age-adjusted 
rates/100,000 in 
males(2007-
2013 
Australia Crisp et al. 2012 295 170 
China Xia et al. 2012 229 129 
Japan  Orimo et al. 2007 180 50 
Republic of Korea Yoon et al. 2011 207 98 
Singapore Asia-Pacific Audit 2013 402 152 
Thailand Wongtriratanachai et al. 2013 368 136 
Source: adapted from (Kanis et al., 2012) and the International Osteoporosis Foundation (IOF) 
Asia-Pacific Regional Audits 2009 & 2013 
 
 Table 2 shows the age-standardised hip fracture rates in some countries in Asia. The data 
show variation in the hip fracture rates; the hip fracture rate is highest in Singapore in females 
and lowest in Japan in both females and males. In both sexes, the rates are higher in Singapore 
and Thailand compared to the other countries.  
 
Interpretation: The data suggest that compared to the other countries, hip fracture rate was 
lowest in Japan because of the good prevention programmes. These include prevention of falls 
and osteoporosis through education appropriate to each age group, guidance on maintenance 
of adequate weight, active intake of calcium, weight-bearing excercises, diet and treatment 
with pharmacological drugs (Orimo, et al 2012). The Ministry of Health, Labour and Welfare 
in Japan has performed osteoporosis screening since 1995 and the number of examinees was 
295,434 in 2006. In 2009, Japan had a total of 10,369 DEXA machines (0.8/10000) which was 
high compared to other countries (MOH of Japan). In 2009, Singapore had a total of 14 DEXA 
machines  with the scanner availability of 0.15/10,000 and Thailand a total of 50 DEXA 
machines with a scanner availability of 0.008/10,000 (Mithal, Lau, 2009). Also, the Japanese 
traditional lifestyle, nutritional habits, genetic differences in body build and more fracture-
resistant bones have been suggested (Fujita, 1994). 
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Table 3: Age-standardised hip fracture rates (per 100,000) in some countries in the Middle 
East 
 
Country Source Age-adjusted 
rates/100,000 in 
females(1995-2013) 
Age-adjusted 
rates/100,000 in 
males(1995-2013) 
Iran Moayyeri et al 2006 165 127 
Lebanon Sibal et al 2011 164-188 88-107 
Saudi Arabia Al Nuaim et al 1995 135 77 
Kuwait Asia Pacific Audit 2013 295 200 
Source: adapted from (Kanis et al., 2012) and the IOF Middle East & African Regional Audit 
2011 
 
 Table 3 shows the age-standardised hip fracture rates in some countries in the Middle East. 
The data show variation: the hip fracture rate is highest in Kuwait, intermediate in Iran and 
Lebanon, and lowest in Saudi Arabia. 
 
Interpretation: The variation in hip fracture rates could be due to: differences in the: 
healthcare delivery programmes, BMD due to vitamin D deficiency, physical activity, body 
build, alcohol intake and data collection methods. (Maaloufet al,2007). Solid epidemiological 
research on osteoporosis and related outcomes is scarce at best; access to densitometry and 
care is limited in many countries often only available in urban centres; reimbursement for 
diagnostic and therapeutics varies widely; the level of awareness of osteoporosis among 
primary healthcare professionals is estimated as poor to medium in many countries; education 
and lifestyle prevention programmes for the general public are generally lacking (Fuleihan, 
Adib 2011). 
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Table 4: Age-standardised hip fracture rates (per 100,000) in two countries in Africa 
 
Country Source Age-adjusted 
rates/100,000 in 
Females(1991-2011) 
Age-adjusted 
rates/100,000 in 
Males(1991-2011) 
Morocco Middle East & Africa 
Regional Audit 2011 
52.1 43.7 
Nigeria Adebajo et al 1991 2 2 
Source: adapted from (Kanis et al., 2012) and the IOF Middle East & African Regional Audit 
2011 
 
 Table 4 shows the age-standardised hip fracture rates in two countries in Africa. The data 
show variations; the hip fracture rate is low in Nigeria and higher in Morocco. 
 
Interpretation: The same explanation for table 3 also holds. West Africa appears to be 
uniquely different with respect to osteoporosis. A study published in Nature reviewed hip 
fracture incidence worldwide and included a chart of age standardised osteoporosis rates. The 
Nigeria values were 2 hip fractures per 100,000 females whereas that of Norway was 532 
(Cauley et al., 2014). A 2-year project conducted by Zebaze and colleagues (Zebaze et al., 
2003) in the West African nation of Cameroon reported a low energy trauma rate for females 
over 35 years at 4.1 per 100,000.  
 
This uniquely low rate did not cause any surprises in the medical community because it was 
theorized as far back as 1966 that Africans did not suffer from post menopausal osteoporosis 
because of short life expectancy, a more active life style than Westerners and lack of medical 
facilities to track and record osteoporosis (Adebajo 1989, Nordin, 1966). But these 
assumptions proved incorrect when osteoporosis rates were compared within regions of Africa 
that shared similar life expectancies and socio-economic conditions.  
 
Genetic tests have shown that Africans have a more efficient process of calcium homeostasis 
compared to European ethnicities despite being low to non-diary consuming (Redmond et al., 
2014), this more than makes up for the reduced calcium intake resulting in low rate of 
osteoporsosis. The preferences for the traditional methods of fracture management may also 
underscore published data (Nottidge, Akpanudo & Akinbami, 2011, Nwadiaro et al., 2008). 
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Table 5: Age-standardised hip fracture rates (per 100,000) in three countries in North and 
South America 
Country Source Age-adjusted 
rates/100,000 in 
Females(2010-2012) 
Age-adjusted 
rates/100,000 in 
Males(2010-2012) 
Columbia Latin America 
Regional audit 2012 
234.9 116.5 
USA Ettinger et al 2010 260 122 
Canada Kanis et al 2012 290 131 
Source: adapted from (Kanis et al., 2012) and the IOF Latin America Regional Audit 2012 
 
 Table 5 shows the age-standardised hip fracture rates in three countries in North and South 
America. Although the data were taken from two different continents, the hip fracture rates are 
comparable.  
 
Interpretation: The hip fracture rates are comparable. In the Latin America Regional Audit of 
osteoporosis in 2012, the organisers reported scarcity of robust data and the lack of national 
databases and fracture registries in many countries in South America (Zanchetta, 2012). 
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Table 6: Age-standardised hip fracture rates (per 100,000) in some countries in Europe 
 
Country Source Age-adjusted 
rates/100,000 in 
Females(2012) 
Age-adjusted 
rates/100,000 in 
Males(2012) 
UK Kanis et al 2012 349 140 
Italy Kanis et al 2012 334 140 
Spain Kanis et al 2012 228 92 
Source: adapted from (Kanis et al., 2012) . 
 
 Table 6 shows the age-standardised hip fracture rates in three countries in Europe. The hip 
fracture rates are comparable in the UK and Italy but lower in Spain. 
 
Interpretation: The hip fracture rate was lowest in Spain. Spain is leading Europe in the 
number of Fracture Liaison Services (FLS) throughout the country. By the end of January 27, 
2017 there were 33 clinics or hospitals listed in the Capture the Fracture (CTF) Map of Best 
Practice, an online map which reflects FLS around the world that have signed up to 
International Osteoporosis International`s (IOF) CTF programme (International Osteoporosis 
Foundation (IOF), 2018). 
 
Summary: Tables 1 to 6 show the regional variations in hip fracture rates. They highlight the 
interactions of multiple risk factors: ageing, cultural and religious practices, dietary influences, 
availability of medical resources, environmental influences and other unidentified factors 
therefore the interpretations for the observations is not simplistic. 
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Wrist fractures show a different pattern of occurrence from hip and vertebral fractures. The 
incidence increases in white women from 45 to 60 years, followed by a plateau. This plateau 
might relate to altered neuromuscular reflexes seen with ageing, which are associated with a 
tendency to fall sideways or backwards, meaning that the fall is not stopped with an 
outstretched arm (Melton, et al 2001). Fracture of the proximal humerus is considered to be 
one of the most important fractures attributable to osteoporosis. In the elderly, it is the third 
most frequent fracture after hip fracture and Colles` fracture (Seeley, et al 1991, Lauritzen, et 
al 1993)  
 
Pelvic ring fractures in the elderly are generally due to relatively trivial trauma and do not, as a 
rule, cause haemodynamic instability, nor are they associated with intrapelvic organ injuries of 
the surrounding soft tissues (Rommens, et al 2017). Burge et al reported that pelvic ring 
fractures in the elderly accounted for 75 of all osteoporosis-associated fractures (Burge, et al 
2007). Andrich et al. reported an incidence of 22.4 osteoporosis-associated fractures per 10, 
000 persons over 60 per year in Germany (Andrich, et al 2015), while a retrospective analysis 
revealed that the incidence of pelvic ring fractures among persons aged 80 or above in Finland 
rose over the 1970 - 1997 from 73 to 364 per 1 000 000 per year. Likewise, Sullivan et al. 
found that the number of pelvic ring fractures among elderly persons in the USA rose by 24% 
(from 26 500 to 33 000) over the period 1993 – 2010 (Sullivan, et al 2014). 
 
 
1.2.3. Secular Trend in the Incidence of Fragility Fractures 
 
Some causes have been suggested for the world-wide secular trends of fragility fractures: 
ageing population, vitamin D deficiency and urbanisation associated with  relative global 
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socioeconomic prosperity. Changes in bone mineral density (BMD) do not appear to play 
major roles in some regions. For example, a study from Sweden showed that between 1970 
and 2001, the age-specific incidence of hip fracture increased by 100% but there was no 
substantial increase in BMD (Ahlborg et al., 2004). Physical inactivity probably due to 
socioeconomic prosperity has been suggested. There is epidemiological evidence linking 
physical inactivity with the risk of hip fracture incidence (Berard, Bravo & Gauthier, 1997). 
Urbanisation has resulted in environmental pollution which blocks the sun rays (specifically 
UVB radiation) required for the synthesis of vitamin D in the skin, contributing to widespread 
vitamin D deficiency in some regions such as Asia ( Mithal 2013). Vitamin D deficiency is 
now recognised as pandemic (Holick et al., 2008). 
 
A systematic review found that in areas where data were available, the prevalence of low 
vitamin D was a problem in all age groups even in countries with sun exposure all year round 
(Palecus et al., 2014). The problem was greater in the Middle East particularly in girls and 
women. There was striking lack of data in most countries of South America and Africa. The 
high prevalence of vitamin D deficiency may be related to several factors such as reduced 
vitamin D photosynthesis in the skin of people with high melamin content or due to ageing, 
use of extensive skin coverage and scarce exposure to sunlight in individuals in Africa, the 
Middle East and Central and South America. 
 
In addition the high rates of obesity worldwide could also have contributed  because vitamin D 
may become `trapped` inside fat tissue so that less of it is available to circulate inside the 
blood (Vanlint 2013). Season appears to be a small cause of the problem as countries with 
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long winters have less deficiency rates overall compared to sunny countries. This is probably 
related to the fortification of staples, comsumption of fatty fish and regular use of vitamin D 
supplements. 
 
Urbanisation has resulted in higher prevalence of harder surfaces on which people fall (Johnell 
et al., 2007). Sudden impact fractures happen when a bone takes a sudden hard hit that puts 
more stress on it than it can handle at once. Urbanisation may partly explain the changes in the 
risk in immigrant populations. For example, the African Americans in USA have lower 
incidence of fractures compared to Caucasians, but the incidence of hip fractures in Blacks in 
the USA is much higher than in African Blacks (Cauley et al., 2008, Cauley et al., 2010). 
Similarly, fracture risk is different in the Japanese population of Hawaii (Ross et al., 1991) and 
Chinese living in Hong Kong and Singapore compared with mainland China (Kanis et al., 
2012).  
 
Fractures incidences have been observed to be higher in colder days and winter seasons 
(Campbell et al., 1988, Nevitt et al., 1993a, Nevitt et al., 1993b, Douglas et al., 2000) but a 5-
year local survey in Pilgrim Hospital, Boston England by this investigator (FI) using the 
National Hip Fracture Database (NHFD) found that 51% of the hip fractures occurred in 
warmer seasons of spring and summer months most likely because of the higher number of 
people   given that east Lincolnshire is a holiday destination  (Royal College of Physicians 
(RCP), 2017a).  
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But the greatest factor in the worldwide increase in fragility fractures is the unprecedented 
increase of the ageing population which has been observed in recent decades. Because of the 
global ageing population, it has been projected that over half of all hip fractures worldwide 
will occur in Asia by 2050 (Lau, Cooper, 1996). The projected increase in the population of 
the elderly and `old old` in some developed countries is presented in Table 7.  From the age of 
65 years, falls, osteoporosis and fragility fractures are common. To put this in context, 
approximately 75% of hip, spine and distal forearm fractures occur in people who are ≥65 
years old.  
 
At the biological level, ageing results from the impact of the accumulation of a wide variety of 
molecular and cellular damage over time. This leads to decrease in physical and mental 
capacity, a growing risk of disease and ultimately death (WHO 2018). Globalisation, 
technological developments, urbanisation, migration and changing gender norms are 
influencing the lives of people directly and indirectly leading to the increasing number of 
surviving generations. 
 
Of the current world population of 7.5 billion, people aged 65 years and above account for 
7.9% (Kanis et al., 2005b).  Life expectancy has increased by about 30 years in many western 
countries during the last century (Christensen et al., 2009, Rossi, Rousson & Paccaud, 2013). 
It is estimated that the population of people aged 80 years and over in Europe will increase by 
between 160% in females and 239% in males in the next few decades (Kanis et al., 2005b).  
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Table 7: Elderly and ‘Old old’ population in some developed countries 
 
Country Elderly (65+) as 
a percentage of 
total 
population in 
1997 
Elderly (65+) as 
a percentage of 
total 
population in 
2025 
‘Old old’ (80+) 
as a percentage 
of total 
population in 
1997 
‘Old old’ (80+) 
as a percentage 
of total 
population in 
2025 
France 15.6 23.7 3.8 6.4 
Sweden 17.5 22.7 4.9 6.8 
United 
Kingdom 
15.8 21.1 4.1 5.8 
Russia 12.5 18.2 2.1 3.4 
Ukraine 14.1 18.1 2.4 3.9 
Romania 12.7 19.5 2.0 4.7 
Australia 12.3 20.4 2.8 5.4 
Japan 15.5 26.8 3.3 8.9 
United States of 
America 
12.7 18.5 3.2 4.3 
Source: adapted from the 2
nd
 edition Oxford Textbook of Geriatric Medicine (Grimley Evans 
et al., 2000). 
 Table 7 shows the percentage of elderly and ‘old old’ in some developed countries. The data 
show that the projected increase will be highest in Japan and lowest in some Eastern European 
countries and USA. 
 
Interpretation: The proportion of people aged 65 years and over and 80 years and over is 
increasing in North America, Europe and Oceania. 
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Over the last 25 years, the number of people aged 85 years and over in the United Kingdom 
has more than doubled to 1.4 million and it is estimated that by 2035, this figure will rise to 
3.5 million with people aged 85 years and over accounting for 5% of the total population 
(Office for National Statistics (ONS), 2014). The number of older Americans is steadily 
increasing and by 2030, 20% of the US population will be aged 65 and older (National Center 
for Health Statistics (NCHS), 2004).  In Asia, a 7.6-fold increase in elderly is predicted 
between 2000 and 2050 (Mithal, Lau E, 2010). In 2000, approximately 46% of men aged 80 
years and older were from Asia, this is projected to rise to 60% by 2050. The population over 
age 60 years in sub-Saharan Africa (50 countries) will increase by 90% between 2006 and 
2030; older people currently account for less than 5% (Kinsella, 1993). The projected increase 
in the population of older people in some developing countries is shown in Table 8.  
 
A recent study showed that there is more than 50% probability that by 2030, national female 
life expectancy will supersede the 90-year barrier, a level that was deemed unattainable at the 
turn of the 21st century (Kontis et al., 2017).  The forecast is that life expectancy will be 
highest in South Korea, some western countries and some emerging economies. The World 
Population Prospects: The 2017 Revision, published by the United Nations Department of 
Economic and Social Affairs (United Nations 2017), provides a comprehensive review of 
global dermographic trends and prospects for the future. Among the ten largest countries 
worldwide, Nigeria is growing most rapidly. Consequently, the population of Nigeria, 
currently the world`s 7
th
 largest, is projected to surpass that of the United States of America 
and become the third largest country in the world shortly before 2050. 
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Table 8: Proportion of persons aged 60 years and over in four developing countries 
Countries Year 
1970 
Year 
1995 
Year 
2020 
China 6.8 9.3 15.5 
Brazil 5.3 7.7 13.5 
India 5.9 7.2 11.0 
Zimbabwe 4.2 4.3 6.2 
Source: adapted from the 2
nd
 edition Oxford Textbook of Geriatric Medicine (Grimley Evans 
et al., 2000). 
 
 Table 8 shows the proportions of persons aged 60 years and over in four countries. The data 
show that the projected increases are comparable in China, Brazil and India and lowest in 
Zimbabwe.  
 
Interpretation: Within the next decade, countries in Asia and South America will experience 
an increase in the proportion of the ageing population. There will also be an increase in 
African countries but this will be slower. According to data from recent population 
predictions, the number of older persons – those aged 60 years or over – is expected to more 
than double by 2050 and to more than triple by 2100, rising from 962 million globally in 2017 
to 2.1 billion in 2050 and 3.1 billion in 2100. Globally, population aged 60 or over is growing 
faster than all younger age groups. 
 
Currently, Europe has the greatest percentage of population aged 60 or over (25 per cent). 
Rapid ageing will occur in other parts of the world as well, so that by 2050 all regions of the 
world except Africa will have nearly a quarter or more of their populations at ages 60 and 
above (United Nations 2019). 
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Compared to 2017, the number of persons aged 60 or above is expected to more than double 
by 2050 and to more than triple by 2100, rising from 962 million globally in 2017 to 2.1 
billion in 2050 and 3.1 billion in 2100. In Europe, 25% of the population is already aged 60 
years or over. That proportion is projected to reach 35% in 2050 and to remain around that 
level in the second half of the century. Populations in other regions are also projected to age 
significantly over the next several decades and continuing through 2100. Africa, for example 
which has the youngest age distribution of any region, is projected to experience a rapid 
ageing of its population. 
 
Although the African population will remain relatively young for several decades, the 
percentage of its population aged 60 or over is expected to rise from 5% in 2017 to around 9% 
in 2050, and then to nearly 20% by the end of the century. Globally, the number of persons 
aged 80 or over is projected to triple by 2050, from 137 million in 2017 to 425 million in 
2050. By 2100 it is expected to increase to 909 million, nearly seven times its value in 2017.  
Population ageing is projected to have a profound effect on societies, underscoring the fiscal 
and political pressures that the health care, old-age pension and societal systems of many 
countries are likely to face in the coming decades. The underlying causes of fragility fractures 
in the ageing population can be divided into two: trauma and weakness in bone strength.  This 
will be the subject of the next narrative. 
 
1.2.4 Causes of Fragility Fractures  
The key causes of fragility fractures are falls (Cummings, Melton, 2002) and compromised 
bone strength (Cummings, Black, 1995, Grisso et al., 1991a, Grisso et al., 1991b, Cummings, 
Faulkner & Cauley, 1993) and both are common in care home residents (Kron M et al 2003). 
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Bone strength depends on the bone mass (BMD) and bone quality which in turn depends on a 
variety of the qualitative aspects of bone structure. Bone quality describes aspects of bone 
composition and structure that contribute to bone strength independently of BMD. These 
include bone turnover, microarchitecture, mineralisation, micro-damage and composition of 
the bone matrix (Compston, 2006).  
 
A systematic review and meta-analysis on risk factors for falls in community-dwelling older 
people identified a total of 74 studies (Deandrea et al., 2010).  The strongest associations were 
found for history of falls (OR was 2.8 for all fallers and 3.5 for recurrent fallers), gait 
problems (OR2.1), walking aids use (OR2.2), vertigo (OR1.8), Parkinson`s disease (OR2.7) 
and antiepileptic drug use (OR1.9).  For other factors, the ORs were moderately above 1 and 
the ORs were generally higher for recurrent fallers than for all fallers.  
 
A systematic review and meta-analysis for risk factors for falls in nursing homes residents 
(NHR) and hospitals inpatients (HI) found the following: for NHR, the strongest associations 
were history of falls (OR3.06), walking aid use (OR2.08), and moderate disability (OR2.08). 
For HI, the strongest association was found for history of falls (OR2.85). No association was 
found with age in NHR (OR1.00) while the OR for a 5 years increase in age of HI was 1.04. 
Female sex was associated with decreased risk (Deandrea et al., 2013).  Although dementia 
was not specifically mentioned as a risk factor in the two systematic reviews, the risk factors 
which were identified are directly or indirectly associated with dementia 
 
25 
 
The risk factors for bone strength can be sub-divided into two: non-modifiable and modifiable. 
Modifiable risk factors are those that can be treated or modified by appropriate intervention, 
whereas the non-modifiable factors cannot be altered by any intervention. The evidence base 
for the list reported here is from the systematic literature review by the Scottish Intercollegiate 
Guideline Network (Scottish Intercollegiate Guidelines Network (SIGN), 2015) and meta-
analyses (Kanis et al., 2005a).  
 
The non-modifiable risk factors are age, gender, ethnicity, previous fracture, family history of 
fragility fractures and reproductive factors (age at menarche of 16 years and over and early 
natural menopause before the age of 45 years). The potentially modifiable risk factors are: 
bone mineral density (BMD), alcohol intake, weight, smoking, and physical inactivity; 
coexisting diseases: diabetes mellitus, inflammatory rheumatic diseases, gastrointestinal 
diseases, cystic fibrosis, epilepsy, human immunodeficiency virus, primary 
hyperparathyroidism and other endocrine diseases, chronic liver disease, neurological 
disorders (Alzheimer’s, Parkinson`s disease, stroke), depression, chronic kidney disease and 
asthma; pharmacological factors: anticoagulants, antidepressants, anticonvulsants, 
antipsychotics, aromatase inhibitors and tamoxifen, beta-blockers, benzodiazepines, hormonal 
contraception, gonadotropin-releasing hormone agonists, loop diuretics, acid suppressive 
drugs, statins, glucocorticoids, and antidiabetic agents.  
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1.2.4.1 Assessment of Bone Mineral Density (BMD) 
 
T-scores have been traditionally used to define BMD. It is a measure of how closely bone 
density compares to that of an average 30-year old female (Meeta et al. 2013). The World 
Health Organisation (WHO) considers the following scores as the standard: 
 T-score above -1 is considered normal bone mass 
 T-score between -2.5 and -1 is low bone mass (also called osteopenia) 
 T- score between -2.5 and below is considered osteoporosis 
 T-score between -2.5 and below with a history of a fracture is considered severe 
osteoporosis 
. 
The original intention of WHO was to choose a threshold that would make osteopenia and 
osteoporosis uncommon at the time of the menopause, on the assumption that bone loss began 
at that time. Thus the diagnostic threshold of a T-score between -1 SD and -2.5 SD was 
anticipated to capture 50% of the population. It is now evident that bone loss occurs from the 
proximal femur at a much earlier age (Melton, et al 2009). The other measure which has been 
largely ignored is the Z-score which compares bone density with people of the same age and 
sex and is a more realistic assessment as it compares “apples to apples”   
 
Osteoporosis is a condition characterised by a reduction in bone mass and density and 
increases the risk of fracture when a person falls. Osteoporosis has been dubbed the `silent 
epidemic` as it can often goes unnoticed until a fracture occurs. Osteoporosis is the most 
common metabolic bone disease and it affects up to 40% of postmenopausal women (Ray et 
al., 1997). The reference value is the NHANES III reference database for femoral neck 
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measurements in women aged 20-29 years (Looker et al., 1997). The NHANES is a 
population-based survey by the Centers for Disease Control and Prevention in the USA 
designed to collect information on the health and nutrition of the US household population. 
NHANES uses a stratified multistage and cluster sampling design to obtain a representative 
sample of the non-institutionalised civilian US population which involves detailed home 
interview and  health examination conducted in a mobile centre. Beginning in 1999, the 
NHANES became a continuous annual survey rather than the periodic survey that it had been 
in the past (Centers for Disease Control and Prevention (CDC), 2001). 
 
BMD using dual-energy absorptiometry (DEXA) scan is the current gold standard for the 
diagnosis of osteoporosis. But over 50% of women who sustained fragility fractures have 
BMD above the WHO-definition of osteoporosis (Nguyen et al., 2007b). Given the limitations 
of BMD in fracture prediction, molecular markers of bone metabolism known as bone 
turnover marker (BTM) have been suggested as novel tools which detect the dynamics of bone 
remodelling to complement the measurement of BMD in the detection and management of 
fragility fractures.  
 
The adult skeleton is continuously remodelled; old bone is removed by osteoclasts and new 
bone is formed by osteoblasts. During skeletal growth, bone formation exceeds bone 
resorption resulting in net gain of bone. However, later in life bone resorption exceed 
formation particularly among oestrogen-deficient postmenopausal women and all older 
individuals. Prolonged bone loss leads to low BMD and eventually osteoporosis (Bauer 2019).  
BTMs are grouped into two based on the metabolic phase of bone: bone formation markers 
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and bone resorption markers. Detailed discussion of BTMs is beyond the remit of this thesis. 
Fragility fractures may result in adverse health outcomes to individuals and society and the 
impact will be the focus of the next discussion. 
 
1.2.5 Costs and Health Impact of Fragility Fractures 
Fragility fractures are associated with high morbidity and mortality (Cummings, Melton, 2002, 
Lips et al., 1997) and because its human and societal cost is projected to increase with the 
ageing population, the World Health Organisation (WHO) requested the Director-General to 
formulate a global strategy for the prevention of this disease (Johnell et al., 2005). 
 
1.2.5.1 Morbidity Associated with Fragility Fractures 
Hip fracture is the most serious type of fragility fracture taking up an average of  1.5 million 
bed days each year, which equates to more than 4,000 NHS beds (RCP, 2016). About 19% of 
orthopaedic beds were occupied by patients with fractured hip in 2016 (Moran, et al 2018).   
The number of bed days for hip fracture patients in Canada is predicted to increase from 
465,000 in 1993/94 to 1.8 million by 2041 (Chen et al., 2009).  Hip fractures account for 
substantial hospital admissions in the USA, of which 140,000 are nursing home admissions 
(Melton, 2003); this is projected to increase to 289,000 by 2030 (Stevens, Rudd, 2013).  The 
degree of morbidity is related to age and the type of fracture. Chrischilles and colleagues 
showed that following hip fracture, 14% of patients aged 50 to 55 years were discharged to 
care homes compared to 55% of patients aged 90 years and above (Chrischilles et al., 1991). 
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A case-control study showed that hip fracture patients were 4.2 times more likely to be unable 
to function in the wider community two years after the fracture and 2.6 times more likely to be 
functionally dependent than controls (Norton et al., 2000). A report from Northern Sydney 
area in Australia showed that after 12 months’ follow-up of community dwelling patients who 
had hip fractures, 76 % were unable to walk as well as before their fracture and 22% required 
nursing home admissions (March, Chamberlain & Cameron, 1996). 
 
A meta-analysis on the long-term disability of hip fractures showed that 20% of the 
participants with a fracture were no longer able to shop independently and 42% had not 
returned to their pre-fracture mobility levels after a year (Bertram et al., 2011). One 
prospective study showed that only 8% could climb stairs compared with 63% before the 
fracture and 6% could walk half a mile compared with 41% before the fracture (Marottoli, 
Berkman & Cooney, 1992). A cause of the excess morbidity is new osteoporotic fractures 
which occur at a rate of 10.4 per 100 patients per year; this is 2.5 times as high as the rate in 
age-matched persons without previous hip fractures (Colon-Emeric et al., 2003a).   
 
Some studies have demonstrated impairment of health status in patients with vertebral 
fractures (Pluijm et al., 2000, Cook et al., 1997). Osteoporotic specific questionnaires showed 
decreased quality of life in patients with vertebral fractures compared with controls and the 
quality of life decreased with increasing number of prevalent vertebral fractures. Men have 
greater functional impairment from vertebral deformities compared to women (Burger et al., 
1997). The Quality of Life Questionnaire of the European Foundation for Osteoporosis 
(QUALEFFO) is the most frequently used questionnaire for measuring health related quality 
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of life of patients with osteoporosis and vertebral fracture (Oleksik et al., 2000). The total 
QUALEFFO score is calculated as the sum of all the responses and then linearly transformed 
in the scale 0 to 100. The higher the score, the worse the health related quality of life 
(HRQOL). 
 
The impact of spinal fractures appears to be greater with lumbar fractures compared to 
thoracic fractures (Pluijm et al., 2000, Cook et al., 1997). Patients with three thoracic fractures 
had a mean score of 35.6 ± 19.7, three lumbar fractures had a mean score of 53.2± 15.8, and 
people without fracture had a mean score of 25.6 ± 14.3 (Silverman et al., 2004). In contrast to 
fractures of the spine and hip, wrist fractures do not seem to be associated with increased 
morbidity. Although wrist fractures can impact some activities such as writing or meal 
preparation, few patients are completely disabled, despite overall reporting only fair-to-poor 
function at 6 months post fracture (Chrischilles, et al 1991). 
 
The morbidity associated with fracture of the proximal humerus is quite substantial, with 
functional capacity impaired for activities of daily living for an average of 2- 3 months. The 
long-term functional outcome is satisfactory in 80% of patients after a simple humeral fracture 
without displacement (Clifford, 1980). Nevertheless, displaced proximal humeral fractures 
may require hospitalisation and generally lead to long-term functional deficit (Mills, et al 
1985). These cases require a mean hospitalisation length of 24 days, second only to hip 
fractures in the number of hospital days it causes (Lippuner, et al 1997). Fragility fractures of 
the pelvic ring in the elderly cause immobility and markedly impair quality of life 
(Oberkircher, et al 2018). 
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In a cohort of 10,000 50-year old white postmenopausal women, 7% of all survivors of 
fragility fractures had some degree of personal disability, 8% required long term institutional 
care,  50% experienced functional decline and  50% who were previously independent were 
disabled (Chrischilles et al., 1991).  
 
Pain is present in many fractures, this is universal and it is a major impediment to recovery in 
hip fractures (Morrison et al., 2003). For a typical economy in the developed countries, the 
occupied bed days for patients 75 years and over with pain due to fractures are high and dwarf 
the combined numbers of heart attack, acute coronary syndrome and stroke (National 
Osteoporosis Society (NOS), 2013). One meta-analysis showed that assuming no pain prior to 
a hip fracture, 47% of patients reported pain one or more years post fracture,  23% reported 
mild pain, 24% moderate pain and 2% severe pain (Bertram et al., 2011).  
 
Symptomatic vertebral fractures account for 52,000 and 2,180 hospital admissions each year 
in America and UK respectively and may result in spinal deformities (Cooper, Campion & 
Melton, 1992). In 2007, hospitalisation for osteoporotic fracture in Australia averaged 262 per 
day, or one person every 5-6 minutes (Fazzalari N, 2009). The proportions of hospital 
admissions due to heart attack, stroke, breast cancer and osteoporotic fractures are shown in 
figure 1. Consistent with the ageing population in the UK, the numbers of fracture neck of 
femur has increased (table 9). This has resulted in higher numbers of admissions for the 
condition and increase in the length of stay.  
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There has been a worldwide campaign to prevent cardiovascular disease (Go Red for women, 
WHO global health days and others) and cancer (Cancer Awareness Month, Blood Cancer 
Awareness, Breast Cancer Now and others) but not as much for fragility fractures which has a 
higher incidence. The data above support the need for the intensification of the current efforts 
at prevention of this global epidemic which deserves more publicity 
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Source: reproduced with the kind permission of the International Osteoporosis Foundation 
(IOF) (Singer et al. 2015). 
 
 
Figure 1: Proportions of hospital admissions for stroke, heart attack, breast cancer and 
osteoporotic fractures in more than 1000 participating hospitals in the USA  
 
Figure 1 shows the proportions of hospital admission contributed to by stroke, heart attack, 
breast cancer and osteoporotic fracture over a 12-year study period from 2000 to 2011. There 
were 4.9 million hospitalisations for osteoporotic fractures (43%), 2.9 million for heart attack 
(25%), 3.0 million for stroke (26%) and 0.7 for breast cancer (6%). Osteoporotic fracture 
accounted for the majority of the admissions with age adjusted outcome rate of 1124 
admissions per 100,000 person years (Singer et al., 2015). 
 
 
Interpretation: Osteoporotic fractures were more common causes of hospital admission 
compared to stroke, heart attack and breast cancer in the study.  
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Table 9: Number of hip fractures and length of stay in Pilgrim Hospital 
 
Calendar 
Year 
 Number 
of hip 
fractures 
in 
England 
& Wales 
 Number 
of hip 
Fractures 
at Pilgrim 
Hospital 
Number of 
patients with 
hip fracture 
from care 
home at 
Pilgrim 
Hospital (%) 
Average length 
of stay in days 
for community-
dwelling 
patients at 
Pilgrim 
Hospital 
Average length 
of stay in days 
for patients 
from care home 
at Pilgrim 
Hospital 
2011 46675 270 63(23.3) 17 19.8 
2012 64580 337 63(18.6) 14.7 13 
2013 67631 340 61(17.9) 12 11.5 
2014 65160 349 53(15.4) 16.3 11.4 
2015 65518 318 61(19.2) 16.2 16.2 
2016 65700 336 70(21) 13.2 14.3 
Source: adapted from the National Hip Fracture Database (NHFD), Royal College of 
Physicians  (RCP), 2017b. 
 
 Table 9 shows that between 2011 and 2016, the incidence of hip fractures increased by  
20,000 nationally and 66 locally. At Pilgrim hospital, care home residents accounted for 19% 
of fracture neck of femur admission. The average lengths of stay for community dwelling 
people and care home residents were 14.9 and 14.4 days respectively. 
 
Interpretation: The number of hip fractures increased by about 42% nationally and 24% 
locally. Care home residents made up about a fifth of the fracture neck of femur admission at 
Pilgrim Hospital. The length of stay for both the community dwelling and care home residents 
were substantial given that for any medical condition, the average was 4.7 days in Scotland, 
7.5 days in Wales (Karakusevic, 2016) and 9 days in Canada (Canadian Institute for Health 
Information (CIHI), 2011).  
 
The NHFD is a National Clinical Audit which was established in 2007 as a joint venture of the 
British Geriatics Society (BGS) and the British Orthopaedic Association (BOA) designed to 
facilitate improvement in the quality and cost effectiveness of hip fracture care in England, 
Wales and Northern Ireland. The first website data entry was in 2007 and the first preliminary 
National report was in 2009 and approximately 19% of cases were reported, in 2010 
approximately 54% of cases were reported, in 2011 approxitaely 76% of cases were reported.  
 
In 2011, there were 176 data reports from the 191 participating hospitals. However in 2012, 
there were 188 participating hospitals  and 95% of cases were reported and since then the 
average proportion of reports has been about 95%. This explains the increase in the national 
number reported between 2011 and 2012 and the plateaux of the figures since then. The 
increase in the number reported at Pilgrim Hospital suggests that the data collection was 
incomplete. This coincided with the visit of the Care Quality Commission (CQC) to the 
Hospital resulting in the drastic reorganisation of services in all the departments. Follwing this 
Pilgrim Hospital subquently went on to be the best Hospital in the country for the management 
of hip fractures for 2 sucessive years; 2012/13, and 2013/2014 (appendix S).  
35 
 
1.2.5.2 Mortality Associated with Fragility Fractures 
Fragility fractures are associated with increased mortality. Hip fractures are particularly 
ominous because they are associated with the worst health outcomes and they account for the 
greatest burden of osteoporotic fractures (Cooper et al., 1993).  A population based study from 
Rochester, Minnesota, USA showed that survival following hip fractures after 5 years was 
about 80% of aged-matched general population without fracture which may persist for up to 
10 years before returning to general population mortality rates (Bliuc et al., 2009).  
 
Hip fractures are associated with 3-month mortality of 5% to 27% (Todd et al., 1995) and a 
peak 12-month mortality of 15% to 19% for women and 25% to 35% for men (Magaziner et 
al., 1989, Forsen et al., 1999). No single factor or aspects of practice accounted for the 
differences in mortality observed but the following were the possibilities: casemix factors, 
nutritional status of the patients, multimorbities, cumulative effects of several aspects of the 
organisation of treatment and the management of fracture of the hip including thromboembolic 
prophylaxis and early mobilisation. Men have a 2-fold excess mortality following hip fracture 
within the immediate post-fracture period (Cooper, Campion & Melton, 1992); death is mostly 
due to underlying medical conditions (Boonen et al., 2004, Magaziner et al., 2000, Hannan et 
al., 2001) but one study showed that 24% of the deaths were related to the hip fracture itself 
(Kanis et al., 2003). 
 
Worldwide an estimated 740,000 deaths annually are associated with hip fractures and the 
total life years lost from hip fractures was 951,000 years (Johnell, Kanis, 2004). Of these 67% 
were women with 50% occurring in developed countries (Western Europe, North America, 
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Japan and Australia). In the USA, around 31,000 excess deaths occur within 6 months of 
approximately 300,000 hip fractures annually (Anonymous, 1993). In the UK, survival post 
hip fracture for men is 63.3% compared to 90.0% for aged-matched males, and 74.9% 
compared to 91.1% for aged-matched females (Van Staa et al., 2001).  Fewer than half of 
death were attributable to the fracture, the rest were a combination of fall and fracture bringing 
to light underlying ill-health (NICE 2009). These findings prompted the formation of the 
collaborative intiatives NHFD and the Blue Book (The British Orthopaedic Association 2007). 
The advantages of thses collaborative approaches are: 
 Improvement in the overall standard of medical care 
 Minimal delay to surgery due to medical problems 
 Improved management of perioperative medical complications 
 Better coordination of multidisciplinary team work 
 Improved communication with patients and relatives 
 Reduction in adverse outcomes 
How to deliver these objectives are set out in the Blue Book (The British Orthopaedic 
Association, 2007). 
 
The mortality after hip fracture is higher in institutionalised patients (Hannan et al., 2001, 
Brauer et al., 2009, Eastwood et al., 2002). A case-control study of 2005 elderly people in 
residential homes in Australia showed that mortality was initially the same within one year of 
surgery but after adjusting for sex, gender, type of institution, weight, immobility, cognition, 
comorbidities and the number of medications, the mortality was higher than in the control 
group. The hazard ratio (HR) post hip was 3.09 three months after surgery, 1.99 at between 
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three and nine months and 0.88 at more than nine months following surgery (Cameron et al., 
2009).  Table 10 shows the 30-day mortality of patients with fracture neck of femur in Pilgrim 
Hospital.  The average 30-day mortality rates for care home residents, community dwelling 
patients in Boston and the national average for patients with fracture neck of femur from 2011 
to 2015 were 9.3%, 8.5% and 7.5% respectively (Royal College of Physicians (RCP), 2017a).  
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Table 10: Mortality of fracture neck of femur in Pilgrim Hospital, Boston, UK 
 
Calendar 
Year 
Total NOF 
(n) 
30-day mortality of 
patients from 
community  
30-day mortality 
patients from care 
homes  
National 
average 30-day 
mortality  
2011 366 13.5 11.1 7.7 
2012 328 7.4 14.3) 8 
2013 353 7.6 3.3 7.6 
2014 317 6.6 11.3 7.3 
2015 350 7.5 6.6 7.1 
Average 30-day 
mortality 
8.5 9.3 7.5 
Source: adapted from the National Hip Fracture Data Base (NHFD), Royal College of 
Physicians (RCP), 2017b. Neck of femur (NOF). 
 
Interpretation:  Table 10 shows that the average 30-day mortality rate for care home 
residents (9.3%) was higher than that of the community dwelling people (8.5%) and the 
national average (7.5%).  
The marked reduction in the 30-day mortality in community dwelling older patients in 2011 
and 2012 were due to the reorganisation of hip fracture services in 2011 following the CQC 
visit; Pilgrim hospital subsequently emerged as the best hospital in the UK for the 
management of hip fractures for 2 years in sucession 2012/13 and 2013/14 
(http://wwwbostonstandard.co.uk appendix S).; the introduction of  the Best Practice Tariff 
(BPT) which served as an incentive because the United Lincolnshire NHS Trust was 
experiencing severe financial difficulties at the time and lastly good intermediate care 
services. Admission avoidance by a hospital-at-home service is associated with a reduction in 
mortality, increased patient satisfaction and can reduce hospital use by 14 days (Shepperd et al 
2008). 
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Studies have also shown premature mortality after non-hip fractures (vertebral, pelvis, distal 
femur, proximal tibia, proximal humerus, multiple ribs.) across all age groups (Center et al., 
1999, Kado et al., 1999). For vertebral fractures, this persists for up to 5 years in both sexes 
(Cooper et al., 1993, Bliuc et al., 2009). In the UK General Practice Research Database 
(GPRD) study, the survival 12 months after vertebral fracture was 86.5% compared to 93.6% 
of aged-matched general population without fracture; after 5 years, survival decreased to 
56.5% compared to 69.9% expected (Van Staa et al., 2001). Some studies have shown that the 
presence of multiple vertebral fractures increases the risk of death (Center et al., 1999, Kado et 
al., 1999, Jalava et al., 2003).There is no excess mortality following distal forearm fractures 
except in elderly men (Johnell, Kanis, 2004, Cooper et al., 1993, Center et al., 1999). The one-
year mortality of osteoporotic pelvic fractures range from 9.5 % to 27% (Oberkircher, et al 
2018).  
 
The risk factors for osteoporotic fractures (osteoporosis and falls) are also independently 
associated with significant mortality and morbidity. For example, for each standard deviation 
(SD) decrease in bone mineral density (BMD), the mortality risk increases by approximately 
1.5 fold (Cooper et al., 1993, Center et al., 1999, Cauley et al., 2000) and falls are a major 
cause of mortality in older people aged over 75 years (Health Education Authority 1999, 1999, 
United States Centers for Disease Control and Prevention (CDC), 2012). 
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1.2.5.3 Economic Impact of Fragility Fractures 
The financial cost of fragility fractures is substantial. Cost rises progressively with age. 
Worldwide in 1990, the estimated cost was $34.8 billion; this is projected to rise to $131.5 
billion (at an average cost of $21,000 per patient) by 2050 (Johnell, 1997).  Costs vary 
worldwide. The direct medical expenditure for osteoporotic fractures in Europe was estimated 
at €36 billion annually, of this, half was accounted for by hip fractures and the cost is expected 
to double by 2050 (Kanis et al., 2005a). Hip fractures account for the highest proportion of the 
burden because of the longer period of hospitalisation, rehabilitation and post admission care 
(de Laet et al., 1996). 
 
In the United States of America (USA), in 1990, an estimated $35 billion was spent on 
fragility fractures, this is set to rise to $131 billion by 2050 (Johnell, 1997). In 1995, the 
expenditure was $13.8 billion of which $48.7 billion was attributable to hip fractures (Ray et 
al., 1997). In Canada, the annual cost for hospitalisation due to hip fractures was estimated at 
$337.5 million (Goeree, O`Brien & Pettit, 1991). In Holland hip fractures accounted for about 
85% of all fracture costs (de Laet et al., 1996). 
 
Direct medical costs for fragility fractures to the UK healthcare economy was estimated at 
£1.8 billion in 2000, (i.e. approximately £6 million per day) with the potential to increase to 
£2.2 billion by 2025, most of these costs related to hip fracture care (Burge et al., 2001, 
Torgerson, Dolan, 2000). Table 11 shows the financial impact of hip fractures at Pilgrim 
Hospital, Boston for three consecutive years. The cost of one hip fracture was approximately 
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£14,000 including consumables. In 2011/12, the total cost of fracture neck of femur was 
nearly equal the combined cost for stroke and ischaemic heart disease. 
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Table 11: Cost of fracture neck of femur, stroke and ischaemic heart disease in Pilgrim 
Hospital. 
 
 Pound 
Sterling in 
2011/12 
Pound Sterling 
in 2013/14 
Pound Sterling 
in 2014/15 
Average 
Fracture neck of 
femur 
7,314,252 .5 2,230,232.8 1,759,575.9 3,768,020.4 
Stroke 
 
4,672,705.8 3,644,692.4 3,230,658.2 3,849,352.1 
Ischaemic heart 
disease 
670,269.11 670,269.11 760,939.17 700,492.5 
Source: Accounts Department of the United Lincolnshire Hospitals NHS Trust (ULHT 2017) 
 
 Table 11 shows that the financial burden was substantial in the three financial years. The data 
show that the financial impact of fracture neck of femur was much higher than ischaemic heart 
disease and comparable to that of stroke. 
 
Interpretation: The average expenditure for fracture neck of femur (£3,768,020.4) was 
comparable to the combined average for stroke and ischaemic heart disease (£2,274,922.3). 
This is substantial given the financial challenges of United Lincolnshire Hospital Trust 
(ULHT). The budget deficit was £73 million in 2016/17 (United Lincolnshire Hospitals NHS 
Trust (ULHT), 2017).  
There was a marked drop in expenditure for fracture neck of femur in 2013/14 and 2014/15. 
The possible explanations were the reorganisation of hip fracture services following the CQC 
visit in 2011/12 which resulted in identification of financial leakages and financial prudency. 
Following this, Pilgrim Hospital was adjudged the best hospital in hip fracture management in 
the UK for 2 sucessive years 2012/13 & 2013/14. (Appendix S) It is noticeable that the 
financial expenditure for stroke and ischaemic disease services did not change remarkably 
duration the same period 
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Countries in Asia have also incurred substantial costs in managing fragility fractures. In 
Chongqing, China, the average cost of hip fracture which was 3603 USD in 2007 has 
increased at a rate of 6% annually and it is estimated that by 2020, the average cost will rise to 
7600 USD. In 2006, the Government of China spent 1.5 billion USD on hip fractures and 
estimates for 2020 and 2050 are 12.5 USD and 264.7 billion USD respectively (Mithal, Lau, 
2009). The average hospital stay for hip fractures in Japan was 48.4 days in 2001; the inpatient 
costs including nursing care increased by between 6.34 USD and 7.58 billion USD by 2002. In 
Australia, the estimated cost of all osteoporotic fractures from 2000 to 2001 was 7.5 billion 
per annum (Australian Dollars) representing 1.2% of the Gross Domestic Product (GDP). The 
management of hip fractures accounted for 63% of the total healthcare expenditure (Polder et 
al., 1998). The costs of managing fragility fractures are also high in other countries in Asia 
such as the Republic of Korea, Malaysia, and Pakistan (Mithal, Lau E, 2010). 
 
The cost of a hip fracture in Brazil is estimated at 3987 USD per patient with an average 
length of hospital stay of 11 days (direct cost is 12,000 USD in private hospitals). In Chile the 
direct hospital cost for treating a hip fracture is estimated at between 2000 USD and 7000 
USD depending on whether the fracture is treated in a public or private healthcare setting 
(Society of Osteoporosis (SCHOMM), the length of hospitalisation for a hip fracture is 5 to 7 
days with an average loss of wages of 45 days. The direct hospital cost of treating a hip 
fracture in Columbia is 6457 USD with an average hospital bed stay of 10 days. There are also 
indirect costs to the patient and families such as productivity loss associated with care 
(Zanchetta, 2012). As hip fractures predominantly occur in elderly people after the age of 80 
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years (Jones et al., 1994), the ageing population worldwide will experience increase in the 
number of hip fractures (Melton, 1993).  
 
Vertebral fragility fractures seldom lead to hospitalisation. In Europe about 8% of vertebral 
fractures are admitted, in the UK about 2% are admitted (Finnern, Sykes, 2003). The 
admission rate in Sweden is higher with 10% for women and 15% for men. The cost of each 
hospital stay is about €3,900.  This represents about 48% of the cost of a hip fracture (Finnern, 
Sykes, 2003). A cost analysis of symptomatic vertebral fractures in UK estimated the average 
additional health cost for the year prior and post-diagnosis was £165 for General Practitioner 
consultation, £134 for referrals and £2,314 for hospital admission i.e. a total of £2,612 
compared to an estimated age-weighted cost of £771 in 1999-2000 (Kanis, 2002a). 
 
1.2.5.4 Disability Adjusted Life Years (DALYs) Lost due to Fragility Fractures 
The morbidity, mortality and cost incurred for fragility fractures can be expressed as the health 
burden which is the Disability Adjusted Life Years (DALYs) lost ie the quality of life lost 
(Johnell, Kanis, 2006). This is in contrast to the quality adjusted life years gained (QALY) ie 
the same quality of life gained although both DALY and QALY are measurements used in 
order to calculate time (in terms of life years) of an individual or a general population.  
 
DALY is a metric used to estimate health loss due to disease, injuries and risk factors by age, 
sex and geography for time points. DALY is the most comprehensive effort which captures 
the mortality, morbidity and their relative importance. It quantifies health loss by combining 
premature death and non-fatal health outcomes (Murray et al., 2012). It is a measure of utility 
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and disutility and the favoured method by the WHO and the World Bank to assess the 
disability incurred by diseases including death and disability that arise in the survivors. It 
allows a method for the direct comparison of burden between different diseases. For fragility 
fractures, it integrates the years lost because of fracture and the disability in those who 
survive. A life lost equals one DALY (1=death, 0=perfect health). If the quality of life is 
halved by a fracture then that is 0.5 DALY. 1 DALY can be thought off as one lost year of 
health life.  
 
Osteoporotic fractures account for a significant burden worldwide (Johnell, Kanis, 2006). 25% 
of the global burden from osteoporotic fractures occurs from hip fracture. In 2000, there were 
about 9 million fragility fractures worldwide of which 1.6 million were hip, 1.7 million 
forearm and 1.4 million clinical vertebral fractures. The total DALYs lost was 5.8 million 
accounting for 0.83% of the global burden of non-communicable disease and 1.75% in Europe 
(Johnell, Kanis, 2006). In the Americas and Europe, osteoporotic fractures account for 2.8 
million DALYs annually (Anonymous. 2003). In Europe apart from lung cancer, fragility 
fractures accounts for more DALYs lost compared to common cancers (Johnell, Kanis, 2006). 
 
The QALY concept allows combining the effects of health interventions on quantity and 
quality of the remaining life years into a single index. QALYs are calculated by multiplying 
the length of time spent in a certain health state by the utility score associated with it (Shepard 
1999). The incremental cost-effectiveness ratio (ICER) is a statistic used in cost-effectiveness 
analysis to summarise the cost-effectiveness of a health care intervention. It is defined by the 
difference in cost between two possible interventions, divided by the difference in their effect. 
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It represents the average incremental cost associated with 1 additional unit of the measure of 
effect. The ICER can be used as a decision rule in resource allocation. If a decision-maker is 
able to establish a willingness-to-pay value for the outcome of interest, it is possible to adopt 
this value as a threshold. If for a given intervention the ICER is above this threshold it will be 
deemed too expensive and thus should not be funded, whereas if the ICER lies below the 
threshold the intervention can be judged cost-effective. This approach has been adopted in 
relation to QALYs; for example, the NICE adopts a nominal cost-per-QALY threshold of 
£20,000 to £30,000 (Appleby, et al 2007). For fragility fractures, the assessment of 
osteoporosis with dexascan and treatment with most of the osteoporotic medications fall below 
this threshold. 
 
1.2.5.5 Carer`s Stress due to Fragility Fractures 
Carer`s stress or care-giver stress is a complication of any long term medical condition on the 
carers. The term can be used interchangeably with carer`s burnout (Hamilton, 2011). It is a 
condition that strongly manifests exhaustion, anger, rage, or guilt resulting from unrelieved 
caring for a chronically ill patient. Although it is not listed in the Diagnostic and Statitical 
Manuel of Mental Disorders, the term is often used by many healthcare professionals. It 
comprises three components: emotional exhaustion – the depletion of emotional resources and 
a diminution of energy; depersonalisation (negative attitudes and feelings, insensitivity and a 
lack of compassion towards those who receive the service or care) and personal 
accomplishment (negative evaluation of one’s work, which is usually associated with feelings 
of reduced competence and ineffectiveness) (Maslach, Jackson & Leiter, 1986).   
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It manifests in many ways: feelings of frustration, tiredness, anxiety, depression, ill health, 
poverty anger, guilt, loneliness, exhaustion, physical injury, elder abuse (I1iffe, Patterson & 
Gould, 1998). Burnout is a concern not only for the individual affected but also units and 
organisations in which the carer works (Bakker, Le Blanc & Schaufeli, 2005). Caring for an 
older family member with a fracture can take a lot of time and energy. This may involve 
organising time off work for medical appointments, making daily phone calls and organising 
services or finding someone trust-worthy to look after an older person. This may result in 
complaints and litigations. The carer may be a spouse who may have chronic ill health which 
limits their activities (Hamilton, 2011). The UK Government now recognises the need to 
support carers and the Department of Health has sponsored services in three geographical 
areas in England to address this. Most carers who received the support found it very valuable 
(Hills, 1991). 
 
While there is anecdotal evidence for carer stress there is little robust data. A systematic 
review and meta-analysis of the impact of carer stress on subsequent institutionalisation of 
community-dwelling older people found the effect was small (Donnelly et al., 2015). Another 
systematic review of stress in staff caring for people with dementia living in 24-hour care 
settings did not show a high prevalence of psychological stress (Pitfield, Shahriyarmolki & 
Livingston, 2011). However, all the studies were small and used instruments with 
unsatisfactory psychometric properties. The number of fragility fractures will increase in the 
coming decades and a high proportion of older people who sustain these will be 
institutionalised, therefore a narrative on care home residents is germane to put this in context.   
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1.2.6 Fragility Fractures in Care Home Residents 
1.2.6.1 General Considerations of Care Home and the Residents 
The last few decades have witnessed an increase of the ageing population and their care has 
presented looming challenges in many countries. As elderly populations continue to grow, the 
number of older people with functional disabilities is also on the increase. Impairments in 
physical and mental functioning in elderly adults reduce healthy life expectancy (World 
Health Organization (WHO), 2014), healthcare costs and makes the need for long-term care 
inevitable in many cases (Lubitz et al., 2003). Consequently, in many countries, there is an 
increasing demand for nursing home care options. Care home residents are a distinct group 
with chronic medical problems which have assumed increased relevance because of the high 
healthcare burden. 
 
A care home is defined as an institution which provides accommodation and care for people 
with complex needs who are unable to look after themselves (National Institute for Health 
Research (NIHR), 2016). The term care home inludess both nursing homes and residential 
homes. Nursing homes provide accommodation and assistance with personal care as well as 
24-hour nursing care. Residential homes provide accommodation without nursing care, some 
homes provide both levels of care. Many care homes offer rehabilitation facilities 
(physiotherapy, occupational therapy and speech & language therapy) and recreational 
activities also. The level of care for the residents can change, more often from residential to 
nursing because of an increase in care needs. 
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Most care home residents are women who are over 85 years old. There is considerable overlap 
in health status and need and support amongst residents in all care homes. The median period 
from admission to care home to death is about 15 months, the average life expectancy is less 
than 2.5 years, but about 27% live for more than 3 years (National Institute for Health 
Research (NIHR), 2016).  Given these, end-of-life care is a core component of care in many 
care home settings which can have impact on research, regardless of the research question. 
 
The National Centre for Health Statistics of the Centers for Disease Control and Prevention in 
the USA (CDC) estimated 1.5 million adults over the age of 65 years are currently living in 
nursing homes; a number expected to triple by 2030 (Centers for Disease Control and 
Prevention, 2012). There are an estimated 450,000 people (0.64% of the population) living in 
care homes in the UK, this is 4% of the population aged 65 years and over; 9.7% of who are 
75 years and over and 23.7% are 85 years and over (Office for National Statistics, 2011). A 
similar proportion (0.68%) has been reported in the Netherlands, where approximately 
117,000 older people out of a national population of 17.08 million live in care homes 
(Verbeck – Qudijk 2012).  
 
The proportion of care home residents is lower in developing countries: social, economic and 
cultural practices are responsible for this. In these countries, older people with care needs can 
rely on kinship networks to provide support, but with the established trend of population 
ageing and the rapid increases in the oldest age groups, the situation is changing. Studies from 
a wide range of developing communities indicate important shifts in inter-generational 
relations, whereby older generations are becoming less confident about receiving care and 
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support from younger family members (Aboderin, 2004, Bhat, Dhruvarajan, 2001) and there is 
evidence that care institutions are becoming an increasingly acceptable alternative to the 
traditional family care (Redondo, Lloyd-Sherlock, 2009). 
 
A survey in India in 1984 showed that  91% of people said it was their duty to care for older 
parents; 10 years later, this had reduced to 77% (Jamuna, 2003). The survey also found no 
children supported the idea of sending older people to care homes in 1984, but 10 years later, 
23% did. This changing social trend has contributed to the growing demand for care homes in 
the city of Buenos Aires, Argentina. According to the 2001 Census, 2% of Argentines aged 65 
years and over, and 5% of people aged 80 years and over were living in care homes, almost all 
of which operated on a private for-profit basis (INDEC, 2001). 
 
In the UK, 75% of care home residents are moderately disabled, with female residents having 
the higher proportion of disability. Shah and colleagues found that the mean age for nursing 
and residential homes was 84.9 and 86.1 years respectively compared to 74.7 for controls 
(Shah et al 2010). A health survey of 410,000 older people found 57% of women and 48% of 
men needed help with one or more `self-care` tasks and the following reasons were given for 
admission to care homes (Bebbington, Darton & Netten, 2001); 
 
Physical health problems            69% 
Mental health problems  43% 
Functional disablement  42% 
Stress on carers   38% 
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Lack of motivation   22% 
Present home physically unsuitable    15% 
Family break-down (incl. loss of carer) 8% 
Need for rehabilitation    6% 
Fear of being the victim of crime  4% 
Abuse                2% 
Loneliness or isolation   2% 
Homelessness               1% 
More than one reason may be given. 
 
Oliver found that the common precipitants of care home admission were dementia, falls and 
fractures, and declining mobility and incontinence (Oliver 2014). 
 
A survey found that local authority funded and self-funded residents differed in their levels of 
dependency and age when entering care; self-funded residents tended to be older and less 
dependent than publicly funded residents (Netten, Darton & Curtis, 2002). 
 
The sources of admissions of the older person to care homes vary (Bebbington, Darton & 
Netten, 2001): 
Admission from hospital    52% 
Admission from a private household   29% 
Admission from one form of care home to another (residential or nursing home) 13% 
Admission from sheltered accommodation 6%. 
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Care home residents have high prevalence of cognitive impairment such as dementia 
(Alzheimer`s Society, 2013), depression (Godfrey, Denby, 2004) musculoskeletal problems 
(Arthritis Research UK, 2015), stroke (Martin, Meltzer & Elliot, 1998), Parkinson`s disease 
(Parkinson`s UK, 2015) and people at the end of life pathway. In a cross-sectional analyisis of 
326 English and Welsh general practices, Shah and colleagues (2010) found that the 
prevalence ratios for dementia were 14.8 (95% CI 13.4 – 16.4) for nursing and 13.5 (95% CI 
12.4 – 14.8) for residential homes compared to controls. Stroke and severe mental illness were 
commoner in nursing and residential homes but hypertension, respiratory and cancer 
diagnoses were slightly less common. Recorded disease prevalences in nursing and residential 
homes were similar (Shah et al 2010).   
 
About 97,000 (17.8% of all those who die in England each year) are from care homes (Office 
for National Statistics (ONS), 2014) and 3,000 care homes in England are now registered for 
end-of-life care; 462 have received the Gold Standards Framework (GSF) accreditation, a 
Quality Hallmark that ensures the integrity and sustainability of the process (Care Quality 
Commission (CQC), 2015). The GSF is a systematic evidenced based approach to optimising 
the care for patients nearing the end of life and is widely used in the community and care 
home setting. The acute hospital training programme focuses on improving care provided by 
frontline generalist ward staff for all patients thought to be in the final months , weeks or days 
of life by introducing earlier identification and anticipation of needs and planning care in 
alignment with patient`s needs and preferences. 
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Hansen LC and colleagues found that care home environment allows staff to form closer 
relationships with residents and their families than is possible in a busy hospital environment 
thereby providing an appropriate environment for end-of-life care (Hanson, Gilliam & Lee, 
2010). Care homes are often characterised by rigid schedules, high workloads, high staff 
turnover and large numbers of unregulated care providers with limited education and training 
(Mentes, Tripp-Reimer, 2002). Medical care is often provided by several General Practitioners 
(GP) whose offices are located off site, pharmacist visits are intermittent and only few care 
homes have advanced medical facilities on site. 
 
There are an estimated 440,000 people living in 18,000 care homes in England (Commission 
for Social Care Inspection (CSCI), 2006). In Lincolnshire, there are 295 care homes 
representing 1.6% of care homes in England. London metropolis has the highest number. The 
UK Government specifies the minimum standard of care desired through the Care Standards 
Act and monitors implementation using the Care Quality Commission (CQC) in England, the 
Care Inspectorate in Scotland and the Care and Social Services Inspectorate in Wales. 
 
1.2.6.2 Incidence and Prevalence of Fragility Fractures in Care Home Residents 
 
People in care homes are 2 to 4 times more likely to have fragility fractures compared to 
community dwelling age matched counterparts (Crilly et al., 2010, Ronald et al., 2008). A 
population based study in Wales showed significantly higher risk of fragility fractures in 
nursing and residential homes than in comparable community dwelling older persons 
(Brennan et al., 2003). Hip fractures are particularly  common and the risk of hip fractures are 
highest in the first months after admission to the care home and decrease with increasing 
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levels of care needs (Rapp et al., 2008).  A plausible explanation is the reorientation in a new 
environment (toilet, furniture, lighting, etc.) which may result in increased risk of falls. 
Friedman and colleagues found that the fall rate of residents to be increased during the first 3 
months after relocation to a new facility (Friedman et al., 1995).  
 
Around a quarter of patients with hip fractures are admitted to hospital from care homes 
(Crilly et al., 2010, Ronald et al., 2008, National Institute for Health and Clinical Excellence 
(NICE), 2011b). Kane and colleagues found that the incidence of long bone fracture was 3.52 
per 100 subjects per year; minor trauma fracture incidence was 0.84 per 100 subjects per year 
(Kane, Burns & Goodwin, 1995). Another study showed higher incidence rates of 10 fractures 
per 100 residents per year (Crilly et al., 2010).  
 
Luthje reported an annual incidence rate of 91 per 100,000 hip fractures (Luthje 1991). 
Galagher and colleagues reported a hip fracture rate of 17 percent in men and 32 percent in 
women who were older than 80 years in Rochester, Minnesota, USA (Gallagher et al., 1980). 
Melton et al found hip fracture incidence was  2.5 times more in women who were older than 
80 (Melton et al., 1982). Ytterstad reported an incidence rate of 70 per 1000 person years 
(Ytterstad, 1999). In the Auckland Hip Fracture Study, 42% of hip fractures occurred in care 
residents and the risk of hip fracture, unadjusted for age and sex was 10.5 times greater for 
care home residents compared with those living in their private homes (Butler et al., 1996). 
Two studies reported that the incidence rate of hip fracture in nursing home residents are more 
than five times higher than rates in community dwellers of the same age and sex (Ooms et al., 
1994, Rudman, Rudman, 1989). 
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One publication of fragility fractures in care homes in Japan found hip fracture incidence of 
14.9 per 1,000 person years for women and 9.7 for men. The incidences of forearm and upper-
arm fracture were 1.9 and 5.1 for women and 0.5 and 2.1 for men respectively (Nakamura et 
al., 2010).  Vertebral fractures have been documented in 30% of care home residents 
(Rodondi, Chevalley & Rizzoli, 2012). Nursing home residents have high prevalent fractures 
(Zimmerman et al., 1999) and have an increased risk of another fracture over the ensuring 2 
years when compared to residents with no fracture history (Lyles, Schenck & Colon-Emeric, 
2008). The different incidences reported show that fracture rates cannot be generalised in care 
home settings because of the different case mix and study methodologies. But, high fracture 
rates will be expected in institutistions that cater for dementia who are ambulant because of 
the higher propensity to falls. 
 
1.2.6.3 Falls in Care Home Residents 
 
The incidence of falls is reported to be about three times higher in care homes than in the 
community (Ytterstad, 1999) with an annual incidence from 600 – 3,600 per 1000 beds 
(Rubenstein et al 1996) This is because care home residents are generally frail and some  have 
been admitted because of increased falls risk.  Each year, a typical nursing home with 100 
beds reports between 100 and 200 falls, half to three-quarters are unreported (ISHN 2017). A 
study of 56 care homes in the UK with a mean occupancy of 1,862 residents showed that there 
were 2,690 falls in a year, with mean falls rates as high as 3 per resident per annum in 
specialist residential homes for clients with dementia (Morse 1994).  In 2006, the US Centers 
for Disease Control and Prevention (CDC) reported between 50% and 75% of older people in 
care homes in the USA sustain falls each year, twice the rate of community dwelling older 
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people, with 2 to 6% of the falls resulting in fractures (United States Centers for Disease 
Control and Prevention (CDC), 2012).  A similar incidence was observed in about 60% of 
cohort in another study (Cryer, Patel, 2002). Kane and colleagues found an incidence of 1.5 
falls per person per year (Kane, Burns & Goodwin, 1995).  
 
Care home residents often fall more than once with an average of 2.6 falls each year 
(Rubenstein et al., 1990). About 35% of fall related injuries occur among residents who cannot 
walk (Thapa et al., 1996). About 1,800 people living in nursing homes die from falls each 
year, 10 to 20% of nursing home falls cause serious injuries; 2 to 6% are complicated with 
fractures (Rubenstein et al., 1988). The causes of falls may be related to dementia (van Staa, 
Leufkens & Cooper, 2002b), urinary incontinence (Colon-Emeric et al., 2003b), sarcopenia 
(low muscle mass) and frailty (Fiatarone Singh et al., 2009). 
 
1.2.6.4 Osteoporosis in Care Home Residents  
 
Osteoporosis is prevalent in the care home population with approximately 50% of men and 
64% to 90% of women meeting the WHO criteria for the diagnosis (Zimmerman et al., 1999, 
Sallin, Mellstrom & Eggertsen, 2005, Toofanny et al., 2004). One study by Aspray and 
colleagues in Newcastle found a high prevalence using BMD at the calcaneus (Aspray et al., 
2006). Vitamin D deficiency, a cause of low BMD is also common with 60% of nursing home 
residents having levels of 25, OH Vitamin D of less than 20ng/ml (Elliott, 2003).  
 
Vitamin D also has neuromuscular functions; deficiency causes skeletal weakness which may 
result in more frequent falls thereby increasing fracture risk (Pfeifer et al., 2001, Gerdhem et 
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al., 2005).  Gerdhem and colleagues found 25(OH) D levels correlated with physical activity, 
balance, gait speed and thigh muscle strength. Given that osteoporosis is very common in care 
home residents one can argue that the all care home residents should be offered 
pharmacological treatment but there is a caveat to such practice as some of the medications  
have potentially dangerous side effects, therefore only those who have been screened should 
be considered for such intervention. 
 
1.2.6.5 Global Initiatives Aimed at Reducing Fragility Fractures 
The global increase in fragility fractures has created concern and coalition of interested parties 
such as Fragility Fracture Networks (FFN) and the Falls & Fracture Alliance (FFA). Strategies 
have been developed for implementation of systemic approaches to fragility fracture 
prevention at state, provincial and national levels. During the first decade of this century, more 
than 50,000 consecutive fragility patients were assessed by the Glasgow Fracture Liaison 
Service (FLS). Consequently, hip fracture rates have reduced by 7.3% compared to a 17% 
increase in England where only 37% of localities operate FLS (Skelton, 2009).  
 
Variants of this service such as Osteoporosis Co-ordinator Programme in Canada and Care 
Manager Programme in the USA, have been developed. The British Geriatrics Society in 
collaboration with the British Association of Orthopaedic Surgeons developed a guideline 
called the Blue Book which is aimed at improving the care for people with fragility fractures. 
As part of this initiative, the National Hip Fracture Data base (NHFD) was also created for 
better management and Ortho-geriatricians were harnessed with the tools needed to tackle 
secondary prevention of fractures and facilitate improvements in the quality and cost 
58 
 
effectiveness of hip fracture care. The successes recorded through these initiatives are rooted 
in risk assessment and health education programmes. 
 
Other modalities of prevention and management of fragility fractures have also been 
developed (Scottish Intercollegiate Guidelines Network (SIGN), 2015). These are: exercise 
programmes, diet and pharmacological agents (alendronic acid, risedronate, zoledronic acid, 
ibandronic acid, cyclical etidronate, strontium ranelate, parathyroid hormone, calcitonin, 
denosumab, hormone replacement therapy (not relevant for care home residents), tibolone, 
raloxifene, Calcium and Vitamin D supplementation). Secondary prevention programmes have 
less chance of success once the irreversible process of osteoporosis has set in, therefore 
primary prevention through risk stratification should be the Holy Grail. The number of 
fragility fractures in care homes is likely to increase because of the ageing population; this 
makes the case for preventive programmes more compelling and strengthens the argument for 
a standardised risk assessment tool for this cohort. 
 
1.2.6.6 The Need for Fragility Risk Assessment Tool for Care Home Residents 
Adults in their eighth and ninth decades of life are less likely to be screened and treated for 
osteoporosis than younger individuals (Berry et al 2019). National (Teede, Jayasuriya & 
Gilfillan, 2007, Papaioannou et al., 2008), regional (McLellan, 2004, Hajcsar, Hawker & 
Bogoch, 2000) and local (Port et al., 2003) audits conducted across the world have shown that 
the usual standard of care results in 80% of fragility fracture patients neither being assessed 
nor treated for osteoporosis. In a community-based survey of 94 older hip fracture patients, 
45% required treatments, 35% fulfilled criteria for investigation and reassessment and 20% 
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needed no future management. But in practice, only 27%  received treatment, 4% had 
undergone DEXA assessment and were untreated and 69% had not been investigated and were 
untreated. In patients meeting the intervention threshold, only 33% of those who required 
treatment were receiving it (Elvey et al., 2014). More recently, the National Audit of Inpatient 
Falls (NAIF) has reported a drop in the number of Trusts that use falls risk tools from 74% in 
2015 to 34% in 2017 (RCP, 2017). Also in a recent review of osteoporosis treatment, it was 
observed that individuals at high risk of fractures did not receive adequate treatment. 
Strategies to address this treatment gap such as nationwide implementation of the Fracture 
Liaison Service and enhanced adherence to therapy are needed; these are important challenges 
for the future (NICE 2018). 
 
Many fractures are preventable but timely intervention depends on identifying the populations 
at risk. Care home residents are at greater risk of future fractures compared to community 
dwelling older people and risk assessment is a cost-effective measure for fracture prevention 
in this cohort (Cali, Kiel, 1995, Girman et al., 2002a). Currently, most fracture risk 
assessments are focused on older people living in the community (Cummings, Black, 1995, 
McGrother et al., 2002, De Laet et al., 1998). The following evidence supports the need for a 
specific fragility risk assessment in care home residents. 
  
1.The benefits of  osteoporosis medications may occur at 6 to 12 months, also  the benefits for 
effective fall prevention interventions might be immediate. As age increases, the number 
needed to treat to prevent 1 hip fracture declines until the age of 80 years (Wells et al 2008). 
Despite a shorter life expectancy, a woman aged 90 years still has a substantially higher life-
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time fracture risk and lower number needed to treat to prevent 1 hip fracture than a woman 
aged 70 years. Therefore, in contrast to cancer and other screening and preventive services, for 
which the benefits of screening cease beyond some age threshold, the effectiveness of fracture 
prevention increases with advancing age (Berry et al 2019).  
 
2. Although the risk factors for fractures in noninstitutionalised populations are well known 
(Norton et al., 2000, Zarowitz et al., 2015, Newman et al., 2003, Cummings et al., 1995), those 
for care home residents are less well studied. In a prospective cohort study, the Fracture Risk 
Epidemiology in the Frail Elderly (FREE) study, designed to evaluate risk factors for falls and 
fractures in a population of 1894 older people (1433 women and 461 men) from 52 care 
homes and 30 hostels in Northern Sydney (Chen et al., 2008), it was found that some of the 
risk factors for fragility fractures in care home residents differed from those in community 
dwelling older people.  
 
An increased risk of hip fracture was significantly associated with older age, cognitive 
impairment, history of fracture since age 50 and lower body weight in the care home residents 
and longer lower length (an index of mature skeletal stature) and poor balance in the 
intermediate-care hostel residents. However the existing fracture risk calculators do not 
include many comorbidities or frailty characteristics common in older adults that influence 
risk benefit assessment when considering pharmacological treatment as a preventive measure 
for osteoporosis (Berry et al 2019) 
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A study reviewed the prevalence of vertebral fracture among 151 oldest old nursing home 
residents using vertebral fracture assessment on dual-energy X-ray absorptiometry (DEXA) 
(Rodondi, Chevalley & Rizzoli, 2012). It was found that while the prevalence of osteoporosis 
and vertebral fractures was high (52% and 36% respectively), including these variables in a 
model did not markedly affect the fracture probability. Duque and colleagues therefore 
suggested that a medical history, which incorporates age and previous fractures, may be the 
most practical way to determine fracture risk in this cohort (Duque et al., 2016).  
 
A systematic review and meta-analysis of fracture risk in long term care found that the 
addition of cognitive impairment and history of falls to FRAX (WHO fragility risk tool) were 
associated with small to moderate increases in fracture probability. This prompted the 
suggestion of the development of a specific fragility risk assessment tool for care home 
residents (Khatib et al., 2014, Girman et al., 2002b). 
 
3. Some studies have demonstrated that elderly people at high risk of future hip and other 
fractures can be identified using bone mineral density (bone mass), particularly  at the hip and 
over 90% of hip fractures occur in older people with low bone mass (Phillips et al., 1988). A 
large cross-sectional study showed continued bone loss between ages 65 and 90 years of 
approximately 0.7 to 1 % annually at the radius, calcaneus and hip with a similar loss of 
approximately 0.3% at the spine (Steiger et al., 1992, Steiger et al., 1995). Another study 
found bone mass continues at the spine, radius, femoral neck and heel for up to 20 years after 
menopause (Harris, Dawsonhughes, 1992). A longitudinal study of 100 women of between 65 
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and 80 years old showed that bone loss at the radius continues at approximately 1%/year at 
least up to the age of 80 years (Sowers et al., 1991, Sowers et al., 1992).  
 
4. Bone loss not only continues but accelerates in old age (Jones et al., 1994, Chapuy et al., 
1992). A large prospective study of 3,000 women aged 65 years and over showed that bone 
loss at the hip and calcaneus accelerates with increasing age (Ensrud et al., 1992, Ensrud et al., 
1997). At the calcaneus, bone loss was 1.2%/year in people aged between 67 and 70 years, 
increasing to 2.8%/year in those who were over 85 years. At the femoral neck, the rate of loss 
increased from 0.4%/year for people aged between 67 and 70 years to 1.1%/year in those who 
are over 85years. Acceleration in bone loss rates was greater in other parts of the hip such as 
the trochanteric and the annual loss at this site increased from 0.4% in people of between 65 
and 70 years to 1.7% in those over 85 years. 
 
5. Minor traumas such as falls are common in older people.  The proportion of older people 
falling is high and various incidences have been quoted. For people who are 65 years and 
above, the proportion sustaining at least one fall was 28 to 35% (Prudham, Evans, 1981, 
Campbell et al., 1981, Blake et al., 1988). This rises to between 32 and 42% in people who are 
75 years and over (Tinetti, Speechley & Ginter, 1988, Downton, Andrews, 1991). A study 
from Australia reported that the incidence of falls in people who are older than 70 years may 
be as high as 49% (Hill et al., 1999). Also about 50% of those who fall do so repeatedly 
(Tinetti, Speechley, 1989, Rubenstein, Josephson & Robbins, 1994). Falls account for more 
than 90% of hip fractures and 87% of all fractures in elderly people (Melton, 1993, Grisso et 
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al., 1991c, Hedlund, Lindgren, 1987).  The two major risk factors for fragility fractures are 
falls and osteoporosis and they are highly prevalent in older people. 
  
6.There is now an increasing armamentarium of efficacious pharmacological therapies which 
reduce the rate of bone loss and fracture risk even after the age of 80 years (National Institute 
for Clinical Excellence (NICE), 2012b, Cummings et al., 2009, Black et al., 1996, McClung et 
al., 2001). The discovery of key pathways regulating bone resorption and formation has 
resulted in new approaches to treatment with medications with distinctive mechanisms of 
action. In people at high risk of fracture, the benefit versus risk profile is likely to be 
favourable for up to 10 years of treatment with bisphosphonates or denosumab. In people at 
high or inmminent risk of fracture, therapy with teriparatide or abaloparatide should be 
considered; however since the treatment duration with these drugs is restricted to 18 to 24 
months, treatment should be continued with an antiresorptive drug (Compston et al., 2017). 
 
Antiresorptive therapy with bisphosphonates or anabolic therapy with parathyroid hormone 
can reduce fracture risk by at least a third within 1 to 3 years (Delmas, 2002). Therefore 
accurately estimating the fracture risk is critical in identifying cost-effective medications for 
intervention (Kanis et al., 2005a, Kanis et al., 2001). Economic models suggest that it might 
be cost effective to treat older women for fracture reduction who have life expectancies of as 
little as 2 years (Pham et al 2011). If life expectancy is less than 1 year, pharmacologic 
osteoporosis treatment should not be provided (Berry et al 2019). 
 
 
64 
 
7. Finally concerns have been raised about serious side effects of antiresorptive therapy 
therefore many physicians prescribe these medications for a finite period usually of between 3 
to 5 years. Reassessment of fracture risk at the end of this period is important since some 
people remain at high risk of fracture and require continued treatment whereas others may 
benefit from a drug holiday. 
 
Patient and General Practitioner (GP) records often contain medical information that may be 
useful in evaluating fracture risk (e.g. age, sex, medications, comorbidities etc.). National 
(NHG Standaard Osteoporose, 2005) and international guidelines (Kanis, 2007) have 
recommended a case-finding approach for identification because it is cost-effective (Compston 
et al., 1998, Jonsson, 1998). Case finding is a strategy for targeting resources at individuals or 
groups who are suspected to be at risk. It involves actively screening high risk groups, rather 
than waiting for symptoms or signs of the active disease. 
 
For several years, BMD alone was used to define susceptibility to fragility fractures until it 
was established that such `osteocentric` position does not explain many fragility fractures and 
that clinical risk factors (CRFs) were also important. Most fragility fractures occur in people 
without osteoporosis (Wainwright et al., 2005), because the sensitivity and specificity of BMD 
are low (Kanis et al., 2001, Henry et al., 2002, Siris et al., 2006).  It is now recognised that 
BMD alone fails to capture other factors that influence bone strength such as bone quality 
(Bouxsein, 2003), bone turnover (Recker et al., 2004), mineral (Turner, 2002), non-mineral 
bone tissue composition (Wang et al., 2002), bone size, bone geometry and microarchitectural 
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properties (Seeman, 1997, Stauber, Muller, 2006), as well as postural reflexes and muscle 
strength deterioration (Wickham et al., 1989). 
 
Several validated fragility risk assessment  tools are now available which incorporate BMD 
and CRFs and express output as 10-year probability risk rather than a densitometric diagnosis 
based on BMD estimate (Kanis et al., 2008, Anonymous, 2013). In England and Wales, NICE 
issued revised guidance on the primary and secondary prevention of osteoporotic fracture in 
postmenopausal women in 2010 and 2011 which incorporates fracture risk assessment, 
osteoporosis treatment thresholds and treatment choices.  
 
The appraisal committee stated that recommendations about treatment should not be based on 
absolute risk because the committee did not agree that all the CRFs used in FRAX were 
appropriate and that absolute risk was not directly related to cost effectiveness since different 
sites have different impacts on quality of life, costs and mortality (National Institute for Health 
and Clinical Excellence (NICE), 2011). The resultant Technology Appraisals require a DEXA 
scan although this is not considered necessary in women aged 75 years or older in whom 
osteoporosis may be assumed (National Institute for Health and Care Excellence, 2008). One 
study found that using this strategy better identified high risk patient groups (Johansson et al., 
2004). Some opinion leaders argue that a model without BMD is nearly as good as one with 
BMD (Black et al., 2001a). 
 
The situation is further compounded because it is not known if these risk models, many of 
which assess fracture risk over a 5 to 10 year period are applicable to care home residents 
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(Berry et al 2019). Care home residents are a distinct cohort and a risk profile which is 
calibrated, validated internally and externally exclusively for this group will be needed. 
Fracture risk is currently assessed opportunistically with no standardised assessment tool for 
care home residents and also there is no universal policy for screening.  Amidst this confusion, 
the National Institute of Health and Care Excellence (NICE) support this investigator`s views 
that studies should be conducted to identify a specific fragility tool for care home residents 
(National Institute for Clinical Excellence (NICE), 2017). 
 
1.2.7 Conclusion 
Fragility fractures are common in older people and the health impact is substantial. The global 
increase in the ageing population has resulted in increased numbers of care homes residents 
who are particularly at high risk. There are now several validated fragility risk assessment 
tools which were designed for community dwelling older persons but it is not known if these 
are practicable for care home residents.  
 
1.3 Aims and Objectives of this Project 
Fragility fractures are common in care home residents and can be prevented by appropriate 
service provision, pharmacological treaments and physiotherapy. National guidelines 
recommend risk assessment to allow initiation of prophylactic measures. But the currently 
available risk assessment tools have been tested in community dwelling adults and not in care 
home residents. It is possible that one or more of the existing tools are also practicable in this 
population. The incidence of fragility fractures in care home residents in the UK was not 
available from published data but one study in Norway reported a rate of 70 per 1000 person 
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years (Ytterstad 1999).  Assessment of the performance of fragility fracture tools thus requires 
a very large study.  
 
1.3.1 Aim of this Study 
The aim of this project was to identify fracture risk assessment tools which are practicable in 
care home residents and to determine which is the most suitable for use in this population. 
 
1.3.2 Objectives  
The objectives are: 
 
1. To conduct a systematic literature review of the existing fragility risk assessments tools 
and select those that can be used in care home residents. 
 
2. To develop a composite questionnaire which can be used to test the fragility fracture 
risk assessment tools in a care home population. This will be done by taking 
information from the systematic review to design the questionnaire. The Timed Up and 
Go Test (TUGT), a primary falls risk assessment tool was added to compare its 
performance with the fragility tools. The Charlson comorbidity Index (CCI) was also 
added because it may inform treatment decisions. The questionnaire and patient 
information sheets will then be assessed by consultation visits to two care homes. 
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3. To undertake an observational study of the feasibility and performance of the fragility 
fracture risk assessment tools identified in objective 1 in care home residents in 
Boston, Lincolnshire, England. 
 
4. To design an Algorithm. 
 
 
The details of the methods, results and discussion for each project will be presented 
sequentially as one informs the other. 
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Chapter 2 Identification of fragility risk assessment tools for care home 
residents: a systematic review 
 
2.1 Abstract 
 
2.1.1 Background 
Fragility fracture risk assessment is important in the identification of older people who are at 
high risk. Many tools are now available for this purpose. Most of them were developed from 
community dwelling older people but it is not clear if any of these are practicable in care home 
residents. To address this knowledge gap, a systematic literature review was conducted.  
 
2.1.2 Objectives 
Two steps were followed in the systematic review:  
1. First, identify existing fragility risk tools. 
2. Second, identify those that can be used in care home residents. 
 
2.1.3 Methods 
1. A combination of electronic and manual searches was used to identify the tools. The 
electronic literature sources were: Cochrane Library, MEDLINE, EMBASE, CINAHL and 
AMED. Inclusion and exclusion criteria were applied and the relevant data collected with a 
data extraction form. 
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2. A priori criteria were used to select the tools that may be practicable in care home residents. 
These were: 
  Prospective design/Systematicreview/Meta-analysis of the study  
 Outcome measures of the study in the design of the tool 
 Generalisability of the tool 
 Cost – effectiveness & Pragmatism of evaluation of the tool 
 
2.1.4 Results 
1.  A total of 1343 citations were identified for the review out of which thirty-three fragility 
tools were obtained. Four tools were derived from general literature review, two were from 
meta-analyses and twenty-seven were from original studies. There was considerable 
heterogeneity in characteristics among the tools.  
 
Most of the tools were derived from North America, Europe and Oceania and were useable 
only in female Caucasians of 50 years and over. The majority of the tools were calibrated 
prognostic models for any major fragility fractures but they were not validated externally. 
Only few tools expressed their output in absolute fracture probability. 
 
The distributions of the domains of the predictors in the tools from the original studies were as 
follows: demography 22 (76%), radiological investigations 20 (69%), comorbidities 19 (66%), 
physical limitations 12 (41%), life style factors 10 (34%), types of medications 6 (21%), living 
arrangements and biochemical indices 2(7%) each. The simplest tools included one or two risk 
factors whereas the complicated ones had more risk factors. 
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2. Four tools were found to be potentially practicable for care home residents by using the 
criteria for selection above. These were the World Health Organisation Fracture Risk Tool 
FRAX (independently and externally validated in many population-based cohorts), 
QFractureScores (independently and externally validated in 2 studies), Garvan nomogram 
(independently and externally validated in 3 studies) and Body Mass Index (BMI) (no 
published external validation studies). BMI is a common predictor in the first three tools. With 
the exception of BMI, their assessments are web-based and outputs are expressed as absolute 
fracture probability. Paper-based version of FRAX is also available. 
 
2.1.5 Conclusions 
Most of the existing tools were not validated and there was substantial heterogeneity in 
characteristics. Four of these are potentially practicable for care home residents. They are 
FRAX, QFractureScores, Garvan nomogram and BMI. They were derived from prospective 
cohorts, used any fragility fracture as outcome, they can be used for both sexes and they are 
attract no monetary cost for assessment. 
 
 2.2 Background 
The marked increase in the numbers of fragility fractures and the accompanying health impact 
poses an immense burden to society in terms of morbidity, mortality and financial costs. 
Consequently, it is essential to accurately assess the individual patient`s fracture risk and 
where indicated, to initiate appropriate treatment that reduces fracture probability (Kanis et al., 
2014). Risk assessment represents a cornerstone in this regard and one of the strategies is 
“case finding” screening for optimal identification of high risk individuals (NHG Standaard 
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Osteoporose, 2005, Kanis, 2007). Case-finding is widely accepted as a cost-effective method 
for identification of people suitable for treatment (Compston et al., 1998, Jonsson, 1998).  
 
There are national guidelines for the management of fragility fractures (National Institute for 
Clinical Excellence (NICE), 2018, and NOGG 2017. NICE recommends FRAX or 
QFractureScores for assessment but NOGG intervention thresholds are based on FRAX 
probability. Although a number of factors were considered in the development of these 
guidelines, cost-effectiveness was central to their design as financial prudency featured in the 
terms of reference. Although the guidelines are simple to use and appeal to service providers, 
the scientific bases for their use are not robust. 
 
A number of original tools are available for fracture risk assessment. Many of these were 
derived in different settings and used different outcome measures. The reliability, sensitivity, 
specificity and validity of many of them have not been tested in care home residents as many 
were developed from relatively healthy community dwelling older persons.  
 
The World Health Organisation (WHO) and the International Osteoporosis Foundation (IOF) 
recommend that fracture risk should be expressed as a 10-year absolute risk using a 
combination of risk factors with or without BMD (Kanis, 2007). 10 years was chosen because 
this time frame is cost effective in modelling and allows 5 years on and 5 years off 
medications (Kanis et al., 2001). But the average life expectancy of care home residents is less 
than 5 years; consequently, this recommended metric of expression may not be useful for care 
home residents.  
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Care home residents are infirm and represent a distinct cohort; the majority have multi-
morbidity resulting in considerable disability which increases fracture risk (Gordon et al., 
2014). Thus, it is important to use validated measures to appraise their fracture risk and 
treatment options administered accordingly. The overarching aim of this project was to review 
the literature systematically and identify within the existing fragility risk assessment tools 
those that can be practicable for care home residents. 
 
2.3 Methodology 
To achieve the aim, two objectives were designed: 
 
1. Identify the existing fragility tools through a systematic literature review. 
2. Then identify within the tools identified in (1) those which can be practicable in care home 
settings using a priori criteria. 
 
2.3.1 Methodology of the first objective of the systematic review: Identification of 
existing fragility tools  
 
2.3.1.1 Search strategy 
Two strategies were used for the search: electronic search and search using other resources. 
 
2.3.1.2 Key words and search string on electronic databases 
The following Medical Subject Headings (MeSH) terms were used: Osteoporosis, Fracture, 
Risk Assessment, Tool (Measure or Scale). These terms were chosen because they were the 
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most frequently used words relating to the subject of this research.  The search string was: 
Osteoporosis AND Fracture AND Risk Assessment AND Tool OR Measure OR Scale in the 
following bibliographic databases: 
 
COCHRANE LIBRARY (1993 to April 2014) 
MEDLINE (1966 to April 2014) 
EMBASE (1947 to April 2014) 
CINAHL (1961 to April 2014) 
AMED (1985 to April 2014) 
 
Tools which were not reported in English language were excluded because of the difficulties 
with translation.   
 
2.3.1.3 Searches in Other Resources 
The reference lists of the full texts were inspected to identify studies that had been identified 
in the primary studies. Additional searches were carried out manually in  grey literature on 
fragility fracture risk assessment tool publications in Keele University and the United 
Lincolnshire NHS Libraries, textbooks of fragility risk assessment tools, dossiers on fragility 
risk assessment tools in organisations such as the World Health Organisation, International 
Osteoporosis Foundation,  pharmaceutical companies, conference abstracts (published and 
unpublished) and references provided by colleagues and opinion leaders on the subject. 
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The deadline for the searches was 30 April 2014 because the proposal for degree progression 
at Keele University had to be submitted by August 2014. All the relevant citations identified 
were exported to RefWorks. 
 
2.3.1.4 Inclusion and Exclusion Criteria 
The Population, Intervention, Comparison and Outcome (PICO) format was used to define the 
inclusion criteria (Moher et al., 2010). Tools which were derived from studies that recruited 
adults of either sex, any ethnic group in any setting, used fragility fractures as outcome and 
only the original tools were included.  
 
Interventional studies were excluded because they have no bearing on model derivation. Case 
reports were excluded because they are too limited in scope. Osteoporosis and falls risk 
assessment tools were excluded because these are not the subjects of interest. Statistical 
models were excluded because they are not feasible for use in care home residents. 
  
2.3.1.5 Method for the Selection of Studies 
The citations obtained were screened in three stages. When the initial lists were obtained, 
duplicates were removed and the remaining screened for relevance from the title and abstract. 
Identified abstracts were scrutinised to ascertain whether they fulfilled the inclusion criteria. 
Where there were insufficient details in the abstract or where abstracts indicated that a study 
was likely to fulfil study criteria, the full text were retrieved. When it was unclear if an article 
fulfilled inclusion criteria, a second reviewer (AP) was consulted and any disagreements were 
resolved by discussion.  
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2.3.1.6 Data Abstraction and Quality Assessment 
The relevant information was extracted by the author using a template designed for the study 
(appendix R). Methodological quality was assessed using Quality Assessment of Diagnostic 
Accuracy Studies tool (QUADAS Appendix O), as recommended by the Cochrane Handbook 
for Systematic Reviews of Diagnostic Test Accuracy (Diagnostic Test Accuracy Working 
Group, The Cochrane Collaboration, 2009). This tool uses a scale where scores of 7 and more 
are high quality studies and scores less than 7 are considered low quality but no study was 
excluded based on the score. 
 
2.3.2 Methodology of Second Objective of Systematic Review: Identifying Fragility Tools 
for Use in Care Home Residents 
The next objective was to select the tools identified from objective one which can be used in 
care home settings. These tools were put through another elimination process using a priori 
criteria. 
 
2.3.2.1 Criteria for Selection 
The criteria which were used in the selection of the tools were:  
 
2.3.2.1.1 Prospective Design/Systematic Review/Meta-analysis 
The data for developing a prognostic model should ideally be derived from prospective 
cohort(s), consequently such models are dynamic and likely to be current and amenable to 
change (Moons et al., 2012). Prospective design assures that exposure was measured before 
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the occurrence of the index fracture(s) thus the risk is not static. A prospective study follows a 
group of individuals over some period until the development of the disease of interest (Porter 
et al., 1990). Prospective studies are well suited for the study of diseases such as fragility 
fractures and are typically ranked highest in the hierarchy of evidence (Porter et al., 1990).  
 
Case-control or retrospective studies on the other hand start at the end point and go backwards 
in time to identify risk factors which the subjects (known as the cases) might have been 
exposed to in the past (Bowers, 1996). Any findings are compared with those obtained from a 
comparison group, called the controls. The most difficult part of a case-control study is 
choosing the controls. Ideally, the controls should be similar to the cases as much as possible 
(without having the disease) and they should be a sample from the same population as the 
cases. A major problem in the selection of appropriate controls is the presence of confounding 
variables. Another problem with case-control studies is that such retrospective studies rely on 
people`s memories which can lead to bias (those with the disease can often recall events which 
may relate to their illness better than those without), or on the accuracy of historic data, which 
may be unreliable. Although case-control studies have the advantage that the results are 
available much earlier, these may be unreliable. Thus, although retrospective cohort studies 
can address long term follow-up, these are usually at the expense of poorer systematically 
obtained data (Moons et al., 2009).  
 
2.3.2.1.2 Outcome Measures of the Study 
Many fragility fracture risk assessment tools use hip fractures as the only outcome measure 
because hip fractures are associated with the highest health burden. However hip fractures are 
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the `final endpoints` of fragility fractures, occurring about 30 years after menopause in women 
(Black, Cummings & Melton, 1992). The natural history of osteoporotic fractures varies 
according to fracture site. Wrist fractures are commonest between 45 and 60 years and ankle 
fractures peak in women between 50 and 70 years (Harvey, Dennison & Cooper, 2008). In 
contrast, vertebral and hip fractures peak later with sharp rise after 70 years for vertebral 
fractures (Harvey, Dennison & Cooper, 2008) while the average age for hip fracture is over 80 
years (Harding, 2018).  
 
Also the determinants that have been shown to predict hip fractures may not necessarily be 
extrapolated to other fractures because hip fractures occur at a later age and their mechanism 
may be different. In addition, hip fractures account for less than 20% of all osteoporotic 
fractures (Strom et al., 2011, Holmberg et al., 2006).  Therefore using hip fracture as the only 
outcome measure may be synonymous with using the greater to predict the smaller such as 
using a major heart attack to predict angina or using a major stroke to predict a transient 
ischaemic attack. Consequently, only tools which predict `any` major osteoporotic fracture 
were selected. 
 
2.3.2.1.3 Generalisability of the Tool 
Fragility fractures occur in both sexes (Kanis et al., 2005b) therefore risk assessment and 
treatment should be offered to all appropriate residents consequently only tools useable in both 
sexes were included. Although the majority of patients who sustain osteoporotic fractures are 
women, a substantial proportion of all osteoporotic patients occur in males. About 40% of 
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women and 13% of men over 50 years will sustain at least one fracture during their remaining 
lifetime (Melton, 1993, Lips, 1997).  
 
In 2005, there were approximately 1.45 million fractures in women older than 50 years and 
594,000 fractures in men in the USA (Burge et al., 2007). Although men account for 29% of 
fractures, the medical costs associated with fractures in older men is substantial; $4.15 billion 
of the total $16.9 billion in cost for both sexes (Burge et al., 2007) and also males are more 
frequently affected by the serious consequences of hip fractures. 
 
The 2001 and 2011 population census in England and Wales showed that there were changes 
in the resident care home population. Fewer women but more men aged 65 years and over 
were living as residents in 2011 compared to 2001. The population of women fell by around 
9,000 (-4.2%) while the population of men increased by around 10,000 (15.2%). This is 
another reason why the tool chosen should be applicable to both sexes (ONS 2011). 
 
2.3.2.1.4 Cost-effectiveness & Pragmatism of Evaluation 
 
The last criterion for the selection was cost effectiveness and pragmatism of the assessment 
tool. Cost-effectiveness is an economic framework that explores the relationship between 
monetary inputs and the desired outcome. It is important to consider cost-effectiveness of 
screening tools in fragility fractures because of the estimated astronomical increase of the 
ageing population and the financial expenditure that could be incurred. In the development of 
predictive models, it is recommended that tests, especially those whose collection requires 
more burdensome and costly measurements, should not be evaluated on their individual 
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predictive abilities but rather on the incremental predictive value beyond established and easy 
to obtain predictors (Moons et al., 2012, Moons et al., 2009, Moons et al., 1999). 
 
While striving to deliver the best healthcare, financial prudency should be considered during 
assessment: the NHS is currently running an aggregate budget deficit of £1.85 billion for the 
2015/2016 financial year (King's Fund, 2016). NICE guidelines are geared towards improving 
outcomes for patients and ensuring efficient use of healthcare resources. For example, 
screening in secondary care based on BMD has been shown not to be cost-effective (Eddy, 
Johnston & Cummings SR, 1998). 
 
The cost of a DEXA scan payable by commissioners in the UK is £69, the latest available 
reference cost for a DEXA scan incurred by providers was £77; in South Africa, it is $130 
USD and between $60 and $100 in the USA.  DEXA scans are expensive, their availability is 
restricted to major hospitals and the labour force required is also substantial (Eastell, 1998). 
DEXA machines range in cost from $25,000 to $85,000. In some countries, it is 
predominantly a research tool. DEXA scans are undertaken only in hospitals, and although the 
examination time is relatively short (between 5 and 7 minutes), the resident will be required to 
disrobe; the process and the logistics may be daunting for the frail elderly care home resident. 
Given these, any tool which involved an expensive or arduous investigation such as BMD was 
excluded. 
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2.3.3 Definition of Terms 
Validity is the extent to which a tool measures accurately what it is designed to measure, 
sensitivity is the extent to which a test identifies people who truly have the condition of 
interest, specificity is the extent to which a test identifies people who truly do not have the 
condition of interest. Both sensitivity and specificity range from 0 to 100%. Because of the 
inter-relationship between sensitivity and specificity increasing one generally decreases the 
other. Both sensitivity and specificity can be integrated into a graph, the receiver operating 
characteristic curve (ROC). 
 
ROC curve graphs sensitivity and specificity throughout the range of test values and quantifies 
the overall performance of the diagnostic test. Accuracy is measured by the area under the 
ROC curve (AUC). The AUC is a measure across all risk values and can range from 0 to 1; an 
AUC of 0.50 means that the diagnostic test has no ability to discriminate between persons with 
and without the disease of interest. The closer the AUC is to 1, the better the ability of the test 
to discriminate. A rough guide for classifying the accuracy of a diagnostic test is the academic 
point system (Metz, 1978): 
 
0.90 – 1 = excellent (A) 
0.80 – 0.9 = good (B) 
0.70 – 0.80 = fair (C) 
0.60 – 0.70 = poor (D) 
0.50 – 0.60 = fail (F) 
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Reliability is the extent to which a scale produces results which can be replicated with 
different observers, responsiveness to change is the ability of the scale to detect change due to 
interventions or over time at all levels of the scale, format/language refers to the ease with 
which the tool can be used (Royal College of Physicians, 1992, Gupta, 2008). 
 
Relative risk (RR) is the likelihood of an event in relation to all possible events. For example 
if a horse wins 2 out of every 5 races, its probability of winning is 2/5 (40%) (Last 2004). 
 
Odds ratio compares events with nonevents. For eample if a horse wins 2 out of every 5 races, 
its odds of winning are 2 to 3 (expressed as 2:3) (Last 2004). 
 
OR and RR are usually comparable in magnitude when the disease is rare. Howver an OR can 
overestimate and magnify the risk especially when the dsease is more common and should be 
avoided in such cases if RR can be used (Last 2004). 
 
Care homes were defined as an institution which provide accommodation and care for people 
with complex needs who are unable to look after themselves. This includes both nursing and 
residential homes. Nursing homes provide accommodation, personal care, and 24-hour nursing 
care. Residential homes provide accommodation and personal care, but not nursing care. Some 
homes provide both levels of care. A dementia home is defined as a care home that provides 
care to patients with dementia. 
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2.4 Results 
2.4.1 Step 1. Identification of existing fragility tools from the systematic literature review. 
 
 
2.4.1.1 Electronic Search   
The electronic search produced a total of 1504 articles including 30 following discussion with 
AP. When duplicates were removed this reduced to 1343. From the 1343, 1314 were rejected  
for  the  following  reasons : 721 were rejected because their titles made it clear that they were 
irrelevant,  7 were rejected because they were case reports, 485 were rejected because they 
were experimental studies, 5 were rejected because they were articles about statistical models,  
96 non-English articles were rejected because translation was not feasible. After this initial 
screening, 37 articles were left each resulting in the derivation of a tool, that is 37 tools. The 
abstract of the articles from which the tools were derived were screened; of these 7 were 
rejected because there were no performance characteristics in 5 and full text was not available 
in 2, leaving a total of 30. 
 
2.4.1.2 Search from Other Resources  
Manual search yielded 15 articles and from each, a tool was derived. Of these, 12 were 
duplicates leaving 3 articles from which 3 tools were derived.  Grey literature search did not 
yield any publication. 
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 2.4.1.3 :Total Number of Tools (electronic and other searches) 
The flow chart for the retrieval of tools is shown in Figure 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Flow diagram of search and study selection of the first part of the systematic 
literature review. 
Interpretation Figure 2 shows that of the initial 1,343 articles identified, 33 fulfilled the 
criteria for the second part of the systematic literature review. 
Finally, 33 tools were left.  Of these, 4 tools were derived from literature review, 2 tools were 
derived from meta-analyses and 27 tools were derived from original studies. The tools selected 
are shown in table 12. 
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85 
 
Table 12: The 33 tools derived from the first part of the systematic literature review 
Tools derived from  
literature review 
(Tool no as list below) 
Tools derived from  
meta-analyses  
(Tool no as list below) 
Tools derived from  
original studies  
(Tool no as list below) 
12,13,18, 29 1, 25 2-11,14 -17,19-24, 26-32,33 
1. Bone mineral density (Marshall, Johnell & Wedel, 1996) 
2. Markers of Bone Resorption Predict Hip Fracture in Elderly Women: The EPIDOS Prospective Study 
(Garnero et al., 1996) 
3. A Simple Risk Score for the Assessment of Absolute Fracture Risk in General Practice Based on Two 
Longitudinal Studies (Pluijm et al., 2009) 
4. Evaluation of a Hip Fracture Risk Score for Assessing Elderly Women: The Melton Osteoporotic Fracture 
(MOF) Study (McGrother et al., 2002) 
5. An assessment Tool for Predicting Fracture Risk in Postmenopausal Women (Black et al., 2001a) 
6. A triage strategy based on clinical risk factors for selecting women for treatment or bone densitometry: the 
EPIDOS prospective study (Dargent-Molina, Piault & Breart, 2005) 
7. QFractureScores (Hippisley-Cox, Coupland, 2009)  
8. Garvan nomogram (Nguyen et al., 2008) 
9.  A nomogram for individualizing hip fracture risk in men and women (Nguyen et al., 2007a) 
10. Fracture Risk Score and absolute Risk of Fracture (FRISK) (Henry et al., 2011) 
11. Added value of Bone Mineral Density in Hip Fracture Risk Scores (Burger et al., 1999) 
12. Osteoporosis: Assessing the risk of a fragility fracture (National Institute for Clinical Excellence (NICE), 
2012b) 
13. Clinician`s Guide to Prevention and Treatment of Osteoporosis (NOF 1998) (Anonymous, 2013) 
14. FRAX (Kanis, 2007) 
15. Peripheral DXA measurements (Barr et al., 2005) 
16. Homocysteine and fracture risk (Perier et al., 2007) 
17. Osteoporotic Hip Fracture Combining Clinical Risk Factors and Heel Ultrasound (Hans et al., 2008) 
18. Simplified System for Absolute Fracture Risk Assessment (CAROC) (Siminoski et al., 2007) 
19. Prediction of Hip Fractures from Pelvic radiographs: (Gluer et al., 1994) 
20. Prediction of hip fracture in elderly women (Porter et al., 1990) 
21.  Prediction of fracture Risk by radiographic Absorptiometry (RA) and Quantitative Ultrasound (Huang et al., 
1998) 
22. Risk factors for Hip Fractures in White Women (Cummings et al., 1995) 
23. Use of clinical risk factors to identify postmenopausal women with vertebral fractures (Tobias et al., 2007) 
24. Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound 
(Diez-Perez et al., 2007) 
25. Body Mass Index(De Laet et al., 2005) 
26. Use of Clinical Risk factors in Elderly Women with Low Bone Mineral density to Identify Women at Higher 
Risk of Hip Fracture (Dargent-Molina et al., 2002) 
27. Assessment of osteoporotic fracture risk in community settings; a study of post (Tan et al., 2008) 
28. Vertebral fracture risk (VFR) score (Lillholm et al., 2011) 
29. Hip Geometry and Its Role in Fracture (Brownbill, Ilich, 2003) 
30. Independent predictors of all osteoporotic-related fractures in healthy postmenopausal women (Albrand et al., 
2003) 
31. A simple clinical score for estimating the long-term risk of fracture in post-menopausal women (van Staa et 
al., 2006) 
32. Factors Associated With 5-Year Risk of Hip Fracture in Postmenopausal Women (Robbins et al., 2007) 
33. The Fracture and Immobilisation Score (FRISC) for risk assessment of osteoporotic and immobilisation in 
postmenopausal women-A joint analysis of the Nagano, Miyama, and Taiji Cohorts (Tanaka et al., 2010) 
 
Interpretation  
Table 12 shows that the majority (27/33 [82%]) of the tools were derived from original 
studies, 4/33 (12%) were from literature review and 2/33 (6%) were from meta-analyses. 
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The results of this part of the systematic review are presented in three sections: review articles, 
meta-analyses and original articles.  
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2.4.1.3.1 Review Articles 
The review articles are shown in Table 13.There were 3 reviews of general guidelines on the 
management of fragility fractures and osteoporosis (National Institute for Clinical Excellence 
(NICE), 2012, National Osteoporosis Foundation (NOF), 1998, Siminoski et al., 2007) and 
one general review of hip geometry and its association with hip fractures (Brownbill, Ilich, 
2003).  
 
The general reviews recommended guidelines for risk assessment in the management of 
fragility fractures. The reviews were sponsored Government agencies and osteoporosis 
organisations and cost effectiveness was a prime consideration. The tool by NICE is 
applicable to both sexes, NOF is applicable to post-menopausal Caucasian females in the USA 
and the tool by Siminoski and colleagues is a recommendation by Osteoporosis Canada & the 
Canadian Association of Radiologists for both sexes. 
 
The review of hip geometry and its association with hip fractures found that hip axis length. 
(HAL), neck shaft angle (NSA) and femoral neck width (FNW) show promise for enhancing 
fracture risk assessment in clinical settings. The review showed that both age and/ or loss of 
body weight are associated with changes in some geometric parameters which affect hip 
strength. It was shown that the greater hip strength in black men and women may be related to 
more favourable geometric parameters. Asian women who have a lower incidence of hip 
fractures compared to Caucasian women have a shorter HAL and a smaller NSA. The authors 
concluded that a longer HAL, wider NSA and FNW, increase the risk of hip fracture. 
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Table 13: Review articles of the systematic literature review from which four tools were derived 
Author(s) Year of 
review 
Type of 
review 
Title of article Conclusion(s) 
NICE  2012 General Osteoporosis: assessing the risk of fragility fracture Guideline for management 
recommended  
NOF  1998 General Osteoporosis: Review of the evidence for prevention, diagnosis 
and treatment and cost-effective analysis 
Guideline for management 
recommended 
Siminoski 
et al  
2007 General Recommendations of bone mineral density reporting in Canada: 
A shift to absolute fracture risk assessment 
Guideline for management 
recommended 
Brownbill 
RA et al  
2003 General Hip Geometry and Its Role in Fracture: What Do We Know so 
far 
Parameters of hip geometry 
are helpful but more research 
is needed 
National Institute for Health and Care Excellence (NICE), National Osteoporosis Foundation (NOF) 
Interpretation 
 Table 13 shows that the review articles addressed different questions. NICE, NOF and Siminoski et al recommended guidelines for 
the management of osteoporosis and fragility fractures. Brownbill et al explored the role of hip geometry as a predictor of hip 
fractures and although some parameters of hip geometry may predict hip fractures, they suggested further research be conducted. 
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2.4.1.3.2 Meta-analyses 
 
2.4.1.3.2.1 Meta-analysis of how Well Measures of Bone Mineral Density Predict 
Occurrence of Osteoporotic Fractures. (Marshall, et al 1996) 
 
Aim  
The aim of the study was to determine by a systematic review of the literature for all 
prospective studies if measurements of bone density in women could predict fractures of any 
type.  The main outcome measure was the relative risk of fracture for a decrease in bone 
mineral density of one standard deviation below age adjusted mean.   
 
Methods 
Only women were included and two types of studies were used for the study: prospective 
cohort studies and case-control studies.  
 
Prospective cohort studies 
 
Table 14 shows a summary of the findings of the prospective cohort studies. There were 
twenty-five publications from 11 populations.  The majority of the studies were from the USA 
(18 [72%]), 3(12%) were from Australia, 2(18%) were from Sweden and one each from the 
UK and Finland (1 [4%]). The studies were undertaken between 1977 and 1994 and the 
ethnicities of the participants were not stated. The population range was from 135 to 9704. 
The mean age range of the participants was from 57 to 83 years, the age was not reported in 
two studies. The follow-up was from 0.7 to 24 years equating to about 90,000 person years of 
observations.   
 
There were more than 2000 incident fractures during the period of observation. The fracture 
sites were the forearm, hip, non-spine, vertebral, proximal humerus, distal forearm, proximal 
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femur wrist and any site. The authors stated that it was not possible to calculate the 
proportions of the fractures by site because definite numbers were not reported in 11 studies. 
The site of bone density measurements were different, the majority was in the proximal radius 
(8 [24%]), the distal radius and calcaneus (7 [21%]), the lumbar spine (3 [9%]), the middle 
radius, proximal femur and forearm (2 [6%]) and the spine and femoral neck 1 [3%]) each. 
The risks were reported as relative risk with the corresponding 95% confidence interval (CI) in 
all publications.  
 
The range of the relative risk (RR) of 1SD deviation in BMD for all the studies was from 1.1 
to 4.4. Most of the sites which were used for BMD measurements had predictive ability for a 
decrease of 1 SD in bone density of from 1.4 to 2.6. The measurement of BMD at the spine 
had predictive ability for a decrease of 1 SD of 2.3 (95% CI 1.9 to 2.8) while measurement at 
the hip had predictive ability for hip fractures of 2.6 (95% CI 2.0 to 3.5). The average total 
scores for quality of the studies ranged from 11.7 to 19.3 out a possible 25. 
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Table 14: Summary of the findings from the 25 prospective cohort studies of the predictive 
value of bone mineral density for fractures 
 
Countries No of studies n (%) 
USA  
Australia 
Sweden 
UK 
Finland 
18(72) 
3(12) 
2(8) 
1(4) 
1(4) 
Population characteristics  (min – max) 
Population size range of cohorts (n) 
Mean age of participants  (years) 
Duration of follow-up in (years)  
Quality scores  
135 – 9704 
57 – 83 
0.7 – 24 
11.7 – 19.3 
Sites of BMD measurement   n (%) 
Proximal radius 
Distal radius 
Calcaneus 
Lumbar spine 
Middle radius 
Proximal femur 
Forearm 
Femoral neck 
8(24) 
7(21) 
7(21) 
3(9) 
2(6) 
2(6) 
2(6) 
1(3) 
Fracture risk (min – max) 
Relative risk of fracture  for 1SD decrease in 
BMD  
1.1 – 4.4 
Source: Marshall et al., 1996 
 
This metanalysis includes prospective studies published between 1994 and 1997.  
 
Interpretation 
Table 14 shows that the majority of studies were conducted in the USA and there was a wide 
range in the sizes of the cohort and duration of follow-up, the participants in the studies were 
middle aged. The majority of the incident fractures occurred in the upper limbs. The range of 
relative risk of fracture for 1SD decrease in BMD was from 1.1 to 4.4. 
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Case-control Studies 
 
Table 15 shows the summary of the findings of the case-control studies. There were twenty 
three studies and all were undertaken between 1991 and 1994. BMD measurements were 
estimated at the femoral neck in the majority (8 [36%]) and 5 (23%) each at the trochanter, 
Ward`s triangle and lumbar spine.  The total number of cases was 1111 (minimum to 
maximum range 18 to 100).  
 
The total number of controls was 1714 (minimum to maximum range 13 to 162). The range in 
bone mineral density between the cases and control was from minus 0.4 to minus 2.2. The 
differences in odds ratios of fracture for 1 SD decrease in BMD were as follows: femoral neck 
1.5 to 9.0; trochanter 1.7 to 3.7; Ward`s triangle 1.5 to 4.8; and the lumbar spine 1.7 to 2.0.   
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Table 15: Summary of the findings from the 23 case-control studies of the predictive value of 
bone mineral density for fractures 
 
 
Population characteristics  (min – max) 
Cases  (n) 
Controls (n) 
Differences in BMD between cases and 
controls  
1111 (18-100) 
1714 (13-162) 
-0.4 - -2.2 
 
Sites of BMD measurement   n (%) 
Femoral neck 
Trochanter 
Ward`s triangle 
Lumbar spine 
8 (36) 
5 (23) 
5 (23) 
5 (23) 
Fracture risk Weighted average of 
OR per 1SD decrease 
in BMDϮ 
 Femoral neck 
Trochanter 
Ward`s triangle 
Lumbar spine 
2.68 
2.79 
2.10 
1.81 
Source: Marshall et al., 1996 
Ϯ confidence intervals were not stated in the publication 
 
The case control studies include studies conducted between 1991 -1994 
 
Interpretation 
Table 15 shows that the majority of the BMD measurements were taken at the femoral neck. 
There was wide variation in the number of participants and BMD measurements in the cases 
and controls, the range was -0.4 to -2.2. The ORs for fracture for 1SD decrease in BMD were 
different between the sites of measurement. 
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2.4.1.3.2.2 Body Mass Index as a Predictor of Fracture Risk: A Meta-analysis (De Laet., 
et al 2005) 
 
Aim 
To quantify the effect of body mass index (BMI) on fracture risk in relation to bone mineral 
density (BMD), age and gender from an international perspective using worldwide data and 
BMI of 25 kg/m² as the reference 
 
Methods 
Baseline and follow-up data from 12 population-based cohorts comprising Rotterdam, 
EVOS/EPOS, CaMos, Rochester, Sheffield, Dubbo, EPIDOS, OFELY, Kuopio, Hiroshima 
and two cohorts from Gothenburg, Sweden were used. BMD was measured using different 
equipment. Fracture ascertainment was undertaken by self-report and or verified from hospital 
central databases. The study was done in 2004. 
 
Results  
The total population was 59,644 (75% were women). The follow-up was 252,034 person years 
(minimum to maximum 1,160 to 56,091), mean age 63.2 years (women 62.2 years, men 66.4 
years), mean BMI was 26 kg/m² (women 25.9 kg/m², men 26.2 kg/m²), mean height 163.3 cm 
(women 160.4 cm, men 172.6 cm), mean weight 69.5 kg (women 66.9 kg, men 77.9 kg). 
There were 5,321 (any fractures), 1,141 (hip fractures), 3,318 (osteoporotic fractures) (table 
16).  
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Table 16: Demography of the study population and outcome of fracture 
 
Sex Sample 
size 
[n (%)] 
Person 
–years 
Any 
fracture 
[n] 
Hip 
fracture 
[n] 
Osteoporosis 
fracture [n] 
Age 
(mean 
years) 
BMI 
(mean 
kg/m²) 
Height 
(mean 
cm) 
Weight 
(mean 
kg) 
All men 14,887 
(25%) 
60,427 837 188 644 66.4 26.2 172.6 77.9 
All 
women 
44,757 
(75%) 
191,607 4,484 953 2674 62.2 25.9 160.4 66.9 
Both 
 
59,644 
(100%) 
252,034 5,321 1,141 3318 63.2 26.0 163.3 69.5 
 
Source: De Laet., et  al 2005: Body mass index (BMI) 
 
Interpretation:  Table 16 shows the ratio of men to women in the study: sample size 1:3, 
therefore the women were considerably more; study period 1:3, therefore women were 
followed-up for considerably longer duration; any fracture 1;5.4, therefore women had 
considerably more fractures of any type;  hip fractures, 1:5.1, therefore  women had 
considerably more hip fractures, osteoporotic fractures, 1:4.2, therefore women had 
considerably more osteoporotic fractures, age, 1.1:1, therefore men were older than women, 
BMI, 1:1, therefore men and women had similar BMI, height 1.1:1, therefore men were taller 
than women, weight 1.2:1, therefore the men were heavier than than the women. 
 
  
96 
 
Without adjusting for BMD, low BMI in men and women combined was associated with a 
significantly increased age-specific risk of fracture while at higher BMI values, the risk of 
fracture decreased (table 17). The risk ratio per unit increase in BMI was: for any fracture 0.98 
(95% confidence interval 0.97 – 0.99), for osteoporotic fracture 0.97 (95% CI 0.96 – 0.98) and 
for hip fracture 0.93 (95% CI 0.91 – 0.94). The relative risk (RR) per change of BMI in men 
and women were similar (p > 0.30). 
 
When BMD was adjusted for, the gradient of risk changed markedly and remained 
significantly different from unity only for hip fracture in women (i.e. the overall effect of BMI 
was mostly due to the influence of BMD). For age, any osteoporotic fracture, the gradient of 
risk per unit of BMI increased with advancing age (without BMD adjustment). In contrast, for 
hip fractures, the gradient of risk decreased with age although the trend was not significant. 
Overall, the RR for hip fracture decreased 0.93 per unit increase in BMI. 
 
For BMI, the RR increased with decreasing BMI but the magnitude of the effect was greater 
for hip fractures than any osteoporotic or any fracture. Relative risk was markedly higher at 
lower values of BMI particularly with a BMI of 20 kg/m² or less. By contrast, between BMI of 
25 kg/m² and 35 kg/m², the difference in RR was small. There were no significant differences 
in these relationships between men and women. 
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Table 17: Relative risk of fracture with and without Bone Mineral Density  
 
BMI  
(not adjusted for 
BMD) 
Any fracture  
RR 
Osteoporotic 
fracture  
RR 
Hip fracture  
RR 
15 
20 
25 
30 
35 
 
1.66 
1.21 
1.00 
0.92 
0.85 
 
1.79 
1.27 
1.00 
0.89 
0.74 
 
4.48 
1.95 
1.00 
0.83 
0.75 
 
BMI  
(adjusted for BMD) 
 
Any fracture  
RR 
Osteoporotic 
fracture  
RR 
Hip fracture  
RR 
15 
20 
25 
30 
35 
1.00 
0.98 
1.00 
1.01 
0.99 
1.00 
0.98 
1.00 
1.01 
0.99 
2.16 
1.42 
1.00 
1.00 
1.18 
 
Source: De Laet., et al 2005: Body mass index (BMI); Bone mineral density (BMD); relative 
risk (RR) 
 
 
Interpretation 
Table 17 shows that when not adjusted for BMD, the relative risk (RR) for any fracture, 
osteoporotic fracture and hip fracture were high at BMI of 15 and 20 kg/m². There RR was no 
risk of fracture at BMI of 25kg/m². RR decreased when BMI were 30 and 35kg/m². When 
adjusted for BMD, the RR was practically nil for all BMIs except for hip fractures at BMI of 
15 and 20 kg/m². This suggests that the major influence of BMI on fractures is mainly through 
BMD except for hip fractures at BMI of 15 and 20 kg/m². 
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2.4.1.3.3 Original Articles 
 
2.4.1.3.3.1 Baseline Characteristics 
Table 18 shows the baseline demographic characteristics of the population included in each of 
the original 27 studies identified in the systematic review. The publication dates show that the 
studies of fragility risk assessment tools has been ongoing for 20 years (1990 to 2010). The 
earliest study was undertaken in 1990 and the majority of studies were conducted between 
2001 and 2010 (n=21 [75%]).  
 
The studies were done in Europe (n= 20(74 %), North America (n=5 [19 %]) and Oceania 
(n=4 (15%). The highest number of publications was in the United Kingdom (n=7 (26%). 
There were no articles from South America, Asia or Africa. 
 
The lowest age limit was 30 years in 2 (7%) studies and the highest was 103 years in 1 (4%) 
study. The majority of studies (n=18 [67%]) reported the participant`s mean age, most of 
which were above 65 years (n=15 [79%]). The remaining studies (n=5 [19 %]) reported age as 
range or participants equal to or above 60 years (n=1 [4 %]).   
 
The majority of the studies (n=21 [78%]) recruited only female participants, while the 
remaining (n=5 [19%]) recruited both males and females. There were no studies exclusively in 
males.  
 
The compositions of ethnic groups were as follows: Caucasians (n=10 [37%]), multiracial 
(n=3 [11%]), Caucasian and Aboriginal (n=2 [7%]) and mainly Caucasian in 1 (4%) study, 
ethnicity was not reported in 10 (37%) studies. There were no publications in other ethnic 
groups. 
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The majority of the studies (n=21 [78%]) included participants exclusively from the 
community, and the remaining studies (n=4 [15%]) recruited from both combined community 
and care home residents, only 1(4%) study recruited exclusively care home residents. 
 
Summary: The demography of the participants shows that the studies were published between 
1990 and 2010. All the studies were done in Europe, North America and Oceania with no 
studies reported in other geographical regions. Most of the participants were middle aged 
female Caucasians who were recruited from the community. There was only one study which 
was conducted exclusively in care homes and there were no studies exclusively in males. 
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Authors (s) 
and year of 
study 
Country of 
study 
Age  
(y) mean 
±SD or 
(range) 
Sex Ethnicity Setting(s) 
Garnero et 
al., 1996 
France 
 
82.5±4.6 
 
Female Caucasian Community 
(90%) 
Care home 
10%) 
Pluijm et 
al., 2009 
Netherlands 
 
74±9.1 
76±6.7 
Female Not stated 
? Caucasian 
 Community 
McGrother 
et al., 2002 
UK 77.9±6.1 
70-103 
Female Not stated Community/ 
care home 
Black et 
al., 2001 
USA 65-85 Female 99.7% 
Caucasian 
Community 
Dargent-
Molina et 
al., 2002 
France 80.5±3.7 Female Caucasian Community 
90%/care home 
10% 
Hippisley-
Cox et al., 
2009 
UK 42.7 
30-85 
Female (50.1%) 
Male (49.9%) 
Multiracial  Community/care 
home 
Nguyen et 
al., 2008 
Australia 71±8 
female, 
70±6 male 
Both;female 
61.3% 
Male 38.7% 
Caucasian 
98.6% 
Aboriginal 
1.4% 
 
Community 
Nguyen et 
al., 2007 
Australia 
 
≥60 
 
Both;female 
60% 
male 40% 
Caucasian 
98.6% 
Aboriginal 
1.4% 
Community 
Henry et 
al., 2006  
Australia 74±7 Female Caucasian Community 
Burger et 
al., 1999 
Netherlands 
 
68.1±7.9 Both;Female 
57.9% 
Male 42.1% 
Not stated? 
Caucasian 
Community 
Kanis et 
al., 2007 
UK 52-82 Both;female 
77% 
male 29% 
Multiracial Community 
Barr et al., 
2005 
UK 68±5.5 60-
80 
Female Not stated Community 
Périer et 
al., 2007 
France 62.2±9 Female Not stated? 
Caucasian 
Community 
 
 
 
 
 
 
Table 18 A: Demography of the participants of the original studies of the systematic review 
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Authors (s) 
and year of 
study 
Country of study Age in 
years 
mean, SD, 
range 
Sex Ethnicity Setting(s) 
 
Hans et al., 
2008 
 
France/Switzerland 
80.4±3.8 
75.2±3.1 
77.6±4.3 
 
Female 
 
Caucasian 
 
Community 
Gluer et 
al., 1994 
USA ≥65 Female Caucasian Community 
Porter et 
al., 1990 
UK 83.4±6.2 
84.6±6.4 
Female Not stated Care home 
Huang et 
al., 1998 
USA 73.7±4.9 
55-92 
Female Caucasian Community 
Cummings 
et al., 1995 
USA 72±5 Female Caucasian Community 
Tobias et 
al., 2007 
UK 65-75 Female Not stated Community 
Diez-Pérez 
et al., 2007 
Spain 72.3±5.4 Female Caucasian Community 
Dargent-
Molina et 
al., 2005 
 
France 
 
80.5±3.8 
 
Female 
 
Caucasian 
 
Community 
Tan et al., 
2008 
Australia 71.3±5.8 Female Not stated 
? Caucasian 
Community 
Lillholm et 
al., 2001 
Denmark 66.9±5.4 Female Not stated 
? Caucasian 
Community 
Albrand et 
al., 2002 
France 31-89 Female Caucasian Community 
Van Staa 
et al., 2006 
UK 50-90 Female Not stated Community 
Robbins et 
al., 2007 
USA 50-79 Female Multiracial Community 
Tanaka et 
al., 2010 
Japan  63.4±11.1 
59.5±11.3 
Female Not stated 
? Japanese 
Community 
United Kingdom (UK)  
Interpretation 
 Tables 18A and 18B show that the studies of fragility risk assessment tools have been 
ongoing for over 20 years. All the studies were conducted in Europe, North America and 
Oceania. Most of the participants in the studies are middle aged female Caucasians who were 
recruited from the community.   
  
Table 18 B: Demography of the participants of the original studies of the systematic review  
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2.4.1.3.3.2 Methodology of the Studies 
 
Table 19 shows the methodology of the twenty seven original articles which were identified in 
the systematic review. The majority of the studies (n=22 [82%]) were prospective, and the 
remaining were cross-sectional (n=2 [7%]), case-control (n=2 [7%]) and a combination of 
prospective and case-control (n=1 [4%]). 
 
The majority of the studies (n=25 [93%]) recruited over five hundred participants. In two 
studies (n=2 [7%]), the study population was less than 130 and in one (n=1 [4%]), the 
participants were more than 2 million. 
 
Most of the initial assessment of the participants (n=18 [67%]) were questionnaire-based. Of 
these, the majority (n=17 [94%]) were by a combination of questionnaire and physical 
examination, and the remainder (n=1 [4%]) by a combination of questionnaire and 
biochemical examination. The assessments of the remaining participants were solely by 
radiological examination in 4 (15%), review of medical record notes, biochemical indices and 
by a combination of physical and radiological examination in 1 (4%) study each. 
 
Most of the studies (n=15 [56 %]) used any incident fracture at any site as the primary 
outcome measure and the remainder used the hip (n=10 [37%]) and the spine (n=2 [7%]). The 
method of verification of incident fractures was mostly by radiological report (n=20 [74%]), 
and the remainder were by self-report (n=2 [7%]), and combination of radiological and self-
report in 2 (7%) studies. There were no records of how incident fractures were verified in the 
others (n=4 [14%]).  
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The follow-up of the participants were reported as years in the majority (n=25 [93%]) and 
person-years (n=2 [7%]) in the remaining studies. In the publications which reported follow-
up as years, the duration of follow-up was three years and over in the majority (n=19 [70%]). 
 
The authors analysed their data by using different statistical methods; Cox regression and 
logistic analysis in 22 (82%) studies, Bayesian model in 2 (7%) studies, correlation 
coefficient, Student`s t test, and Mann Whitney test in 1 (4%) study each. 
 
Most of the authors (n=16 [59%]) included conflict of interest statements in the publications 
but the remainder (n=11 [30%]) did not. Most of the authors (n=19 [70%]) stated that they had 
obtained favourable ethical approval from the appropriate regulatory authorities and there was 
no documentation from the remainder (n=8 [30 %]). 
 
Summary: The methodology of the studies shows that the majority (82%) were prospective. 
Most (93%) of the studies recruited over five hundred participants using questionnaire-based 
approach for the initial assessment. The primary outcome measures in just over half (56%) of 
the studies were incident fractures at any sites, these were often (74%) verified radiologically. 
In the majority (70%) of the studies, the follow-up duration of the participants was over three 
years. The majority (59%) of the authors included conflict of interest statement and most 
(70%) of them stated they had obtained ethical approval from the regulatory authorities. 
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Author(s) Design of 
study 
No. of 
participants 
Type of assessment at 
recruitment 
Site of 
primary 
outcome 
measure 
of study 
Method of 
fracture 
verification 
Duration 
of follow-
up (y) 
Method of 
statistical 
analysis 
Conflict 
of 
interest 
declared 
 
Ethical 
approval 
for study 
Yes/No 
Garnero et 
al., 1996 
Prospective 7,598 Questionnaire/biochemical Hip Not stated 1.8 Correlation 
correlation 
Not 
declared 
Yes 
Pluijm et 
al., 2009 
Prospective 4,919 Questionnaire/physical  Any Radiological 6-8.9  Cox 
regression 
Not 
declared 
Yes 
McGrother 
et al., 2002 
Prospective 1,289 Questionnaire/physical Hip Radiological 5.5  Logistic 
regression 
Not 
declared 
Not 
stated 
Black et 
al., 2001 
Prospective 9,704 Questionnaire/physical Any Radiological 5  Logistic 
regression 
 
Declared 
Yes 
Dargent-
Molina et 
al., 2002 
 
Prospective 
 
7,575 
 
Questionnaire/physical 
 
Any 
 
Self-report 
 
4  
 
Cox 
regression 
 
Declared 
 
Not 
stated 
Hippisley –
Cox et a.,l 
2009 
 
Prospective 
 
2,357,895 
 
Medical records 
 
Any 
 
Radiological 
 
15,947515 
Person ys 
 
Cox  
regression 
 
Declared 
 
Yes 
Nguyen et 
al., 2008 
Prospective 2,216 Questionnaire/physical Any Radiological 13  Bayesian 
model 
Declared Yes 
Nguyen et 
al., 2007 
Prospective 1,948 Questionnaire/physical Hip Radiological 13  Bayesian 
model 
Declared Yes 
Henry et 
al., 2006 
Cross-
sectional 
600 Questionnaire/physical Any Radiological 5.8  Logistic  
regression 
Not 
declared 
Yes 
Burger et 
al 1999 
Prospective 5,208 Questionnaire/physical Hip Radiological 3.8  Logistic 
regression 
Declared Yes 
Kanis et 
al., 2007 
Prospective 59,644 Questionnaire/physical Any Radiological/self-
report 
250,000 
Person ys 
Poisson 
regression 
Not 
declared 
Yes 
Barr et al., 
2005 
Prospective 7.604 Radiological Any Self-report 1.5-2.1 
 
Logistic 
regression 
Declared Yes 
 
 
  
Table 19A: Methodology of the original studies included in the systematic review 
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Author(s) Design of 
study 
No. of 
participants 
Type of assessment at 
recruitment 
Site of  
primary 
outcome 
measure 
of study 
Method of 
fracture 
verification 
Duration 
of follow-
up in ys 
Method of 
statistical 
analysis 
Conflict 
of 
interest 
declared 
 
Ethical  
approval 
for study 
Yes/No 
Périer et 
al., 2007 
Prospective 671 Biochemical Any Radiological 10  Cox 
regression 
Not 
declared 
Not stated 
Hans et 
al., 2008 
Prospective 12,958 Questionnaire/physical Hip Radiological 3.2  Poisson 
regression 
Not 
declared 
Not stated 
Gluer et 
al., 1994 
Prospective/ 
Case 
control 
9,704 Radiological Hip Radiological 3.3  Logistic 
regression 
 
Declared 
 
 Yes 
Porter et 
al., 1990 
Prospective 1,414 Physical/radiological Hip Not stated 2  Student`s t 
test 
Declared Not stated 
Huang et 
al., 1998 
Prospective 560 Radiological Any Radiological/self-
report 
2.7  Logistic 
regression 
Declared Yes 
Cummings 
et al., 1995 
Prospective 9.516 Questionnaire/physical Hip Radiological 4.1  Cox`s 
regression 
Not 
declared 
Yes 
Tobias et 
al., 2007 
Cross-
sectional 
540 Questionnaire/physical Spine Radiological Not stated Logistic 
regression 
Declared Yes 
Diez-Pérez 
et al., 2007 
Prospective 5,201 Questionnaire/physical Any Radiological 3  Cox`s  
regression 
Declared Yes 
Dargent-
Molina et 
al., 2005 
Prospective 7,512 Questionnaire/physical Hip Not stated 3.9  Cox`x 
regression 
Declared Yes 
Tan et al., 
2008 
Case- 
control 
104 Physical/radiological Any Radiological Not stated Logistic  
regression 
Not 
declared 
Yes 
Lillholm 
et al., 2001 
Case-
control 
126 Radiological Lumbar 
spine 
Radiological 6.3  Mann-
Whitney 
test 
Declared Not stated 
 
 
Table 19B: Methodology of the original studies included in the systematic review (continued) 
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Author(s) Design of 
study 
No. of 
participants 
Type of assessment at 
recruitment 
Site of 
primary 
outcome 
measure 
of study 
Method of 
fracture 
verification 
Duration 
of follow-
up in ys 
Method of 
statistical 
analysis 
Conflict 
of 
interest 
declared 
 
Ethical 
approval 
for study 
Yes/No 
Albrand 
et al., 
2002 
Prospective 672 Questionnaire/physical Any Radiological 5.3  Logistic  
regression 
Not 
declared 
Yes 
Van Staa 
et al., 
2006 
Prospective 366,104 Questionnaire Any Not stated 5.8  Cox`s  
regression 
Declared Not stated 
Robbins 
et al., 
2007 
Prospective 93,676 Questionnaire Hip Radiological 7.6  Cox`s  
regression 
Declared Yes 
Tanaka et 
al., 2010 
Prospective 1,787 Questionnaire Any Radiological 5.3  Poisson 
regression 
Not 
declared 
Not stated 
 
Interpretation 
Tables 19A, 19B and 19C show the methodology of the original studies included in the systematic review.  The majority were 
prospective. There were over five hundred participants in most of the studies; one study recruited over 2 million participants. The 
method of assessment of the participants during recruitment was mostly questionnaire-based. The primary outcome measures were 
incident fractures at any site and these were often verified radiologically. The follow-up period was over 3 years in the majority of 
studies. Regression methods of analysis were the commonest method of analysis. Most of the authors included conflict of interest 
statements and also stated they had obtained ethical approval for the studies from the appropriate review boards. 
 
 
  
Table 19C: Methodology of the original studies   included in the systematic review (continued) 
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2.4.1.3.3.3 Findings from the Original Studies 
Table 20 shows the results of the findings from the 27 original studies. The performance 
characteristics of the tools were reported as follows:  
 
 Area under the receiver operating curve (AUC) of the receiver operating characteristics 
(ROC) curve 15 (54%) 
 Sensitivity and specificity 3 (11%) 
 Sensitivity and specificity and AUC 2 (7%) 
 Odds ratios (OR) 2 (7%) 
 Relative risk (RR) 2 (7%) 
 C-statistics 2 (7%) 
 There was no performance report in one 1 (4%) study 
 
Most of the tools (n=19 [70%]) were not validated internally or externally (n=21 [78%]) and 
only 3 (11%) were validated both internally and externally. The output of the tools were 
reported as absolute probability (pseudocalibration as there are no current gold standards for 
comparison)  in the majority (n=19 [70%]).  
 
The output of the tools were reported as absolute risk in 13 (48%), RR in 2 (7%) and not stated 
in 12 (44%) studies. The models contained variable numbers of predictors with a range of 1 to 
18. The commonest number of predictors was 1 (n=5 [19%]). 
 
Few studies reported missing data (n=6 [22%]) and the loss to follow-up of the participants 
was reported in 2 (7%) studies. 
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Summary: The findings from the studies show that the majority used AUC to report 
performance, most of the tools were not validated internally or externally, only a few were 
validated both internally and externally. Most of the tools were calibrated and these were often 
undertaken by the authors. The metric of expression of the tools was often by absolute risk. 
The tools contained variable numbers of predictors but most of them had only one predictor. 
Few studies reported missing data and loss to follow-up of the participants. 
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Table 20 A: Findings from the original studies included in the systematic review 
 
Author(s) Performance 
characteristics 
of tools 
Internal 
validation 
of tools? 
External 
validation 
of tools? 
Internal 
and 
external 
validation 
Tool 
calibrated? 
Authors 
involved in 
calibration? 
Output 
of tools 
No. of 
risk 
factors 
in tools 
Missing 
data 
reported? 
Loss to 
follow-up 
reported? 
Garnero et 
al., 1996 
Sen. 30-36 
Spec. 81 
No No No No NA NA 2 No No 
Pluijm et 
al., 2009 
c-statistic 0.77 Yes No No Yes Yes 10 y 
absolute 
risk 
5 No No 
McGrother 
et al., 2002 
ROC 
0.82@3ys 
0.77@5.5ys 
No No No No NA NA 6 Yes Yes 
Black et 
al., 2001 
ROC 0.714  
w BMD 
0.77 wo BMD 
No Yes No Yes Yes 5 y 
absolute 
risk 
7 w 
BMD 
No No 
Dargent-
Molina et 
al., 2002 
Sen. 37.3 
Spec. 85.4 
 
No No No Yes Yes Not 
stated 
6 w 
BMD 
Yes No 
Hippisley-
Cox et al., 
2009 
ROC 0.89(hip) 
in females, 
0.86(hip) for 
males, 0.79 for 
other fractures 
in females, 
0.69 for males 
Yes Yes Yes Yes Yes 1-10 y 
absolute 
risk 
18 Yes No 
Nguyen et 
al., 2008 
ROC 0.85 Yes Yes Yes Yes Yes 5&10 y 
absolute 
risk 
4 No No 
Nguyen et 
al., 2007 
ROC 0.85 Yes No Yes Yes Yes 5&10 y 
absolute 
risk 
4 No No 
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Table 20B: Findings from the original studies included in the systematic review (continued) 
 
Author(s) Performance 
characteristics 
of tools 
Internal 
validation 
of tools? 
External 
validation 
of tools? 
Internal & 
external 
validation  
Tool 
calibrated? 
Authors 
involved in 
calibration? 
Output 
of tools 
No. of 
risk 
factors 
in tools 
Missing 
data 
reported? 
Loss to 
follow-up 
reported? 
Henty et 
al., 2006 
Sen. 59.2 
Spec. 64.8 
ROC 0.66 
No No No Yes Yes 5&10 y 
absolute 
risk 
5 w 
BMD 
No No 
Burger et 
al., 1999 
ROC 0.88 w 
BMD, 0.83 wo 
BMD 
No No No Yes Yes 4 y 
absolute 
risk 
6 No Yes 
Kanis et 
al., 2007 
Sen.60.8, spec. 
65.6, ROC 
0.68 (UK) 
Yes Yes Yes Yes Yes 10 y 
absolute 
risk 
12 w 
BMD 
Yes No 
Barr et al., 
2005 
ROC 0.635 No No No Yes Yes Not 
stated 
1 No No 
Périer et al 
2007 
RR 1.03 No No No Yes Yes Not 
stated 
1 No No 
Hans et al., 
2005 
ROC 0.63-0.81 No No No Yes Yes 10 y 
absolute 
risk 
7 No No 
Gluer et 
al., 1994 
ROC 0.81 No No No Yes Yes Not 
stated 
1 No No 
Porter et al 
1990 
No induces 
reported 
No No No No NA NA 3 No No 
Huang et 
al.,   
1998 
OR 
1.5(vertebral 
fracture), 1.89 
(non-spine) 
fracture, 1.72 
(any fracture) 
No No No Yes Yes Absolute 
risk 
1 No No 
Cummings 
et al., 1995 
RR 0.6-2.8, RR 
0.7-2.0 for 
base model 
+fractures+ 
BMD 
No No No No NA RR 17 Yes No 
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Table 20C: Findings from the original studies included in the systematic review (continued) 
 
Author(s) Performance 
characteristics 
of tools 
Internal 
validation 
of tools? 
External 
validation 
of tools? 
Internal & 
external 
validation  
Tool 
calibrated? 
Authors 
involved in 
calibration? 
Output 
of tools 
No. of 
risk 
factors 
in tools 
Missing 
data 
reported? 
Loss to 
follow-up 
reported? 
 
Tobias et 
al., 2007 
 
ROC BMD 
0.68, 4 CRFs 
0.74,BMD + 4 
CRFs 0.78 
 
Yes 
 
No 
 
No 
 
No 
 
NA 
 
Not 
stated 
 
5 
 
Not stated 
 
Not stated 
Diez-
Pérez et 
al., 2005 
ROC 0.67-0.69 No No No 
 
No NA Absolute 
risk 
6 Not stated Not stated 
Dargent-
Molina et 
al., 2005 
Sen. CRFs vs 
BMD,51vs 34.9 
Yes No No Yes Yes Not 
stated 
7 Not stated Not stated 
Tan et al., 
2008 
ROC 0.77 No No No No NA Not 
stated 
3 Not stated Not stated 
Lillholm 
et al., 
2001 
ROC 0.82 No No No Yes Yes  Not 
stated 
1 Not stated Not stated 
Albrand 
et al 2002 
OR 1.76 – 1.22 No No No No NA Not 
stated 
7 Not stated Not stated 
van Staa 
et al., 
2006  
ROC 0.86(hip), 
0.69(vertebral), 
0.60(others) 
No Yes No Yes Yes 5 y 
absolute 
risk 
6 Yes Not stated 
Robbins 
et al., 
2007 
ROC 0.80 Yes No No Yes Yes 5 y 
absolute 
risk 
11 Not stated Not stated 
Tanaka et 
al., 2010 
c-statistic 0.727 No Yes No No NA RR 5 Not stated Not stated 
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Sens.: sensitivity, Spec.: specificity, PPV.: positive predictive value, NA.: not applicable 
RR.: relative risk, SD.: standard deviation, BMD.: bone mineral density 
ROC.: receiver operating characteristic, WHO.: World Health Organisation, OR.: odds ratio 
CRF.: clinical risk factor, BMI.: body mass index, w.: with, wo.: without 
 
Interpretation 
 Tables 20 A, 20B and 20C show that the majority of the publications used the AUC under the 
ROC to report on the discriminatory capacity of the tools. The majority were not validated 
internally or externally. Most of the tools expressed output as absolute probability. Missing 
values and follow-up were often not reported. 
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 2.4.1.3.4. Quality Assessment of the Studies 
 
Tables 21 and 22 show the scores of the studies on QUADAS. A score of 7 and above out of 
the maximum possible of 14 is regarded as good quality study on this scale. The majority of 
the studies (n=22 [67%]) scored 7 and above each but there were variations in scores in each 
of the 14 domains. 
 
The highest scores were in domains 2 and 10 (85%) and the lowest was in 3 (12%). The study 
with the highest score was De Laet et al., 2005 and the studies with lowest scores were NICE, 
NOF and Huang et al., 1998. 
 
 
 
114 
 
Table 21: Scores of the studies of the systematic review on the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) 
N= no , Y= yes, U= unknown 
Interpretation: Table 21 shows that the scores on QUADAS indicate that the majority of the tools were of good quality but there were variations in many 
domains.  
 
Fracture risk assessment tools 
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Yes/No/Unknown 
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Was the Spectrum of patients representative of 
the patients who will receive the test in 
practice?  
N N N Y N N Y N N N N Y N Y N N N N N Y N N N Y Y N N N U U N N N 
Were selection criteria clearly described? 
 
Y Y Y Y N Y Y Y Y N Y Y Y Y N Y Y N Y Y Y Y Y Y Y Y Y Y U Y Y Y Y 
Is the reference standard likely to correctly 
classify the target condition? 
N N U U U U U U U U N U N U N N Y U N U U N Y U Y U N Y U U U U U 
Is the period between reference standard and 
index test short enough to be reasonably sure 
that the target condition did not change 
between the two tests?  
U N U U U Y U U U U Y U Y U Y Y Y N Y U U U Y U Y Y Y Y U Y U Y Y 
Did the whole sample of a random selection of 
the sample, receive verification using a 
reference standard of diagnosis? 
Y Y U Y Y Y U Y Y Y Y N U Y Y Y Y N Y U N U Y U Y Y Y Y U Y U Y Y 
Did patients receive the same reference 
standard regardless of the index test results? 
 
N Y Y Y Y Y Y Y Y Y Y N N Y Y Y Y Y Y Y N U Y U Y Y Y Y U Y U Y Y 
Was the reference standard independent of the 
index test (i.e. the index test did not form part 
of the reference standard)? 
Y Y U U Y Y U Y Y Y Y N N Y Y Y Y Y Y U U U Y Y Y Y Y Y U Y U Y Y 
Was the execution on the index test described 
in sufficient detail of permit replication of the 
test?   
Y Y N Y N Y Y Y Y N Y N N Y Y Y Y Y Y Y Y Y N Y Y Y Y Y U Y Y N Y 
Was the execution of the reference standard 
described in sufficient detail to permit its 
replication?  
N Y N N N N U Y Y Y Y N N U Y Y Y Y Y U U U Y Y Y Y Y Y U Y U N Y 
Were the index test results interpreted without 
knowledge of the results of the reference 
standard?  
Y Y Y Y Y Y Y Y Y Y Y N N Y Y Y Y U Y Y U Y Y Y Y Y Y Y U Y Y Y Y 
Were the reference standard results 
interpreted without knowledge of the results of 
the index test?  
Y Y U Y U Y U Y Y Y Y N N U U U Y Y Y U U U Y U Y Y Y Y U Y Y Y Y 
Were the same clinical data available when test 
results were interpreted as would be available 
when the test is used in practice? 
N Y Y U Y Y Y Y Y Y Y N N Y Y U U U U U U U N U Y U U U U U U Y Y 
Were uninterpretable/Intermediate test results 
reported?  
N N N Y Y U Y U U U U N N Y U U Y U U U N U U U Y U Y U U U Y U U 
Were withdrawals from the study explained? 
 
N N Y Y Y N Y U U U Y N N Y Y U U U Y U N Y U U Y Y U U U U Y U U 
Total 6 9 4 8 7 8 8 9 9 7 11 2 2 10 9 8 11 5 10 4 2 4 9 6 13 10 10 10 0 9 5 8 10 
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Table 22: Summary of the responses on the Quality Assessment of Diagnostic Accuracy Studies  
Questions Yes No  Unknown 
Was the spectrum of patients representative of the patients who will receive the test 
in practice? n (%) 
7 (21) 24 (73) 2 (6) 
Were selection criteria clearly described? n (%) 28 (85) 4 (12) 1 (3) 
Is the reference standard likely to classify the target conditions correctly n (%)? 4 (12) 9 (27) 20 (61) 
Is the period between the reference standard and the index test short enough to be 
reasonably sure that the target condition did not change between the two tests? n (%) 
15 (46) 2 (6) 16 (49) 
Did the whole sample of a random selection of the sample receive verification using 
a reference standard of diagnosis? n (%) 
22 (67) 3 (9) 8 (24) 
Did patients receive the same reference standard regardless of the index test results? 
n (%) 
25 (76) 4 (12) 4 (12) 
Was the reference standard independent of the index test? (i.e. the index did not form 
part of the reference standard) n (%) 
23 (70) 2 (6) 8 (24) 
Was the execution of the index test described in sufficient details to permit 
replication of the test? n (%) 
25 (76) 7 (21) 1(3) 
Was the execution of the reference standard described in sufficient details to permit 
its replication? n (%) 
18 (55) 8 (24) 7 (21) 
Were the test results interpreted without knowledge of the results of the reference 
standard? n (%) 
28 (85) 2 (6) 3 (9) 
Were the reference standard results interpreted without knowledge of the results of 
the index test? n (%) 
20 (61) 2 (6) 11 (33) 
Were the same clinical data available when the test results were interpreted as would 
be available when the test is used in practice? n (%) 
14 (42) 4 (12) 15 (46) 
Were uninterpretable test results reported? n (%) 8 (24) 6 (18) 19 (56) 
Were withdrawals from the study explained? n (%) 12 (36) 6 (18) 15 (46) 
Quality Assessment of Diagnostic Accuracy Studies (QUADAS) 
Interpretation  
 Table 22 shows that although the majority of the responses to the questions on QUADAS were `yes`, the response 
relating to the reference standard were low which highlights the fact that currently there is no single diagnostic test for 
fragility fractures. For fragility fracture risk assessment, FRAX is the most widely used. Many publications did not report 
on uninterpretable test results and withdrawals which threaten validity of the data.  
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2.4.1.3.5. Characteristics of the Tools 
Table 23 shows the distribution of the predictors in the tools. They were grouped into 8  
domains: 
 
 Dermography; refers to the characteristics such as age, sex, ethnicity 
 Radiological investigations; refers to the radiological investigation and fractures 
 Comorbidities; refers to the presence of one or more diseases in the same person 
 Physical limitations; refers to difficulty performing any physical activities 
 Life style; refers to behavioural and social issues that may impact health such as 
alcohol, smoking 
 Types of medications; this refers to the different drugs which may have effect on falls 
and musculoskeletal health 
 Living arrangement; refers to the way someone organises how and where they live 
 Biochemical indices; a number of biochemical indices are related to falls and 
musculoskeletal health  
 
The most common was demography (n=22 [76%]). In this domain, the distribution of the risk 
factors was as follows: age 15 (52%); body mass index/weight 13 (49%); gender 9 (31%); 
ethnicity 3 (10%); and height after 25 years 1 (3%). 
 
The next domain was the result of radiological investigations (n=20 [69%]). The distribution of 
predictors in this domain was as follows: axial BMD 10 (35%); broad band ultrasound 
attenuation (BUA) 6 (21%); vertebral morphology 3 (10%); peripheral BMD 2 (7%); and X-
ray pelvis 1 (3%). 
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Comorbidities was the next commonest domain (n=19 [66%]). The distribution of the risk 
factors were as follows: history of prior fractures 15 (52%); history of falls 9 (28%); diabetes 
mellitus 3 (10%); rheumatoid arthritis 2 (7%); other causes of osteoporosis 2 (7%); dementia 2 
(7%); and history of back pain 1 (3%); cancer 1 (3%); asthma/copd 1 (3%); IHD/stroke 1 (3%); 
chronic liver disease 1 (3%); chronic kidney disease 1 (3%); Parkinson`s disease 1 (3%); 
malabsorption 1 (3%); endocrine problems 1 (3%); and history of early menopause 1 (3%). 
 
The next domain was physical limitations (n=12 [41%]). The distribution of the risk factors 
were as follows: use of the arms to stand up 3 (10%); visual defects 3(10%); use of walking 
aids 2(7%); reported poor health 2 (7%); grip strength 2 (7%); gait speed 2 (7%); poor 
circulation in the feet 2 (7%); poor trunk manoeuvre 1(3%); assistance with activities of daily 
living (ADLs) 1 (3%); tachycardia 1 (3%); and the ability to tandem walk 1 (3%). 
 
The next domain was life style factors (n=10 [34%]). The distribution of the risk factors were 
as follows: history of smoking 7 (24%); physical activities 3 (10%); alcohol history 2 (7%); 
calcium intake less than 250mg/day 1 (3%); and history of taking great amount of caffeine 
1(3%). 
 
The next domain was the types of medications taken by the patient (n=6 [21%]). The 
distribution were as follows: oral corticosteroids 3 (10%); anticonvulsants 2 (7%); recent use of 
CNS drugs 2 (7%); and oestrogen only HRT 1 (3%). 
 
The last two domains were living arrangements (living in a care home) and biochemical 
indices (bone turnover markers) which contained 1 (3%) risk factor each.  
  
Summary: There was considerable heterogeneity in the broad categories of the predictors of 
the tools. The most common were demographic variables. The next were radiological 
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investigations, comorbidities, physical limitations, life style factors, the types of medications, 
living arrangements and biochemical indices in that order. 
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Table 23A: Characteristics of the tools identified  in the systematic review 
 
Variables M
a
r
sh
a
ll
 e
t 
a
l 
1
9
9
6
 
G
a
rn
er
o
 e
t 
a
l 
1
9
9
6
 
P
lu
ij
m
 e
t 
a
l 
2
0
0
9
 
M
c
G
ro
th
e
r
 e
t 
a
l 
2
0
0
2
 
B
la
ck
 e
t 
a
l 
2
0
0
1
 
D
a
r
g
e
n
t-
M
o
li
n
a
 e
t 
a
l 
2
0
0
6
 
H
ip
p
is
le
y
-C
o
x
 &
 C
o
u
p
la
n
d
 
N
g
u
y
en
 e
t 
a
l 
2
0
0
8
 
N
g
u
y
en
 e
t 
a
l 
2
0
0
7
 
H
en
ry
 e
t 
a
l 
2
0
0
6
 
B
u
r
g
e
r
 e
t 
a
l 
1
9
9
9
 
K
a
n
is
 e
t 
a
l 
2
0
0
7
 
B
a
r
r
 e
t 
a
l 
2
0
0
5
 
P
e
r
ie
r
 e
t 
a
l 
2
0
0
7
 
H
a
n
s 
e
t 
a
l 
2
0
0
8
 
G
lu
e
r
 e
t 
a
l 
1
9
9
4
 
P
o
r
te
r
 e
t 
a
l 
1
9
9
0
 
H
u
a
n
g
 e
t 
a
l 
1
9
9
8
 
C
u
m
m
in
g
s 
e
t 
a
l 
1
9
9
5
 
T
o
b
ia
s 
e
t 
a
l 
2
0
0
7
 
D
ie
z
-P
e
r
e
z
 e
t 
a
l 
2
0
0
7
 
D
e
 L
a
e
t 
e
t 
a
l 
2
0
0
5
 
D
a
r
g
e
n
t-
M
o
li
n
a
 e
t 
a
l 
2
0
0
2
 
T
a
n
 e
t 
a
l 
2
0
0
8
 
L
il
lh
o
lm
 e
t 
a
l 
2
0
1
1
 
A
lb
r
a
n
d
 e
t 
a
l 
2
0
0
2
 
V
a
n
 S
ta
a
 e
t 
a
l 
2
0
0
6
 
R
o
b
b
in
s 
e
t 
a
l 
2
0
0
7
 
T
a
n
a
k
a
 e
t 
a
l 
2
0
1
0
 
Demographic Details                                                           
Age     X   X X X X X   X X               X X   X     X X X X 
Gender             X X X   X X         X   X       X X           
Ethnicity             X X                                       X   
Body Mass Index or Weight     X X X X X     X X X     X             X         X X X 
Height after 25 years                                     X                     
Life Style Factors                                                           
Smoking     X   X   X       X X     X                         X   
Alcohol             X         X                                   
Calcium intake < 250mg/day                                         X                 
Taking great amount of caffeine                                     X                     
Physical activity                                     X             X   X   
Living arrangement                                                           
Care home             X                                             
Community                                                           
Physical Limitations                                                           
Use of walking aid     X               X                                     
Poor trunk manoeuvre       X                                                   
Reported poor health                                     X                 X   
Use of arms to stand up         X                   X       X                     
Instrumental ADL assistance           X                                               
Grip strength           X                                       X       
Visual defects           X                         X       X             
Tachycardia                                     X                     
Ability to do tandem walk                                             X             
Gait speed                                 X           X             
Poor circulation in feet       X                                       X           
Family History                                                           
Family history of fracture         X   X         X                 X         X   X   
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Table 23B: Characteristics of the tools identified in the systematic review (continued) 
 
Variables 
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Comorbidities                                                           
Prior fracture     X     X X X X X   X     X         X X     X   X X X X 
Epilepsy       X     X                                             
Diabetes Mellitus             X               X                         X   
History of Fall             X X X X         X           X   X       X     
Dementia             X                   X                         
Cancer             X                                             
Asthma/COPD             X                                             
IHD/Stroke             X                                             
Chronic Liver disease             X                                             
Chronic Kidney disease 4 or 5             X                                             
Parkinson`s Disease             X                                             
Rheumatoid Arthritis             X         X                                   
Malabsorption             X                                             
Endocrine problems             X                                             
Other causes of secondary 
osteoporosis                       X             X                     
History of early menopause                                                           
History of back pain                                       X                 X 
Radiological Features                                                           
Axial BMD X X       X     X X X X                       X   X     X 
Geometric and structure of 
femur                                                           
X-ray pelvis                               X                           
BUA Index                             X   X X X   X     X           
Vertebral morphology       X                               X         X         
Hip Geometry                                                           
CT models                                                           
Peripheral BMD                         X         X                       
Biochemical Features                                                           
Bone turnover markers   X                                                       
Serum Homocysteine                           X                               
Medications                                                           
Use of oral steroids       X               X                               X   
Taking oestrogen only HRT             X                                             
Antidepressant             X                                             
Anticonvulsant             X                       X                     
Recent use of CNS drugs                                       X               X     
X= present 
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Interpretation : Tables 23A and 23B show that QFractureScores (Hippisley-Cox et al,2009) had the highest number of predictors which 
were distributed in most of the domains. BMD (Marshall et al, 1996) had only one predictor which was in the radiological domain. The 
predictors in the other tools were in between. 
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2.4.2. Summary of Findings  
Thirty three tools informed this review: 4 general literature based review based tools, 2 meta-
analyses based tools and 27 original study based tools. The main findings from the reviews 
were: 
 
General literature review based tools. Of the four tools, three were synthesised by opinion 
leaders. The articles which they reviewed and their quality (quantity risk of bias) were not 
stated and guidelines were subsequently produced for their use. In the fourth article, the author 
suggested that hip geometry was a promising tool for predicting hip fractures and more 
research was needed. This researcher awarded scores of between 0 and 5 to the methodology 
on QUADAS. 
 
Meta-analyses based tools.  The first of the two meta-analyses  was conducted in 1994 and the 
tool was based on the relative risk of fragility fracture in females, age adjusted sustaining 
fragility fractures for 1 SD difference in BMD.  The articles which were used were published 
from 1985 to 1994. Two types of studies were used: prospective cohort studies (11 of them) 
and case-control studies (8 of them). All the measuring sites had had similar predictive 
abilities (RR 1.5 [95% Confidence interval 1.4 to 1.6]) for decrease in bone mineral density 
except for measurement at spine for predicting vertebral fractures (RR 2.3 [11.9 to 2.8]) and 
measurements at the hip for hip fractures (RR 2.6 [2.0 to 3.5]). The quality of scores for the 
prospective studies ranged from 11.7 to 19.3 out of a possible 25 but the assessors did not state 
the quality of the case-control studies. This researcher rated the quality of the entire meta-
analysis as poor and awarded 6 on QUADAS. 
 
The second meta-analysis based tool, BMI was conducted in 2004 and it explored the effects 
of BMI, BMD, age and sex on the risk of fractures using international population-based 
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cohorts. The data were robust that low BMI increase fracture risk while BMI of 25kg/m² and 
above is protective. The authors did not report quality assessment of the studies they used; this 
researcher awarded a score of 13 on QUADAS.  
 
Original study based tools. A total of 27 tools were identified. All the tools were derived in 
developed countries between 1990 and 2010. The majority (82%) of the tools were derived 
from prospective studies. Just over a half (57%) used any incident fractures as primary 
outcome which were verified radiologically in the majority (71%). Although the majority of 
the authors included conflict declaration, 39% did not. Most (71%) of the authors stated they 
had ethical approval from the appropriate review board and there was no such documentation 
in 29%. This author`s assessment of the quality of the studies ranged from 2 to 13 out of a 
possible 14. 
 
 
2.4.3. Step 2 Selecting Tools for Care Home Residents 
 
2.4.3.1. The selection process 
The flow chart is shown in Figure 3. When the first criterion (was the design of the study 
prospective, systematic review or meta-analysis?) was applied, 24 (82.7%) fragility tools 
remained. When the second criterion (is the tool useable for any fragility fracture?) was 
applied, 14 (58%) fragility tools were left. When the third criterion (is the tool applicable to 
both sexes?) was applied, 4 (28.6%) fragility tools were left. When the last criterion (is the 
tool cost effective or pragmatic for care home residents?) was applied, 4 tools were left; they 
are FRAX, QFractureScores, Garvan nomogram and body mass index (BMI).  
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1. Marshall et al., 1996 
2. Garnero et al., 1996 
3. Pluijm et al., 2009 
4. McGrother et al., 2002 
5. Black et al., 2001 
6. Dargent-Molina et al., 2002 
7. Hippisley Cox & Coupland 2009 
8. Nguyen et al., 2008 
9. Nguyen et al., 2007 
10. Henry et al., 2006 
11. Burger et al., 1999 
12. NICE Clinical guide 146 
13. NOF 1998 
14. Kanis et al., 2007 
15. Barr et al., 2005 
16. Perier et al., 2007 
17. Hans et al., 2008 
 
18 Simoniski et al., 2007 
19  Glüer et al., 1994 
20   Porter et al., 1990 
21   Huang et al., 1998 
22   Cummings et al., 1995 
23   Tobias et al., 2007 
24   Diez-Perez et al 2007 
25    De Laet et al., 2005 
26  Dargent-Molina et al., 
2005 
27 Tan et al., 2008 
28 Lillholm et al., 2011 
29 Brownbill et al., 2003 
30 Albrand et al., 2002 
31 Van Staa et al., 2006 
32 Robbins J et al., 2007 
33 Tanaka S et al., 2010 
 
 
Was the study 
prospective or systematic 
review or meta-analysis? 
If yes accepted 15 Porter et al., 1990 
16 Huang et al., 1998 
17 Cummings et al., 1995 
18 Diez-Perez et al., 2007 
19 De Laet et al., 2005 
20 Dargent-Molina et al., 
2005 
21 Albrand et al., 2002 
22 Van Staa et al., 2006 
23 Robbins J et al., 2007 
24 Tanaka S et al., 2010 
 
1. Marshall et al., 1996 
2. Garnero et al., 1996 
3. Pluijm et al., 2009 
4. McGrother et al., 2002 
5. Black et al 2001 
6. Hippisley Cox & Coupland 2009 
7. Nguyen et al., 2008 
8. Nguyen et al., 2007 
9. Burger et al., 1999 
10. Kanis et al., 2007 
11. Barr et al 2005 
12. Perier et al., 2007 
13. Hans et al., 2009 
14. Glüer et al., 1994 
Was any fragility 
tool the endpoint? 
If yes accepted 
 1. Marshall et al., 1996 
2. Pluijm et al., 2009 
3. Black et al 2001 
4. Hippisley Cox & Coupland 2009 
5. Nguyen et al., 2008 
6. Henry et al., 2006 
7. Kanis et al., 2007 
8. Barr et al., 2005 
9. Perier et al., 2007 
10. Huang et al., 1998 
11. Diez-Perez et al., 2007 
12. De Laet et al., 2005 
13. Van Staa et al., 2009 
14. Tanaka S et al., 2010 
 
 
Is the tool 
practicable in 
both sexes? 
If yes accepted 
1. Nguyen et al., 2008 (Garvan nomogram) 
2. Hippisley Cox & Coupland 2009 (QFractureScores) 
3. Kanis J et al., 2007 (FRAX) 
4. De Laet et al., 2005 (Body Mass Index) 
 
Is the tool cost 
effective/ pragmatic 
for care home 
residents? 
If yes accepted 
1. Nguyen et al., 2008 (Garvan nomogram) 
2. Hippisley Cox & Coupland 2009 (QFractureScores) 
3. Kanis J et al., 2007 (FRAX) 
4. De Laet et al., 2005 (Body Mass Index) 
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Figure 3: Flow diagram of the second part of the systematic review showing the selection of 
the tools for use in care homes 
 
Interpretation  
Figure 3 shows that of the 33 tools, when the first criterion was applied 24 were selected, 
when the secord criterion was applied, 14 were selected, when the third criterion was applied, 
4 were selected and when the last criterion was applied, the 4 tools were found practicable for 
use in care home residents. They were FRAX, QFractureScores, Garvan nomogram and body 
mass index (BMI). 
 
2.4.3.2. The Characteristics of the Selected Tools 
The predictors in the tools are shown in Table 24.  
 
FRAX has twelve predictors these are: age, sex, smoking status, alcohol history, weight, 
height, diabetes mellitus, parental history of fractures, history of prior fractures, rheumatoid 
arthritis, malabsorption, endocrine disorders, and oral corticosteroids. The output of the tool is 
10 year absolute probability which can be computed with or without BMD. The 
sociodemographic predictors in FRAX account for half of the risk factors and the remaining 
are comorbidities. 
 
QFractureScores has twenty-six predictors these are: age, sex, ethnic status, smoking history, 
alcohol status, diabetes mellitus, past history of fractures, parental history of fractures, living 
in care home, history of falls, dementia, cancer, asthma/copd, heart attack/angina/TIA, chronic 
liver disease, chronic kidney disease, Parkinson`s disease, rheumatoid arthritis, malabsorption, 
endocrine disorders, epilepsy/anticonvulsants, antidepressants, corticosteroid tablets, 
oestrogen HRT only, body mass index (height, weight). The output is as annualised absolute 
fracture risk for 10 years. The comorbidities in QFractureScores make up 70% of the 
predictors while the sociodemographic risk factors account for the rest. 
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Garvan nomogram has five predictors these are: age, sex, previous history of fractures, history 
of falls and femoral neck BMD. The output of the tool is as 5 or 10 year absolute probability. 
When the femoral neck BMD is not available, body weight can be used as surrogate. If the 
body weight is used, the demographic predictors in Garvan nomogram account for 60% while 
the comorbidities account for the rest. 
 
BMI is the only predictor in the fourth tool. Body weight or body mass index is common to all 
the tools. Age, sex, previous history of fractures and history of falls are common to FRAX, 
QFractureScores and Garvan nomogram. Age, sex, smoking status, alcohol status, diabetes 
mellitus, parental history of fractures, previous history of fractures, rheumatoid arthritis, 
malabsorption, endocrine disorders, oral corticosteroid use, weight, and height are common to 
FRAX and QFractureScores. 
 
FRAX, QFractureScores and Garvan nomogram have output of 10 year absolute probability 
but only QFractureScores has annualised fracture risk for 1 to 10 years. 
 
Summary: The four fracture risk assessment tools selected for use in care home residents 
contain variable numbers of predictors. QFractureScores has the highest while body mass 
index has the lowest. Body mass index/weight is a common predictor in all four. All the 
models except BMI are calibrated and the outputs are expressed as 10-year absolute 
probability. Only QFractureScores has annualised absolute risk score for one to ten years and 
it is also the only model which includes the type of living accommodation as predictor.  
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Table 24: The predictors of the 4 tools identified from the second part of the systematic 
review. 
 
 
Variables  
 
FRAX 
 
 
QFractureScores 
Garvan 
nomogram 
 
Body mass 
index 
Age X X X  
Sex X X X  
Ethnic status  X   
Smoking status X X   
Alcohol status X X   
Diabetes mellitus X X   
Parental history of 
fractures 
X X   
Previous history of 
fracture 
X X X  
Living in care home  X   
History of falls  X X  
Dementia  X   
Cancer  X   
Asthma  X   
COPD  X   
Heart attack/angina/TIA  X   
Chronic liver disease  X   
Chronic kidney disease  X   
Parkinson`s disease  X   
Rheumatoid arthritis X X   
Malabsorption X X   
Endocrine disorders X X   
Epilepsy/anticonvulsants  X   
Antidepressants  X   
Corticosteroid tablets X X   
Oestrogen HRT only  X   
Body mass index  X  X 
Height (cm) X X   
Weight (kg) X X X  
Femoral neck BMD X  X  
10-year fracture 
probability 
X X X  
X=present 
COPD=chronic obstructive pulmonary disease 
TIA=Transient ischaemic attack 
BMD Bone mineral density 
 
Interpretation 
Table 24 shows that the predictors in the four tools were different. QFractureScores had the 
highest and BMI the lowest. BMI was a common predictor in FRAX, QFractureScores and 
Garvan nomogram. 
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2.5 Discussion 
The key findings of this systematic literature review were: 
1. In the first part, 33 fragility assessment tools were identified of which 4 were literature 
review based, 2 were meta-analyses based and 27 were original studies based. 
2. In the second part of the review 4 of the 33 tools identified in the first part were practicable 
for care home residents; these were FRAX, QFractureScores, Garvan nomogram and BMI. 
 
The discussion that follows will be presented in four sections: section 1 will be the review 
articles, section 2 will be the meta-analysis, section 3 will be the original studies and section 4 
will be discussion of the four tools which were finally selected for care home residents.  
 
2.5.1 Review Articles 
The two national guidelines (NICE and NOF) cited earlier were developed from general 
literature review by opinion leaders. The international validity of candidate risk factors and the 
extent to which they can identify a reversible risk is amenable to an evidenced-based 
approach. There are well-established methods for evaluating the quality of evidence of 
different approaches (Khan K, 2003). The lowest level of evidence is provided by expert 
committees or clinical experience i.e. level V11 evidence. Systematic reviews and meta-
analysis represent the gold standards because they constitute level I evidence and provide 
more robust evidence than general literature reviews. 
 
The publication by Brownbill and colleagues identified some indices of hip geometry as 
predictors of hip fractures in females (HAL, FNW and NSA). It was suggested that the 
different incidence rates in hip fracture in females may be explainable by these but it is not 
known if these measurements also predict other fractures. While these measurements may be 
useful in a subset of the population, further studies are needed to assess their usefulness as 
predictors of fragility fractures. 
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2.5.2 Meta-analyses  
 
2.5.2.1 Meta-analysis of How Well Measures of Bone Mineral Density Predict 
Occurrence of Osteoporotic Fractures 
The aim of the meta-analysis to determine the ability of measurements of bone density in 
women to predict later fractures; a combination of prospective cohort and case-control studies 
were used. The main outcome measure was the relative risk of fracture for a decrease in BMD 
of one standard deviation below age adjusted mean. The results were similar in the two 
groups, therefore the authors concluded that measurement of BMD can predict fracture risk 
but cannot identify individuals who will have a fracture. 
 
The study had some strengths; first the design (meta-analysis) of the study. Meta-analysis of 
high quality randomised controlled studies that show consistent effects is the gold standard in 
evidence based intervention and the inclusion of an internal control is important for the highest 
level of evidence (Khan K, 2003). But the demonstration of a significant risk for 1SD decrease 
of BMD in postmenopausal women would not provide enough evidence for a similar degree of 
risk in males because a sample frame that does not capture the population in which the test 
would be applied results in a lower level of evidence (level II studies and below).  
 
The results of the group analyses were similar; the different designs (prospective cohort and 
case-control) indicate consistency of the relative risk of fracture for fractures in women. 
However, case-control studies are efficient only for studies aimed at finding the independent 
predictors of an outcome out of a larger set, not for developing a prediction model. This is 
because this design does not allow for estimation of absolute risks because the correct baseline 
risk or hazard cannot be retrieved from the data except by using a nested case-control or case-
control design (Moons, 2010, Biesheuvel et al., 2008). 
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This meta-analysis had limitations: the restriction of the search language to English may have 
omitted some publications. It compared BMD with a group of Swedish women but mortality 
and fracture rates vary between populations which may underestimate or overestimate risk. 
Also, the studies were conducted in the developed countries (USA, Sweden, UK, Finland, and 
Australia) which suggest that the findings may not be applicable to other geographical 
settings.   
 
The ethnic composition of the participants was not stated; ethnic composition is important 
because of the known differences in fracture risk. Also, the results may not be applicable to 
males as only females were included. Therefore, from a clinical perspective, the participants 
are not representative of those who will   receive the test in practice. In addition, different 
techniques were used in the baseline assessment of the BMD; BMD measurements between 
techniques are not transferable and comparable because the correlation coefficients between 
skeletal sites are too low for predictive purposes and population variances differ as do 
apparent rates of bone loss.  
 
Although BMD is the gold standard for the diagnosis of osteoporosis, the technique of 
estimation has some limitations; DEXA provides a two-dimensional projection of a three-
dimensional structure, therefore it cannot capture bone geometry or microarchitecture. 
Consequently, the BMD values obtained with DEXA do not represent the true volumetric 
bone mineral density but rather a projected areal bone mineral density, DEXA estimation is 
confounded by bone size because it cannot distinguish between increased BMD values arising 
from thicker bones (geometric change) and those arising from increased tissue mineral density 
(material change). DEXA estimates can be distorted by aortic calcification, soft-tissue 
calcification, and other artefacts in an older individual who are at greater risk of fracture. 
DEXA does not distinguish the contributions from trabecular and cortical bones. 
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DEXA provides static information and may not detect any differences for several years after 
osteoporosis treatment (Bonnick, Shulman, 2006, Delmas, 2000, Roux et al., 2005) and the 
assessment is not pragmatic for care home residents who will be required to disrobe. DEXA 
scans are expensive, their availability is restricted to major hospitals and the cost of 
examination is substantial. The labour force required is also immense (Eastell, 1998). In some 
countries, it is predominantly a research tool. DEXA machines range in cost from $25,000 to 
$85,000. DEXA machines are not portable unlike quantitative ultrasound (QUS). Given these 
limitations, BMD is not recommended as a sole predictor for fracture assessment. 
 
It is unclear whether uninterpretable tests and withdrawals were reported in the studies which 
were analysed. The analyses were based on relative risk but this approach does not include the 
background risk of the individual patient beyond age and gender-adjustments, therefore it is an 
imperfect estimate of the absolute risk for an individual over a given period. This researcher`s 
quality assessment score on QUADAS was 6. 
 
2.5.2.2. Body Mass Index as a Predictor of Fracture Risk 
The findings were convincing that low BMI is associated with a substantial increase in 
fracture risk of similar magnitude in men and women whereas high BMI is protective. The risk 
associated with low BMI was present at most ages for all types of fractures but was strongest 
for hip fracture. At BMI of 30 kg/m² and 35 kg/m², BMD appears to have less influence on hip 
fractures given the RRs reported. It is plausible that the impact of the force of impact may be 
more important at these values of BMI because the bigger the mass, the greater the 
gravitational force.  
 
The strength of the study was that it was an international prospective cohort study with 
prolonged periods of follow-up. The limitations were: cohorts in Middle East, South America 
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and Africa were not included therefore it is not known how the findings apply to people in 
these continents.  BMD assessments were done by different methods which may also affect 
the estimates.  Lastly fracture assessment was sometimes by self-report which may have 
introduced some bias if these were not verified by X-ray reports. 
 
2.5.3 Original Articles 
2.5.3.1 Main Findings 
The results show fragility tool derivation has been ongoing for many years. 33 fragility tools 
were identified, but only 6 (18%) were externally validated in a population-based setting 
(Fracture Risk Index, FRAX, QFractureScores, Garvan nomogram, Simple Clinical Score and 
FRISC). There was only one study that recruited elderly female participants exclusively from 
the care home and geriatric settings (Porter et al., 1990). All the studies were conducted in 
developed countries and most of them recruited only postmenopausal female Caucasians. 
 
2.5.3.1.1 Historical Perspective 
 
About two decades ago, BMD provided the most useful proxy measure for fracture assessment 
(Ross et al., 1990) but it has since been recognised that clinical risk factors play significant 
and independent roles (Cummings, Black, 1995, Burger et al., 1999, Dargent-Molina et al., 
1999). Epidemiological studies show that most fragility fractures occur in osteopenia patients 
i.e. patients with normal BMD (Wainwright et al., 2005). Using WHO criteria, it has been 
demonstrated that the risk prediction algorithms that do not include bone mineral density are 
almost as good as those that do (Black et al., 2001b). Only 34% of women and 21% of men 
who sustained non-vertebral fracture had BMD in the osteoporotic range (Schuit et al., 2006), 
only half of elderly women with incident hip fracture had BMD in osteoporotic range at 
baseline (Wainwright et al., 2005) and only 10 to 44% of bone fractures can be attributed to 
low bone mass (Stone et al., 2003).  
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Also BMD explains less than 50% of the variation in whole-bone strength (Melton, 1993, 
Dufresne et al., 2003, Cummings, Bates & Black, 2002). The National Osteoporosis Risk 
Assessment Study showed that 82% (1852) of 2259 postmenopausal women with a fracture 
after 1-year of follow-up had T-score above -2.5 and 67% (1514) had a T-score greater than -
2.0 (Siris et al., 2004). Similarly, in the Rotterdam Study only 56% (280 of 499) of the non-
vertebral fractures in women and 79% (115 of 1450 in men occurred in people with T-score in 
the osteoporotic range (Schuit et al., 2006). Analysis of data on trials of antiresorptive drugs 
showed improvement in spinal BMD during treatment accounted for only a small part in the 
observed reduction in risk of vertebral fracture (Cummings, 2002, Sarkar et al., 2002).  
 
2.5.3.1.2 Geographical Setting 
 
Most studies were conducted in Europe, North America, and Australia therefore it is 
questionable if the models derived can be used in other geographical settings such as Asia, 
Africa or South America. The setting of model derivation has an influence on demographic 
variables because of the differences in environment and cultural practices (sunlight exposure, 
diet, education, religion). Tools are dependent on the accuracy of epidemiological data used to 
derive them; therefore tools validated in one population may not necessarily be useable in 
others. Studies over the last decades have demonstrated geographical variation in the 
incidence of hip fracture across continents as well as among different parts of a region (Johnell 
et al., 2007, Johnell et al., 1992). For example, the incidence of hip fracture is highest in 
Sweden and North America with almost seven-fold lower rates in Southern European 
countries and hip fracture rates are lower in Asia and Latin American populations. 
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2.5.3.1.3 Design of Study 
 
The majority of studies were prospective; this has merit because of the time dependent nature 
of fragility fractures. Prospective studies usually have fewer potential sources of bias and 
confounding variables. (Bowers, 2000). Consequently, the Guideline Development Group 
recommends that research in the development of fragility risk tools should be prospective 
(Guideline Development Group, 2012). The majority of the participants in the studies were 
community based. Given this, most of the tools may not be useable in the high-risk frail 
elderly such as care home residents. 
 
2.5.3.1.4 Number of Participants in Study 
 
Many of the studies recruited over 500 participants; this numerical value has some merit as it 
increases the study power and makes statistical inferences more robust. The larger the study 
sample, the more it reflects the source population, and the less the performance in the study 
sample deviates from the performance that would theoretically be found in the source 
population. To increase the statistical power of a test, it is important that there are a large 
number of randomly selected participants. For a 95% confidence interval (which means that 
there is only a 5% chance the sample results differ from the true population average), a good 
estimate of the margin error (or confidence interval) is given by the equation: 1/√N where N is 
the number of participants or sample size (Niles, 2006). In medical research, a study sample is 
supposed to be a random draw from a larger (theoretical) target or source population. 
However, the selection of participants in the majority of the studies was not random casting 
doubt on the representativeness of the study population.   
 
To reduce the margin of error to plus or minus 5%, 500 randomly selected participants is 
suggested but no firm guidelines exist on sample size requirements to develop or validate 
studies (Collins, Michaelsson, 2012, Vergouwe et al., 2005) and effective sample size is not 
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driven by the number of subjects but the number of events. Empirical simulations have found 
that at least 100 events are required to validate a prediction model (Vergouwe et al., 2005). 
Many of the studies did not report the number of incident events therefore it is not known if 
these studies were underpowered. 
 
2.5.3.1.5 Age of the Participants 
 
Most studies recruited people of 50 years and over, the age at which fragility fractures 
commonly begin to occur; this has merit. Age is a powerful independent risk factor for 
fragility fractures. At the age of 50 years, approximately 75% of people hospitalized for 
vertebral fractures have fractures attributable to low energy injuries, increasing to 100% by the 
age of 90 years (Johnell, 2005). In women with osteoporosis (T-score of minus 2.5), the 
probability of hip fracture is five times greater at the age of 80 years than at the age of 50 
years (Kanis JA et al 2008). But surprisingly, age was largely ignored as a predictor in some 
models.  
 
2.5.3.1.6 Sex of the Participants 
 
Most tools were derived from females; while it is established that the incidence rate of 
fragility fractures is higher in females, an increasing proportion of males also sustain fragility 
fractures (Kanis et al., 2001, Cummings, Bates & Black, 2002, Kanis, 2002b, Compston, 
Rosen, 2006, Morales-Torres, Gutierrez-Urena & PANLAR, 2004), therefore many of the 
tools may not be useable in both sexes.   
 
2.5.3.1.7 Race/Ethnicity of the Participants 
 
Most studies did not state the ethnicity of the participants; about 37% were derived from 
Caucasians only therefore their application is not generalizable to other ethnic groups. 
Worldwide, the incidence of hip fractures varies with ethnicity (Kanis, 2002b). Rates of hip 
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fractures are highest in Northern European countries where the 10-year relative probability of 
hip fractures averaged for age and sex is 1.25 in Sweden compared to 0.62 in Singapore and 
0.08 in Chile (Kanis, 2002b).  Persons of African ancestry, have very low rates of hip fractures 
(GRIFFIN et al., 1992). One large-scale multi-ethnic longitudinal study showed that African-
American and Asian women had lower risks of fracture than white women, after adjusting for 
weight, BMD, and other clinically important factors (Barrett-Connor et al., 2005). 
 
There is much less ethnic variability in morphometric vertebral fractures worldwide. The 
prevalence of vertebral fractures in women older than 65 years is 70% for white women, 68% 
for Japanese women, 55% for Mexican women and 50% in African American women (Cauley 
et al., 2008, Cummings, Melton, 2002, Clark et al., 2009). Epidemiological data show that 
Asian ethnicity is associated with lower BMD values compared to other ethnicities when 
adjusted for body mass index (Goh, Low & DasDe, 2004). Low BMD values were also 
obtained in Sub-Sahara region in Black-African women from Gambia but fragility fractures 
are rare in this population (Aspray et al., 1996). This contrasts with Black Americans and 
Brazilians who have higher BMD than Caucasians, after adjustment for socioeconomic status 
(Siqueira, Facchini & Hallal, 2005).  
 
2.5.3.1.8 Fracture Outcome of the Study 
 
Most of the studies used any osteoporotic fracture as outcome which suggests that the majority 
of the tools could be used for predicting any fragility fracture. About 37% of the tools used hip 
fracture limiting their application. Vertebral fractures typically occur earlier and are an 
established risk factor for hip fractures (Kanis et al., 2005a). Therefore, from a fragility 
prevention perspective, a risk assessment that predicts vertebral fracture may be more useful.  
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2.5.3.1.9 Methods of Verification of Outcome of Study 
 
The majority of studies verified fractures radiologically which provided robust evidence for 
fracture. About 18% were by self-report which may have introduced response bias and cast 
doubts on the results. Although self-report represents a cheap way of collecting data, they rely 
on the honesty of the participant. Even when a participant is trying to be honest, they may lack 
the introspective ability to provide an accurate response to a question. Also participants may 
have varying understanding or interpretation of a research question. Ideally to avoid possible 
bias, it is suggested that the outcome measurement should be blinded to or independent of any 
knowledge of the predictors under consideration (Moons et al., 2012). 
 
2.5.3.1.10 Duration of Follow-up of the Participants 
 
For the development of prognostic models, the duration of follow-up for the outcome data 
collection should be clearly defined. In this review, about 50% of the models were derived 
following 4 or more years of follow-up. This has merit because of the time dependent nature 
of fragility fractures. The European Medicine Agency (EMA) recommends that a period of 2 
to 5 years should be allowed for evaluation of osteoporotic medications (European Medicines 
Agency (EMA), 2005).  
 
2.5.3.1.11 Validation of the Tools 
 
Few tools were validated internally, externally or both. Both internal and external validations 
are recommended in the development of tools (Leslie, Lix, 2014). Internal validation refers to 
the process of assessing the reproducibility of the risk in the same population and confirms 
that no other data other than the study sample are being used. Internal validation can be 
assessed by generating a random subset from the sample population and evaluating 
performance in another subset of the same population. Prediction models can be expected to 
perform optimistically in the data sample from which they are developed compared with the 
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performance found when tested in new but comparable individuals. External validation refers 
to the generalisation of the model in other populations. External validation can be assessed by 
comparing the efficacy of the model in a different population to the one in which the model 
was developed. The validation cohort may be from the same geographical region (e.g. same 
country or region) but at a different point in time. 
 
2.5.3.1.12 Methods of Statistical Derivation of the Tools 
 
The majority of tools were derived using appropriate statistical techniques (logistic regression 
and Cox regression models). Parametric or semi-parametric models for producing risk 
estimates include linear regression for continuous outcomes (e.g. for prediction of BMD 
scores) and logistic or Cox proportional hazards regression models for dichotomous outcomes 
(e.g. fractures or no fractures (Callas, Pastides & Hosmer, 1998). The logistic model is 
adopted when the observation time for risk estimation of the event of interest is fixed for each 
participant while the Cox model is often adopted when the duration of the observation period 
for the event of interest varies.   
 
The Cox model also computes for competing risks such as fracture, death or study closing 
date. Since many of the risk factors for fractures are also the risk factors for death (e.g. old 
age, medical comorbidities), failure to consider competing mortality may result in inflation of 
fracture probability. For example further analysis in a study found that in subgroups with high 
mortality (men, age >80 years, presence of diabetes), the failure to account for competing 
mortality overestimated fracture probability by 16-56% with the standard non-parametric 
(Kaplan-Meier) method  and 15 to 29% with the standard parametric Cox model (Leslie et al., 
2013). 
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2.5.3.1.13 Method of assessing Discriminatory Ability of the Tools 
 
The discriminative abilities of the tools were expressed using the area under curve (AUC) of 
the receiver operating characteristics (ROC) and the performances of the tools were modest. 
Discrimination (the model`s ability to distinguish between people who do or do not have the 
condition of interest) is a key component in the predictive ability of a tool. The ability of a 
model to discriminate between people with and without the outcome can be summarised using 
the AUC of the ROC or the c-statistic (Ikeda, Ishigaki & Yamauchi, 2002, Harrell, Lee & 
Mark, 1996) as the appropriate method to estimate the accuracy of species distribution in 
models (Fielding, Bell, 1997, Pearce, Ferrier, 2000, Manel, Williams & Ormerod, 2001, 
McPherson, Jetz & Rogers, 2004).   
 
ROC curves were developed during World War II to assess the performance of radar receivers 
in signal detection (to estimate the trade-off between hit rates and false alarm rates), and were 
subsequently adopted in biomedical applications, mainly for comparing the performance of 
diagnostic tests (Pepe, 2000). In spite of its wide use and generally good performance 
(Bradley, 1997), research efforts have been devoted to calculations of AUC variations to 
provide measure of variance or to estimate the AUC`s statistical significance (Provost, 
Fawcett, 2001, Fawcett, 2004, Ferri et al., 2005, Forman, Cohen, 2005). Consequently, some 
authors have begun to question the indiscriminate use of AUC as the standard measurement 
metric (Termansen, Collin & McClean, 2006, Lobo, Jimenez-Valverde & Real, 2008). 
 
Kanis et al have criticized the use of AUC arguing that ROC curves should not be used 
because ROC curves are traditionally applied to diagnostic criteria and not predictive 
algorithms (Kanis et al., 2012). It was argued that that there is a mistaken belief that ROC 
capture all that is required to judge the performance characteristics of a test ignoring the three 
fundamental limitations of such analysis: lack of sensitivity of ROC to additional variables, 
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inappropriateness of comparing AUCs across studies and the inability of ROC to determine 
the use of a clinical tool to identify risk categories for intervention.  
 
Other researchers support Kanis's view stating that AUC scores ignore the actual probability 
scores because it is insensitive to transformations of the probabilities that preserve their ranks 
(Ferri et al., 2005). Also it is argued that AUC is a discrimination index that represents the 
likelihood that a presence will have a higher predicted value than an absence (Hosmer, 
Lemeshow, 2000) regardless of the goodness of fit of the predictions (Vaughan, Ormerod, 
2005). Therefore, it is possible that a poorly fitted model (overestimating or underestimating 
all the predictions) has a good discrimination and a well-fitted model has poor discrimination.  
 
Baker and Pinsky argue that ROC summarises model performance over all conditions 
including regions rarely needed in practice, for example, the extreme right and left of the 
curve (Baker, Pinsky, 2001). Also AUC weights omission (false negatives) and commission 
(false positives) errors equally, but in many applications of distribution modelling, omission 
and commission errors may not have the same importance (Fielding, Bell, 1997, Peterson, 
2006). Finally, Pontius and colleague argue that ROC plots do not provide information about 
the spatial distribution of model errors since it is impossible to decide if the biases are 
homogeneously distributed across the modelled territory, or if the lack of distribution is due to 
the incapacity to  predict specific regions correctly (Pontius, Schneider, 2001). Although these 
arguments are persuasive, there is currently no alternative to the ROC. 
   
2.5.3.1.14 Calibration of the Tools 
 
Many of the tools were calibrated. Calibration is the agreement between observed and 
predicted event rates for groups of individuals and it is important for a risk model. Calibration 
is also useful for comparisons of accuracy between prediction models (Collins, Mallett & 
Altman, 2011, Mallett et al., 2010). The Brier score provides an indication of the agreement 
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between an observed binary outcome and the predictive probability of that outcome i.e. 
calibration and discrimination. Scores can range from 0 to 0.25 for a non-informative model 
assuming 50% incidence of the outcome; lower Brier scores indicate improved model 
accuracy (Brier, 1950, Blattenberger, Lad, 1985). 
 
A perfectly calibrated model is one in which the observed and the predicted event rates of 
interest are the same. Calibrations in most of the studies were undertaken by the authors 
without independent evaluators; this makes it difficult to exclude bias. Calibration is most 
valuable if conducted by an independent third party who can provide an impartial perspective. 
There are two benefits to having an independent evaluation; first, the independent evaluator 
asking the questions will pose them in such a way as to gather maximum insights from 
interviews without the bias that might be introduced by the innovator and second, the 
respondent is more likely to share profound insights with an independent third party whereas 
they might be reluctant to do so with the innovator.  
 
2.5.3.1.15 Output of the Tools 
 
Few studies expressed their output in the format suggested by WHO and IOF i.e. absolute risk 
estimates (Kanis, 2002b). The absolute risk of a disease is the risk of developing it over a time 
period based on the population relative risk (PRR). The absolute risk estimates provide a 
clinically meaningful dimension of the actual risk of fracture and a more robust basis for 
intervention.  Ten years was chosen by the WHO because this time frame is cost effective in 
modelling and allows 5 years-on and 5 years-off treatment (Kanis et al., 2001, Siris, Delmas, 
2008, AnkjaerJensen, Johnell, 1996).  
 
However the use of this metric has resulted in treatment recommendations that contradict 
those of some national guidelines such as NICE and the National Osteoporosis Foundation 
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(NOF). For example using FRAX, a fifty-year old postmenopausal woman with a BMI of 24.1 
kg/m², and no clinical risk factors, and a T-score of -2.5 SD meets the threshold for 
pharmacological therapy based on the T-score. However, the fracture probabilities calculated 
with the WHO model (8.7% for major osteoporotic fracture and 2.5% for hip fracture) are 
below the treatment threshold. Conversely, an 80-year-old postmenopausal woman with the 
same body mass index, a parental history of hip fracture, and a T-score of -1.0 SD has a 10-
year risk of 26% and 9.9%, for a major osteoporotic fracture and a hip fracture respectively; a 
level of risk at which treatment should be considered using FRAX but there is no strong 
evidence to support treatment of patients with this level of BMD.  
 
The situation is further compounded because the 10-year absolute fracture probability may not 
be applicable to the frail elderly care home resident whose life expectancy is on average 5 
years. Tools are dependent on the accuracy of the epidemiological data which are used to 
derive them and validation in one population may not apply in others. Many of the models are 
more applicable to groups of individuals rather than to an individual, because they were 
developed based on the concept of risk stratification in which continuous variables were 
categorised into subgroups.  The risk grouping approach attempts to create homogenous 
groups of individuals which may in fact be impossible and unnecessary, because there may be 
variation in other risk predictors.  At the patient level, an individual is likely to be unique in 
risk profile therefore the risk of fracture for the individual should take that uniqueness into 
account. The different methods of fracture risk expression highlight the diversity of views and 
calls for a consensus approach. 
 
2.5.3.1.16 Governance Issues of the Publications 
 
About 40% of the authors received research grants from pharmaceutical companies. It is not 
clear if these incentives had influence on model derivation and validation. While 53.9% of the 
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studies received favourable ethical approval about 40% did not. This indicates a breach of the 
Declaration of Helsinki (WMA, 2013) and failure to comply with the International Guidelines 
for Good Medical Practice (IGCP) which may be perceived as fraudulent. The Declaration of 
Helsinki is a set of ethical principles regarding human experimentation developed for the 
medical community by the World Medical Association (WMA). It is widely regarded as the 
cornerstone document of human research ethics and the International Conference on 
Harmonisation provides guidelines for good clinical practice (Guideline for Good Clinical 
Practice-ICH, 2016).   
 
2.5.3.2 Methodological Quality 
Many the studies were adjudged to be of good quality on QUADAS. QUADAS is 
recommended for quality assessment by the Cochrane Group (Diagnostic Test Accuracy 
Working Group, The Cochrane Collaboration, 2009). It is challenging to use all the generic 
items in the QUADAS check list when assessing studies of fragility risk tools because there is 
currently no reference standard. In this systematic review there were many methodological 
shortcomings and similar observations have been reported in other studies (Nelson et al., 2010, 
Rubin et al., 2013, Rud et al., 2007, Steurer et al., 2011). For example, one publication by 
Kanis et al observed that many external validation studies of models did not incorporate death 
hazard when assessing tool performance (Kanis et al., 2012). 
 
The final models/algorithms were often presented clearly and in the majority of the tools, it 
would be possible to collect the risk predictors in clinical practice. However, these attributes 
were overshadowed by the poor quality of data collection. For example, it was unclear if all 
participants answered all questions or whether some were intermediate, uninterpretable or 
missing. Only a few studies reported missing data and one of them handled it by using 
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multiple imputation methods (Hippisley-Cox, Coupland, 2009). Missing data can threaten 
internal and external validity of the risk model.  
 
Excluding the participants with missing values from the analysis reduces the effective sample 
size and the participants with the completely observed data are then not a random subsample 
of the original study sample (Little, Rubin, 1987, Moons et al., 2006). Ignoring missing 
observations can reduce statistical power to detect associations of the outcome and predictor 
variable and lead to erroneous inferences about the strength of association as well as affecting 
the predictive ability of the model. Few studies reported participants’ withdrawals: thus there 
exists the possibility of inadequate or biased estimates of the performances of the tools in 
these studies. The absence of methodological transparency in some of the studies means that 
the scores obtained on QUADAS were at best approximations. 
  
2.5.4 The Fragility Assessment Tools 
The tools identified in this review have different predictors with the majority having four and 
above. There is no consensus on the numbers of variables to be included in a model. Four was 
chosen in this study because that was the modal value. The systematic review by Nayak and 
colleagues used five as threshold (Nayak et al., 2014). In the selection of predictors, it is 
important that predictive models contain an appropriate number and range of risk factors 
which should be easy to identify in clinical practice. The usefulness of a prediction model is 
dependent amongst others on the diagnostic accuracy and ease of use (Kanis, 2007). Risk 
factors should be unambiguous and easy to determine. 
 
Most of the models included baseline demographics: age, gender, BMI, weight, and ethnicity. 
The age is particularly important because epidemiological data show that fragility fractures are 
commonest after 50 years especially in women after menopause (Van Staa et al., 2001, Kanis, 
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2012, Office of the Surgeon General (US), 2004) and age has the strongest known association 
with BMD and fragility fractures (Rubin et al., 2011).  
 
About half of the tools included BMD as a predictor. But the detection rates (sensitivity) for 
fractures using BMD are low as 96% of fragility fractures occur in women without 
osteoporosis (Kanis et al., 2001), reference has been made to this earlier. The low sensitivity 
and specificity of BMD as predictor of fragility fractures was underpinned in some tools in 
which the fracture probability can be calculated with and without BMD estimation (Kanis et 
al., 2001, Kanis, 2007, Nguyen et al., 2008). 
 
The next commonest group of predictors included in many tools was comorbidities of which 
prior fracture and falls were in the majority. This has merit because it has been recognised 
since the 1980s that fractures beget fracture. About 50% of patients presenting with hip 
fractures have sustained fractures in the past (Gallagher et al., 1980, Edwards et al., 2007). 
Two meta-analyses concluded that a prior fracture is associated with a doubling of future risk 
(Klotzbuecher et al., 2000, Kanis et al., 2004). Women with prevalent vertebral deformities 
have a risk of sustaining a subsequent vertebral fracture of five times that of a woman without 
prevalent vertebral deformities (Black et al., 1999). With regards to falls, approximately 95% 
of hip fractures are caused by falls (Nyberg et al., 1996) and most osteoporotic fractures result 
from trauma (Winner, Morgan & Evans, 1989).  
 
It was surprising that both diabetes mellitus (DM) and dementia did not feature in many risk 
models given that they are common in older people and are now established risk factors for 
fragility fractures. The prevalence of diabetes mellitus is increasing worldwide (Borissova et 
al., 2015, Nguyen et al., 2015). Its prevalence is higher in the elderly than in younger people 
(Sloan et al., 2008). Casperson and colleagues estimate that diagnosed and undiagnosed DM 
affects about 10.9 million US people aged  65 years and over and this is projected to reach 
146 
 
26.7 million by 2050 (Caspersen et al., 2012). There are about 60 million people with DM in 
the European region or about 10.3% of men and 9.6% of women aged 25 years and over 
(WHO Regional Office for Europe, 2017). One meta-analysis showed that both type 1 and 
type 2 DM are associated with significantly increased risk of hip fractures in both sexes 
(Janghorbani et al., 2007). 
 
Dementia and fracture are common problems in the elderly population. About 0.5% of the 
global population (or more than 35 million people) worldwide have dementia. The population 
of people with dementia is expected to double within the next 20 years (Querfurth, LaFerla, 
2010, Sousa et al., 2009). Dementia is associated with increased risk of falling and low BMD 
(Friedman et al., 2010, Amboni, Barone & Hausdorff, 2013) both of which are risk factors for 
fragility fractures. In one study in Taiwan, during a 3-year follow-up period, 264 patients with 
dementia (18.7%) and 1098 patients without dementia (15.6%) sustained incident fractures. 
Dementia was found to be independently associated with increased risk of hip fractures 
(adjusted HR 1.92, 95% CI 1.48-2.49) (Wang et al., 2014). A systematic review and meta-
analysis on fracture risk in long term care found that falls and cognitive impairment are 
associated with increased risk of fractures (Khatib et al., 2014) 
 
 In conclusion, there was significant heterogeneity in study characteristics, predictor variables, 
outcome assessment and follow-up periods therefore a meta-analysis could not be undertaken.  
 
2.5.5 Findings from Other Studies   
The discussion in this section will focus on FRAX, QFractureScores, Garvan nomogram and 
body mass index (BMI) because they were identified as the fragility tools which may be 
practicable in care home residents in this systematic review. FRAX, QFractureScores and 
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Garvan nomogram are the best studied fragility tools which used robust theoretical aspects for 
development and validation (Leslie, Lix, 2014). 
 
2.5.5.1 FRAX 
 
FRAX is the most widely tool used globally. It has been validated in many population-based 
cohorts and incorporated in many national guidelines (Austria, China, Germany, France, Italy, 
Japan, Spain, Sweden, Switzerland, Turkey, USA, Argentina, Belgium, Finland, Hong Kong, 
Lebanon, New Zealand and UK) (Kanis et al., 2013, Silverman SL, 2010)  and it is 
recommended by NICE (National Institute for Clinical Excellence (NICE), 2012b). There are 
country and region specific versions available at the University of Sheffield website 
(http://www.shef.ac.uk/FRAX). It is available in many languages including English, Chinese, 
French, German, Italian, Japanese and Spanish. FRAX gives an absolute rather than a relative 
risk score. The extensive epidemiological data from various geographical areas in the world 
has permitted separate models to be constructed for different regions for example in very high 
risk geographical areas (e.g. Scandinavia), high risk (e.g. Western Europe), moderate risk (e.g. 
southern Europe), and low risk (e.g. developing countries).  
 
In the UK, FRAX 10-year fracture probability output is linked to the National Osteoporosis 
Guideline Group (National Osteoporosis Guideline Group (NOGG), 2008) guidance which 
offers a management algorithm to prompt a decision about treatment; the green zone 
recommends lifestyle advice; amber zone recommends DEXA scan to refine the risk and a red 
zone recommends that pharmacological intervention should be considered. FRAX has 12 
predictors and most of these are dichotomised. The responses are computed to give a sum total 
in percentage, 0 to 100. The higher the score, the higher the fracture risk.  Although FRAX is 
web-based, paper chart versions are available where access to computers is limited 
(www.shef.ac.uk/FRAX).  
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FRAX can be used with and without BMD. In countries where DEXA scans are not available, 
FRAX without BMD can be used. In the countries where DEXA scans are limited, FRAX 
without BMD can be used for a selection of patients for DEXA assessment. FRAX is 
internally and externally validated. It has modest performance using ROC and it is reliable and 
easy to use. Although FRAX has utility as a clinical tool it has some limitations: 
  
1. It does not incorporate fall, a major cause of fragility fractures. The reason given is that 
fall is not amenable to pharmaceutical intervention and the definition of fall is not 
universal. But most fragility fractures result from falls and an increased propensity to 
fall is a risk factor for fractures (Dargent-Molina et al., 1999, Genant et al., 1999). The 
multidisciplinary intervention study by Close and colleagues (1999), in the Prevention 
of Falls in the Elderly Trial (PROFET) showed that some falls in the elderly are 
preventable; this might involve medication review (Close et al., 1999). Also, Calcium 
and Vitamin D supplementation have been associated with significant improvement in 
musculoskeletal function with a reduction in the risk of falls decreasing by 49% 
(Latham et al., 2003). 
 
2. Some of the predictor variables in FRAX such as alcohol and steroid use do not take 
account of dose-response. There is robust evidence that the risk associated with excess 
alcohol and glucocorticoids are greater at higher doses. Daily doses of oral 
glucocorticoids (OG) between 2.5 and 5 mg increased fracture risk by 50% (van Staa, 
Leufkens & Cooper, 2002a). Hip fracture risk rose from 1.77 at daily doses of 2.5 to 
7.5mg and 2.27 at 7.5mg or greater. Clinical vertebral fracture risks were 2.29 for a 
daily dose less than 2.5mg, 2.59 for 2.5mg to 7.5mg and 5.18 at 7.5mg or greater. 
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3. The risk of fracture is higher with any parental fragility fracture. A parental history of 
any fracture is associated with a modest but significant increased risk of any 
osteoporotic fracture (RR=1.18, 95% CI=1.06-1.31) and hip fracture; RR=1.49, 95% 
CI 1.17-1.89 (Kanis et al., 2004). A stronger association was observed for a maternal 
history of hip fracture with RR of up to 1.5 for any fracture and RR of up to 2.0 for hip 
fracture (LaFleur et al., 2008). However, a large-scale Finnish study failed to find a 
significant genetic contribution to fall-related osteoporotic fractures (Kannus et al., 
1999).  
 
4. Participants were relatively healthy community dwelling adults therefore the 
performance of the tool in the frail elderly such as care home residents is not known. 
 
5. It is established that the risk of fractures increases with the number and type of 
previous fractures sustained (Klotzbuecher et al., 2000) but this is not factored into 
FRAX. Also, FRAX underestimates the risk of vertebral fractures because many of 
them are not detected clinically. 
 
6. Rheumatoid arthritis is included in FRAX permutation because its effect is considered 
over and above that accountable for by BMD alone. However, inflammatory 
conditions such as psoriatic arthritis, systemic lupus erythematosus (SLE), 
spondyloarthritis and many drugs such as heparin, anti-retroviral agents and poor 
nutrition which have similar effects on BMD are not included in FRAX. 
 
7. FRAX cannot be used for patients who are under treatment for osteoporosis because 
pharmacological therapy reduces fracture risk without changes in BMD (Saag, 
Geusens, 2009).  
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8. Only a few clinicians use FRAX. Some years ago, few Clinicians went on line to 
access FRAX because it is web-based but that is likely to change with the advent of the 
Electronic Patient Record (EPR) system by the National Programme for Information 
Technology (NPHT) launched in 2007 ( HOC 2007). 
 
9. FRAX is not designed for use in people under the age of 40 years or over the age of 90 
years; therefore it does not accurately predict fracture risk across all age groups 
(Browner, 2007). 
 
10. The lack of flexibility of FRAX remains a critical limitation. A flexible tool should 
allow the adjustment of risk gradients and the inclusion of new risk factors either 
agreed locally or internationally. For example, FRAX allows for input of femoral 
BMD only regardless of values at other sites. 
 
2.5.5.2 QFracture Scores 
 
QFractureScores (Hippisley-Cox, Coupland, 2009) is recommended by NICE. The derivation 
and validation cohorts were large. Missing data were accounted for and fracture probability 
can be computed yearly for 10 years making it very valuable for people with short life 
expectancy such as care home residents. The discriminative ability of QFractureScores is 
modest and it is reliable and responsive to change (Leslie, Lix, 2014). It has been 
independently and externally validated in the UK (Collins, Mallett & Altman, 2011) and Israel 
(Dagan et al., 2017). QFractureScore has 29 predictors and like FRAX most of them are 
dichotomised. The computation is web-based and it is presented as a percentage from 0 to 100, 
the higher the score the higher the fracture risk. 
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QFractureScores has some limitations: it consists of a number of predictors which makes 
assessment cumbersome (Rubin et al., 2013). QFractureScores is the most complex of the four 
tools; it has 31 clinical risk factors in the updated version (QFracture-2016) therefore the 
applicability of the tool in clinical setting is questionable. The usefulness of a tool is 
dependent to some extent on the ease of use. Also, in the development of QFractureScores, the 
risk factors were only assessed at baseline, not taking into account any changes in risk factor 
status during follow-up. For example a person who developed an incidental stroke would be 
incorrectly classified during the follow-up. 
 
 
2.5.5.3 Garvan nomogram  
 
Garvan nomogram (Nguyen et al., 2008) showed modest efficacy. Garvan nomogram is 
responsive to change and a simple tool to use. Fracture risk assessment is within the repertoire 
of many frontline practitioners (Rubin et al., 2013). Garvan nomogram has 6 predictors. When 
BMD is not available, body weight can be substituted. Garvan nomogram is web-based and 
like FRAX and QFRactureScores, the output is presented as a percentage; 0 to 100, the higher 
the score, the higher the fracture risk. The two versions (one with BMD and the other with 
weight if BMD is not available) give options for application particularly where BMD 
assessment is not available (Leslie et al 2014). Fracture probability can be computed for 5 
years and 10 years. These advantages make it an attractive fragility tool for care home 
residents.  
 
The limitations of Garvan nomogram are: although it has been independently validated in 
Canada (Langsetmo et al., 2011), Norway (Ahmed et al., 2014) and Israel (Dagan et al., 2017), 
it has only been calibrated for an Australian population, it does not include other risk factors 
as FRAX and QFractureScores therefore it might underestimate fracture risk when other 
relevant clinical risk factors are present, it is useable only in people older than 60 years and it 
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does not include an explicit compelling mortality risk adjustment (Leslie et al., 2013), 
consequently the fracture probability may be overestimated.  
 
2.5.5.4 Body Mass Index 
 
BMI is a recognised risk factor for fragility fractures and it is a predictor in many fracture 
prediction models. It was derived from a meta-analysis of 12 prospective population-based 
cohorts, the same as FRAX. There are no publications on external validation.  
 
There is an association of fracture risk with low BMI and age: in younger people, low BMI 
may be associated with physical fitness and lower risk of fracture but in the elderly, fractures 
are more common because of frailty and the negative effects of relative gonadal deficiency on 
the bone.  The risk is strongest for hip fractures but the association is not linear being higher at 
lower BMI (De Laet et al., 2005). BMI is easy to use and it is routinely assessed in most care 
homes during admission and follow-up.  A limitation of BMI is that it can be influenced by 
changes in height: for example height loss associated with vertebral collapse, thus in people 
with significant height loss, fracture risk can be underestimated.  The other limitations of BMI 
are discussed in chapter 4. 
 
2.5.6 Strengths and Limitations of this Systematic Review 
This systematic review had some strengths. To my knowledge this is the first systematic 
review to identify the fragility risk tools for potential use in care home residents and the 
methods used followed the analytical methods and standards established by the Preferred 
Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) group. Additionally, 
the methodological qualities of the studies were assessed using QUADAS.  
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The study also had limitations: although effort was made to include the totality of published 
literature on the subject, it is possible that some studies escaped detection particularly those 
that were published after the literature search was performed. All the publications were 
reviewed initially by only the researcher and a second opinion was sought only when there 
were uncertainties therefore some relevant citations may have been missed. Also a meta-
analysis of the included studies was not performed due to considerable heterogeneity in the 
study characteristics.  
  
2.6 Conclusion 
This systematic review identified 33 existing fragility risk tools of which four may be useable 
in care home residents. These tools are FRAX, QFractureScores, Garvan nomogram and BMI. 
Apart from BMI, all the tools are web-based (FRAX has paper-based version) and express 
fracture risk as absolute probability. They contain varying numbers of predictors of which 
BMI is common. In the next project, a questionnaire will be developed using all the predictors 
from the tools and acceptability tested in two care homes in preparation for the observational 
cohort study. 
 
2.7  Addendum 
 
As the initial literature search on which this project is based was conducted in 2014 a further, 
updated, search was conducted to determine whether any new fragility fracture assessment 
tools have been reported and evaluated since. The period of search was from 15/04/2014 to 
19/07/2019. Identical search terms, search strings and databases (section 2.3.1.2 in thesis), 
were used and only publications in English language were included as in the previous search. 
The same criteria and procedures as in the initial search (section 2.3.1.4 in thesis) were used 
for the screening and the selection of publications and all the decisions were independently 
verified by the same second reviewer, AP. 
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A total of 989 publications were identified and 550 were left after duplicates were removed. 
Of these 289 were rejected because their titles indicated that they were irrelevant, 40 were 
rejected because they were experimental studies, 28 were rejected because they were statistical 
models, 2 were rejected because they were case reports and 191 publications were rejected 
because they contained tools which I had reviewed previously.  A total of 11 full journal 
publications were reviewed and of these 2 have informed the addendum, in addition a 5
th
 
paper was identified from the reference list of Walter and colleagues (2017). Eight papers 
were rejected as they did not meet the criteria. There were 3 papers that suggest microRNAs 
have a future potential but the biomarkers are yet to be isolated (Walter et al., 2017, Hellmeier 
et al., 2016, & Bedene et al., 2016). In community dwelling older adults, the FRAX remains 
less sensitive than suggested in the literature (Atkinson et al et al., 2015, Duncan et al., 2014 & 
Holloway et al., 2015). 
 
MicroRNAs define the physiological nature of the cell and play significant roles in the diverse 
biological processes such as cell differentiation, proliferation, death, immunity and 
metabolism (Wahid et al., 2014). Aberrantly expressed miRNAs can be used as biomarkers for 
the diagnosis of a variety of diseases including osteoporotic fractures. A number of miRNAs 
have been discovered. At the cellular level, miR-21 and miR-148a are known to play specific 
roles in bone homeostasis. Seeliger and colleagues discovered 9 upregulated circulating 
miRNA (miR-21, miR-23a, miR-93, miR-100, miR-122a, miR-124a, miR-125b, and miR-
148a) that could significantly distinguish between serum samples of osteoporotic and non-
osteoporotic fractured patients in a cohort (Seeliger et al.2014). Kocijan and colleagues (2016) 
found that a set of 19 miRNA was consistently upregulated in three subgroups of 46 
premenopausal women, 52 postmenopausal women and 55 males and that these were excellent 
discriminators of patients with low-traumatic fractures with area under the curve of between 
0.81 and 0.89. Over a lifetime, estimating miRNA could avoid 57,919 fractures compared with 
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DEXA, 31,285 fractures compared with FRAX and 133,394 fractures compared with no 
monitoring (Walter et al 2017). 
 
Analyses of miRNA have the advantage that they are minimally invasive requiring only blood 
samples; therefore they could be useful for care home residents. But there are a number of 
confounding variables with their estimation and diagnostic thresholds are yet to be established.  
Also the cost effectiveness of miRNA profiling is not yet known (Walter et al 2017), therefore 
if I had identified this tool as a predictor before now, it would not have been selected as a tool 
for use in care home residents.  However, these biomarkers could open a novel method for the 
diagnosis and response to treatment of fragility fractures but more research is needed. 
 
For the identification of high risk people, many guidelines recognise that widespread 
screening is currently neither feasible nor desirable and therefore adopt the case-finding 
strategy. The National Institute for Health and Care Excellence (NICE) has recently released 
new guidance for fragility fractures (NICE 2016).  The guidelines state that fracture risk 
should be considered in the following  circumstances : in all women aged 65 years and over 
and all men aged 75 years and over, in women aged under 65 years and men aged under 75 
years in the presence of risk factors such as previous fragility fracture, current use or frequent 
use of oral systemic glucocorticoids, history of falls, family history of hip fracture, other 
causes of secondary osteoporosis, low body mass index  less than 18.5 kg/m², smoking and 
alcohol intake of more than 14 units per week for women and more than 21 units per week for 
men. NICE guideline recommends that fracture risk should be estimated using diagnostic tools 
such as FRAX or QFractureScores.  
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The Scottish Intercollegiate Guidelines Network (SIGN 2015) recommends that the 
assessment should be carried out preferably using QFractureScores because of the extensive 
validation of QFractureScores in the UK population. The National Osteoporosis Guideline 
Group (NOGG) recommends the fracture risk assessment should be undertaken with FRAX 
and vertebral fracture assessment should be considered in postmenopausal women and men 
age > 50 years if there is a history of ≥ 4 cm height loss, kyphosis, recent or current long-term 
oral glucocorticoid therapy, or a BMD T-score ≤ - 2.5 (NOGG 2018). In the United States, the 
National Osteoporosis Foundation (NOF 2008) recommends  FRAX and uses these  risk 
factors for case-finding: previous fragility fractures (vertebral or non-vertebral), low body 
weight (less than 127Ibs [58kg] for USA citizens) and a family history of fragility fractures.  
But in my study, I found that both FRAX and QFractureScores were ineffective in care home 
residents. Vertebral fracture assessment was not done in my study because it was not 
practicable. 
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Chapter 3. Consultation Visits to Two Care Homes to Determine the 
Acceptability of a Fragility Risk Assessment Questionnaire 
 
3.1 Abstract 
3.1.1 Background 
Fragility fractures are common in care home residents and risk assessment is important in 
identifying high risk people in this cohort. The last project identified four tools FRAX, 
QFractureScores, Garvan nomogram and BMI as useable in this group. A composite 
questionnaire was then developed using the pdf versions of these tools but it was unclear if it 
would be feasible given the inherent difficulties conducting research in care home residents.  
The aim of this consultation project was to sample the views of care home staff and residents 
on the questionnaire and the information leaflets in two care homes in Staffordshire, UK.  
 
3.1.2 Aims 
Three steps were used: 
. First, design a composite questionnaire and information leaflet; 
. Second, identify two care homes in Staffordshire; 
. Third, undertake consultation visits. 
 
3.1.3 Methods 
A composite questionnaire was designed by including all the predictors from the four tools as 
they appeared in the PDF versions. Next  care homes were  identified through the internet  by 
using the key words `care homes, Newcastle-Under-Lyme` and then contact their managers 
requesting consultation visits. If the care managers agreed to this, the research documents 
were sent by postal mail ahead of the scheduled visits.  
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3.1.4 Results 
Two care homes were identified from the yield and the care managers agreed to the visit on 
the first telephone contact. Two group consultations and four individual consultations with 
care residents took place. Following the feedback, the composite questionnaire and the 
information leaflets were modified to reflect the views of the participants.  
 
3.1.5 Conclusions 
The project was valuable as it provided useful feedback which resulted in the modifications of 
the documents in preparation for the observational study. 
 
 3.2 Background 
It has already been demonstrated that fragility fractures are common in care home residents; 
however, there is no standardised fracture assessment tool in this high-risk cohort. In the last 
project, the following tools were shown to be usable in this group: FRAX (Kanis et al., 2008), 
QFractureScores (Hippisley-Cox, Coupland, 2009), Garvan nomogram (Nguyen et al., 2008) 
and Body Mass Index (De Laet et al., 2005).  A composite questionnaire comprising the 
covariates in these tools is important in simultaneously evaluating their performance. 
Prompted by the proposal that women should be involved in the design and conduct of 
research into breast cancer, I decided to adopt a similar approach with care home residents 
(Thornton, 1993, Baum, 1993). 
 
Conducting research in care home residents could be daunting (Hall, Longhurst & Higginson, 
2009, Luff, Ferreira & Meyer, 2011). They are a distinct group compared to community 
dwelling older people of the same age in almost every way including mortality (Nimmo, 
Peterkin & Coid, 2006), health status (Sinclair et al., 2001) and needs (Petty, Scrivener, 1998). 
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Also care managers and care home staff are the residents` `gate keepers` and it is impossible 
and impolitic to conduct research without them as identifying residents and gaining access 
requires their involvement. Research ethics committee chairpersons frequently field questions 
from researchers wanting to know when and why gatekeeper permission should be sought.  
 
Conscientious and well-informed negotiations with gatekeepers are required in order to 
honour the ethical obligations to conduct appropriate stakeholder engagement before and 
during research, along with respect for autonomy of institutions and their 
employees/clients/service recipients. Therefore it was important to evaluate the acceptability 
of the composite questionnaire and associated research documents in residents and care home 
staff prior to the observational study. Two care homes were identified in North Staffordshire 
for the consultation. 
 
Consultations are valuable in many aspects of research including the design, conduct and 
analysis of the data obtained. There are recommended guidelines for consultations (Cabinet 
Office, 2018) and the method employed depends on the type of study. Generally, consultations 
can be divided into two types: quantitative, for example, surveys, and qualitative, for example 
interviews and focus groups. Quantitative and qualitative methods, although different, are 
complimentary. Often the best and most useful consultation is developed using a combination 
of the two.   
 
The type of consultation chosen for this feasibility study was qualitative, comprising 
individual  and group consultation. This design was driven by the type of setting and the hope 
of bringing together the strengths of the two approaches. For care home residents, individual 
interview was preferred because of the logistical problems of getting the participating 
residents together at the same time. For care staff, group consultation was chosen because they 
are the advocates of the residents. 
160 
 
 
Individual interviews are one-to-one discussions, framed around an area. Because only one 
person is being interviewed, it gives in-depth, detailed personal information and identifies new 
issues that may not have been thought of. A  group consultation is a small number of people 
(typically 8 to 12) brought together to consider a topic or issue. It is indicated when looking 
for qualitative or descriptive feedback aimed at generating new ideas and identifying issues for 
larger consultation practices.  
 
Group consultations are usually led by facilitators. Their advantages include: ability to involve 
service users directly in discussion or dialogue about a specific issue; permitting individuals to 
freely express their views in an informal environment; generating detailed and quick feedback 
on a specific issue; skilled facilitators can respond quickly to non-verbal signals and direct the 
consultation accordingly (Derbyshire County Council, 2017). The disadvantages of group 
consultation are: there can be disagreements and irrelevant discussion which distract from the 
main focus. Some participants may find a group consultation intimidating; participants may 
feel under pressure to agree with the dominant view.  This study will explore the experiences, 
attitudes, opinions and feelings of the residents and care staff toward the questionnaire and 
information document designed for the next project.  
 
Care home residents are a vulnerable cohort because often they are physically and mentally 
challenged and their life expectancy is short. Bebbington and colleagues found that 79% of all 
older people admitted to care homes have high levels of physical frailty and 44% have some 
degree of cognitive impairment (Bebbington, Darton & Netten, 2001). Consequently, the ethos 
in many care homes is end-of-life care. Given this, the researcher was unsure how the 
proposed research and documents would be perceived by both care home staff and residents. 
The aims of the feasibility project therefore were: 
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1.  To determine if the assessment process will be acceptable to the residents and carers; 
2. To determine whether the documents are workable; 
3. To determine if the whole process is feasible. 
  
3.3 Methodology 
Three steps were followed: 
1. Design the questionnaire and information leaflet; 
2. Identify two care homes in Newcastle-Under-Lyme; 
3. Undertake the consultation study. 
 
  3.3.1 Design of the Questionnaire  
 
3.3.1.1 Selection of Items for the Questionnaire 
A structured composite questionnaire that captured all the covariates in each tool FRAX, 
QFractureScores, Garvan nomogram, and BMI was designed by copying them exactly as they 
appear in the PDF versions. This was to enable evaluation of their performances 
simultaneously. The questionnaire also included the type of setting (RH, NH, dementia) as this 
will be required during data analysis; the contact details of the settings, consultee and the 
General Practitioner as these will be required to schedule appointments; the clinical outcomes 
( falls, fractures, falls & fractures, mortality and duration of recruitment for each participant) 
as these will be required for data analysis; the date of recruitment and proposed date of 
termination for each participant as these will ensure timely follow-up. Timed Up & Go Test 
(TUGT) and Charlson comorbidity index (CCI) were included, the rationale for their inclusion 
are discussed next. 
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3.3.1.1.1 Timed Up and Go Test (TUGT) 
The TUGT (Podsiadlo, Richardson, 1991) is a standard falls risk assessment tool that was 
included for comparison of falls risk with the fragility tools. There are many tools for 
assessing falls risk in older people. Three systematic reviews identified varying numbers. The 
first identified 25 but found insufficient evidence that any screening instrument exists for 
predicting falls (Gates et al., 2008). The second identified 21 tools but did not undertake 
assessment of their efficacy (Perell et al., 2001). The third identified 45 and found that the 
Berg Balance scale in combination with self-reported imbalance to be the best (Jarnlo, 2003) 
but using this tool in this observational study was not feasible because of the anticipated 
challenges of obtaining self-reported history of imbalance from cognitively impaired residents 
who will be recruited. 
 
The TUGT assesses gait and balance and is recommended by the American Geriatrics Society, 
the British Geriatrics Society and the American Academy of Orthopaedic Surgeons Panel on 
Fall Prevention (Anonymous, 2001) as well as the National Institute for Health and Care 
Excellence (NICE, 2013). It measures the time that a person takes to rise from a chair, to walk 
3 metres, to turn around, to walk back to the chair and to sit down. The TUGT was developed 
as a simple test to assess basic mobility in older people and requires both static and dynamic 
balance. It is can be used in primary care settings as no special equipment is required. The 
original TUGT validation study identified that people who complete the test in 30 seconds or 
more tend to require assistance with climbing stairs and leaving the house. However, more 
studies identified that compared with the prototype model reference standard, a TUGT cut-off  
of 12 seconds or more had a high specificity for identifying very few false positives (Bischoff 
et al., 2003) and a meta-analysis of 21 studies showed that the mean (95% confidence interval) 
TUGT time for individuals at least 60 years of age was 9.4 (8.9-9.9) seconds (Bohannon, 
2006). 
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3.3.1.1.2 Charlson Comorbidity Index (CCI) 
The Charlson Comorbidity Index (Charlson et al., 1987) was included to guide treatment 
decisions because of the relatively short life expectancy of care home residents. The current 
guidelines do not explicitly address life expectancy; it is an important consideration when 
choosing preventive treatment. There is substantial heterogeneity in life expectancy among 
older adults. Median life expectancy for an 80 year-old woman is approximately 10 years; 
however, for women in the “healthiest” quartile, life expectancy is more than 14 years, 
whereas for women in the “sickest” quartile, life expectancy is less than 5 years ( Pham et al 
2011).  
 
Clinicians tend to overestimate survival, and so it is recommended to use standardised tools 
such as life tales or ePrognosis (University of California, San Francisco) to estimate remaining 
life expectancy instead. The CCI is another method for predicting mortality by classifying or 
weighting comorbidities. It has been used in a number of studies to stratify patients in order to 
control  the confounding influence of comorbid conditions on overall survival (Wahigren et al 
2011). 
 
A systematic review of comorbidity indices identified 54 articles and the two most commonly 
used were the Elixhauser comorbidity measure (ECM) (Elixhauser et al., 1998) and Charlson 
Comorbidity Index (CCI) (Sharabiani, Aylin & Bottle, 2012). Comparatively, Elixhauser 
appears to have better performance in all aspects of validity. ECM used administrative data to 
identify 30 International Classification of Diseases (ICD) comorbidities that had a major 
impact on short-term outcomes in acutely hospitalised patients but the feasibility of collecting 
ICD coded comorbidities from care home nursing records persuaded this researcher to choose 
the CCI instead. 
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The CCI predicts the mortality for a patient who may have a range of comorbid conditions, a 
total of 22 are included in the model. The CCI score at 12 months may be useful when 
considering pharmacological intervention or not. Patients with anticipated death of 12 months 
or less are not suitable for osteoporotic medications but palliation and end of life care (The 
Gold Standard Framework (GSF) Team, 2018). Information on the demographic and medical 
covariates can be obtained from the case files and the CCI calculated on-line (Vaugier, 2018). 
 
3.3.2 Identification of the Care Home in Staffordshire 
Identification of the care homes was done online on Google  using the key words `care homes, 
Newcastle-under Lyme`.  
 
3.3.3 Consultation Meeting with the Care Managers and Residents 
The care managers of the homes identified were contacted by telephone and the reasons for 
the proposed visit were discussed. These were to obtain the views of staff and residents with 
mental capacity on the composite questionnaire and information leaflet. Two sets were posted, 
one for care home nursing staff, the other for residents who have mental capacity and have 
been identified by the care home manager as persons interested in looking at the material and 
giving advice on format and content. The care managers were asked to make extra copies of 
the documents for distribution to nursing staff and residents who they had identified. 
 
3.3.3.1 Consultation with Care Home Staff 
Two consultations following the same pattern and using the same format were scheduled four 
months apart. The consultations took place in the offices of the care managers between 
0930hrs and 1030hrs on 27/04/2013 and 27/08/2013. The following people attended each 
meeting: the investigator/facilitator, the care manager and other care staff (nurses and care 
assistants) employed by the homes. The lead supervisor of this research was present in one of 
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the meetings. When the group consultation meeting was about to start, all the sound systems 
were switched off, a brief introduction was made by this researcher and the meeting was 
declared open for general discussions.  
 
3.3.3.2 Consultation with the Residents 
The meeting took place with each resident in their private rooms immediately after the group 
consultation and a carer  was in attendance. The meeting with the residents took place 
separately. The residents were seated either on the chair or bed and put at ease by the carer  
who introduced the investigator, FI. When the resident made it clear they were happy to be 
consulted, the researcher stated the purpose of the visit and asked the residents for their 
opinion concerning the research documents which they had received earlier using a structured 
interview.  
 
3.4 Results 
 
3.4.1 The Questionnaire 
Table 25 shows the composite questionnaire which includes all the predictors of the four tools 
as well as other variables detailed in the methodology section. They are: age, date of birth, sex, 
weight, height, prior fracture, parental fragility fracture, smoking status, alcohol history, 
ethnicity, nursing or care home, medication use, history of rheumatoid arthritis, diabetes 
mellitus, dementia, previous fractures, previous falls, cancer, asthma or COPD, chronic kidney 
disease, chronic liver disease, Parkinson`s disease, malabsorption syndromes, endocrine 
problems, epilepsy, 10 year absolute fracture risk, time to complete each tool, TUGT, number 
of comorbidities, CCI, outcome measures, type of care home, contact details of care 
homes/relatives/GP, recruitment date and proposed date of termination. Ethnicity questions 
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and categories were those used by the Office of Population Censuses and Surveys (OPCS) 
(Office of National Statistics (ONS), 2018). 
 
QFractureScores has the highest numbers of predictors of 29,  BMI has only one 1 predictor. 
FRAX has 12 predictors and Garvan nomogram has 6 predictors. BMI is a common predictor 
in all the tools. 
 
The composite questionnaire consists of sixty seven questions which can be subdivided into 
two categories: predictors in the tools (n=44 [66%]) and other variables (n=23 [34%]).The 
majority of the questions relating to the predictors are dichotomised (n=24 [58%]). 
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Table 25: The composite questionnaire derived from the pdf versions of FRAX, 
QFractureScores, Garvan nomogram and BMI 
 
A. FRAX 
Number Variables 
1 Age 
2 Date of birth (Year, Month, Day) 
3 Sex (Male, Female) 
4 Weight (kg) 
5 Height (cm) 
6 Previous fracture (No, Yes) 
7 Parental Fractured Hip (No, Yes) 
8 Current smoking (No, Yes) 
9 Glucocorticoids (No, Yes) 
10 Rheumatoid arthritis (No, Yes) 
11 Secondary osteoporosis (No, Yes) 
12 Alcohol 3 or more units/day (No, Yes) 
13 10-year absolute probability 
14 Time to complete FRAX in minutes 
 
B. QFractureScores 
Number Variables 
1 Age (30-99) 
2 Sex (Male, Female) 
3 Ethnicity (White or not stated, Indian, Pakistani, Bangladeshi, 
Other Asian, Black Caribbean, Black African, Chinese, Other 
Ethnic group) 
4 Smoking (Non-smoker, ex-smoker, light smoker (less than 10), 
moderate smoker (10-19), heavy smoker (20 or over) 
5 Alcohol status (None, <1 unit per day,1-2 units per day, 3-6 units 
per day, 7-9 units per day, > 9 units per day) 
6 Diabetes (None, Type 1, Type 2) 
7 Do either your parents have osteoporosis/hip fracture? (No, Yes) 
8 Do you live in a nursing or care home? (No, Yes)* 
9 Have you had a wrist, spine, hip or shoulder fracture? (No, Yes) 
10 History of fall? (No, Yes) 
11 Dementia? (No, Yes) 
12 Cancer? (No, Yes) 
13 Asthma or COPD? (No, Yes) 
14 Heart attack, angina, stroke or TIA? (No, Yes) 
15 Chronic liver disease? (No, Yes) 
16 Chronic kidney disease (No, Yes) 
17 Parkinson`s disease? (No, Yes) 
18 Rheumatoid arthritis or SLE? (No, Yes) 
19 Malabsorption e.g. Crohn`s disease, ulcerative colitis, coeliac 
disease, steatorrhea or blind loop syndrome? (No, Yes) 
20 Endocrine problems e.g. thyrotoxicosis, hyperparathyroidism, 
Cushing`s syndrome? (No, Yes) 
21 Epilepsy or taking anticonvulsants? (No, Yes) 
22 Taking antidepressants? (No, Yes) 
23 Taking steroid tablets regularly? (No, Yes) 
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24 Taking oestrogen only HRT? (No, Yes) 
25 Body mass index  
26 Height (cm) 
27 Weight (kg) 
28 10-year absolute probability 
29 Time to complete QFractureScores in minutes 
 
C. Garvan Nomogram 
Number Variables 
1 Sex (Male, Female) 
2 Age (60-96 years) 
3 Fracture since age of 50 (Excluding major trauma e.g. car accidents)(0.1,2, or ≥3  
4 Falls over last 12 months (0, 1, 2 or ≥ 3) 
5 Weight (kg) 
6 10-year absolute probability 
7 Time to complete Garvan nomogram in minutes 
 
 
D. Timed Up & Go Test  
Number Variables 
1 TUGT (Actual time taken for test) 
2 Time to complete TUGT in minutes (including preparation) 
3 Participant unable to undertake  
 
E. Other variables in the composite questionnaire 
Number Variables 
1 Number of comorbidities 
2 Charlson`s Comorbidity Index  
3 Falls in study 
4 Fractures in study 
5 Falls and fractures in study 
6 Outcome of participant  
7 Name of care home 
8 Type of care home 
9 Telephone number of care home 
10 GP of participant 
11 Telephone number of Participant`s GP 
12 Next of kin of Participant (NOK) 
13 Telephone number of NOK 
14 Date of recruitment of participant 
15 Proposed termination date of participant 
Table 25 shows the composite questionnaire derived from the pdf versions of FRAX, 
QFractureScores, Garvan nomogram and BMI. Panel A shows items for FRAX, panel B items 
for QFracture Score, Panel C the Garvan Nomogram, panel D the Timed Up & Go Test 
TUGT), and panel E other variables. *In this table the term care home is used to refer to a 
residential home. The term is taken form the original paper describing the score and has not 
been changed, but has been interpreted as referring to a ‘residential home’.   
 
Interpretation 
There were 68 variables in the composite questionnaire. QFractureScores had the highest 
number and the TUGT the least.  The majority (78% [53/68]) of the variables were derived 
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from the tools. Forty one percent (28/68) of variables in the composite questionnaire were 
dichotomised.  
 
 
3.4.2 Identification of the Care Homes in Staffordshire 
Two care homes were identified in Newcastle-Under-Lyme: the G and Q nursing homes. They 
were located about 0.5 miles from the office of the lead supervisor (CR) therefore she attended 
one of the meetings. The two care homes provided RH, NH and dementia care. 
 
3.4.3 Consultation with Care Staff and Residents 
 
3.4.3.1 Consultation with Care Staff 
The care managers welcomed the visit and were happy to make the time because they felt falls 
and fractures were common problems in care homes. A total of 8 people attended the two  
group consultations comprising two care managers and 6 carers, they were all female.  
 
For the questionnaire, one comment was that a question which has been asked earlier should 
not be repeated because it is time wastage and may cause irritation to some residents. 
Generally, the participants felt the research documents were adequate. 
 
For the information leaflet, the participants felt that two versions should be produced: a 
summary version and a more detailed section, both in bold bigger font (e.g. 16) (appendix E 
and G). This is for the benefit of residents whose vision may be impaired and attention span is 
limited.  Otherwise the care home staff felt that the information leaflet was comprehensive and 
usable. It was suggested that for residents without mental capacity, contact with the consultee 
should be through the care managers so that confidentiality is not breached. If the consultee 
was agreeable to be contacted, then the researcher would discuss the study by telephone and if 
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they are happy to act on behalf of the resident, the research documents including the consultee 
form should be posted in a stamped self-addressed envelope. 
 
For the observational study, they suggested that the researcher should attend general resident/ 
relative meetings because this would provide a reasonable forum to discuss the research with 
more people thereby enhancing the chances of recruitment. Also, it was suggested that any 
time the researcher visits the resident, a care nurse should be in attendance to inspire 
confidence and prevent elder abuse. Each meeting lasted for about one hour. At the end the 
author expressed gratitude to the participants. 
 
3.4.3.2 Consultation with Residents 
A total of 4 care home residents participated in the interview and they were all females. All 
four residents were happy with the documents and willing to participate in the observational 
study if invited. Midway during the consultation, one of the residents drifted off to sleep. The 
meetings lasted for about 30 minutes each. At the end, the researcher expressed gratitude to 
the residents and nurse for their time. 
 
3.5 Discussion 
 
The feedback from the feasibility consultation provided valuable insight that helped in refining 
the questionnaire and information leaflet. Also, the views expressed assisted in planning the 
best methods to approach potential participants and consultees for the planned observational 
study.   
 
There are recognised weaknesses with group consultations, these include: the danger of one or 
two people influencing the group and the process requires trained facilitators and assistant 
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facilitators. Consultations are not statistically reliable and the small numbers of participants 
involved mean it is extremely difficult to extrapolate the results to a whole population with 
any degree of confidence.  It can be time consuming therefore people may not attend. Also it 
requires a quiet/private location for optimal concentration and the diversity of opinion 
expressed may make it difficult to condense the results (Derbyshire County Council).  
 
The group consultations in this study were not `hijacked` by any persons. All the participants 
told the investigator that they had opportunity to express their opinions freely in a cordial, 
non-threatening atmosphere although I had no formal training in facilitating. Group size 
theory suggests eight to be the perfect group dynamic but there are discussions as to whether 
this includes the facilitator/assistant. In this project there were 5 in each meeting. The 
feedback from each meeting was similar but it is not known if they captured the opinion of the 
greater majority of care staff. The interviews with the residents were one to one because of the 
logistical problems of getting many residents together in a quiet room at the same time. 
Although these had the advantage of privacy there might have been restraints because 
residents may have had difficulty expressing their opinion freely to a stranger. Organising 
these meetings was time consuming because of the different schedules of the participants.  
 
There are few publications on consultation methods in care homes. One systematic review by 
Bradshaw and colleagues explored living well in care homes (Bradshaw, Playford & Riazi, 
2012). In the review, 31 studies were identified from which four themes affecting the quality 
of life of care home residents emerged. One of the four themes was relevant to this project: 
close relationship with peer residents within the care home. Although connectedness was not 
explored in this study, it is conceivable that the four residents who participated were sociable 
and could engage with others.  
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Four non-systematic reviews explored the improvement in the quality of life through 
consultation methods. All four found that by taking time to explore the views of care staff, 
they could engage and strategize with residents about the implementation process. Participants 
clearly appreciated being involved in the decision-making process relating to the planning and 
implementation of interventions. These findings highlight the importance of using a 
participatory approach when engaging care staff in research activities during the planning 
phase, to encourage them to be more involved in the decision making and to acknowledge 
their contributions as being a meaningful component of the project (Kaasalainen et al., 2010). 
Also, these meetings promote effective communication and build positive relationships 
between researchers and care staff.   
 
Van de Pol and colleagues (2015) found staff gained practical inspiration from participating in 
relevant research if it contributes to advancing their practical knowledge (van de Pol, 
Marjolein Helena Johanna et al., 2015). Mentes & Tripp-Reimer (2002) found that 
consultation methods assist researchers to realise the normal routines in the care home and 
provide important information about which parts of the intervention are too time consuming 
for staff. The study by Wilson and colleagues highlighted the importance of collective 
engagement through consultation in identifying leadership and organisation of care in building 
reciprocal relationship between residents, families and care staff (Wilson, 2009). These 
observations underpin the need to be mindful of the strong influence of the practice 
environment when trying to implement new strategies. The findings from the consultation 
visits for the project are consistent with the views which have been expressed and encourage 
prior consultation with residents and care home staff when conducting research in this setting. 
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  3.5.1 Limitations of the Project 
The project had some limitations. Firstly, the group and individual consultation consisted of 
few and highly selected people therefore it is not known if the views expressed represent the 
generality. Secondly, the researcher is not a trained facilitator; therefore all aspects of the 
subject may not have been explored. The researcher was also the facilitator; this may have 
unduly influenced the participants. Aware of this potential bias, the investigator had 
participants review their opinion, checked for alternative explanations, reviewed the findings 
with peers and allowed  free discussion by the participants and only intervening to bring the 
discussion back to the subject.   Thirdly, the project was conducted in Staffordshire and it is 
not known if the views expressed are representative of similar groups in Lincolnshire where 
the observational study was conducted. Finally, family members were not represented in the 
meetings therefore their views were not captured. 
 
3.6 Conclusion 
This study demonstrated that using two consultation methods at the planning stage of the 
research is useful in evaluating the acceptability of the questionnaire and information leaflets. 
The available publications support the rationale for this project.  By synthesising the opinions 
expressed by the care home residents and care staff, important adjustments that facilitate the 
research process were made. Staff and residents welcomed the opportunity to engage with the 
researcher and suggested the best ways of implementing the proposed observational study. 
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Chapter 4. Observational study of falls and fractures in a care home 
population 
 
4.1 Abstract 
 
 4.1.1 Background 
The systematic review of fragility fracture risk assessment tools in chapter 2 identified 33 
fragility fracture assessment tools but only four were practicable in care home residents. These 
were FRAX, the QFractureScore, the Garvan nomogram and BMI all of which were derived 
from community-based older people. These tools were designed to predict fractures, not falls.  
 
Care home residents are distinct and it is not known if these tools will be practicable in this 
cohort.  The aims of this pilot study were the following: to determine the recruitment rate of 
care home residents for the study; to identify if the existing fragility risk assessment tools and 
the Timed Up and Go Test, a falls risk assessment tool (TUGT) predict falls,  fractures and 
combined falls and fractures in care home residents and and to determine if the tools are easy 
to use by determining their duration of assessment.  
 
4.1.2 Methods 
This was an observational prospective cohort study. Inclusion criteria were: adults living in a 
care home from whom informed signed consent could be obtained directly or indirectly from a 
consultee. Exclusion criteria were: residents on the end of life pathway and non-English 
speaking residents when interpreters could not be obtained.  Participants were recruited from 
18 care homes in Boston, Lincolnshire, and followed up for 12 months. The outcome 
measures were falls, fractures, combined falls and fractures, mortality and the duration of 
recruitment including measuresments and case file review. These outcomes were assessed by 
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the recruitment rate, time to complete assessment using of the tools (i e the actual duration to 
compute the scores on the computer for FRAX, QFractureScores and Garvan nomogram, the 
calculator for BMI and the duration to perform the test for the TUGT ), screening performance 
and the clinical discriminatory capacities of the tools.  
 
4.1.3 Results 
217/618 (35%) care home residents were enrolled between April 2015 and May 2016, and all 
217 were included in the analysis. The main reason for non-enrolment was inability to obtain 
consent from consultees in residents unable to provide informed consent themselves. All 217 
(100.0 %) were Caucasian by ethnicity and 134 (61.8%) were female. The mean age was 81.2 
(12.5 SD) years.  There were 94 fallers of which 10 had incident fractures. 
 
The mean times taken to complete the risk assessment were: 1 minute for FRAX, Garvan 
nomogram, and BMI and 2 minutes for QFractureScores and the TUGT. These excluded the 
the duration needed to collect the relevant information from the case file and treatment sheet. 
 
The sensitivity and specificity of the tools were as follows: QFractureScores 10 year fracture 
probability for major fracture of ≥ 20%; falls 69.1% and 36.6%, fractures 90% and 35.3%, 
combined falls & fractures 90% and 35.3% respectively; BMI of ≤ 20kg/m²; falls 41.5% and 
73.2%, fractures 60% and 68.1%, combined falls & fractures 60% and 68.1% respectively; 
BMI of ≤ 25kg/m²; falls 74.5% and 43.9%, fractures 90% and 31.2%, combined falls & 
fractures 90% and 31.2% respectively; TUGT of ≤ 12 seconds falls 95.7% and 40%, fractures 
100% and 8.2%, combined falls and fractures 100% and 8.2% respectively. The sensitivity 
and specificity of FRAX and Garvan nomogram were not calculated because neither tool 
significantly predicted falls, fractures or combined falls and fractures. 
 
176 
 
Binary logistic regression analyses were as follows: FRAX prediction of falls odds ratio (OR) 
1.003 SE 0.011 (p=0.813), prediction of fractures OR 1.027, SE 0.024 (p=0.267), prediction of 
combined falls and fractures OR 1.027, SE 0.024 (p=0.267); QFractureScores prediction of 
falls OR 1.007, SE 0.005 (p=0.160), prediction of fractures OR 1.024, SE 0.011 (p=0.036), 
prediction of combined falls and fractures OR 1.024, SE .011 (p=0.036); Garvan nomogram 
prediction of falls OR 1.010, SE 0.005 (p=0.054), prediction of fractures OR 1.021, SE 0.011 
(p=0.062), prediction of combined falls and fractures OR 1.021, SE 0.011 (p=0.062); BMI 
prediction of falls OR 0.952, SE 0.021 (p=0.015), prediction of fractures OR 0.868, SE 0.073 
(p=0.024), prediction of combined falls and fractures OR 0.868, SE 0.073 (p=0.024); TUGT 
of ≤ 12 seconds prediction of falls OR 0.999, SE 0.000 (p=0.013), prediction of fractures OR 
1.000, SE 0.001 (p=0.829), prediction of combined falls and fractures OR 1.000, SE 0.001 
(p=0.829).  
 
4.1.4 Conclusions 
This pilot study was feasible mainly for the residents who possess mental capacity. Although 
the average times to conduct the risk assessment could be accommodated within routine work 
schedules, conduct of the TUGT was challenging. The screening performances of the tools 
were generally poor; of the fragility tools, BMI of 25kg/m² or less had the highest sensitivity 
for predicting falls. BMI was the only tool that significantly predicted falls, fractures and 
combined falls and fractures,  
 
QFractureScores predicted fractures and combined falls and fractures, TUGT predicted falls 
but the associations were weak. Neither FRAX nor Garvan nomogram predicted these 
outcomes. A fully powered study that will include a representative sample of residents without 
mental capacity is feasible if the current legislation that governs consent for people without 
mental capacity changes but it is arguable if such a study is necessary because cognitive 
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impairment is common in care home residents. However, this pilot project has provided the 
necessary data to design a future fully powered study. 
 
4.2 Background  
In project one, I found FRAX, QFractureScores, the Garvan nomogram and BMI, were  
practicable for care home residents. These tools were designed to predict fractures and not 
falls therefore it was important to include a primary falls risk assessment tool, the Timed Up 
and Go Test (TUGT) which was recommended for falls assessment in the priamary care 
setting by the National Clinical Care Excellence (NICE) for comparison.   
 
4.2.1 Aims of Project 
The aims of this pilot study were: 
1. To determine recruitment rate of care home residents for the study 
2. To identify if the existing scores for fracture risk and the TUGT have relevance for care 
home use in the frail elderly 
3. To determine if the tools are practicable (feasible) 
4. To determine if clinical algorithm can be developed as most tools are for 10 year prediction 
risk (not relevant in a care home population)  
 
4.3 Methodology 
In order to meet aim 1: 
1. The total number of participants was calculated as a proportion of the entire care home 
population. 
2. The proportions of mentally competent and incompetent participants were calculated. 
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For aim 2: 
1. A range of independent and dependent variables were measured 
2. Then the sensitivity and specificity of the tools were estimated 
3. Then the relationship between independent and dependent variables were modelled 
4. Then the sample was clustered into three groups (falls, fractures, falls and fractures) 
and the differences between them with respect to the measures taken were explored. 
 
For aim 3: 
1. The duration for the risk assessment of each tool was determined 
2. Then a telephone interview of 20 care home managers in Lincolnshire (on what they 
considered an easy fragility tool to use in care home residents) was conducted. 
 
For aim 4: 
1. Develop a clinical algorithm using factors which were identified as relevant from the 
exploratory analyses.  
 
 4.3.1 Design of the Study 
This was a multicentre, prospective, observational, open cohort pilot study. An open design 
was used because this allowed participants to be enrolled throughout the 12 month period of 
study (i.e. not all participants were recruited at the same time as in a closed study). A closed 
cohort is one with fixed membership. Once the cohort is defined by enrolling participants and 
follow-up begins, no one can be added. The number of participants may decline because of 
death or loss to follow-up, but no additional participants are added. As a result closed cohorts 
always get smaller over time. Also a closed study would have been impossible to conduct by a 
single person because that would require many assessors working concurrently.  
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4.3.2 Setting 
Participants were enrolled by one investigator (FI) from all 18 care homes in Boston. These 
care homes provide 24-hour institutional care for adults who require care for conditions such 
as old-age disability, dementia and learning disability. In the residential homes, the residents 
are generally more mobile and are less dependent on others to perform activities of daily 
living compared to those in the nursing homes. Nursing home residents are usually extremely 
frail and incapable of standing unaided, they ambulate only with assistance and most of their 
activities are conducted under heavy supervision. Some of the care homes in this project are 
registered to cater also for people who are on the end-of-life pathway.  
 
The town of Boston is situated on the East coast of England in the county of Lincolnshire, 
where the River Witham becomes the Haven on its short journey to the Wash (figures 4 and 
5). The town is approximately 120 miles directly north of London. According to the 2001 
census, there were 35,124 people residing in Boston town, of whom 48.2% were male and 
51.8% were female. 23% of the resident population were of retirement age. By mid-year 2015, 
the population had increased to 66,900 (Office of National Statistics (ONS), 2018).  
 
The local population is older than the national average with 21% aged above 64 years 
compared with 18% nationally (Office of National Statistics (ONS), 2018). In the 2011 census 
the Borough of Boston had a population of 64,000 with 15% of the population born outside of 
the UK and 11% in the European Union accession countries such as Poland and Lithuania. 
The non-white population made up 2.4% of the total population in 2011 (Office of National 
Statistics (ONS), 2018).  
 
Pilgrim Hospital is the major provider of secondary care in Boston and immediate surrounding 
areas. As such, it plays a vital role in the community and serves a very large rural community 
with an estimated catchment population of about 400,000 which is more than the national 
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average of between 200,000 and 300,000. (Advisory Committee on Resource Allocation 
(ACRA), 2016). 
 
Figure 4 is a map of the United Kingdom (UK) showing Lincolnshire in red, and Figure 5 is a 
map of part of Lincolnshire showing the location of Boston where this observational study was 
undertaken.  
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Reproduced with the kind permission of Wikipedia 
 
 
Figure 4: A map of the United Kingdom (UK). 
 
Interpretation  
The county of Lincolnshire is shaded in red and situated on the East coast of England in figure 
4. 
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Reproduced with the kind permission of Wikipedia 
 
Figure 5: A map of part of the county of Lincolnshire showing Boston. 
 
Interpretation 
Figure 5 shows that Boston is a town and a small port in Lincolnshire on the East coast of 
England, approximately 100 miles north of London. It is the largest town of the wider 
Borough of Boston.  
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4.3.3 Order of Selection of Care Home Sites  
To avoid bias in the selection process of the order of the 18 care homes, a randomisation 
sequence was computer generated thus (Random.org, 2018) (appendix P); 
1. Enter the smallest value i.e. 1  
2. Enter the largest value i.e. 18  
3. Enter 1 for format 
4. Get sequence 
 
4.3.4 Participants 
Participants were enrolled from April 5, 2015 to May 12, 2016 from the 18 care homes in 
Boston and number of residents in each care home at the first visit of the investigator was 
taken as the resident population.  
 
4.3.5 Study Criteria 
 
4.3.5.1 Inclusion Criteria 
 
Residents were eligible for inclusion in the study if they were adults and provided informed 
written (signed) consent directly or indirectly (from a consultee). 
 
4.3.5.2 Exclusion Criteria 
Residents were excluded for the study if they were on end of life pathway, they were non-
English speaking and interpreters were not available. 
 
An anonymised screening log was kept of all potentially eligible participants including 
residents who were excluded (and the reason for exclusion) and residents who were not 
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approached or included (and the reasons for this). Appendix L shows the template of the 
screening log. 
 
4.3.6 The Process of Recruitment 
Recruitment of participants followed a systematic process which started with the initial contact 
with the care home, then obtaining consent and then finally undertaking the interview and 
assessments. All visits, written and emailed communications, and phone calls were conducted 
by a single researcher, FI. 
 
4.3.6.1 First Visit (preparatory visit) 
The researcher contacted the care home manager or deputy by phone and explained the 
purpose of the research and then scheduled an appointment to visit and discuss the details. The 
care home manager or deputy assisted in identifying potentially eligible residents and advise 
whether they were likely to be able to give fully informed consent, or whether a consultee may 
be required. 
 
4.3.6.2 Second Visit (information giving to residents) 
Prior to any contact with residents the researcher introduced himself to the care home manager 
or deputy. The purpose of the visit was discussed and the resident was given the information 
leaflet (see appendix). After this, another appointment was scheduled to respond to questions, 
clarify concerns and obtain consent, if the resident was willing to participate. A minimum 
period of 24 hours was observed for the resident to reconsider before signing the consent as 
recommended by Integrated Research Application System (IRAS). 
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4.3.6.3 Third Visit (consent taking and recruitment) 
 
4.3.6.3.1 Residents with Mental Capacity 
The researcher assessed mental capacity by asking the resident if they had read and understood 
the study detailed in the participant information leaflet which they had received earlier. The 
resident was asked to summarise what they understood of the study, what their participation 
involved, the potential risks and benefits of the study. If they were able to communicate these, 
then mental capacity was established and the resident was asked if they had any questions or 
needed clarification on any aspect of the study.  
 
The resident was then asked if they would like to participate. If the answer was `yes`, then the 
resident was requested to sign the consent form in the presence of a witness (the original copy 
put in the participant`s case file, one copy was given to the resident, and the third copy was put 
in researcher`s file). If the answer was `no`, the researcher thanked the resident for the taking 
time to read the information leaflet. For the residents who signed the consent form, another 
appointment was scheduled to administer the questionnaire and take study measurements.  
 
4.3.6.3.2 Residents without Mental Capacity 
The Department of Health guidance (Department of Health (DOH), 2001) states that for 
residents who cannot give informed consent, assent should be sought, usually from a near 
relative. Therefore the care home manager or deputy was asked to introduce the study to 
consultees and obtain permission for their contact details to be forwarded to the researcher for 
discussion. If the consultee was happy to act on behalf of the resident and felt that the resident 
would be prepared to take part in the study, the consultee information leaflet and the consultee 
forms were posted in a stamped self-addressed envelope for return. Verbal consent via the 
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telephone, confirmed by an independent witness, was also accepted. When assent was 
obtained, the care home manager or deputy was informed and a time scheduled to conduct the 
assessment in the manner similar to participants with mental capacity. 
 
4.3.6.4 Fourth Visit (Collection of Study Outcomes) 
 
The fourth visit was undertaken at the end of 12 months for each participant. The incident 
books were reviewed for the study outcomes; falls, fractures, combined falls and fractures. 
The care home manager or nurse were asked if the participant was alive or dead.  
 
4.3.7 Duration of the Consenting Process and Assessments 
The time taken to complete the recruitment and baseline assessment of the participant was 
calculated from the time of first contact with the participant to the time when the assessment, 
measurements and case file reviews were completed.  For the participants who required 
consultee, the duration was taken from the time the research documents were posted by mail to 
receiving signed consent and completion of the baseline assessment process and case file 
review.   
 
4.3.8 Administration of the Questionnaire 
All questionnaires were interviewer-administered to eligible residents who gave informed 
consent after discussions with the care manager on the fourth visit. The meeting took place in 
the resident`s private room with a carer in attendance for the entire duration of the visit. The 
resident was given options to be seated in the chair or bed and was put at ease by the care 
nurse. Eye glasses and hearing aids were checked to ensure they were in good working 
condition and then worn or fitted. With the permission of the resident, all the sound systems in 
the room were switched off when the questionnaire administration and assessments were 
undertaken. 
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4.3.8.1 Residents with Mental Capacity 
The carer introduced the researcher who then explained the purpose of the scheduled meeting. 
Mental capacity was reassessed in the understanding that it can fluctuate. If it was absent, the 
researcher expressed gratitude to the resident and carer for their time and the resident was 
transferred to the pathway for participants without mental capacity described earlier. If mental 
capacity was present and the resident was still willing to participate, the researcher then sat on 
a chair about 2 feet away facing the participant and asked the questions one at a time but 
skipped if a similar question was asked earlier. After this, the measurements were taken by 
following the methods described below.  
 
At the end, the researcher expressed gratitude to both the resident and carer for their time and 
proceeded to obtain more information from the participant`s casefile and drug chart. The next 
of kin identified as the primary care-giver in the nursing admission notes was interviewed 
when the resident was unable to communicate, too ill or where the required information was 
unclear. The General Practitioner (GP) was contacted for clarification when necessary. 
 
4.3.8.2 Residents without Mental Capacity 
The researcher was introduced to the resident by the carer.  The researcher then made attempts 
to facilitate understanding of the reason for the meeting and to reassure the resident. Due to 
lack of mental capacity, prompts were repeated as necessary to reduce anxiety. After this, the 
researcher proceeded to take measurements by following the methods already described. 
Thereafter, the researcher expressed gratitude to both the resident and carer for their time. The 
participant`s casefiles and drug chart were then obtained for more information. Where these 
were not available, the next of kin or GP were contacted for clarification. 
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4.3.9 Measurements 
The measurements required for the study were: the height, the weight, the body mass index 
and the Timed Up and Go Test (TUGT). 
 
4.3.9.1 Height 
For the participants who were ambulant, the height measurements were done by using wall 
mounted scales. For the participants who were chair or bed bound, the height were estimated 
by using the ulna length. Measurement was taken at the left forearm with a tape measure from 
the point of the elbow (olecranon process) and the midpoint of the wrist (styloid process) 
(Haboubi, Hudson & Pathy, 1990). If the left forearm was not accessible or deformed by 
previous fracture or disease, the right forearm was used instead. The measurement was 
initially in centimetres and then converted to meters by dividing the number obtained by 100. 
 
4.3.9.2 Weight   
For the participants who were ambulant, the weight measurement were done by sit-in 
electronic Seca weighing scales (which were available in all the care homes) with the 
participant wearing light clothes and the feet off the ground.  For the participants who were 
bed bound, the weight was measured by using the hoists (which were available in all the care 
homes). All the measurements were in kilograms. 
 
4.3.9.3 Body Mass Index 
The body mass index was calculated by dividing the weight in kilograms by the height in 
meters squared. 
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4.3.9.4 Timed Up & Go Test 
1. A flat stretch of space in the care home about 10 feet (3 metres) long was identified for the 
test. 
2. The participant was asked to sit in an armchair placed so that it faced one end of the test 
space with their back to the chair and their arms resting on the arm rests of the chair. 
3. The participant was asked to stand up from the chair then walk the distance of 10 feet (3 
metres) then turn around, then walk back to the chair and then sit down again.  
 
The procedure was timed using a stop watch. Timing began when the resident started to rise 
from the chair and ended when he or she returned to the chair and was seated again. The 
resident was given one practice trial and then three tests were taken. The mean duration in 
seconds of the three tests was calculated. The participants were allowed to use any walking 
aids and/or assisted by the care nurse if they so desired. 
 
4.3.10 Collection of Clinical and Demographic Data 
The participant characteristics were obtained from interviews, medical record review, GP and 
relatives. These included: age, sex, weight(kg), height(cm), body mass index(kg/m²), smoking 
history, alcohol history, type of care home, history of previous fractures, parental history of 
osteoporosis and fractures, history of falls, glucocorticoids, rheumatoid arthritis, secondary 
osteoporosis, diabetes mellitus, endocrine problems, dementia, cancer, asthma, ischaemic 
heart disease, cardiovascular disease, chronic liver disease, chronic kidney disease, 
Parkinson’s disease, malabsorption, epilepsy, taking anticonvulsants, antidepressants, 
oestrogen only HRT, number of co-morbidities. 
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The 10-year fracture probability for FRAX, QFractureScores, Garvan nomogram, average 
duration in seconds to complete each fracture risk assessment, Charlson`s Comorbidity Index 
(CCI) and the duration in days to complete recruitment/assessment were computed. 
 
4.3.11 Follow-Up 
After the screening visit, each participant was followed-up for 12 months. Twelve months 
follow-up was chosen for 2 reasons: 
1. The investigator had limited time for the study 
2. There might be a low retention rate of the participants if the duration of follow-up is 
longer than 12 months given the high mortality rate of care home residents.  
12 Monthly visits to each of the care homes were conducted by the investigator. During these 
visits staff and incident books were consulted to verify the number of falls, fractures and 
mortality. At the end of the 12 months, the number of falls, fractures and deaths were collated 
and cross referenced with the monthly data. If there were no incidents before a participant 
died, this investigator assumed that no incident had occurred. Significant study events were 
recorded prospectively in a field note book and reviewed monthly.Participants and their 
families were not consulted directly during follow-up.  
 
 
4.3.12 Outcomes 
The outcome measures were the recruitment rate, ease of use of the tools (assessed by the 
duration in minutes taken to assess each participant with the tool), screening performance of 
the tools, clinical outcomes (falls, fractures, combined falls and fractures, mortality), the 
clinical discriminatory capacities of the tools and the duration of recruitment of the 
participants.  
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4.3.12.1 Recruitment rate 
The recruitment rate was determined by the number of participants as a proportion of the care 
home resident population. 
4.3.12.2 Ease of Use           
 
Justification 
The ease of clinical use determines acceptance of the tool and it is a function of the ease of the 
required associated procedures, extent of demand on staff time, perceived efficiency, quality 
and added clinical value of speedy results and the actual reduction in time to a result for the 
new diagnostic test compared with the method in use. To the best of the researcher`s 
knowledge, only one formal rating system (US Food and Drug Administration (FDA), 2013) 
has been described to score ease and speed of use of diagnostic methods which are applicable 
to laboratory investigations therefore for this project, the duration taken to compute the risk 
assessment was taken as the surrogate measure of the ease of clinical use. 
 
4.3.12.2.1 Duration of Risk Assessment  
The duration of the risk assessment was defined as an uninterrupted time period (using a stop 
watch) beginning from the time point when the first data for the risk model were entered on to 
the computer to be processed until the output. If the process was interrupted, the procedure 
was repeated.  This assessment took place in the office of this investigator using the raw data 
which were collected following the care home visit. 
 
4.3.12.2.2 Interview with Care Home Managers Relating to Ease of Use 
 
A supplementary telephone interview was conducted in 20 different randomly selected care 
homes in Lincolnshire to explore what the care home managers felt were the desirable  
features of a fragility risk assessment tool that  could affect the ease of use. 
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4.3.12.3 Sensitivity and Specificity, Positive and Negative Predictive Values   
 
The screening tests that were assessed were the sensitivity, the specificity, the positive 
predictive values (PPV) and negative predictive values (NPV). The sensitivity is how good the 
screening test is in identifying disease in people. The specificity is the accuracy of the 
screening test in correctly classifying truly non-diseased people. The positive predictive value 
is the probability that subjects with a positive screening test truly have the disease. The 
negative predictive value is the probability that subjects with a negative screening truly do not 
have the disease. The formula for calculating these are detailed in the statistical analysis 
section.  
 
4.3.12.4 Primary Outcome 
In this project prediction of falls was used as the primary measure to evaluate the performance 
of the fragility tools.  
 
4.3.12.4.1 Justification for Using Falls as a Primary Measure 
Fall is an indirect assessment and surrogate for fractures because it has internal validity as it is 
highly unlikely for participants to have non-vertebral fractures without falls. Falls are more 
common than fractures. Older people in care homes have increased levels of chronic illness, 
polypharmacy and cognition, vision, vestibular, strength and balance impairment and falls 
become relatively more important in this population (Hayes et al., 1993, Visentin et al., 1995).  
 
According to the World Health Organisation (WHO), falls are the leading cause of chronic 
disability worldwide (Murray, Lopez, 1996). The number of hospital admissions due to an 
older person falling is set to rise to nearly 1000 a day in England and Wales by the end of the 
decade according to the data obtained by the Local Government Association (Local 
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Government Association (LGA), 2018). Fall-related injuries are also the leading cause of 
death in the over 65s and cost the NHS over £2 bn. a year and 4 million bed days (Fenton 
2014).  
 
Falls account for about 90% of hip fractures and 87% of all fractures in elderly people (Diez-
Perez et al., 2007). The annual incidence of falls in care homes is reported to be 1.5 falls per 
person (Nurmi, Luthje, 2002) compared to fracture incidence of 70 per 1000 person years 
(Ytterstad, 1999). Thus preventing falls in frail older people may result in reduction of the 
incidence of fractures.  
 
A fall was defined as an unexpected event in which the participant comes to rest on the 
ground, floor or lower surface (Lamb et al., 2005). It was not necessary for the fall to be 
observed to be counted as an event.  
 
4.3.12.5 Secondary Outcomes  
The secondary outcomes were:  the clinical discriminatory capacity of the tools for  fractures, 
combined falls and fractures (and falls discussed above),  the number of incident falls, incident 
fractures, combined incident falls and fractures, the duration taken to complete risk 
assessments, the duration of the recruitment and assessment process (including consent and 
data collection) and mortality. 
 
Justification  
1. Prediction of falls and fractures: this will assess how good the fragility tools are in 
predicting falls and fractures in the frail elderly. 
2. Number of falls: this will assist in the calculation of fall incidence. 
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3. Number of low trauma non-pathological fractures: this will assist to calculate fracture 
incidence  
4. Number of falls and fractures: this will assist to define the number of fractures that result 
from falls. 
5. Mortality: this will inform the design of larger studies in future. 
6.  Duration to complete the recruitment and assessment of participants: this will inform the 
design of larger studies in future. 
 
Fractures were defined as break in the continuity of the bone verified by x-ray. A fragility 
fracture was defined as fracture sustained after low trauma. Skull fractures, facial fractures, 
fractures resulting from road traffic accidents and pathological fractures were excluded. While 
fractures did not have to be symptomatic to be included, asymptomatic fractures would not 
have been identified, as there was no systematic radiological screening.   
 
Fractures in the participants were identified by the care home incident books and verified by 
X-ray reports or the General Practitioner (GP) records. Deaths were verified from the GP 
register.  
 
4.3.13 Development of Algorithm 
 
From the exploratory analyses of the data, some factors which could be useful in the 
development of a clinical algorithm were identified using backtracking process. This was 
reported by: 
 Following a step- by- step process 
 Including variables and their usage 
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 If there were any loops, give sub number lists 
 And going back to step number if loop or condition failed 
 
4.3.14 Data Management 
The participants` anonymised data were checked for accuracy (by cross-checking the data 
entries) and then exported to a password protected EXCEL spreadsheet for storage. Later, they 
were exported to the Statistical Package for Social Scientists (SPSS) and before embarking on 
the data analysis, they were probed for missing values using the software.  
 
4.3.15 Scoring of the Responses 
Categorical variables were coded numerically and quantitative variables were recorded as the 
raw values. Appendix N shows the scoring system. Where an answer was not available, it was 
recorded as unknown.  
 
4.3.16 Sample Size  
A particular challenge of a pilot study is recruiting an appropriate study population. Formal 
sample size calculations are not required (Thabane et al., 2010). As there were no previous 
data, sample size calculation was based on feasibility considerations. It was considered 
possible to recruit 5 participants per week. Assuming a 40 week working year, this would 
enable the researcher to recruit 200 residents, a number adjudged by the consultant statistician 
to be adequate to provide a meaningful primary outcome measure. This was higher than the 24 
to 50 recommended for feasibility studies (Brown, 1995, Julious, 2005). 
 
A statistical rule of thumb is that 15 to 20 incidents are required per covariate to give good 
estimates of a prognostic model (Peduzzi et al., 1996). For this study, there were two 
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covariates (the absolute fracture risk probability score and the number of co-morbidities). 
Using these, it was estimated that 30 to 40 falls may occur in the 200 participants during the 
study duration of 12 months. However, Marshall and colleagues found an incidence of 1.6 
falls per person per year in a care home population (Marshall, Johnell & Wedel, 1996). If this 
was true for this population, 212 falls would be expected. 
 
4.3.17 Statistical Analysis 
Categorical variables were reported as absolute numbers and percentages. Continuous 
variables were tested for normality and then reported either as means and standard deviations 
or median and interquartile range.  
 
The sensitivities, specificities, positive predictive values (PPV) and negative predictive values 
(NPV) of the tools were calculated at generally accepted thresholds using standard formula 
(MEDCALC, 2018). The identification of the groups was facilitated using pivot tables on 
EXCEL spread sheet.  
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 Sensitivity= 
𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒓𝒖𝒆 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆𝒔
 𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒓𝒖𝒆 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆𝒔  + 𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒇𝒂𝒍𝒔𝒆 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆𝒔
 
 
Specificity= 
𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒓𝒖𝒆 𝒏𝒆𝒈𝒂𝒕𝒊𝒗𝒆
𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒓𝒖𝒆 𝒏𝒆𝒈𝒂𝒕𝒊𝒗𝒆 +  𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒇𝒂𝒍𝒔𝒆 𝒏𝒆𝒈𝒂𝒕𝒊𝒗𝒆
 
 
PPV= 
𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒓𝒖𝒆 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆
𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒓𝒖𝒆 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆 +  𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒇𝒂𝒍𝒔𝒆 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆
  = 
𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒓𝒖𝒆 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆𝒔
𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆 𝒄𝒂𝒍𝒍𝒔
 
 
N PV= 
𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒓𝒖𝒆 𝒏𝒆𝒈𝒂𝒕𝒊𝒗𝒆𝒔
𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒓𝒖𝒆 𝒏𝒆𝒈𝒂𝒕𝒊𝒗𝒆𝒔 +  𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒇𝒂𝒍𝒔𝒆 𝒏𝒆𝒈𝒂𝒕𝒊𝒗𝒆𝒔 
 = 
𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒓𝒖𝒆 𝒏𝒆𝒈𝒂𝒕𝒊𝒗𝒆𝒔
𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒏𝒆𝒈𝒂𝒕𝒊𝒗𝒆 𝒄𝒂𝒍𝒍𝒔 
 
 
 
Crude incidence rate  =
𝑵𝒖𝒎𝒃𝒆𝒓 𝑶𝒇 𝑪𝒂𝒔𝒆𝒔
𝑷𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏
  𝒙 𝟏𝟎𝟎   
 
PPV= Positive predictive value 
NPV= Negative predictive value 
 
Exploratory analyses were done to determine the relationship between the clinical outcomes 
(falls, fractures and death), the tools and the predictors. First homogeneity within groups were 
determined by Levene`s test before further exploration with appropriate statistical tests, 
parametric or non-parametric. Binary logistic regression models were then used to model the 
prediction of falls, fractures combined falls and fractures (dependent variables) for each tool 
and predictor (independent variables) (Campbell, Machin, 2000).  
 
Odds ratios (OR) were used to measure the strength of association between dependent and 
independent variables - the exponentiation of the beta coefficients (Exp B) (LaMorte W.). A 
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value greater than 1 indicates an increase of risk by 1 unit increase of the predictor, a value of 
1 indicates that there is no influence of the predictor and a value less than 1 indicates a 
decrease of risk by 1 unit increase of the predictor. The size of the effect of the ORs was 
calculated in percentages by using the formula (Gingaras C); 
 
Percentage increase in risk = OR – 1 X 100 (if OR was greater than 1) 
 
Percentage decrease in risk = 1- OR X 100 (if OR was less than 1)  
 
All p-values were reported as two-tailed and values of 0.05 or less indicate statistical 
significance. The analyses were performed using SPSS software (version 24; SPSS Inc. 
Chicago, IL, USA). 
 
4.3.18 Study Governance 
The protocol, amendments, patient information sheets, informed consent forms and informed 
consultee forms for this study were reviewed and approved by the independent ethics 
committees (Health Research Authority [HRA]); the Lincolnshire Research Ethics Committee 
(LREC Reference; 14/EM/1225) on the 09/01/2015 (appendices A & B) and the institutional 
review board of the Research Governance unit; the Research and Development Department of 
the United Lincolnshire Hospitals Trust (ULHT Reference; 141014Ihama) on the 11/03/2015 
(appendix C). A substantial amendment (addition of a consultee information sheet) was 
approved by the ethics committee on the 10/03/2015.  
 
The R & D monitored the conduct of the study (by periodic visit to the office of the 
investigator to inpect the research documents and their storage) to ensure compliance and 
fidelity to the protocol and also to verify the accuracy and completeness of the data on behalf 
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of Keele University. Clinical oversight was done by the clinical supervisor (CR) and together 
with the co-supervisor (AP) offered guidance on the statistical analysis of the data and 
structure of the thesis. 
 
All the participants provided informed written signed consent either directly or indirectly from 
consultees. This study was conducted according to the good clinical practice guidelines, 
applicable local laws and the ethical principles encoded in the revised Declaration of Helsinki 
(WMA, 2013) and standards of the International Council for Harmonisation guidelines for 
Good Clinical Practice (Guideline for Good Clinical Practice-ICH, 2016). The study was 
registered on a public database and can be viewed on the link provided (INVOLVE, 2018). 
  
4.3.19 Confidentiality 
The participants were assigned unique study codes which did not include identifiable 
descriptors. From the point of recruitment into the study, these codes were used for 
identification. The participant`s identifiable raw data were kept in a locked office 
(investigator`s office) in a locked cabinet for 3 years and then destroyed.   
 
4.3.20 Definition of Terms 
 
Definition of terms is in appendix N. 
 
4.4 Results 
 
4.4.1 Recruitment 
 
All the 18 care homes in Boston participated in the study (table 26). 17 (94%) were privately 
owned and the other was owned by a charity. The total number of residents (at the first visit of 
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the investigator to each care home) was 618. The services which they offered were as follows: 
residential/nursing/dementia 8 (44%), residential/dementia 7 (39%), residential/nursing/ 
dementia/adult learning disability 1 (6%), dementia only 1 (6%), and adult learning disability 
only 1 (6%). Seventeen (94%) of the care homes provided dementia care, 16 (94%) of which 
were with residential and/ or nursing care. Each care home had varying bed capacity; the mean 
was 34 (minimum to maximum range 17 to 92). Twenty seven (4.4%) residents were excluded 
because they were on end of life pathway, 111 (18%) were excluded because although they 
possessed mentally capacity, they did not provide consent, 263 (42.6%) were excluded 
because they did not possess mental capacity and informed consent was not obtained from the 
consultees (figure 6). 
 
The total number of residents that possessed mental capacity in all the 18 care homes was 
258/618 (42%) of whom 147/258 (57%) provided informed consent. The total number of 
residents without mental capacity was 333/618 (54%) of whom consultee consent was 
obtained in 70/333 (21%). Thus of the 217/618 (35%) participants, 147/217 (68%) possessed 
mental capacity and 70/217 (32%) did not. Before this study, none of the care homes had 
participated in research. 
 
Summary: A range of residents from residential homes, nursing homes, dementia care homes 
and institutions that offer services for adults with mental disability participated in the study. 
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 Excluded 
 
 
 
 
 
 
Figure 6: Flow diagram showing the recruitment process of the participants from the 18 care 
homes 
Interpretation 
Figure 6 shows that the total number of care home residents at the first visit of the investigator to 
all 18 care homes was 618 (100%). Of this, 27 (4%) were excluded because they were on end of 
life care pathway, 111 (18%) were excluded because although they had mental capacity, they 
declined consent and 263 (42.6%) were excluded because they lacked mental capacity and 
consent could not be obtained from consultees. Informed written consent was obtained from 35% 
(217/618) of the residents. 
  
Total number of care home residents at the first 
visit to care home = 618 (100%) 
 
End of life care =   27 (4.4%) 
Mentally competent but no 
consent obtained = 111 (18%) 
Mentally incompetent and 
consent not obtained from 
consultee = 263(42.6%) 
Participants recruited = 217 (35%) 
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Table 26: Recruitment and mental capacity of residents in each of the 18 care homes 
 
 
 
 
 
No 
 
 
 
Type of 
care home 
 
 
 
 
Number 
of 
residents 
at first 
visit 
 
 
Number 
of 
residents 
excluded 
by care 
home 
manager 
n (%) 
Number of 
residents with 
mental capacity 
n (%) 
Number of 
residents without 
mental capacity 
n (%) 
 Number of 
residents 
consenting 
& 
assenting  
n (%) 
 
Care home 
previously 
involved in 
research 
 
 
Consent  
 
Not 
consenting  
Assenting  
 
Not 
assenting  
Yes 
(%) 
No 
(%) 
1 RH/dementia (SC) 39 3(7.6) 8(28.6) 14(71.4) 12(80) 3(20) 18(46.1)  No 
2 RH/dementia 
(RCH) 
27 0(0) 0(0) 5(100) 3(13) 20(87) 3(11.1)  No 
3 RH/dementia (TM) 25 1(4) 7(70) 3(30) 9(64.3) 5(35.7) 16(64)  No 
4 RH/dementia (FH) 25 0(0) 7(77.8) 2(22.2) 6(31.3) 11(68.8) 12(48)  No 
5 RH/NH/dementia 
(WG) 
19 6(31.6) 5(55.6) 4(44.4) 2(20) 8(80) 7(36.8)  No 
6 RH/NH/dementia 
(ME) 
34 2(5.9) 8(57.1) 6(42.9) 8(40) 12(60) 16(47.1)  No 
7 RH/NH/dementia 
(WF) 
27 0(0) 9(81.8) 2(18.2) 2(12.5) 14(87.5) 11(40.7)  No 
8 RH/NH/dementia 
(HC) 
92 2(2.2) 29(61.7) 18(38.3) 7(15.5) 38(84.4) 34(37)  No 
9 Adult learning 
disability (A) 
17 0(0) 9(90) 1(10) 0(0) 7(100) 9(52.9)  No 
10 RH/NH/adult 
learning 
disability/dementia 
(V) 
30 1(3.3) 6(100) 0(0) 4(16.7) 20(83.3) 10(33.3)  No 
11 RH/dementia (OR) 35 0(0) 10(66.7) 5(33.3) 12(60) 8(40) 22(62.9)  No 
12 RH/NH/dementia 
(W) 
35 4(11.4) 11(78.6) 3(21.4) 0(0) 21(100) 11(31.4)  No 
13 RH/NH/dementia 
(G) 
37 2(5.4) 12(54.5) 10(45.5) 3(7.1) 14(73.3) 13(35.1)  No 
14 RH/dementia 
(TMGH) 
22 0(0) 3(33.3) 6(66.6) 0(0) 8(100) 3(17.6)  No 
15 RH/NH/dementia 
(EL) 
41 2(4.9) 8(38.1) 13(61.9) 3(10) 18(90) 10(24.4)  No 
16 Dementia (SJ) 35 4(14.3) 0(0) 0(0) 4(10) 27(90) 3(10)  No 
17 RH/dementia 
(GRH) 
38 0(0) 10(58.8) 7(41.2) 0(0) 21(100) 10(26.3)  No 
18 RH/NH/dementia 
(WLC) 
40 0(0) 5(29.4) 12(70.6) 5(26.3) 8(73.7) 10(27.8)  No 
Total number 618 27 (4.4) 147(57) 111(43) 70(22.1) 263(77.
9) 
217(35.6)  No 
RH=residential home 
NH=nursing home 
The initials represent the names of the care homes 
Interpretation 
Table 26 shows that of the 18 care homes, 89% (16/18) offered RH care, 50% (9/18) offered NH 
care, 94% (17/18) offered dementia care and 11% (2/18) offered care for adult learning disability. 
The services were combined in the majority 89% (16/18) and single in 11% (2/18). None of the 
care homes had participated in research before now. 
  
203 
 
4.4.2 Baseline Characteristics of the Participants 
From the 5
th
 of April 2015 to the 12
th
 of May 2016, a total of 217 residents were enrolled from 
the 18 care homes. The GPs and the next of kin were contacted 24 and 17 times respectively to 
clarify the presence or absence of comorbidities in the participants. Questions asked were guided 
by the questionannire. The baseline characteristics are summarized in table 27. The mean age was 
81.2 years (SD 12.5), 134 (61.8%) were females and all 217 (100%) participants were Caucasian. 
The mean weight was 69.2 kilograms (SD 21.8) [mean of 62.1 kg (SD 21.6) for females and 
mean of 69.7 kg (SD 21.2) for males], mean height was 167.9 centimeters (SD 8) [mean of 164.8 
cm (SD 6.2) for females and mean of 172.7cm (SD 8.1) for males]. Nine (4.2%) participants were 
current smokers, 5 (2.3%) took 3 or more units of alcohol daily and the majority (177 [81%]) 
were living in a residential home.  
 
The comorbidities were as follows: dementia 70 (32%), IHD/stroke/TIA 53 (24.4%), type 2 
diabetes mellitus 40 (18.4%), epilepsy/taking anticonvulsants 30 (13.8%), cancer 27 (12.4%), 
chronic kidney disease 18 (8.3%), asthma/COPD 17 (7.8%), Parkinson`s disease 10 (4.6%), 
chronic liver disease 4 (1.8%), malabsorption 4 (1.8%),  secondary osteoporosis 3 (1.4%), other 
endocrine problems 3 (1.4%),  type 1 diabetes mellitus 2 (0.9%) and rheumatoid arthritis 1 
(0.5%). The majority (84.8%) of the participants had one or more comorbidities. Seventy (32.3%) 
took antidepressants, 30 (13.8%) antiepileptic medications but it was unclear if these were also 
for pain relief, 7 (3.2%) oral glucocorticoids) and 2 (0.9%) estrogen only HRT. The majority of 
the participants had history of falls (163 [75%]) and the frequencies were: 1 fall 52 (24%), 2 falls 
94 (43.3%). 82 (37.8%) had prevalent fractures as follows: 1 fracture 64 (29.5%), 2 fractures 14 
(6.5%), 3 or more fractures 12 (5.5%). 18 (8.3%) participants had parental history of fractures. 
The mean 12-months Charlson Comorbidity Index (CCI) was 30.7% (SD 20.8). 
 
Summary: The demography and clinical characteristics of the participants show that they were 
mostly frail elderly Caucasian females. The majority did not smoke or take alcohol in excess. 
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Most of the participants were in residential care. About two-thirds of the participants had fallen in 
the past and over 40% had sustained fractures. The participants had different comorbidities and 
the majority had multmorbidities. The participants had a mean CCI of 30.6% which indicates that 
they were not at imminent risk of death in 12 months. 
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Table 27A: Baseline characteristics of the participants 
 
Age Mean, (SD) 
Age of the participants in years,  81.2 (12.5) 
Sex n (%) 
Male 
Female  
83 (38.2) 
134 (61.8) 
Ethnic group n (%) 
Caucasian  
Others  
217(100) 
0 (0) 
Physical characteristics Mean (SD) 
Mean weight of both sexes in kg  
Mean weight of females 
Mean weight of males 
Mean height of both sexes in cm. 
Mean height of females 
Mean height of males 
69.2 (21.8) 
62.1 (21.6) 
69.7 (21.2) 
167.9 (8) 
164.9 (6.2) 
172 (8.1) 
Social history  n (%) 
Alcohol ≥ 3 units/day 
Smoking  
5 (2.3) 
9 (4.2) 
Type of accommodation n (%) 
Residential 
Nursing 
177 (8) 
40 (19) 
Falls in the previous 12 months (in and out of care home) n (%) 
Number of falls =0  
Number of falls=1 
Number of falls=2 
Number of falls=≥3 
71 (32.7) 
52 (24) 
94 (43.3) 
0 (0) 
Prevalent fractures n(%) 
Number of prevalent fractures=0 
Number of prevalent fractures=1 
Number of prevalent fractures=2 
Number of prevalent fractures=≥3 
117 (58.5) 
64 (29.5) 
14 (6.5) 
12 (5.5) 
Other comorbidities  n (%) 
Rheumatoid arthritis 
Secondary osteoporosis 
Type 1 diabetes mellitus 
Type 2 diabetes mellitus 
Other endocrine problems 
Dementia 
Cancer 
Asthma/COPD 
IHD/Stroke/TIA 
Chronic liver disease 
Chronic kidney disease 
Parkinson`s disease 
Malabsorption 
Epilepsy/anticonvulsants 
1 (0.5) 
3 (1.4) 
2 (0.9) 
40 (18.4) 
3 (0.9) 
68 (31.3) 
27 (12.4) 
17 (7.8) 
53 (24.4) 
4 (1.8) 
18 (8.3) 
10(4.6) 
4 (1.8) 
30 (13.8) 
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Table 27B: Baseline characteristics of the participants (continued) 
 
Medications n(%) 
Oral corticosteroids 
Taking oestrogen only HRT 
Taking antidepressant 
7 (3.2) 
2 (0.9) 
70 (32.3) 
Parental history of any osteoporotic fracture n (%) 
Number of Participants with Parental history of fractures 18 (8.3) 
Number of comorbidities n(%) 
Number of comorbidities=0 
Number of comorbidities=1 
Number of comorbidities= ≥2 
1 (0.5) 
32 (14.7) 
164 (84.7) 
12 month Charlson Comorbidity Index Mean (SD) 
Score on the Charlson Comorbidity Index 30.7 (20.8) 
 
N.B: 36 participants were on Adcal D3 (combination of calcium and vitamin D) but none was on 
any other osteoporotic medication. 
 
Interpretation  
Tables 27A and 27B show that most of the participants were elderly female Caucasians. There 
were differences in the mean weights and heights between the males and females. The male 
participants were taller and heavier than the females. The majority of the participants did not 
smoke or take alcohol in excess and most of them were in residential setting. 
 
63% (136/217)  had past history of falls and they were multiple in 43% (94/217). 37.8% (82/217) 
had prior fractures and they were single in about 30% (64/217).Nearly all the (99.6%[216/217]) 
participants had comorbidities and the majority had multimorbities. 
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4.4.2.1 Missing Data 
There was no missing data at base line or follow-up. 
4.4.3 Outcomes 
In this section the assessment of the outcome measures of the study are reported in the following 
order:  the ease of use of the tools, the screening performances of the tools, the clinical 
discriminatory capacity of the tools, and finally a summary of the important results. 
 
4.4.3.1 Ease of use of tool (duration of risk assessment) 
The mean duration to complete fragility fracture risk assessments were as follows: FRAX 1 
minute, QFractureScores 2 minutes, Garvan nomogram 1minute, BMI 1minute, and TUGT 2 
minutes (table 28) 
 
Summary: Risk assessment with FRAX, QFractureScores, Garvan nomogram and BMI were not 
time consuming and can be accommodated within clinical schedules of care home staff.  
 
 
Table 28: The duration of risk assessment for each of the tools 
Tool Duration of assessment in mins.  
FRAX 
QFractureScores 
Garvan nomogram 
Body mass index 
TUGTϮ 
1 
2 
1 
1 
2 
 
Timed Up & Go Test (TUGT). Ϯ Ninety-three (43%) participants could not perform the TUGT 
and 83 (38%) needed a walking aid.  
 
Interpretation: Table 28 shows that the duration of assessment was longest for QFractureScores 
and TUGT and lowest for FRAX, Garvan nomogram and BMI. The short duration suggest that 
assessments with any of these tools were not time consuming.  
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4.4.3.2 Interview of Care Home Managers 
 The telephone interview survey of the 20 different randomly selected care home managers (table 
29) showed that the majority of respondents felt that the duration of 5 minutes or less would be 
acceptable but 20% did not regard the duration as an issue. All the respondents advised that a 
simple tool which is of tick box style and devoid of medical jargons would be helpful. Just under 
half felt that a web based tool would be discouraging.  
 
Table 29: Telephone survey of 20 care home managers on the important features in fragility tool 
that influence ease of use 
 
Qualities of a useable tool suggested by 20 care 
home managers 
Responses  
Duration of assessment in minutes n (%) 
≤ 5  6 (30) 
≥10 -15 5 (25) 
≥16 -20 2 (10) 
≥20 -25  0 (0) 
≥26 - 30 3 (15) 
Unlimited duration 4 (20) 
Simplicity of tool (tick box style, easy to read and 
understand) 
 n(%) 
Number of managers that suggested simplicity 
improves use of tool 
20 (100) 
Web-based assessment is a disadvantage n (%) 
Number of managers who felt web-based tool is a 
disadvantage 
9 (45) 
 
Interpretation 
Table 29 shows that the majority of the care home managers felt that the assessment duration of 5 
minutes or less would be good and all of them felt that the tool should be simple. 45% felt a web-
based tool would be discouraging to use, this suggests that the majority (55%) did not consider 
this to be a problem. 
. 
 4.4.3.3 Screening Performances of the Tools 
The sensitivity, specificity, positive predictive value and negative predictive values of the tools 
are presented in table 30. FRAX and Garvan nomogram were excluded because neither tool 
demonstrated statistically significant association for the prediction of falls, fractures combined 
falls and fractures. 
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For BMI, the range of normality is between 20 kg/m² and 25 kg/m² (UK Metric Association, 
2013). For FRAX, QFractureScores and Garvan nomogram, a 10-year fracture probability 
estimate of 20% or above for major osteoporotic fracture is recommended (Dawson-Hughes et 
al., 2008). Individuals with a 10-year estimated risk of major osteoporotic fracture between 10% 
and 20% are at moderate fracture risk, whereas individuals with an estimated risk of at least 20% 
have a high risk for fracture (Viswanathan et al 2018).  For the TUGT, people who take longer 
than 12 seconds to complete the TUGT have high risk of falls (Bischoff et al., 2003b). 
 
Table 30 show the actual scores and table 31 the summary of the screening performances of the 
tools. 
 
For falls assessment, TUGT showed the highest level of sensitivity and QFractureScores the 
lowest, QFractureScores showed the highest level of specificity and TUGT showed the lowest, 
BMI of 20kg/m² and below showed the best positive predictive value and TUGT showed the 
worst, TUGT showed the highest negative predictive value and QFractureScores the lowest. 
For fracture assessment: TUGT showed the highest level of sensitivity and QFractureScores the 
lowest; QFractureScores showed the highest level of specificity and TUGT the lowest, 
QFractureScores showed the highest level of positive predictive value and TUGT the lowest, 
TUGT showed the highest negative predictive value and BMI of 20 kg/m² and less the lowest. 
 
For combined falls and fracture assessment the performances of the tools were similar to the 
performances for fractures.  
 
Summary: The interpretation of the screening results was based on the recommendations of the 
Royal College of Physicians (The Royal College of Physicians of London and The British 
Geriatrics Society, 1992) which states: ` When screening, sensitivity (avoiding false negatives) 
may be more important than specificity (avoiding false positives) because opportunities for 
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clarifying the status of the false positives patients will arise but the false negative patients is lost 
to further scrutiny`. For the PPV and NPV values, these are dependent on the prevalence of the 
disease in the population of interest (Lalkhen, McCluskey, 2008) and because falls are more 
common than fractures they were used as the outcome for this evaluation. 
 
TUGT had the highest sensitivity for falls and of the fragility fracture tools, BMI of 25kg/m² had 
the highest. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
211 
 
Table 30: Screening performance of the tools 
 
 
Tools 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
PPV value 
(%) 
 
NPV 
(%) 
Body Mass Index 
of ≤20kg/m² 
Falls 
Fractures 
Falls & fractures 
of ≤25kg/m² 
Falls 
Fractures 
Falls & fractures 
 
 
41.5 
60 
60 
 
74.5 
90 
90 
 
 
73.2 
68.1 
68.1 
 
43.9 
31.2 
31.2 
 
 
54.1 
8.3 
8.3 
 
50.4 
6.5 
6.5 
 
 
62.1 
95.2 
95.2 
 
76.2 
98.7 
98.7 
QFractureScores 
of ≥ 20% 10 y 
probability for 
major fractures 
Falls 
Fractures 
Falls & fractures 
 
QFractureScores 
of  ≥ 20% 1 y 
probability for 
major fractures 
Falls 
Fractures 
Falls & fractures 
 
 
 
 
69.1 
90 
90 
 
 
 
 
 
8 
30 
30 
 
 
 
 
36.6 
35.3 
35.3 
 
 
 
 
 
86 
85.5 
85.5 
 
 
 
 
45.5 
6.3 
6.3 
 
 
 
 
 
48.5 
9.1 
9.1 
 
 
 
 
60.8 
98.6 
98.6 
 
 
 
 
 
36.6 
96.2 
96.2 
TUGT of ≤ 12 s 
Falls 
Fractures 
Falls & fractures 
 
95.7 
100 
100 
 
40 
8.2 
8.2 
 
45 
5 
5 
 
95 
100 
100 
Positive predictive value (PPV), Negative predictive value (NPV) 
 
Interpretation 
The rational for this interpretation is based on the study which classified mammograms as good 
tests for detecting breast cancer with sensitivity of ≥70% (Stephanie 2014). 
 
Table 30 shows that the sensitivity for the prediction of falls was poor for BMI of ≤ 20kg/m² and 
QFractureScores fracture probability of 1-year but good for BMI of 25kg/m² and TUGT. For 
fractures and falls & fractures combined, the sensitivity was good only for BMI of 25kg/m², 
Qfracturescores of 10-year fracture probability and the TUGT.  
 
The specificity for falls and falls & fractures combined was good only with BMI of ≤20kg/m² and 
QFractureScores fracture probability of 1-year. The positive predictive values for the tools for 
any outcome were poor but the negative predictive values were good with BMI, QFractureScores 
and TUGT for fracture and falls & fracture combined and only with TUGT for falls. 
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Table 31: The summary of the screening performance of the tools for falls, fractures, falls and 
fractures 
Outcome  Best 
sensitivity 
Worst 
sensitivity 
Best 
specificity 
Worst 
specificity 
Best 
PPV 
Worst 
PPV 
Best 
NPV 
Worst 
NPV 
Falls TUGT QFrac. QFrac. TUGT BMI≤20 TUGT TUGT QFrac. 
Fractures TUGT QFrac. QFrac. TUGT QFrac. TUGT TUGT BMI 
≤20 
Falls & 
fractures 
TUGT QFrac. QFrac. TUGT QFrac. TUGT TUGT BMI 
≤20 
QFrac. = QFractureScores 
BMI ≤ 20 = BMI of 20kg/m² and less 
PPV= positive predictive value 
NPV=negative predictive value 
 
Interpretation 
Table 31 shows that the tool with the best sensitivity for any of the outcome was TUGT and the 
tool with the worst sensitivity was QFractureScores. QFractureScores had the best specificity and 
TUGT the worst specificity for any outcome. The best PPV tool for falls was BMI ≤ 20kg/m² and 
QFractureScores for fractures and combined falls & fractures.  The worst tool for the PPV tool 
was TUGT for any outcome. The best tool for the NPV for any outcome was TUGT and the 
worst tool for NPV for falls was QFractureScores and for fractures and falls & fracture 
combined, BMI ≤20kg/m². 
 
The Royal College of Physicians recommend that for screening, sensitivity (avoiding false 
negatives) may be more important than specificity (avoiding false positives) because 
opportunities for clarifying the status of false positive will arise but the false negative patient is 
lost to further scrutiny (RCP 1992). 
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4.4.4.1 Clinical Discriminatory Capacity of the Tools  
4.4.4.1.1 10 year Risk of Major Osteoporotic Fractures and Mean BMI and TUGT Scores of 
the Participants 
Table 32 shows the mean (SD) 10-year risk of major osteoporotic fracture for FRAX, 
QFractureScores and Garvan nomogram and the mean BMI and TUGT. The 10-year absolute 
probabilities of major osteoporotic fractures of the tools were: FRAX 19.5% (SD 12, 95% CI 
17.9 - 21.1), QFractureScores 35.8% (SD 26.5, 95% CI 32.2 - 39.3) and Garvan nomogram 
42.1% (SD 27.8, 95% CI 38.4 - 45.9). The mean BMI was 24.3 kg/m² (SD 7.2, 95% CI 23.3 - 
25.2) and the mean time for the TUGT was 33.8 seconds (SD 23.4, 95%CI 29.6 - 37.9).  
 
Summary: The mean 10-year absolute risk of major osteoporotic fractures estimates of the 
participants for FRAX, QFractureScores and Garvan nomogram were different. FRAX predicted 
a 19.5% risk while QFractureScores and Garvan nomogram predicted about twice the risk. For 
the fragility tools, a 10-year fracture probability estimate of 20% or above for major osteoporotic 
fracture is recommended for treatment following guidelines (Dawson-Hughes et al., 2008). Thus 
both QFractureScores and Garvan nomogram indicate that the participants are at high risk of 
major osteoporotic fractures and for appropriate residents, pharmacological treatment should be 
offered. However the scores between the fragility tools are not interchangeable. The medications 
recommended by NICE (2016) are: bisphosphosnates (alendronic acid, ibandronic acid, 
risedronate and zoledronic acid) and nonbisphonates (raloxifene, denosumab, teriparatide, 
calcitriol and hormone replacement therapy [HRT]). HRT is not relevant for care home residents. 
 
The mean BMI of participants was within the normal range of 20 to 25 kg/m² (Hellec, Campbell-
Scherer & Allan, 2015) and 55 (25%) of the participants were below the normal range. The mean 
TUGT was over two-times the normal for community dwelling older people i.e. 12 seconds. 
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However it was within the range of 12.7 to 50.1 seconds for institutionalised women (Bischoff et 
al., 2003a). 
 
Table 32: Results of the fragility risk assessment in this pilot study 
 
Test Result 
10-year probability of any osteoporotic fracture with FRAX, mean(SD)  
10-year probability of any osteoporotic fracture with QFractureScores, mean (SD)  
10-year probability of any osteoporotic fracture with Garvan nomogram, mean(SD)  
BMI kg/m², mean (SD)Ϯ 
BMI less than 20 kg/m², n (%) 
Timed Up and Go Test, mean (SD) in seconds 
19.5 (12) 
35.8(26.5) 
42.1 (27.8) 
24.3 (7.2) 
55 (25) 
33.8 (23.4) 
Ϯ The body-mass index is the weight in kilograms divided by the square of the height in metres. 
Interpretation 
Table 32 shows that the scores of the 5 tools were different. For 10-year fracture probability, 
QfractureScores had the highest and FRAX the lowest. The mean BMI of the participants was 
within the normal range but 25% were below normal. The mean TUGT duration was about 2.8 
times normal (normal is ≤12 seconds). 
 
 
 
4.4.4.1.2 Logistic Regression Models of the Tools 
Table 33 shows the odds ratios (OR) of the binary logistic regression models of the tools. 
 
The odds ratios for the prediction of falls were as follows: FRAX 1.003, standard errors (SE) 
0.011 (p=0.813); QFractureScores 1.007, SE 0.005 (p=0.160), Garvan nomogram, 1.010, SE 
0.005 (p=0.054), TUGT 0.999, SE 0.000 (p=0.013), and BMI 0.952, SE 0.021 (p=0.015). The 
effect size for a unit increase of each tool for the prediction of falls was: FRAX 0.3 times more, 
QFractureScores 0.7 times more, Garvan nomogram 1.01 times more, TUGT 1.001 times less, 
BMI, 1.1 times less.  
 
For fractures the ORs were as follows: FRAX 1.027, SE 0.024 (p=0.267), QFractureScores 
1.024, SE0.011 (p=0.036), Garvan nomogram 1.021, SE 0.011 (p=0.062), BMI 0.868 (p=0.024) 
and TUGT 1.000 (p=0.829). The effect size  for a unit increase of each tool were: FRAX 1.027 
times more, QFractureScores 1.024 times more, Garvan nomogram 1.021 times more, BMI 1.2   
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times less, TUGT no effect. The same ORs and effect sizes were obtained for combined falls and 
fractures as for fractures for all the tools.  
 
Summary  
Of the four tools, only BMI predicted falls, fractures and combined falls and fractures. A unit 
increase of BMI resulted in statistically significant decrease of falls risk, fracture and combined 
falls and fracture risk of 4.8% 13.2% and 13.2% respectively. 
 
A unit increase in QFractureScores resulted in a non-significant increase of falls risk, significant 
increase of fracture risk and combined falls and fracture risk of 0.7%, 2.4% and 2.4% 
respectively. Practically, these were not relevant.    
 
A unit increase of FRAX resulted in a non-significant increase of falls, fracture and combined 
falls and fracture risk of 0.3%, 2.7% and 2.1% respectively.  
 
A unit increase of Garvan nomogram resulted in non-significant increase of falls, fracture and 
combine falls and fracture risk of 1%, 2.1% and 2.1% respectively. 
 
A unit increase in TUGT resulted in a significant increase of falls risk of 0.1% but no effect on 
fracture and combined falls and fracture risk. Practically, this was not relevant. 
 
The associations of the tools with the clinical outcomes falls, fractures, combined falls and 
fractures were weak although statistically significant in some cases. The screening performance 
of FRAX and Garvan nomogram were not calculated because they did not show significant 
association for falls, fractures and combined falls and fractures. 
 
 
216 
 
Table 33: Odds ratio and Standard errors of the binary logistic models  
Tools OR, SE for 
prediction of falls 
(p) 
OR, SE for 
prediction of 
fractures (p) 
OR, SE for prediction of 
combined falls & fractures 
(p) 
FRAX  1.003,0.011 (0.813) 1.027,0.024 (0.267) 1.027,0.024 (0.267) 
QFractureScores 1.007,0.005 (0.160) 1.024,0.011 (0.036) 1.024, 0.011 (0.036) 
Garvan nomogram  1.010,0.005 (0.054) 1.021,0.011 (0.062) 1.021, 0.011 (0.062) 
BMI 0.952,0.021 (0.015) 0.868,0.073 (0.024) 0.868, 0.073 (0.036) 
TUGT  0.999,0.000 (0.013) 1.000,0.001 (0.829) 1.000, 0.001 (0.829) 
Statistically significant values p≤0.05 
OR = Odds ratio 
SE = Standard error 
p= level of statistical significance 
Statistically significant odds ratios are given in bold 
 
Interpretation 
Table 33 shows that of the tools, only BMI was a predictor of falls, fractures and combined falls 
& fractures. TUGT was a predictor of falls and QFracturescores was a predictor of fractures and 
combined falls & fractures. 
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4.4.5 Summary of the results 
 
This pilot study was feasible but the majority of the participants possessed mental capacity and 
this was not representative of the care home resident population, the majority of whom did not 
have mental capacity. The tools were easy to use as per the duration to complete the risk 
assessment but there were logistic problems particularly with the participants who did not possess 
mental capacity. The sensitivity, specificity, positive predictive values, and negative predictive 
values were generally poor. Of the tools, BMI of 25 kg/m² was the best predictor of falls, 
fractures and combined falls and fractures and the impact was more with fractures than falls. All 
the participants were Caucasians. 
 
4.4.6 Field Notes 
These were the field notes during the recruitment and follow-up of the participants: 
 
1. The TUGT was performed in a public area in one care home; this led to two instances of 
interruption; one from a passing member of the public and the other by a wandering resident.  
 
2. All the care home documentations were paper-based and there were variations between care 
homes, Zermansky et al observed the same (Zermansky et al., 2007). GP letters and care 
plans were often missing. However, there was consistency in the documentation of resident’s 
contact details, medicine records and accident books which contained details of falls and 
other incidents. 
 
3. On six occasions, the data collection from the drug charts were appropriately interrupted by 
drug rounds. 
 
4. One care home manager mailed information sheets to the next of kin/guardian of all residents 
in the care home regardless of mental capacity.   
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5. A care home manager excluded some residents who were bed bound but not classified as end 
of life because she felt they were unlikely to experience falls. 
 
6. The recruitment process was delayed in two care homes because the information sheets were 
given to the residents for less than 24 hours before consent was due to be obtained.  
 
7. Care home staff were often diligent and supportive as they claimed research was a new 
experience. One deputy care home manager remarked `I am happy we have been included in 
this study which may have a positive impact on the care we give to our care home residents. 
More of this please’. 
 
8. Falls were recorded in an incident book in 17 out of 18 care homes, this facilitated data 
collection. The care home without an incident book documented falls within the residents` 
individual care plans; this made accurate and reliable identification of falls more challenging. 
 
4.5 Discussion 
The key findings from this observational study were: .the study included a wide range of 
residents from residential homes, nursing homes, dementia care homes and institutions that offer 
services for adults with mental disability. Just over a third of care home residents were recruited. 
Most of the participants in the study had mental capacity which did not represent the care home 
population, most of whom lack mental capacity. Thus the study was feasible mainly for care 
home residents who had mental capacity. The duration of the risk assessments were short and can 
be accommodated within nursing care schedules but the TUGT posed logistic problems 
particularly in some participants who lacked mental capacity. The screening performances of the 
tools were generally poor but TUGT, a tool designed primarily for falls assessment had good 
sensitivity. BMI was the only tool that showed significant association with falls, fractures and 
combined falls and fractures but the associations were weak. QFractureScores had significant 
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association with fractures and combined falls and fractures and the TUGT had significant 
association with falls and like BMI the associations were weak. Both FRAX and Garvan 
nomogram did not show significant association with these outcomes. All the participants were 
Caucasians. The participants were generally frail but the mean Charlson`s Comorbidity Index 
was 30.7% which suggests that the majority were not at imminent risk of dying within 12 
months. The mean CCI of the 54 of the 217 participants (24%) who died was 36%. Falls are 
common in care home residents but most of them were not complicated by fractures.  
 
The discussion is presented in the order in which the results were reported: baseline 
characteristics of the participants, primary feasibility, ease of clinical use, screening performance, 
clinical discriminatory capacity of the tools, exploratory analysis of the outcomes and finally 
recommendation for clinical practice.  
 
4.5.1 Participant Characteristics 
The sociodemographic characteristics of the participants in this study show that they were frail; 
the majority were females, mean age 81.2 years, (maximum to minimum age range 36 to 103 
years). The relatively younger participants were recruited from a facility that caters exclusively 
for people with learning disability. All the participants were Caucasians, thus the findings may 
not be applicable to other ethnic groups. Most of the participants had multi-morbidities. The 
commonest diseases were dementia, diabetes mellitus, cancer, cardiovascular diseases, chronic 
kidney disease, epilepsy and asthma/chronic pulmonary disease.  
 
These characteristics are broadly similar to the characteristics of the care home residents in the 
large BUPA multinational survey in the UK, Australia, New Zealand and Spain (Lievesley, 
Crosby, 2011).  
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All the participants in this research were Caucasians. This is because Boston is in a semirural 
location and the immigrant population is small. According to the Office of National Census, the 
non-white population made up only 2.4% of the total population in 2011 compared with the 
national non-white population of 14 % and 30.2% in London (Office of National Statistics 
(ONS), 2018). Cultural and religious practices may also have contributed.  
 
It is not known what the effects of Brexit on migration will be and there are arguments on either 
side (Begum, 2018). The majority of participants were in residential care in comparison to the 
BUPA multinational survey where nearly three quarters were in nursing homes (Lievesley, 
Crosby, 2011). This is probably because they were less frail and or there were fewer facilities that 
cater for nursing home residents in Boston. 
 
4.5.2 Recruitment of the Participants 
The study included a wide range of residents from residential homes, nursing homes, dementia 
care homes and institutions that offer services for adults with mental disability. Just over a third 
of care home residents were recruited. Most of the participants in the study had mental capacity 
which does not represent the care home population thus the data is skewed in favour of residents 
who possess mental capacity. 
 
The majority of residents in the 18 care homes in this study lacked mental capacity and assent 
was obtained in 21%. This may have been due to the dearth of face to face contact with 
consultees as the participation rate increased when this researcher managed to meet with the next 
of kin or guardian face to face. Zermansky and colleagues obtained higher assent rate of 41% 
(Zermansky et al., 2007). Consent was 57% in residents who possessed mental capacity 
compared to 42% by Zermansky et al and the overall consent/assent  was 35% compared to 42% 
(1163/2779) by Zermansky and colleagues.  
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This might have been because they had a dedicated research nurse and this researcher did not. 
Unfortunately, the other available publications (Nijs et al., 2006, Fossey et al., 2006, Winblad et 
al., 2006, Law et al., 2006) in care home research did not state consent/assent rates. The 
recruitment is worryingly low especially for the residents without mental capacity who constitute 
the higher proportion of care home residents. The proportion of the participants who were 
excluded from this study because they were on end of life care pathway was 4.4% compared to 
27% in a study by Hall and colleagues (Hall, Longhurst & Higginson, 2009). 
 
There are three plausible explanations for this; first, there is a dearth of palliative care services in 
Lincolnshire. A recent local mortality report for the United Lincolnshire Hospital Trust showed 
that the Trust is currently 10% below the national average for palliative care coding for 
mortalities (United Lincolnshire Hospitals NHS Trust (ULHT), 2018). Second there may be 
resistance to changing the established clinical practice code of identifying people who should be 
on end of life care pathway. This was highlighted in a recent report of the Trust`s Mortality 
Review Action Group (United Lincolnshire Hospitals NHS Trust (ULHT), 2017).  Finally it may 
reflect the study population.  
 
4.5.3 Ease of Clinical Use 
The duration that was taken to undertake the risk assessment were 1 minute each for FRAX, 
QFractureScores, Garvan nomogram and 2 minutes each for QFractureScores and TUGT. These 
can be accommodated within clinical practice schedules. There are no publications for duration 
of risk assessment tools therefore comparisons could not be made. Experience and speed in using 
these tools are achieved with practice. Assessments for FRAX, QFractureScores and Garvan 
nomogram are web-based therefore require computers. Computers are readily available in most 
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developed countries but availability does not necessarily translate to use because many 
practitioners may not interrupt their schedules to use the computer. 
 
One experiment found that providers who are well versed in osteoporosis care were unlikely to 
access a web-based fracture risk tool. Only 1 in 20 providers who referred patients for bone 
densitometry testing responded to a mailed invitation to access a tool like FRAX (Watts, Ettinger 
& LeBoff, 2009). This is likely to change with the introduction of the Patient Electronic 
Healthcare Record System which mandates all GPs to go online for patient management.  The 
TUGT poses logistic problems in the frail elderly resident particularly in the cognitively 
impaired. Conducting it requires adequate space, stop-watch and focused commitment which 
could be challenging. 
 
4.5.4 Clinical Discriminatory Capacity  
 
The odds ratios for the prediction of the outcomes of the tools indicate that for a unit increase in 
the score, there was  0.3% non-significant increase in fall risk, 2.7% non-significant increase in 
fracture and combined falls and fracture risk for FRAX, 0.7% non-significant increase in falls 
risk, 2.4% significant increase in fracture and combined falls and fracture risk for 
QFractureScores; 1% non-significant increase in falls risk, 2.1% non-significant increase in 
fracture and combined falls and fracture risk for Garvan nomogram; 4.8% significant reduction in 
falls risk, 13.2% significant reduction in fracture and combined falls and fracture risk for BMI; 
0.1% significant reduction in falls risk and no change in fracture and combined falls and fracture 
risk for TUGT. 
 
The results show that there were differences in the performances of the tools. FRAX, 
QFractureScores and Garvan nomogram were not good at predicting falls within the one year of 
follow-up. Although there were statistically significant differences for the prediction of fractures 
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and combined falls and fractures for FRAX, Garvan nomogram and QFractureScores, the effect 
sizes differed only a little, therefore for practical purposes, none of them was effective at 
predicting fractures and combined falls and fractures in this cohort.  TUGT, the tool 
recommended by National Institute for Care Excellence (NICE) for falls risk assessment 
predicted falls but again the effect size was minimal; therefore it was not useful as falls risk tool 
in this cohort.  
 
This finding emphasises the limitations of p-values in interpreting research data. A recent Nature 
commentary (Diong, 2016) highlighted a statement by the American Statistical Association on 
the principles to guide the use of p-values for interpretation of research findings out of concern 
for the lack of understanding of p values and what they imply. Specifically the 6 principles of the 
statement are: 
 
1. P values can indicate how incompatible the data are with a specified statistical model; 
2. P values do not measure the probability that the studied hypothesis is true, or the 
probability that the data were produced by random chance; 
3. Scientific conclusions and business or policy decisions should not be based only on 
whether a p value passes a specific threshold; 
4. Proper inference requires full reporting and transparency; 
5. A p value, or statistical significance, does not measure the size of an effect or the 
importance of a result; 
6. By itself, a p-value does not provide a good measure of evidence regarding a model or 
hypothesis. 
 
BMI predicted falls, fractures, combined falls and fractures with the highest odds ratios but the 
associations were weak. The effects were more on fractures than falls. The influence of BMI on 
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fractures is largely through the BMD. This was shown in a large population-based prospective 
meta-analysis which was cited earlier (De Laet et al., 2005). 
 
The underlying mechanisms by which low BMI causes falls and fractures are conjectural but 
might include greater liability to falls (Willig, Luukinen & Jalovaara, 2003), nutritional 
deficiencies of protein and amino acids, vitamins A, C, D, and E as well as minerals such as iron, 
selenium and zinc (Bischoff et al., 2003a, Wootton et al., 1979, Cespedes, 2017). Low BMI also 
results in compromised immune system with increased propensity to falls and fractures because 
of infections, lethargy, insomnia (Cespedes, 2017) and the decreased padding over the greater 
trochanter (Nilsson, 1970). The effects of some unmeasurable factors such as reduced mobility 
which result in secondary osteoporosis has also been suggested (Frost, 1997). There are also the 
effects of inflammatory secondary to low BMI. 
 
The skeletal and the muscular organ systems are tightly intertwined: the strongest mechanical 
forces applied to bones are those created by muscle contractions that condition bone density, 
strength, and microarchitecture. Not surprisingly, decrease in muscle strength leads to lower bone 
strength. Ageing per se and the reduced gonadal hormone levels seen in ageing are responsible 
for the increase in catabolic pro-inflammatory cytokines such as IL-1, IL-6 and tumour necrosis 
factor (TNF-a) which are partly regulated by anabolic hormones. Low BMI is also associated 
with elevated levels of these cytokines (Takele et al., 2016) which have detrimental effects on 
both the muscle and the bones.  
 
In the muscle the cytokines result in reduced muscle mass and increased muscle weakness 
(sarcopenia) (Bischoff et al., 2003a, Bischoff et al., 2003b) by causing muscle breakdown, the 
molecular basis is linked to the ubiquitin-proteasome system and the muscle fibre actin and 
myosin proteolysis (Glass, 2010). Sarcopenia is considered one of the hallmarks of the aging 
process. It is characterised by the loss of fast-twitch type 11 fibres and loss of motor-neurons 
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both of which are important factors involved in the onset of fall (Cederholm, Cruz-Jentoft & 
Maggi, 2013).   
 
In the bone the cytokines are partly responsible for the differentiation of osteoclast precursors 
into activated osteoclasts via the RANKl/RANK/OPG pathway that result in osteoporosis 
(Boyce, Xing, 2007). Cathepsin K, a protease with specific action on bone collagen and 
expressed by osteoclasts has also been implicated in the process. Thus the combined effect of 
sarcopenia and osteoporosis i.e. the hazardous duet (Crepaldi, Maggi, 2005) contribute to the 
increased risk of falls and fractures especially in the frail older person. 
 
Body mass index (BMI) is a measure of weight adjusted for height and it is calculated as weight 
in kilograms divided by the square height in metres (kg/m²). Obtaining accurate weight and 
height measurements in the elderly can be challenging due to the changes in body physique and 
decline in mobility. Weight can be assessed with sit-in weighing scales or by hoist in bed bound 
residents. Height can be measured either with wall-mounted scales for ambulant residents or ulna 
length and demispan in those who cannot stand (BAPEN, 2018). For the residents in whom 
conventional measurements cannot be done, BMI estimates can be obtained by the mid-upper 
arm circumference (MUAC) (BAPEN, 2018). BMI assessment is simple, non-invasive, and 
inexpensive and within the repertoire of most care home nurses and BMI nomograms are widely 
available. Where there is access to proper equipment, BMI can be calculated with reasonable 
accuracy.  
 
Besides falls and fracture assessment, measurement of BMI has other health benefits. It is a 
surrogate measure for body fat and a high BMI has been shown to predict future morbidity and 
mortality (Abdelaal, Le-Roux & Docherty, 2017). Thus, it has been used to track weight status in 
individuals and populations. Its use has resulted in an increased availability of published data that 
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allow health professionals to make comparisons across time, regions and population sub-groups. 
It is debated that different reference standards should be used for specific sub-groups. There is 
robust evidence that at any given BMI, some health risks such as diabetes mellitus are higher in 
some ethnic groups than others (Deurenberg-Yap et al., 2000). In the current study, all the 
participants were Caucasians therefore BMI could not be compared between ethnic groups. 
 
The use of BMI for risk assessment has some limitations. It does not take into account the weight 
from fat, bone or lean body mass. People with large amount of muscle mass such as athletes may 
have high BMI and be perfectly healthy. Conversely, BMI can underestimate health risk in 
people who are within the normal reference range but are not healthy (Cespedes, 2017). Also, it is 
not a good measure of weight in short or tall people. For example, it may underestimate the true 
values in people with vertebral collapse (Trefethen, 2013). With age, body fat increases and 
muscle mass decreases (Rothman, 2008) therefore BMI may not correspond to the proportional 
changes in body fat or mass. Finally, BMI does not correct for sex differences in age related 
decline in muscle mass. 
 
FRAX and Garvan nomogram were not predictors of any of the outcomes. QFractureScores 
predicted fractures but not falls which is consistent with the fact that it is a fragility tool. BMI is a 
common predictor in the three fragility models. A plausible explanation for the differences 
observed was that many of the predictors in the models were not essential and therefore diluted 
the association of BMI towards the null. An attempt was made to obtain the weightings of the 
predictors for FRAX from the WHO headquarters in Switzerland but the researcher was informed 
it is classified information. TUGT was a predictor of falls but not of fractures consistent with the 
fact that TUGT is a falls risk tool. Although the mean duration of TUGT was statistically 
significant, the effect size was small which may be because the derivation cohort of the TUGT 
was younger (mean age 79.1 years) compared to this cohort (mean age 81.2 years). 
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There were no publications that compared the performance of fragility risk tools in care home 
residents but some were available for community dwelling older people. A study compared 
FRAX, Garvan nomogram, age plus prior fracture using the GLOW cohort (Sambrook et al., 
2011). The AUC for hip fracture were 0.78, 0.76, 0.76 respectively and 0.61, 0.64 for major 
osteoporotic fractures for FRAX and Garvan nomogram. Another study compared FRAX (New 
Zealand) and Garvan nomogram in participants who were enrolled in a 5-year randomised control 
trial of calcium supplementation (Bolland et al., 2011). For hip fracture, the AUC for FRAX 
incorporating BMD was 0.70 (95% CI 0.64-0.77), FRAX without BMD 0.69 (95% CI 0.63-0.76), 
and 0.67 (95% CI 0.60-0.75) for Garvan nomogram. For major osteoporotic fractures, the AUC 
were between 0.60 and 0.64 for Garvan nomogram and FRAX plus BMD. Neither FRAX nor 
Garvan nomogram demonstrated better discrimination compared to the Kanis risk algorithm 
which uses age and BMD alone in the assessment of fracture risk (Kanis et al., 2001).  
 
Henry and colleagues (2011) compared FRAX (UK and USA) and Garvan nomogram in 600 
post-menopausal Australian women; for major osteoporotic fracture without BMD (AUC 0.66) 
and with BMD (AUC 0.67-0.70) were comparable (Henry et al., 2011). Cummins and colleagues 
(2011) also showed that the AUCs of QFractureScores and FRAX were comparable in a group of 
246 postmenopausal women aged 50-85 years from six centres in Ireland and the UK, the AUCs 
were: 0.632 vs 0.710 for hip fractures and 0.668 vs 0.665 for major osteoporotic fractures 
respectively (Cummins et al., 2011).  
  
4.5.5 Screening Performance of the Tools 
The screening performance showed that generally, the fragility risk tools had poor sensitivities 
and specificities. Screening tests assist to identify accurately diseased and non-diseased 
individuals; there is rarely a clean distinction between “normal and “abnormal” but 100% is 
desirable. The sensitivity of a clinical test refers to how accurately the screening test is in 
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identifying disease in people who truly have the disease. The specificity focuses on the accuracy 
of the screening test classifying truly non-diseased people (Felson, 2018). Sensitivity and 
specificity focus on the efficacy of the screening tool for a population and not the individual per 
se. The RCP (1992) recommends that when screening, sensitivity (avoiding false negatives) may 
be more important than specificity (avoiding false positives) because opportunities for clarifying 
the status of false positive patients will arise but the false negative is lost to further scrutiny.  
 
The predictive values take the test results a step further to the individual level. Thus the PPV is 
the probability that subjects with a positive screening test truly have the disease and the NPV is 
the probability that subjects with a negative screening test truly do not have the disease. Unlike 
sensitivity and specificity, the PPV and NPV are dependent on the prevalence of the disease. A 
common condition will result in a high PPV and low NPV whereas an uncommon condition will 
result in a low PPV and a high NPV. Thus in daily practice, the clinician and patient will be more 
interested in the predictive values (Altman, Bland, 1994). 
 
Of the fragility tools, BMI of 25kg/m² or less had the highest sensitivity of 74.5%. Compared to 
the fragility tools, the TUGT had the highest sensitivity of 95.7% for falls, but specificity was 
poor at 40%. This was not surprising because TUGT is primarily a falls risk assessment tool. 
Sensitivity of 70% and above is regarded as good. Mammograms are an example of a test that 
generally has a high sensitivity (70 – 80%) (Stephanie 2014) 
 
4.5.6 Conclusions 
 
This pilot study has added to the knowledge base in falls and fragility risk assessment in care 
home residents. It has provided important process, resource, management and scientific data to 
guide the design of a future powered study. The complex fragility tools are not useful for risk 
assessment in care home residents and the simpler tools are not only cost saving but more 
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practical and effective. The tools were generally easy to use but their sensitivity and specificity 
were poor. 
 
Of the four fragility risk assessment tools, Body Mass Index (BMI) was the best predictor of 
falls, fractures and combined falls and fractures although the associations were weak. 
QFractureScores predicted fractures and combined falls and fractures but neither FRAX nor 
Garvan nomogram predicted any of the outcomes and the Timed Up and Go Test predicted falls 
only. This preliminary evidence requires confirmation in a future definitive adequately powered 
study that incorporates a representative sample of residents without mental capacity. 
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Chapter 5 Exploratory analysis of the data of the Observational Study and 
Clinical Algorithym 
 
5.1 Abstract 
 
5.1.1 Background 
A general review of the data of the observational study showed that there were differences in the 
clinical outcomes in the 18 care homes and three subgroups of participants were identified. The 
aim of the exploratory analyses was to identify the factors which may be useful for the 
development of a clinical algorithm.  
 
5.1.2 Methodology 
The methodology of the observational study has been described in chapter four. The three 
subgroups of participants identified were: 
Group 1: the participants who did not fall and did not sustain incident fractures 
Group 2: the participants who had falls but did not sustain incident fractures 
Group 3: the participants who had falls and sustained incident fractures 
 
5.1.3 Results 
The fall incidence in the residents was 2.7 per resident per year and 1.5 per participant per year 
and incident fractures were 0.17 per resident and 0.05 per participant. There were variable 
numbers of falls and fractures in the care homes. Of the 10 incident fractures, 40% occurred in 
the participants who had dementia and all incident fractures resulted from falls. There was a 
reduction in the number of fallers following institutionalisation 165 vs. 94 but fractures were 
more 88 vs. 103 
 
The covariates that showed significant association with falls were: age OR 1.025 (p=0.030), 
Parkinson`s disease OR (p=0.017), prior history of falls OR 1.949 (p=0.014), body weight OR 
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0.982 (p=0.008), BMI OR 0.952 (p=0.015), alcohol use OR 0.000 (p=0.016). For fractures and 
combined falls and fracture the significant associations were: age OR 1.025 (p=0.030),  BMI OR 
0.886 (p=0.024), body weight OR 0.952 (p=0.019). When the Bonferroni correction was applied 
the only covariate that was different between the groups was the body weight. 
 
There were significant differences between subgroups. The differences were: age. no falls, no 
fracture group vs  falls, no fracture group (p=0.017), no fall, no fracture group vs  fall & fracture 
group (p=0.046); body weight no fall, no fracture group vs  fall, no fracture group (p=0.0170, no 
fall, no fracture group vs fall & fracture group (p=0.014); Parkinson`s disease no fall, no fracture 
group vs fall, no fracture group (p=0.025): QFractureScores no fall, no fracture group vs fall & 
fracture group (p=0.020); Garvan nomogram no fall, no fracture group vs fall & fracture group 
(p=0.025); BMI no fall, no fracture group vs no fall, no fracture group (p=0.042), no fall, no 
fracture group vs fall & fracture group (p=0.021); TUGT no fall, no fracture group vs fall, no 
fracture group (p=0.002). However when the Bonferroni correction was applied, the only tool 
that differentiated fallers from non-fallers was the TUGT. 
 
5.1.4 Conclusions 
Falls were common in the residents and participants but fractures, less so. All the incident 
fractures resulted from falls. Despite the small representation of participants who lack mental 
capacity, 40% of the incident fractures were observed in this group, thus dementia is a strong risk 
factor for fractures in this cohort. Body weight and body mass index predicted falls, fractures, 
falls and fractures combined. There were some demographic differences between fallers and non-
fallers but there were no differences between fallers who sustain fractures and those who did not. 
However, when Bonferroni correction was applied, the only predictors that were significantly 
different between the groups were body weight and the TUGT but as the numbers of the 
participants in subgroups were small and not equal, the findings may be spurious. 
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5.2 Background 
A general review of the data of the observational study in chapter four showed that there were 
variations in the number of clinical outcomes between the 18 care homes. Also three subgroups 
of the participants were identified. These were: group 1, the participants who did not fall and did 
not sustain incident fractures; group 2, the participants who had falls but did not sustain incident 
fractures; group 3, the participants who had falls and sustained incident fractures. The aim of the 
exploratory analyses was to identify the factors which may be useful for the development of a 
clinical algorithm. 
 
5.3 Methodology 
The methodology of the observational study has been described in chapter four. The clinical 
outcomes in each care home were obtained from the study database and tabulated. The 
participants were divided into three subgroups: 
Group 1: the participants who did not fall and did not sustain fractures 
Group 2: the participants who had falls but did not sustain incident fractures 
Group 3: the participants who had falls and sustained incident fractures. 
 
5.3.1 Statistical Analysis 
 
The comparison between groups was done using appropriate statistical methods. To compare all 
three groups simultaneously (Bonferroni correction), the desired alpha value (α = 0.05) was 
divided by the number of groups (i.e. 3) to obtain the p value (Bland, Peacock, 2000) i.e.  0.017. 
Box and whisker plots were plotted where appropriate 
 
 
 
 
 
 
233 
 
5.4 Results 
 
5.4.1 Falls and Fractures in Care Home Residents and Participants 
 
Table 34 shows the total number of falls and fractures in care homes residents and the 
participants.  
 
5.4.1.1 Residents 
 
There were 1671 falls in all 18 care homes with population of 618 residents. The fall incidence 
was 2.7 per resident per year (1671/618). The total number of fractures in all the 18 care home 
residents was 103, that is, fracture incidence of 0.17 fractures per year (103/618).  The proportion 
of falls resulting in fractures was 6.2% (103/1671 x 100).  
 
5.4.1.2 Participants 
 
The total number of falls and fractures in the 217 participants (35% of care home population) 
were 325 and 10 respectively that is fall incidence of 1.5 per participant per year and fracture 
incidence of 0.05 per participant per year respectively.  This equates to 3.1% (10/325 x 100) of 
fractures complicating the falls. 
 
Ninety four (42%) out of the 217 participants in the study had a fall; that is classified as fallers. 
Ten (5%) participants in the study had both falls and a fracture; that is every participant who had 
an incident fracture also had a fall.  
 
Summary: There was a high incidence of falls (1.5 per annum) in participants, but only few 
resulted in fractures (3.1%).There were higher incidence of falls (2.7 per annum) in all residents 
(including those not enrolled in the study) and a higher proportion of these resulted in fractures 
(6.2%). The data show higher incidence of falls and fracture in an unselected sample of all care 
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home residents (about 50% more compared to the participants) therefore the data for the 
participants is skewed. This was due to the disproportionate representation of residents without 
mental capacity because of the difficulties encountered with consent.  
 
Falls were common in this population with average annual incidence of 1.5 falls per participant 
and 2.7 falls per resident. Fall incidence in nursing care facilities are reported to be about three 
times that in the community, equating to rates of 1.5 falls per bed per year (Luukinen 1994, 
Rubenstein 1994) or 1.4 falls per person per year (Nurmi 2002). The Center for Disease Control 
in the USA reported an incidence rate of 2.6 falls per person per year (Rubenstein et al 1990). 
Thus these data compare with previous studies. Within the 12 month follow-up period, fractures 
were infrequent in the participants, affecting only 5% of participants but they were more common 
in the care home residents (17%) and all the fragility fractures resulted from falls.  
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Table 34: Comparison of clinical outcomes in the participants and the residents.  
 
Participants in this study Result 
Total number of participants in this study   217 
Number of fallers  94 
Total number of falls in participants over 12 months 325 
Number of fractures in participants 10 
Fall incidence per participant per year of study 1.5 
Fracture incidence per participant per year of study 0.05 
Proportion of falls resulting in fractures in the participants 3.1% 
Duration in days taken to consent and baseline assessment and review  
Median 
Interquartile range (IQR) 
Minimum  to maximum 
 
10 
10 
1 - 299 
Number of participants who died during 12 months of follow-up (%) 54 (25) 
Mean Charlson comorbidity index of all participants (SD) 30.6 (20.7) 
Mean Charlson mortality index of participants who died (SD) 36 (21.1) 
All residents of the 18 care homes  Result 
Total number of care home residents  618 
Total number of falls in care home residents 1,671 
Total number of fallers Not availableϮ 
Total number of fractures in  care home residents 103 
Fall incidence per resident per year of study 2.7 
Fracture incidence per resident per year of study 0.2 
Proportion of falls resulting in fractures in the care home residents 6.2% 
Ϯ;  no falls was available in 2 care homes 
 
Interpretation 
Table 34 shows that the incidence of falls in the participants was 1.5 per participant per year and 
0.05 per participant per year for fractures. The proportion of fractures that complicated falls in the 
participants was 3.1%. For the residents, the fall incidence and fracture complication rates were 
approximately double at 2.7 per resident per year and 6.2% respectively; the fracture incidence 
was 0.2 per resident per year. This suggests that the resident population had a higher proportion 
of people who were susceptible to falls and fractures e.g people with dementia. The duration for 
recruiting participants was considerable and the mortality was high. 
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5.4.2 Number of Falls in Each of the 18 Care Homes in All Residents and Participants  
 
The aim was to explore variations in the distribution of falls amongst the care homes and to 
determine whther falls in participants were representative of falls in the whole care home 
population. . 
 
Table 35 shows the numbers of falls in each care home during the study period. The table shows 
that falls occurred in most of the care homes and the numbers were variable in both the residents 
and the participants. The crude falls incidence rate was highest in two facilities, ME and SJ. Both 
of them catered for patients with dementia but the latter was exclusively for dementia. The lowest 
was in A, a facility for adults with learning disability. All (100%) the facilities conducted routine 
falls risk assessment on the residents of which 14(78%) used the facility`s own risk tool and the 
remaining 4(22%) used generic tools. 
 
Summary: Falls occurred in most of the care homes. The crude falls incidence was particularly 
high in a facility exclusively for dementia care and low for adults with learning disability. The 
residents in the latter home were much younger. All care homes conducted routine falls risk 
assessments, but most of them used the facility`s falls risk assessment tool which were different in 
each care home. 
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Table 35: Falls in each Care Home during the study period 
 
No Care homes Total 
number 
of falls 
in 12 
months 
in all 
residents 
n=618 
Total 
number of 
falls in  
participants 
in 12 months 
n=217 
 
Falls  
incidence 
/100 
residents 
Routine 
falls risk 
assessment 
Y/N 
Type of 
falls risk 
tool 
Used in 
care 
home 
1 RH/dementia (SC) 59  6 151 Y Company 
2 RH/dementia (RCH) 67 2 248 Y Company 
3 RH/dementia (TM) 96 9 384 Y Company 
4 RH/dementia (FH) 63 1 352 Y Generic 
5 RH/NH/dementia (WG) 10 0 53 Y Company 
6 RH/NH/dementia (ME) 250 85 735 Y Company 
7 RH/NH/dementia (WF) 93 7 344 Y Company 
8 RH/NH/dementia (HC) 262 86 284 Y Generic 
9 Adult learning disability 
(A) 
9 2 53 Y Generic 
10 RH/NH/dementia (VC) 171 33 570 Y Company 
11 RH/dementia (OR) 53 20 151 Y Company 
12 RH/NH/dementia (W) 113 22 323 Y Company 
13 RH/NH/dementia (G) 66 7 178 Y Company 
14 RH/dementia (TMGH) 40 13 182 Y Generic 
15 RH/NH/dementia (EL) 79 19 193 Y Company 
16 Dementia (SJ) 240 1 727 Y Company 
17 RH/dementia (GRH) NA 6 NA Y Company 
18 RH/NH/dementia (WLC) NA 6 NA Y Company 
 Total  1,671*  325  18  
Y= yes 
 N=no  
The initials represent the names of the care home 
RH= residential home 
NH= nursing home 
Company= facility`s own falls risk assessment tool 
Generic= common falls risk assessment tool 
 NA= not available (no falls log was available)  
 
Interpretation 
Table 35 shows that there were 1,671 falls in the 618 residents excluding two care homes in 
which falls incidents were not available and there were 325 falls in the 217 paraticipants. All the 
care home residents including the participants had incident falls. The highest incident occurred in 
a facility that cared exclusively for residents with dementia. All the care homes conducted falls 
assessment on residents routinely and the majority used the facility`s falls risk assessment tool 
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5.4.3 Classification of Care Home by Fallers (1 or more falls) and Fractures (1 or more 
fractures) 
 
Table 36 shows the fallers with prevalent and incident fractures in the care homes. During the 12 
months follow-up, 94 participants (43%) were classified as fallers of which 10 (11%) had 
incident fractures. One hundred and sixty five (76%) were classified as fallers with 88 (53%) 
prevalent fractures. Seventy-one (43%) participants who were classified as fallers did not fall 
following institutionalisation and there was a reduction of fractures by 88%. 
 
There were 103 incident fractures in all the residents. Fifteen (83%) care homes recorded incident 
fractures but there were variations in the numbers. The incidence rate was highest in WLC and 
zero in three care homes. There were 10 incident fractures in the participants of which 3 (33%) 
occurred in a facility that provided residential and dementia services (SC). The care home with 
the highest number of fractures was also the most challenging home for this researcher: it was 
more difficult to arrange appointments and there were several cancellations. 
 
Summary: Prevalent falls and fractures were common in the cohort but there was a reduction in 
falls following admission to the care homes (165 vs 94). However incident fractures increased 
(103 vs 88). This suggests that although there were fewer fallers, falls resulted in more fractures. 
This may be related to reduced bone strength due to the relative immobility of the residents 
secondary to frailty and vitamin D deficiency. One review from the electronic records of 265,195 
participants in the UK found an increased incidence of fractures at all sites was strongly 
associated with advancing frailty. (Ravindrarajah et al.,2017).  
 
Vitamin D deficiency is common in care home residents and it increases the risk of falls and 
fractures (Chapuy et al., 1992).  Another explanation is undernutrition which is common in care 
home residents. Undernutrition particularly protein malnutrition contributes to the occurrence of 
osteoporotic fracture by lowering bone mass and altering muscle strength (Rizzoli, Bonjour 
239 
 
1999).  At least a third of care home residents are undernourished (Stephenson 2015). Finally, the 
fall mechanics that result in fragility fractures may be more common in care home residents.   
Incident fractures occurred in most care home residents, but only about 10% of these occurred in 
the participants. There was no documented history of falls in three residents who had prevalent 
fractures in care home A.  
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Table 36: Fallers with and without fractures in each care home 
 
Care homes  
No of fallers in 
participants 
during 12 
months of study 
*n,(%) 
No of fallers in 
participants 12 
months prior to 
study Ϯ*  
n,(%) 
Participants 
during 12 
months of 
study 
 (n) 
 
Participants 
with 
incident 
fractures 
*n,(%) 
Participant
swith prior 
fractures 
*n,(%) 
Residents 
with incident 
fractures 
*n, (%) 
 
RH/dementia (SC) 7 (18) 14 (36)  6 3 (8) 9 (23) 9 (1.5) 
RH/dementia (RCH)_ 2 (7.4) 3 (11) 2 0 (0) 1 (4) 4 (0.6) 
RH/dementia (TM) 9 (36) 15 (60) 9 1(4) 11(44) 2 (0.3) 
RH/dementia (FH) 2 (8) 8 (32) 1 0 (0) 3 (12) 0 (0) 
RH/NH/dementia (WG) 0 (0) 7(37) 10 2 (11) 2 (11) 1 (0.2) 
RH/NH/dementia (ME) 6 (18) 13 (38) 85 1(3) 5 (15) 11 (1.8) 
RH/NH/dementia (WF) 7 (26) 8(30) 7 0 (0) 3 (11) 0 (0) 
RH/NH/dementia(HC) 18 (20) 23 (25) 86 0 (0) 7 (8) 12 (1.9) 
Adult disability (A) 2 (12) 0(0) 2 0 (0) 3 (18) 7 (1.1) 
RH/NH/ADD (VC) 8 (32) 8 (32) 33 0 (0) 3  7 (1.1) 
RH/dementia (OR) 8 (23) 17(49) 20 2 (6) 12 (34) 7 (1.1) 
RH/NH/dementia (W) 6 (17) 7(20) 22 0 (0) 7 (20) 4 (0.6) 
RH/NH/dementia (G) 5 (14) 10(37) 7 1 (3) 4 (11) 9 (1.5) 
RH/dementia (TMGH) 3 (14) 2(9) 13 0 (0) 1(5) 5 (0.8) 
RH/NH/dementia (EL) 1 (2) 9(22) 19 0 (0) 4 (10) 0 (0) 
Dementia (SJ) 3 (9) 3(9) 1 0 (0) 0 (0) 2 (0.3) 
RH/dementia (GRH) 1 (3) 9(24) 6 0 (0) 9 (24) 12 (1.9) 
RH/NH/dementia (WLC) 6 (15) 6 (15) 6 0 (0) 4 (10) 17 (2.8) 
Total 94  165  325 10 88 103 
*As a percentage of the care home population on recruitment; Ϯ 12 months prior to the study (past history of falls). RH= residential home,  
NH= nursing home, ADD= adult learning disability/dementia. The initials represent the names of the care homes 
Interpretation 
Table 36 shows that there was a reduction in the number of fallers following institutionalisation (165 vs. 94) but there were increase in the numbers of 
fractures (88 vs 103). 
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5.4.4 Association of the Covariates in the Tools with Falls, Fractures, Combined Falls & 
Fractures 
The prediction of falls, fractures and combined falls and fractures is shown in table 37. The 
statistically significant associations were, for falls: Parkinson`s disease OR 5.628, p=0.017, 
history of falls OR 1.949, p=0.041, age OR 1.025, p=0.030, body weight OR 0.982, p=0.008, 
body mass index OR 0.952, p=0.015, alcohol OR 0.000, p=0.016; for fractures and combined 
falls and fractures: age OR 1.072, p=0.041,  body weight OR 0.952, p=0.019 and body mass 
index OR 0.868, p=0.024.  
 
Summary: For falls, Parkinson`s disease, history of falls, age, body weight, body mass index and 
alcohol use were the significant predictors. The effect size for a unit increase of the predictor 
were, for falls: Parkinson`s disease (5.6 more), history of falls (2 times more), age (1.025 times 
more), BMI (1.1 times less), body weight (1.01 less), history of alcohol (the effect size could not 
be determined).   
 
For fractures, body weight and body mass index were the significant predictors. The effect size 
for a unit increase of the predictor was BMI (1.2 times less), body weight (1.1 less). Similar ORs 
were obtained for combined falls and fractures as for fractures. For the three outcomes, body 
weight and body mass index were the only significant predictors but the associations were weak. 
The effect sizes were higher for fractures, combined falls and fractures than for falls.  
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Table 37: Odds ratios of the binary logistic models of the predictors and outcome   
Predictors   Unadjusted OR 
for the 
prediction of 
falls (p) 
Unadjusted OR for 
the prediction of 
fractures (p) 
Unadjusted OR for the 
prediction of combined falls 
and fractures (p) 
Age 
Sex 
Body weight 
Body height  
Body mass index 
Previous fractures 
Parental fractures 
Current smoking 
Alcohol 
Glucocorticoids 
Rheumatoid arthritis 
Secondary Osteoporosis 
Diabetes 
Type of care home 
History of falls 
Dementia 
Cancer 
Asthma 
Cardiovascular illness 
Chronic liver disease 
Chronic kidney disease 
Parkinson`s disease 
Malabsorption  
Endocrine problems 
Epilepsy 
Taking antidepressants 
Taking oestrogen HRT 
1.025 (.030) 
1.176 (.564) 
0.982 (.008) 
0.981(.254) 
0.952 (.015) 
1.218 (.484) 
0.764 (.550) 
0.819 (.691) 
0.000(.016) 
0.513 (.423) 
0.764(.195) 
2.652 (.411) 
0.786 (.181) 
0.653 (.236) 
1.949(.041) 
0.880 (.667) 
1.481 (.341) 
0.694 (.487) 
0.907 (.760) 
4.022 (.194) 
1.051 (.920) 
5.628 (.017) 
1.315 (.786) 
1.312 (.849) 
1.170 (.691) 
0.892 (.698) 
0.000(.131) 
1.072 (.041) 
0.680 (.577) 
0.952(.019) 
0.987(.745) 
0.868 (.024) 
2.586 (.146) 
1.242(.846) 
2.984 (.233) 
0.000 (.490) 
0.000 (.412) 
0.000 (.758) 
0.000 (.593) 
0.677 (.425) 
0.479 (.481) 
3.097 (.223) 
1.490 (.553) 
0.774 (.805) 
3.200 (.208) 
2.150 (.265) 
7.556(.151) 
0.000 (.183) 
2.444(.465) 
0.000 (.537) 
0.000 (.663) 
0.682 (.708) 
0.511 (.376) 
0.000 (.663) 
1.072 (.041) 
0.680 9.577) 
0.952 (.019) 
0.987 (.745) 
0.868 (.024) 
2.586 (.146) 
1.242 (.846) 
2.984 (.233) 
0.000 (.490) 
0.000 (.412) 
0.000 (.758) 
0.000 (.593) 
0.677 (.425) 
0.479 (.481) 
3.097 (.223) 
1.490 (.553) 
0.774 (.805) 
3.200 (.208) 
2.150 (.265) 
7.556 (.151) 
0.000 (.183) 
2.444(.465) 
0.000 (.663) 
0.000 (.663) 
0.682 (.708) 
0.511 (.663) 
0.000 (.663) 
 p= level of statistical significance. Significant odds ratios are given in bold. HRT: hormone 
replacement therapy.  
Interpretation 
Table 37 shows that the predictors that demonstrated statistically significant associations with 
falls were age, body weight, BMI, alcohol consumption, prior history of falls and Parkinson`s 
disease. Of these, Parkinson`s disease had the highest odds ratio. For fractures and combined falls 
& fractures; they were age, body weight and BMI. Body weight and BMI were the only 
predictors that had statistically significant association with all three outcomes. 
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5.4.5 Comparison of the Subgroups of Participants 
 
Table 38 shows the comparison of the three subgroups of participants (Group 1: No falls or 
fractures, Group 2: Falls but no fractures, Group 3: Falls and fractures). It is divided into 4 
sections, (A) demographic characteristics, (B) fragility fracture risk factors, (C) number of 
comorbidities, and (D) fagility fracture risk assessment scores. 
 
Comparison of demographic characteristics 
Demographic characteristics for each of the three groups are shown in table 38 A. The mean ages 
of the groups ranged from 78 to 88 years. Fallers were significantly older than non-fallers. 
Patients who fell and fractured were non-significantly older than those with falls alone. Most 
were female (58-70%), all were Caucasians, and the majority (lived in residential settings (79-
90%), with no significant diffences between gourps for any of these. When the three groups were 
compared simultaneously using the Bonferrani correction, there were no differences between the 
groups. 
 
Comparison of risk factors for fragility fractures 
Risk factors for fragility fractures for each of the three groups are shown in table 38 B. Fallers 
had significantly lower body weight compared with non-fallers (mean.65.4 vs 72.8 kg, p=0.017). 
Participants with falls and fratures had even lower weight (mean 55.5 kg). This was statistically 
significant in comparison with those who neither fell nor fractured, but not in comparison with 
fallers. There was a significantly higher incidence of Parkinson’s disease in fallers than in non 
fallers (8.3 vs 1.6%, p=0.025). There was no significant difference in any of the other risk factors 
for fragility fractures between the three groups. When the three groups were compared 
simultaneously using the Bonferrani correction (p=0.017), the only statistically significant risk 
factor was body weight (p=0.017, 0.014). 
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Comparison of comorbidities for fragility fractures 
Number of comorbidities for each group are shown in table 38C. They ranged from 0 to 10 and 
over. The majority (99.5% [21/217]) of the participants had multimorbidities (2 or more long 
term health conditions) and there were no significant differences between the groups. 
 
Comparison of the scores for the tools 
The mean scores of the tools are shown in table 38D. There were no differences between groups 
with FRAX and Garvan nomogram. There were statistical diffences in the QFractureScores 
between the no fall no fracture and the combined fall and fracture groups (53.8 vs 33.5, p= 
0.020). There were statistical differences in the BMI between no fall no fracture and the fall no 
fracture groups (25.3 vs 23.2, p=0.042 and the no fall no fracture and the combined fall and 
fracture groups (25.3 vs 20, p=0.021). There was statistical diffence in TUGT  between  no fall 
no fracture and fall no fracture groups (40.9 vs 27.3, p=0.002). When the three groups were 
compared simultaneously, the only statistically significant tool was the TUGT (p=0.002). 
 
 
 
.   
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Table 38 A: Demographic and clinical characteristics of the three subgroups and their comparison: demographic characteristics 
 
Variable Statistical 
method  
(Group 1) 
No falls or 
fractures 
(Group 2) 
Falls & no 
fracture 
(Group 3) 
Falls & 
fractures 
Comparison 
Groups 1&2 
p value 
Comparison 
Groups 
1&3 
p value 
Comparison 
Groups 
2&3 
p value 
Age (y), mean(SD) FET 79.5(13.3) 82.9 (11.3) 88.1(17.2) 0.053 0.046 0.161 
Sex, female ,n (%)  FET 78 (63.6) 49 (58.3) 7 (70) 0.471 1.000 0.735 
Ethnicity: Caucasian, n (%)  NA 123 (100) 84 (100) 10 (100) NA NA NA 
Setting: Residential, n (%) FET 97 (78.9) 71 (84.5) 9 (90) 0.367 0.400 1.000 
Significant p-values are given in bold.  
Interpretation 
Table 38A shows that the age range of the participants was from 79.5 to 88.1 years. Those who had no fall or fractures were the youngest and the 
participants who fell and fractured were the oldest; those who fell but had no fracture were in between.  There were statistically significant differences in 
the mean ages between the groups. In all three groups, females were in the majority. All the participants were Caucasians and the majority of the 
participants in each group were cared for in residential settings.  
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Table 38 B: Demographic and clinical characteristics of the three subgroups and their comparison: demographic characteristics: fragility fracture risk 
factors  
Variable Statistical 
method  
(Group 1) 
No falls or 
fractures 
(Group 2) 
Falls & no 
fracture 
(Group 3) 
Falls & 
fractures 
Comparison 
Groups 1&2 
p value 
Comparison 
Groups 1&3 
p value 
Comparison 
Groups 2&3 
p value 
Current smoking n, (%) FET 11 (8.9) 5 (6) 2 (20) 0.598 0.253 0.160 
Alcohol≥ 3 units/day, n (%) FET 5 (4.1) 0 (0) 0 (0) 0.082 1.000 -- 
Weight (kg) mean(SD) STT 72.8 (21.7) 65.4 (21.8) 55.5 (10.1) 0.017 0.014 0.160 
Height (cm) mean (SD) STT 168.3 (8.1) 167 (7.8) 167 (8.4) 0.225 0.602 0.093 
Prior fall, n (%) FET 86 (69.9) 68 (81) 9 (90) 0.078 0.280 0.683 
Prior fracture, n (%) FET 44 (35.8) 32 (38.1) 6 (60) 0.770 0.176 0.306 
Parental fracture, n (%) FET 8 (6.5) 7 (8.3) 1 (10) 0.786 0.516 1.000 
Secondary osteoporosis,n (%) FET 1 (0.8) 2 (2.4) 0 (0) 0.567 1.000 1.000 
Diabetes mellitus, n (%) PCS 28 (22.7) 13 (15.5) 1 (10) 0.280 0.631 1.000 
Dementia,n (%) FET 40 (32.5) 24 (28.6) 4 (40) 0.646 0.730 0.478 
Cancer,n (%) FET 13 (10.6) 13 (15.5) 1 (10) 0.393 1.000 1.000 
Asthma/COPD,n (%) FET 11(8.9) 4 (4.8) 2 (20) 0.290 0.253 0.122 
Cardiovascular disease,n (%) FET 31 (25.2) 18 (21.4) 4 (40) 0.618 0.454 0.236 
Chronic liver disease,n (%) FET 1 (0.8) 2 (2.4) 1 (10) 0.567 0.145 0.289 
Chronic kidney disease,n (%) FET 10 (8.1) 8 (9.5) 0 (0) 0.727 0.348 0.392 
Parkinson`s disease,n (%) FET  2 (1.6) 7 (8.3) 1 (10) 0.025 0.210 1.000 
Malabsorption,n (%) FET 2 (1.6) 2 (2.4) 0 (0) 1.000 1.000 1.000 
Other endocrine disease,n (%) FET 1 (0.8) 1 (1.2) 0 (0) 1.000 1.000 1.000 
Epilepsy,n (%) FET 16 (13) 13 (15.5) 1 (10) 0.685 1.000 1.000 
Oral steroids,n (%) FET 5 (4.1) 2 (2.4) 0 (0) 0.703 1.000 1.000 
Antidepressant,n (%) FET 41 (33.3) 27 (32.1) 2 (20) 0.881 0.499 0.719 
HRT,n (%) FET 2 (1.6) 0 (0) 0 (0) 0.515 1.000 1.000 
Significant p-values are given in bold.  
Interpretation: Table 38B shows that the only significant risk factors between the groups were body weight and the presence of Parkinson`s disease. 
The participant who had no fall or fractures had the highest weight followed by the participants who fell but had no fracture and the participants who had 
combined falls and fractures had the lowest weight. Parkinson`s disease was commonest in the participants who fell but had no fractures. 
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Table 38 C: Demographic and clinical characteristics of the three subgroups and their comparison: comorbidities 
 Statistical 
method  
(Group 1) 
No falls or 
fractures 
n (%)  
(Group 2) 
Falls & no 
fracture 
n (%)  
(Group 3) 
Falls & 
fractures 
n (%)  
Comparison 
Groups 1&2 
p value 
 
Comparison 
Groups 1&3 
p value 
 
Comparison 
Groups 2&3 
p value 
 
No of comorbidities 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
≥ 10 
 
 
 
 
 
 
PCS 
 
1 (0.8) 
17 (13.8) 
29 (23.6) 
24 (19.5) 
23 (18.7) 
17 (13.8) 
8 (6.5) 
1 (0.8) 
2 (1.6) 
1 (0.8) 
0 (0) 
 
0 (0) 
14 (16.7) 
16 (19) 
20 (23.8) 
14 (16.7) 
8 (9.5) 
8 (9.5) 
2 (2.4) 
1 (1.2) 
0 (0) 
1 (1.2) 
 
0 (0) 
1 (10) 
4 (40) 
2 (20) 
0 (0) 
0 (20) 
0 (10) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
 
 
 
 
 
 
0.782 
 
 
 
 
 
 
0.924 
 
 
 
 
 
 
0.734 
Charlson comorbidity score 
mean (SD) 
STT 30 (19.1) 31.3 (23.2) 33.1 (20.7) 0.655 0.624 0.817 
Interpretation: Table 38C shows that multimorbidity (presence of 2 or more long-term health conditions) was present in all three groups but there were 
no statistical differences between groups. The range of the mean Charlson Comorbidity Index was from 30 to 33.1 and there were no statistical 
differences between the groups. 
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Table 38 D: Demographic and clinical characteristics of the three subgroups and their comparison: Fagility fracture risk assessment scores 
 
No of comorbidities Statistical 
method  
(Group 1) 
No falls or 
fractures 
n (%)  
(Group 2) 
Falls & no 
fracture 
n (%)  
(Group 3) 
Falls & 
fractures 
n (%)  
Comparison 
Groups 1&2 
p value 
 
Comparison 
Groups 1&3 
p value 
 
Comparison 
Groups 2&3 
p value 
 
FRAX score  
mean (SD) 
STT 19.1 (12.3) 19.6 (10.8) 23 (17.5) 0.754 0.280 0.305 
BMI  
mean (SD) 
STT 25.3 (7.1) 23.2 (7.3) 20.0 (3.4) 0.042 0.021 0.170 
QFractureScores 
mean (SD) 
STT 33.5 (25.8) 36.9 (26.4) 53.8 (30.1) 0.357 0.020 
 
0.063 
Garvan nomogram score  
mean (SD)  
STT 38.3 (27.3) 45.8 (27.8) 58.7 (27.2) 0.055 0.025 0.169 
TUGT 
 mean (SD) 
STT 27.3 (15.8) 40.9 (28.8) 32.7 (14.4) 0.002 
 
0.398 0.463 
Significant p-values are given in bold 
Interpretation 
Table 38D shows that the mean scores of the participants in the groups were different. The scores for FRAX and Garvan nomogram were not 
statistically different. The mean BMI were statistically different; no fall no fracture group had the highest weight and the combined falls and fracture the 
lowest. The mean QFractureScores was statistically different; the combined fall and fracture group had higher scores compared to no fall no fracture 
group. The mean TUGT duration was statistically different between  the fall no fracture group and the no fall no fracture group. 
 
n= number 
NA= Not applicable 
HRT= Hormone replacement therapy 
SD= Standard deviation 
TUGT=Timed Up &Go Test. 
STT=Student`s t-test  
FET=Fisher’s Exact Test 
PCS=Pearson Chi Square 
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5.4.6 Distribution of BMI in the Subgroups of Participants 
 
The rationale was to explore the distribution of BMI in the three groups. 
 
The box and plot chart of BMI is shown in figure 7.  `No falls and no fracture` chart represents 
the distribution of the participants in group 1. The minimum BMI was 14 kg/m² and the 
maximum was 42 kg/m². The lower quartile was 20 kg/m² and the upper quartile was 29 
kg/m². The interquartile range was 9. The median was 24 kg/m² and there were four outliers 
above the upper quartile. These observations were classified as outliers because they were 
outside the `1.5 X IQR rule` (Khan Academy, 2018). 
 
`Fall but no fracture` chart represents the distribution of BMI in the participants in group two. 
The minimum BMI was 13 kg/m² and the maximum was 38 kg/m². The lower quartile was 
17.8 kg/m² and the upper quartile was 26.6 kg/m². The interquartile range was 8.8. The median 
was 21.2 kg/m² and there was one outlier above the upper quartile (Khan Academy, 2018). 
 
`Fall and fracture` chart represents the distribution of BMI in group three. The minimum BMI 
was 14 kg/m² and the maximum was 25.4 kg/m². The lower quartile was 18 kg/m² and the 
upper quartile was 23.3 kg/m². The interquartile range was 5.3. The median was 19.9 kg/m² 
and there were no outliers. 
 
Summary  
The distributions of the participants in group one shows that the majority of the participants 
were either normal or overweight, a few were underweight, obese and morbidly obese. The 
median was at the upper half of the normal range (20-25 kg/m²). There were four outliers and 
these participants were morbidly obese. In group two, the majority of the participants were 
underweight, normal and overweight, a few were underweight and obese. The median was at 
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the lower half of the normal range. There was one outlier and this participant was morbidly 
obese.  The majority of the participants in group three were in the lower half of the normal 
range, a few were underweight. The median was below the normal range. 
 
The majority of the participants in groups one and two were more dispersed around the 
median compared to group three where they were more compact. Thus, the majority of the 
participants in group one appeared to be well nourished, those in group three were 
malnourished and those in group two were in-between if BMI is used as surrogate for 
assessing nutritional status. 
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Figure 7: Box plot of the BMI of the three subgroups 
Interpretation 
Figure 7 shows that the distribution of BMI in the three subgroups was different. The median 
of the no fall no fracture group was the highest, the interquartile range was also the highest. 
The combined falls & fracture group had the lowest median and interquartile range. This 
suggests that the combined fall & fracture group was the most frail and least nourished of the 
three. No fall, no fracture group had 4 outliers, fall no fracture group had 1 outlier and 
combined fall & fracture had no outlier.  
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5.4.7 Mortality 
 
Fifty- four participants (25%) died during the 12 months of follow-up. 
 
Interpretation: The mortality of the participant was high when compared to community 
dwelling older people. It was not clear if the deaths were related to incident fractures. 
 
5.4.8 Charlson Co-morbidity Index (CCI) 
The mean Charlson Comorbidity Index was 30.6% (SD 20.7) for all the participants and 36% 
(SD 21.1) in those who died.  For the participants who died, the statistics  of using a CCI 
threshold  of ≥ 36% were as follows; 
1st quartile 28% 
2nd quartile (median) 26% 
3rd quartile 54% 
Interquartile range 26 
Minimum – maximum range 12 – 85 % 
Sensitivity = 29 % 
Specificity 77% 
CCI prediction of outcome (alive/dead) R² (coefficient of determination)]= 0.021 (p=0.034) 
(normal range 0 – 1) 
When the CCI threshold was increased to ≥ 85%, the sensitivity and specificity for prediction 
of death were 30 and 77 % respectively 
 
Summary: During the 12 months of study, the mean Charlson Comorbidity Index did not 
indicate high risk of death in the participants. The mean score was higher in those who died. 
However the sensitivity was not good. At higher CCI of 85% the sensitivity and specificity  
did not change remarkably. 
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5.4.9 Duration of Recruitment 
 
The median duration for recruitment including information giving, consent, and baseline 
assessment was 10 days (minimum to maximum range 1 - 299).  The longest recruitment 
duration of 299 days was a lone outlier which was caused by the late return of the consultee 
form. 
 
Summary: The recruitment process was very time consuming with long periods of time 
between identifying a patient and obtaining consent. The recruitment duration for each 
participant was considerable. 
 
 
5.5 Discussion 
 
The main findings from the exploratory analyses are: 
 
 Falls were common in the care home residents but fractures were less common. 
 All the fractures in the participants resulted from falls. 
 Falls and fractures were commonest in the facilities that catered for the participants 
with dementia. 40% of the fractures occurred in the participants with dementia. 
 There was reduction in falls following institutionalisation but fractures increased. 
 The significant predictors of falls were: Parkinson’s disease (OR 5.628), history of 
prior falls (OR 1.949), age (OR 1.025), BMI (OR 0.952), body weight (OR 0.982) and 
alcohol use (OR 0.000). 
 The significant predictors of fractures, falls and fractures combined were: age (OR 
1.072), body weight (OR 0.952) and BMI (OR 0.868). 
 The Bonferroni correction showed that the significant differences between the three 
subgroups were the body weight and the TUGT.  
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 The mortality of the participants was considerable, 25% died in the 12 months of 
follow-up. 
 The recruitment duration for each participant was considerable, the median was 10 
days. 
 
 The discussion that follows will compare these findings with published articles. 
 
5.5.1 Falls and Fractures in the Residents and Participants 
 
The results show that the incidence of falls and fractures in care homes in Boston were 2.7 and 
0.2 per resident year respectively. Given that the falls data was not obtained from two care 
homes, the overall incidences were probably higher. The corresponding incidences were 1.5 
falls and 0.05 fractures per participant per year. 
 
Previous studies have shown that falls are common in the elderly population. About 30% 
experience a fall annually, this risk increases after the age of 75 with 50% of elderly people 
over the age of 80 years having at least one fall every year. Fall incidence in care home 
facilities are reported to be about three times that in the community, equating to 1.5 falls/per 
bed per year (Luukinen et al., 1994, Rubenstein, Josephson & Robbins, 1994) or 1.4 falls per 
person per year (Nurmi, Luthje, 2002). The Centers for Disease Control reported a higher 
incidence of 2.6 per person per year (Centers for Disease Control and Prevention, 2012). The 
results from this study are comparable to the CDC and higher than the earlier studies. This 
may be related to differences in research methodologies or an increasing propensity to fall in 
an ageing population (Tinetti, Williams, 1997, Downton, Andrews, 1991).  
 
There were ten incident fractures in the participants and all of them resulted from falls which 
shows that falls are important causes of fractures. This is consistent with previous publications 
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that over 90% of hip fractures and over 87% of all fractures in older people result from falls 
(Grisso et al., 1991, Melton, 1993). Various incidences of fractures in care homes have been 
reported. Ytterstad reported 70 per 1000 person years (Ytterstad, 1999)  while Kane reported 
35 per 1000 person years for all long bone fractures (Kane, Burns & Goodwin, 1995). These 
incidences could not be compared with data from this pilot study because of the different 
metrics of reporting. 
 
There were at least 1,671 incident falls but only 103 incident fractures in the residents that is, a 
complication rate of 6%; in the participants there were 325 falls and only 10 incident fractures 
that is, a complication rate of 3%. This shows that in this cohort, fractures were uncommon 
complication of falls. Previous publications have reported that only about 5% of falls result in 
fractures (Tinetti, Speechley & Ginter, 1988, Campbell et al., 1981, Lord, Mclean & Stathers, 
1992), although a systematic review showed that the complication rate was higher at between 
10 and 20% (Sterke et al., 2008).  
  
5.5.2 Incidence of Falls and Fractures in each Care Home 
 
The results show that incident falls occurred in most of the care homes  which offered 
combined services. The crude incidence rates were variable but they were particularly high in 
a care home that catered exclusively for residents with dementia. The Alzheimer’s Society 
report that people with dementia are four to five times more likely to fall than older people 
who do not have cognitive impairment (Alzheimer Society Manitoba, 2014). Van Dijk and 
colleagues (1993) reported 1,343 falls over a 2-year period in 240 patients with dementia 
(Vandijk et al., 1993). Another study found that dementia participants experienced nearly 8 
times more incident falls than controls (Allan et al., 2009). 
 
 256 
 
There were reductions in falls following admission to the care homes. There are some 
plausible explanations for this. First, falls assessments were undertaken on the participants 
during admission and appropriate personalized care was instituted (Department of Health, 
2001). Second, falls and fractures were the reasons for the admission to the care home 
therefore some of the participants received one to one care and were therefore less likely to 
fall.  The publicity given to risk assessments since the establishment of the Care Quality 
Commission    (CQC) in 2009 followed by the personalised care makes the second proposition 
more likely. Although this hypothesis is speculative, it is supported by a publication that falls 
prevention programmes which were introduced to new entrants in 300 nursing homes in 
Germany reduced the incidence of falls and fractures (Rapp et al., 2008).  
 
 Since 2003, given the well recognised association of vitamin D and musculoskeletal health 
and the high prevalence of calcium and vitamin D deficiency in care home residents and the 
reduction of hip fracture rates following supplementation (Chapuy et al., 1992), I wrote to all 
GPs in North Lincolnshire to prescribe calcium and vitamin D for care home residents, if 
appropriate. Since April 2015, low level prevention of falls has formed part of Lincolnshire`s 
Wellbeing Service (Lincolnshire County Council 2015). The Wellbeing Service provides a 
range of interventions and community based support to promote confidence in living 
independently. Preventing and reducing the incidence of falls is a key challenge for 
organisations and is a top priority of Commissioners, Providers and Voluntary Services in 
Lincolnshire. For example the North East Lincolnshire Falls Prevention Collaborative was 
formed in 2005 to address the issue of falls in this area. They are a group of specially trained 
community volunteers who provide advice and information on how to prevent and reduce falls 
amongst the elderly working alongside health professionals, police, local authorities and local 
organisations.(Leary 2005).  
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Although all the care homes in this study undertook falls risk assessment, 72% used their own 
risk tool, and 27% used generic falls tools. In other words there was no uniformity in the types 
of tool which were used. The falls risk assessment tools currently used for the elderly do not 
show sufficiently high predictive validity for differentiating high and low risk fall risk (Park, 
2017) and it was noticeable that no care home used the TUGT or the 180 degree turn tests 
which are recommended by NICE (NICE, 2013).  
 
The standard of documentation in the care homes was inconsistent in this study. Oygard et al 
also observed that there were significant differences between the nursing homes in how 
frequently an injury report form was completed (Oygard et al., 2017). The causes for the 
variations may be related to education, experience of the care home staff, poor labour force, 
pragmatism of falls risk tool and the fear of litigation or negligence.  Accurate documentation 
is important for data analysis and implementation of preventive strategies.  
 
Accurate and timely documentation ensure that people who are at increased risk are identified 
and appropriate interventions implemented. It is recommended that this risk assessment is 
carried out for all patients over the age of 65 years. This should take place no later than 24 
hours after admission, or after the first meeting with the patient. Fall assessment must be 
conducted by a nurse or healthcare worker and be re-assessed if the patient`s general level of 
fitness changes or if the patient has a fall, or at least once a year for any long-stay patient. 
 
5.5.3 Association of the Covariates in the Tools with the Outcomes 
 
Binary logistic regression analyses showed that for falls, Parkinson`s disease (OR 5.625, 
p=0.017), history of prior falls (OR 1.949, p=0.041),  age (OR 1.025, p=0.030), body mass 
index (OR 0.952, p=0.015),  body weight (OR 0.982, p=0.008) and history of alcohol use (OR 
0.000, p=0.016) were the predictors, for fractures and combined falls and fractures, age ( OR 
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1.072, p=0.041)  body weight (OR 0.952, p=0.019) and BMI (OR 0.865, p=0.024) were the 
predictors. Body weight and BMI were the only predictors for all the three outcomes but the 
effect size were small. 
 
A systematic review and meta-analysis of falls risk factors in nursing home residents and 
hospitals found the strongest associations were: history of falls (OR 3.06), walking aid use 
(OR 2.08) and moderate disability (OR 2.08) for the nursing home cohort (Deandrea et al., 
2013). In a prospective study of 18,855 care home residents in 272 nursing homes, Kiely et al 
also found that the most important predictor was a history of falls (Kiely et al., 1998). They 
found that residents with a fall history were three times more likely to fall during the follow-
up period than residents without such a history.  The other independent risk factors that they 
found were: wandering behaviour, use of a cane or walker, deterioration in activities of daily 
living performance, age greater than 87 years, unsteady gait, independence in performing 
transfers, not requiring a wheelchair and male gender. The definition of what constitute a care 
home was not clear from the publications. The participants in this pilot study were partly from  
residential homes (81%) and partly from  nursing homes (19%). Nursing home residents are 
generally frailer and more dependent and the type of care is strongly related to functional 
impairment particularly mobility (Fried, Guralnik, 1997). 
 
For fractures, a systematic review and meta-analysis of fracture risk factors in care home 
residents identified prior fractures, female gender, low BMI, older age, low BMD, 
glucocorticoid use, rheumatoid arthritis, cognitive impairment, mobility and history of falls 
(Khatib et al., 2014). There were few incident fractures in this study during the relatively short 
duration of 12 months which may explain the differences. Before a new treatment for 
osteoporosis can be approved, the European Medicine Agency (EMA) recommends that 
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placebo-controlled trials be conducted for a minimum period of 2 years (European Medicines 
Agency (EMA), 2006).  
 
5.5.4 Comparison of the Groups 
 
The significant differences between fallers and non-fallers were: older age, low body weight, 
BMI, alcohol use and Parkinson`s disease. 
 
The participants who had falls were significantly older (mean age 82.9 years) than those who 
did not (mean age 79.5 years).  Older age has been identified as a risk factor for falls in many 
studies. The proportion of falls in people who are 75 years and older has been reported to be 
between 32 and 42 % in community dwelling people (Downton, Andrews, 1991, Tinetti, 
Speechley & Ginter, 1988).  Both Luukinen et al and Rubenstein et al  reported falls incidence 
rate of 1.5 falls per bed per year (Luukinen et al., 1994, Rubenstein, Josephson & Robbins, 
1994) or 1.4 falls per person per year in care home residents (Nurmi, Luthje, 2002). Kiely et al 
reported a threshold of 87 years and older as a falls risk factor in nursing home residents 
(Kiely et al., 1998) but a systematic review and meta-analysis did not (Deandrea et al., 2013). 
The differences may be due to inconsistences in research methodologies and the different 
definitions of what constitute a fall. It was not 2005 until  that a universal definition was 
adopted  (Lamb SE et al 2005). 
 
Low body weight and body mass index were significantly associated with falls in this study 
but the associations were weak. No fall no fracture group  had BMI of between 20 and 28 
kg/m², fall no fracture group , 19 to 26 kg/m² and fall & fracture group  between 18 and 22 
kg/m². But this data did not give clarity to the exact thresholds at which falls occur. There was 
a dearth of publication for comparison. One study in a cohort of 1377 community-dwelling 
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people in Northern Taiwan did not show that body weight and body mass index were 
significant risk factors for falls (Lin, Liao & Pu, 2011). However, the mean age of the 
participants in that study was 74.9 ± 6.8 years, of which 48.9% were females. 
 
Parkinson`s disease was more common in the participants who fell compared to those that did 
not (8.3% vs 1.6%, p= 0.025). A large study which compared the fall incidence of 28,280 
Parkinson`s disease patients with 28,280 matched non-Parkinson`s patients, found an overall 
adjusted incidence rate ratio was 2.05 (95% CI 1.88 - 2.24) (Kalilani et al., 2016). A 
systematic review and meta-analysis also found that Parkinson`s disease had a strong 
association with falls (OR 2.7; 2.8) (Deandrea et al., 2010).  Parkinson`s disease captures 
some of the causes of falls such as gait and balance abnormalities (Youn et al., 2017, Kerr et 
al., 2010, Bloem et al., 2004) but the frequency of falls declines in the late stages because of 
the patient`s immobility (Bloem, van Vugt & Beckley, 1999). 
 
For fractures, the significant differences between those who sustained fractures and those who 
did not were age, body weight and BMI. The mean age of the participants in the fracture group 
was 88 years. Many studies have shown that increasing age is associated with higher fracture 
risk (Kanis et al., 2001, Hui, Slemenda & Johnston, 1998). Old age is associated with lower 
BMD in both sexes and all races. Age has a particularly strong relationship with hip fracture 
risk. From the known relationship there is approximately a 4-fold increase in hip fracture risk 
between the age of 55 and 85 years in women because of the age-related decrease in BMD. In 
practice, the incidence in many countries is much higher than this (Kanis et al., 2001). Using 
DEXA scan at the femoral neck to predict hip fracture risk, at 50 years, the 10-year hip 
fracture probability is approximately 2% in women but at the age of 80 years, it is 12% for the 
same T-score. This indicates that age has some other effects on fracture risk independently of 
BMD.  
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However, one study of 1414 ambulant women in residential homes in Yorkshire, England 
found that the mean age of participants who sustained hip fracture was not significantly 
different from those that did not (85.3 years vs 83.9 years, p=0.07) but the mean broad band 
ultrasonic attenuation (BUA, a non-invasive radiation free assessment of skeletal structures) 
index and score for cognisance for the group that had incident fractures were significantly 
lower compared to women who did not (Porter et al., 1990).  The participants who sustained 
fractures were significantly more mobile. Generally, residents who are more mobile by default 
expose themselves to more risky situations that result in falls. This explanation is supported by 
Chandler et al who reported independence in transfer to be a significant predictor of 
osteoporotic fractures in female nursing home residents (Chandler et al., 2000). 
 
In this pilot study, the participants who had falls or combined falls and fractures had 
significantly lower body weight compared to the participants who did not fall (mean 65.4 and 
55.5kg vs 72.8kg, p=0.011, 0.009)  respectively and  similar differences were observed for 
BMI (23.2 and 20 kg/m² vs 25.3 kg/m², p=0.042, 0.021). There were no statistical differences 
in mean height between the groups (167cm, 167 vs 168.4 cm p= 0.504, 0.891) suggesting that 
the differences in body weight were responsible for the differences observed.  
 
Low body weight or low BMI is a reported risk factor for fractures whereas high BMI appears 
to be protective (Cummings, Black, 1995, Honkanen et al., 2000, Joakimsen et al., 1998, 
Turner, Faile & Tomlinson, 1999, van der Voort, Geusens & Dinant, 2001). But one meta-
analysis showed that being underweight had no significant effect on the risk of fracture in men 
(RR; 0.89, 95% CI; 0.53-1.49, p=0.658) and women (RR; 0.98, 95% CI: 0.79-1.20, p=0.816) 
in BMD-adjusted studies. However, when the results were not adjusted for BMD, being 
underweight increased the risk of fracture in men (RR: 1.89, 95%CI 1.18-3.15, p=0.009) and 
women (RR: 1.51, 95%CI 1.35-1.68; p=<0.001) (Xiang et al., 2017).  
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It is reported that in all age groups, low BMI is associated with all fragility fractures especially 
hip fractures but the risk ratio is not linear being markedly higher at lower BMI particularly of 
≤20kg/m².  By contrast between BMI of 25 and 35kg/m², the differences in the risk ratio are 
small. A study from Japan found that both underweight and overweight/obesity are risk factors 
for fractures at different sites. It was reported that underweight was associated with increased 
incidence of femoral neck and long bone fractures while overweight/obesity were associated 
with vertebral fractures (Tanaka et al., 2013).  In many studies, BMI was chosen rather than 
weight to explore the association with fracture risk because of the variation in the average 
weight and height in different populations which is reduced by adjusting weight for height; 
also BMI is as good a predictor of fractures in most studies of hip fractures (Johnell et al., 
1995, Kanis et al., 1999).  
 
There were differences in the mean scores of FRAX, QFractureScores and Garvan nomogram. 
QFractureScores and Garvan nomogram were predictors of fractures not of falls and FRAX 
was not a predictor of any of the outcomes. The possible explanations for the differences have 
been discussed earlier. The TUGT scores were significantly different between no fall no 
fracture and fall no fracture groups (p=0.002) but not in no fall no fracture and fall & fracture 
groups (p=0.398) and 2 and 3 (p=0.463). This suggests that the TUGT was good at identifying 
fallers and non-fallers only. The mean duration for the test was 33.8 seconds which is much 
higher than the recommended threshold of 12 seconds (Bischoff et al., 2003) Ninety three 
(42.9%) participants could not undertake the test and of those who did, 83(38%) performed it 
with the assistance of walking aids. This indicates that the majority of the participants had 
significant problems with mobility.  
 
A systematic review of falls risk assessment tools showed there is a lack of evidence regarding 
which assessment tool is most predictive of falls and therefore most useful (National Institute 
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for Health and Clinical Excellence (NICE), 2014). The National Institute for Health and Care 
Excellence (NICE) however suggested that the TUGT (Podsiadlo, Richardson, 1991) and the 
Turn 180˚ (Kobayashi, Usuda, 2016) are useful in primary care settings as no special 
equipment is required (NICE, 2013). It is recommended that the Turn 180˚ should not be used 
in patients who require a walking aid to turn and are not able to fully weight bear and who 
cannot follow instructions (National Institute for Health and Clinical Excellence (NICE), 
2014). Therefore this model will not be useful for care home residents because most of them 
require assistance with mobility. 
 
5.5.4.1 Fall Mechanics and Fractures 
 
In this study, it was observed that there were no differences in characteristics between the fall 
no fracture group  and the fall & fracture. What then determines the risk of fractures in people 
who fall? Cummings and Nevitt have propounded a hypothesis of how a fall could cause a 
fracture (Cummings, Nevitt, 1989). This was tested in two case-control studies: one was in the 
community (Nevitt et al 1993), the other was in a nursing home (Hayes et al., 1993) but much 
of the findings related to hip fractures in Caucasian women. 
 
Bones break when the force applied to it exceeds its strength. Falls are the most common types 
of force involved in fractures. 80% of non-spine fractures are attributed to falls (Nevitt, 
Cummings, 1992b) but only 5% of falls in the elderly result in fractures of which 1% are hip 
fractures (Cummings, Nevitt, 1989, Nevitt, Cummings, 1992a, Tinetti, 1986). These suggest 
that the fall mechanics are important in the genesis of fractures. They postulated that for a 
fracture to occur, the faller must be orientated so that the point of impact is or is near the hip 
and that the protective responses (such as the strength of an outstretched hand) and shock 
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absorbers must also fail to reduce the energy to a level less than that required to break the 
proximal femur. 
 
Falling onto the side of the leg or buttock near the greater trochanter was 20 to 30 times more 
likely to cause a hip fracture than falling onto other parts of the body. Falls that occur while 
turning were associated with hip fractures (Cummings-Vaughn, Gammack, 2011). One study 
in care home residents found an increased risk of hip fractures with falls to the side (OR 3.9, 
1.3-11), low hip BMD (OR 1.8, 1.03-3.0) and impaired mobility (OR 6.4, 1.9-21.0) 
(Greenspan et al., 1998). Among women who landed near the greater trochanter during a fall, 
those who landed on outstretched hands or broke the energy of the fall by grabbing or hitting 
an object before hitting the floor had about a third risk of fracturing the hip compared with 
women who did not (Nevitt et al., 1993a). The reduced muscle strength and impaired reflexes 
in  older people reduce the effectiveness of automatic protective responses that are necessary 
to break the energy of impact. 
 
The energy of impact is the product of velocity and mass of an object. This implies that taller 
and heavier fallers would have greater risk of fracture. A fall from a standing height generates 
about 400 to 500 joules which is about 10 times the energy required to fracture the proximal 
femur of an elderly woman (Hayes et al., 1993, Hayes, Piazza & Zysset, 1991). The velocity 
of the impact depends on the height of the fall which means that the risk of hip fracture would 
increase as the distance from the greater trochanter to the floor increases.  
 
Hayes and colleagures (1993) reported  that each 9 centimetre increase in a person`s height 
would increase the risk of fracture by about 50%. Of people who fell on the hip, taller women 
had greater risk of fracture (1.5 fold increase in the odds ratio for a fracture for each SD 
increase in height i.e. 6 centimetres). To support this observation, a large prospective study 
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among middle aged women found that taller women (1.7 meters) had a much greater risk of 
hip fracture than shorter women (1.55 meters) (Meyer, Tverdal & Falch, 1993). This increased 
risk may also be accentuated by the longer hip axis in taller people (Faulkner et al., 1993). 
The mass of an object is the other determinant of the energy of impact.  
 
In one community based study, there was a non-significant trend towards greater fracture risk 
among obese women who fell onto the hip after adjusting for other predictors of hip fracture 
(Nevitt et al., 1993b). Conversely larger body mass may be protective because it is 
accompanied by more padding of the greater trochanter thereby reducing fracture risk from 
trauma.  Robinovitch et al estimated that a three-fold increase in trochanteric soft tissue in 
women reduces the fall impact force at the bone by about one-third (Robinovitch, Hayes & 
Mcmahon, 1991). Some studies have shown that wearing protective pads over the greater 
trochanter dramatically reduced the risk of hip fracture in nursing home residents (Lauritzen, 
Petersen & Lund, 1993, Parker, Gillespie & Gillespie, 2000). 
 
The risk of fracture is also dependent on the amount and rate of energy that is transmitted to 
the bone by the texture of the surface of impact. Falling on a soft surface is less likely to cause 
a fracture than on a hard surface such as concrete. Nevitt and colleagues observed that after 
adjusting for the other predictors of hip fractures, women who fell on a hard surface were 
three times more likely to suffer hip fracture than those who landed on a soft surface; 11% of 
people who fell on hard surfaces sustained fractures (Nevitt et al., 1993a). This finding has 
implication for the kind of flooring that should be used in care homes.  
 
Van Schooten et al observed that frequent fallers had a lower risk of injury per fall and they 
suggested that the circumstances of falls and the development of adaptive protective responses 
are possible explanations (van Schooten et al., 2017). In essence, the factors that determine 
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fractures from falls are: the energy generated by the fall, the protective responses which 
mitigate the potential energy and any factors that help to absorb the energy before it is 
delivered to the skeleton. 
 
Bone strength provides the last resistance to fracture. There is an inverse relationship between 
the bone density (strength of bone) and the risk of fracture (Nevitt et al., 1993a). Bone strength 
is dependent on the geometry, mass and qualitative factors such as trabecular integrity and 
amount of fatigue fractures present. In this study the effect of BMI was more on fractures than 
falls (ORs 0.868 vs 0.952). The plausible explanation is the disproportionate reduction of bone 
strength because of the reduced mechanical loading from low BMI due to reduced mobility 
and multi-morbidities. 
 
There is limited research on the mechanics of other types of fragility fractures. Almost all 
wrist fractures resulted from fall onto an outstretched hand (Nevitt et al., 1993a). Falling 
backwards or obliquely forward, landing on the hand and putting out the hand to break a fall 
are associated with increased fracture of the distal forearm (Nevitt et al., 1993a, Palvanen, 
Kannus & Parkkari, 2000). Falling obliquely forward or sideways, landing on a hard surface 
and especially on the shoulder is associated with 90% to 97% of proximal humerus fractures 
(Palvanen, Kannus & Parkkari, 2000, Keegan et al., 2004). Although most vertebral fractures 
are considered to be atraumatic, it is believed that common activities (lifting and bending) and 
body habitus (upper body weight and kyphosis) can substantially influence the forces applied 
to the vertebral body (Hayes, Piazza & Zysset, 1991). 
 
Thus, the number of falls, type of fall and the strength of the bone appear to be the important 
determinants of fractures but these were not validated in this pilot study because that was not 
the aim.  
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5.5.5 Mortality  
 
Fifty-four (24%) participants died during the 12 months of follow-up. This is comparable to 
the results of Shah and colleagues who found 12 month mortality of 26.2% of 2,558 residents 
(Shah et al., 2013). A large BUPA survey of 11,565 residents reported that half died by 462 
days, around 27% lived for more than three years, with the longest stayer living for over 20 
years. Residents had a 55% chance of living for the first year after admission, which increased 
to nearly 70% for the second year before falling back over subsequent years (Forder, 
Fernandez, 2011).  
 
This data shows that care home residents have reduced life span and therefore relatively short 
window of opportunity for intervention. Thus, a prognostic model that accesses conditions in 
this cohort for over 2 years is unlikely to be useful clinically as most of the participants may 
be dead. Treatment decisions are often based on prognosis and the Charlson Comorbidity 
Index (CCI) score may be useful for this purpose. The mean scores for all the participants 
were 30.6% and 36% in those who died but there are no published data for comparison. 
 
5.5.6 Duration for Recruitment 
 
The median duration for the recruitment of each participant was 10 days, and for one 
participant who required Consultee consent, it was 299 days. There are no publications for 
comparison of the optimum duration for recruitment. Walters and colleagues observed that 
recruitment of participants was often slower or more difficult than expected and many trials 
fail to reach the planned sample size within the originally envisaged trial time scale (Walters 
et al., 2017). A long duration can have substantial impact on the number of participants who 
can be recruited, the numbers of investigators and therefore the feasibility of the study. 
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5.5.7 Strengths and Weaknesses of the Study 
 
Strengths and weaknesses discussed below relate to the observational study (chapters 4 and 5). 
5.5.7.1 Strengths 
 
1. To my knowledge, this is the first study to evaluate the performances of four fragility 
risk assessment tools exclusively in care home residents simultaneously. The 
methodology was rigorous and it followed international guidelines.  
2. The follow-up duration of 12 months is a strength given the relatively short life 
expectancy of care home residents. FRAX, Garvan nomogram estimate fracture 
probability in 10 years by which time many of the care home residents may be dead. 
QFractureScores assesses fracture probability annually for 10 years; in this context it is 
an advantage for care home residents.   
3. The sample size of 217 participants was large for a feasibility study. Isaac and Hill 
suggested 10 to 30 participants for pilot studies (Isaac, Michael B, 1995, Hill, 1998); 
Julious and van Belle suggested 12 (Julious, 2005, van Belle, 2002), Treece and Treece 
suggested 10% of the project sample size (Treece, Treece, 1982). Therefore given the 
relatively large number of participants in this project, the data could be pooled into 
subsequent powered studies if type 1 and type 2 errors are controlled for.  
4. All the 18 care homes in Boston participated in this study which included both sexes 
and residents of residential and nursing homes, therefore the results have the potential 
for greater generalisability. 
5. There were no missing data therefore the inferences from the project are valid. 
 
5.5.7.2 Weaknesses 
1. Many residents who did not possess mental capacity and were at high risk of falling 
did not provide informed consent through Consultees therefore only a few (32%) of 
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them were recruited. More incident falls and fractures may have been recorded if a 
higher proportion of them had been recruited. For example of the 10 incident fractures, 
4 (40%) occurred in this subgroup and given that the majority (54%) of the care home 
residents lacked mental capacity, the data are skewed. A possible solution to mitigate 
this limitation would be to improve staff education, to encourage people to develop 
interest in care home research and for the Government to set up schemes to achieve 
this. In addition, the Government could consider including in the Lasting Power of 
Attorney (LPA) application the question ‘If you are admitted to a care home in the 
future, would you be willing to participate in research`?  Research regulatory bodies 
such as the Health Research Authority (HRA) could modify some of the rules that 
govern participation in care home research without compromising the standards that 
breach research ethics. For example, the care manager could be authorised to be a 
proxy decision maker if the ethics committee considers the proposal to be non-
invasive. Also, the waiver of consent adapted by the USA should be considered 
(Wichman, Sandler, 1997). This guidance recommends public consultation. In this 
regard, the theme for discussion should be waiver for observational studies. A futher 
method to facilitate research participation is to initiate the discussion with the next of 
kin at the point of admission to the care home. If it is felt that the resident would be 
willing to participate in future research, then the authority to consent could be 
delegated to the care home managers. 
 
2. The study was not powered for any analysis therefore the inferences made may not be 
valid. Determining the optimal sample size for a study assures an adequate power to 
detect statistical significance and avoid making type 1 and type 11 errors (Jones, 
Carley & Harrison, 2004). A type 1 error is when the null hypothesis is incorrectly 
rejected and a type 11 error is when the alternative hypothesis is incorrectly accepted. 
 270 
 
Using too many participants in a study is expensive and exposes more number of 
subjects to procedures. Similarly if a study is underpowered, it will be statistically 
inconclusive. Sample size is a function of three factors: the significance level, power 
and magnitude of the differences (effect size) (McCrum-Gardner, 2010). This study 
does provide data to inform fully powered studies. 
 
3. While the study duration of 12 months may be considered a strength for study of falls 
(because it limits recall errors), paradoxically it is a weakness for a study on fragility 
fractures because of the relatively short duration which limits the number of incident 
fractures. Before a new treatment for osteoporosis can be approved, the European 
Medicine Agency (EMA) recommends that placebo-controlled trials be conducted for 
a minimum period of 2 years for studies when the primary outcome is BMD and 3 
years when the principal criterion for efficacy is a demonstration of a clinically 
significant reduction in the number of patients with vertebral fractures (Committee for 
Proprietary Medicinal Product (CPMP), 2002). 
 
4. There might have been misclassification bias because spine fractures could have been 
missed as X-rays of the spine were not done before or during the study. Approximately 
two-thirds of vertebral fractures are not associated with fracture-related back pain 
(Cooper et al., 1992, Kotowicz et al., 1994). 
 
5. There might have been under-reporting of falls by care home staff because they were 
missed or due to malpractice. Nursing malpractice is a growing area (Boockvar, Lachs, 
2002). The fear of malpractice litigation together with the importance placed on family 
anxieties may result in underreporting of incidents. It is more difficult to under report 
non-spine fractures because they are more obvious. 
 271 
 
6. Despite explicit explanation of the exclusion criteria for this study (i.e. residents on 
end of life care and residents who are non-English speaking and interpreters are not 
available), some care home managers contacted only residents whom they felt could 
participate. Thus the selection of participants was not random and the inferences from 
the project may not be generalizable. 
 
7. Interrater reliability of the individual components of the questionnaire and assessments 
were not done. This may have introduced experimenter bias in the scores of the tools. 
  
Despite these limitations, this project has provided data for the development of an algorithm 
for fracture assessment for care home residents. This will be discussed in the next chapter. 
 
5.5.8 Conclusions 
The exploratory analyses showed that the fall incidence in this cohort was high and compares 
with published data. Incident fractures were not so common which also support 
epidemiological studies that most falls do not result in fractures and that most fractures result 
from falls.  There were variations in the numbers of falls and fractures in the care homes.  This 
indicates that the type of facility and residents has an influence on the occurrence of these 
incidents.  There was reductions in falls but not fractures following institutionalisation. 
 
The predictors that were significantly associated with falls, fractures, combined falls and 
fractures were older age, low body weight, low body mass index, history of alcohol use, 
history of prior falls and history of Parkinson`s disease. Although dementia did not feature as a 
significant predictor, it was interesting to note that of the 10 incident fractures, 40% occurred 
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in the participants with dementia despite the small representation of this group which suggest 
that it is an important risk factor for fractures. 
 
The subgroup comparisons showed that the significant differences between the fallers and 
non-fallers were: fallers were older, had lower body weight, took more alcohol and had history 
of Parkinson`s disease compared to the non-fallers. For fractures, those who sustained incident 
fractures were older and had significantly lower body weight compared to those who did not 
have fractures. 
 
The scores on the tools were different; the participants who had falls had longer TUGT and 
lower BMI compared to the participants who did not fall. Also the participants who had fallen 
and sustained fractures had lower BMI, higher QFractureScores and Garvan nomogram scores 
compared to those who  did not fall but there were no significant differences in TUGT 
between the groups. There were no differences in the fallers who sustain fractures and those 
who did not. 
 
The mortality of the participants was high given that 25% died during the 12 months of 
follow-up: the mean CCI index was higher in this group compared to the mean for all the 
participants. 
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Chapter 6 Discussion, Conclusions and Future Research 
6.1 Introduction   
 
Many tools exist for the assessment of fragility fracture risk in older persons but these were 
developed from community-based older people and it is not known if they can be used for care 
home residents. The overarching aim of this project was to identify fracture risk assessment 
tools which are practicable in care home residents and to determine which is most suitable for 
use in this population. This was addressed by a systematic literature review of fragility 
fracture risk assessment tools, development and testing of a questionnaire containing the 
predictors of fragility fractures, and conducting a pilot study compare the tools identified.  
 
The systematic literature review identified thirty-three fragility tools of which four were 
practicable for care home residents. These were FRAX, QFractureScores, Garvan nomogram 
and BMI. Testing of the questionnaire developed from the tools in consultation with care 
home staff and residents led to refinements including increases in font size and addition of a 
consultee information sheet. The majority of the participants in the observational study had 
full mental capacity, which was not representative of the care home resident population as a 
whole, thus the data was skewed. The key finding was that all four fragility tools had poor 
screening performance. BMI was the best predictor of falls, fractures and combined falls and 
fractures but the associations were weak. QFractureScores was a predictor of falls and 
combined falls and fractures.  Neither FRAX nor Garvan nomogram were predictors of these 
outcomes. Of the 10 incident fractures, 40% were observed in participants who had dementia 
despite the small representation of this group, thus dementia is a strong risk factor for fractures 
in this cohort.  
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The narrative that follows will summarise and discuss the findings of each results chapter, 
develop an algorithm for screening fracture risk in care home residents, discuss strengths and 
weaknesses and explore potential avenues for future research.   
 
6.2. The Systematic Literature Review 
 
The systematic literature review identified thirty-three tools, the majority of which were not 
externally validated.  Four of these tools were potentially practicable for use in care home 
residents. These were FRAX, QFractureScores, Garvan nomogram and BMI. Two systematic 
reviews of fragility risk tools also identified these tools and noted that only few models were 
externally validated (Nayak et al., 2014, Rubin et al., 2013).  FRAX, QFractureScores and 
Garvan nomogram estimate fracture risk over a period of between 5 and 10 years although 
QFractureScores has provision for annualised risk. BMI has not been calibrated. 
 
The absolute risk of fracture depends upon the age and life expectancy as well as the current 
relative risk.  Most care home residents are over 85 years and they have an average life 
expectancy of two and a half years (National Institute for Health Research (NIHR), 2016).  
This may limit the use of many existing tools in the target population. While the WHO and the 
International Osteoporosis Foundation recommend that fracture risk should be expressed as a 
probability over a 10 year interval (Kanis, 2002), such time frames are too long for care home 
residents. The observational study conducted as part of this thesis showed that 25% of 
participants died within a year, thus confirming the need to ensure that fracture assessment 
tools are reliable in such a frail population.   
 
The methods and the duration of assessment with each tool are likely to affect uptake in 
clinical practice. Some of the tools, such as FRAX, QFractureScores and Garvan nomogram 
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are web-based and can only be assessed through the internet, therefore require computers 
which may not be readily available. However FRAX also has a paper-based version. A 
previous study has shown that providers who are well versed in osteoporosis care were 
unlikely to access a web-based fracture risk tool, only 1 in 20 providers who referred patients 
for bone densitometry testing responded to a mailed invitation to access a tool quite similar to 
FRAX (Watts, Ettinger & LeBoff, 2009).  This is likely to change with the introduction of the 
Patient Electronic System.  The fracture assessment process should be simple enough to be 
accommodated within routine work schedules.  
 
6.3 The Consultation Visit 
 
Conducting research in care homes is challenging, therefore it was essential to undertake 
consultation visits in preparation for the observational study although this was not required by 
the Ethics committee and the Research and Development Department of the ULHT. The aim 
of the consultation visits was to determine the acceptability of the research documents and 
make adjustments if necessary.  Involving care home staff and residents early in the 
development of the study also ensured that a baseline of knowledge and understanding could 
be established for future dialogue.  
 
The feedback came in the form of both detailed comments and minor corrections to the draft 
text. Some aspects in the research documents were confirmed as acceptable and other sections 
refined as a result of the feedback obtained.  The changes made included increases of font size, 
avoidance of open questions, deletion of duplicate questions and development of separate 
information sheets for participants and consultees. Suggestions came from consultation 
participants with in-depth knowledge and experience of care home procedures such as 
managers, deputy managers, nurses, care assistants and residents. The feedback helped to 
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further the understanding of various aspects of care home daily routines, future vision, 
appreciation and expectations.  
 
The consultation led to an increased awareness of the importance of the research amongst care 
home staff, and the feedback provided invaluable insights that ensured that the research 
documents were practicable and could be easily implemented in the observational study. This 
confirms reports of earlier consultation studies which found the exercise useful in developing 
the protocol and exploring ethical issues (Koops, Lindley, 2002, Ali, Roffe & Crome, 2006). 
 
6.4. The Prospective Observational Cohort Study 
The aims of the pilot study were to evaluate the feasibility of a fully powered study, to identify 
if the existing scores for fracture risk have relevance for care home use in the frail elderly, 
ease of use  and of the Timed Up and Go Test (TUGT).  
 
All the eighteen care homes in Boston participated, making the study representative of local 
care homes.  However, only 217 (35%) participants were recruited out of 618 residents in 
these homes, with the main reason for non-recruitment being the inability to obtain informed 
consent in residents who lacked capacity.  This was a major issue affecting recruitment, as 
54% of the care home population lacked mental capacity, and it was difficult to contact 
consultees. Of the participants only 32% lacked mental capacity, thus the participants were not 
representative of the care home population.   
 
The tools were generally easy to use with average duration of each risk assessment of between 
1 and 2 minutes; this can be accommodated within routine work schedules.  However, 
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assessment with the TUGT posed logistic problems, particularly with participants who did not 
have mental capacity.  
 
Care home residents are a high risk group for fragility fractures, and it is important that the 
tool for this cohort has good screening performance. The sensitivity and specificity of the tools 
were generally poor, BMI had acceptable scores and the TUGT had high sensitivity for the 
prediction of falls, but the specificity was low. There were no published data for comparison.   
 
The clinical discriminatory capacity of the tools showed that the complex models (FRAX, 
QFractureScores,  Garvan nomogram and TUGT) were not as good as the much simpler BMI. 
This was consistent with the results of Rubin and colleagues (Rubin et al., 2013). Of the five 
tools, BMI was the best predictor of falls, fractures and combined falls and fractures, 
QFractureScores predicted fractures and combined falls and fractures but neither FRAX nor 
Garvan nomogram predicted these outcomes. The TUGT is a dedicated falls risk assessment 
tool and predicted falls, as expected, but the association was only weak.  
 
It is interesting to note that, while BMI is an aspect of each of the three specific fracture risk 
assessment tools, it was a better predictor on its own than as part of the tools. This is a very 
useful finding for clinical practice, as BMI is easy to assess, and available for all care home 
residents, making routine screening for fracture risk a simple procedure, which can be 
introduced at no cost. One meta-analysis of fracture risk in 1,734 care home participants also 
found that the risk of fracture increased with decreasing BMI (HR 0.94, 95% CI = 0.90-0.98) 
(Khatib et al., 2014).  
 
As the participants in this observational study were not representative of residents without 
mental capacity, it is unclear whether the findings also apply to patients with cognitive 
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problems. However, while there were only 10 fractures in 217 study participants, 4 occurred in 
patients with dementia. Dementia is included as a predictor only in the QFractureScores, 
which in itself was not useful for fracture prediction.  The reasons for this are unclear, but the 
effect of dementia may have been diluted by other factors or, as in this study, insufficient 
numbers of participants with dementia were included in the development of the tool. This 
information was not available in the original paper describing the tool (Hippisley-Cox, 
Coupland, 2009). The observational study in this thesis showed that 40% of patients with 
fractures had dementia, suggesting that dementia may indeed be an important predictor for 
fractures.  
 
A systematic review and meta-analysis of 13 prospective cohort studies also identified 
cognitive impairment as risk factor of fractures in long term care (Khatib et al., 2014). 
Conversely, a meta-analysis of 24 studies in nursing homes and hospitals did not specifically 
identify dementia as a risk factor for falls in care home residents (Deandrea et al., 2013).  
These two reviews are not directly comparable, as one examined fractures and the other falls. 
The observational study here is small, and might therefore overestimate the risk in the 
subgroup with dementia. However, an increased risk in residents with dementia is plausible, 
and should be confirmed in a future fully powered study.  
 
6.5 Exploratory Analyses and Clinical Algorithm 
 
The main findings from the exploratory analyses were: 
 
The time it took to recruit each participant was considerable, with a median of 10 days. 
Falls were common in the care home residents but fractures were less common. 
All fractures in the participants resulted from falls. 
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There was a marked reduction in the number of fallers following institutionalisation. 
Falls and fractures were commonest in facilities that catered for the participants with 
dementia.  
Mortality of the participants in this study was high, 25% died in the 12 months of follow-up. 
40% of the fractures occurred in the participants with dementia. 
Significant predictors of falls were Parkinson’s disease (OR 5.6), history of prior falls (OR 
1.9), age (OR 1.025), body weight (OR 0.982) and BMI (OR 0.982), while alcohol use 
appeared protective (OR 0.000), but numbers were small. 
The only predictors of fractures were: age (OR 1.072), body weight (OR 0.952) and BMI (OR 
0.868).  
Significant predictors of fractures, falls and fractures combined were the same as for fractures 
alone.  
 
When participants were divided into three subgroups (no falls or fractures, falls only, and 
combined falls and fractures) comparison of basic demographics, comorbidities and scores on 
the fragility fracture assessment tools showed no significant differences for any of the 34 
variables compared (table 37) other than body weight and TUGT after application of the 
Bonferroni correction. Body weight was significantly lower in the participants with combined 
falls & fractures than in those with no events, and TUGT was significantly longer in 
participants who had falls. As the three subgroups are relatively small and not equal in size, 
statistical analysis is likely to result in spurious results.  While of some interest for hypothesis 
generation, they are not usable for the development of a predictive model.  
 
The fall and fracture incidence obtained in this observational study is comparable with 
published data in older people (Luukinen et al., 1994, Rubenstein, Josephson & Robbins, 
1994, Nurmi, Luthje, 2002, Centers for Disease Control and Prevention, 2012).  A substantial 
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number of the incident fractures that occurred in the participants of this study occurred in 
those who lacked mental capacity (40%). One systematic review cited earlier found that 
cognitive impairment was associated with an increase in the risk of fragility fractures (Khatib 
et al., 2014). A systematic review on the risk factors for falls cited earlier found that history of 
falls, walking aid use and moderate disability had the strongest association (Deandrea et al., 
2013). These two studies are not directly comparable, as the outcomes are fractures in one, and 
fall in the other.   
 
My take on the findings of Deandrea et al (2013) is that cognitive impairment was not 
excluded as a risk factor for fractures given its known association with the risk factors which 
they identified. Residents with dementia who constitute high proportions of care home 
residents are very difficult to recruit.  
 
The group comparisons using the Bonferroni correction showed that body weight and TUGT 
were the significant factors. Many studies have used BMI to explore fracture risk because of 
the variation in average weight and height in different populations which is mitigated by 
adjusting the weight for height and also in studies on hip fractures, BMI was as good a 
predictor as body weight (Johnell et al., 1995, Kanis et al., 1999). In this study there were no 
statistically significant differences between the heights of the participants therefore BMI could 
be used instead of the body weight.  
 
The TUGT showed high sensitivity for falls prediction but it is not pragmatic and the reasons 
are discussed in section 6.6.2. Mortality of care home residents in the study here was high 
(25%), as in other studies in care home populations (Shah et al., 2013, Forder, Fernandez, 
2011). This means that a tool which assesses fracture risk on a short term basis is desirable.  
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6.6 Implications of the Findings of this Study for Clinical Practice and Future Directions 
 
6.6.1 Screening for Fragility Fractures 
 
This study shows that there are several well established fragility fractures risk assessment 
tools, but that only BMI is useful for screening in a care home population. The study also 
showed that recruitment of a representative care home population is difficult, as individuals 
with dementia are underrepresented, because they are unable to give informed consent. As it is 
also difficult to obtain consent from consultees in this group, a representative prospective 
study may not be possible. However, care home residents are at high risk of fractures, and risk 
assessment is important to allow treatment of individuals at highest risk. The results of this 
study give an indication of the population most at risk, and may be used to develop a screening 
algorithm. The choice of suggested indicators, based on this work, is discussed below.  
 
BMI was the strongest predictor of falls and fragility fractures in the care home population 
studied. A BMI of 19.9 kg/m² was the median for participants who had incident falls and 
fractures  and a BMI of 21.2 kg/m² was the median for participants who had incident falls but 
no fractures. Therefore a BMI of 21.2 kg/m² or below was taken as a cut-off to define high 
risk of falls and fractures.  The proportion of participants in the study here who had BMI of 
21.2 kg/m² and would reach the cut off was about 32%. This is comparable to the published 
data for the wider older population (Inelmen et al., 2003, Ray, Laur & Golubic, 2014, Tamura 
et al., 2013, Russell, Elia, 2011).  
 
The suggested cut off of a BMI of 21.2 kg/m² is consistent with, but a bit higher than the cut 
off identified by an earlier meta-analysis. De Laet and colleagues found that the risk ratio for 
fractures was markedly higher at the lower values of BMI, particularly with a BMI of 20 
kg/m² and less. A BMI of 20kg/m² or lower was associated with nearly 2-fold increase in risk 
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ratio (RR = 1.95) when compared with a BMI of 25 kg/m².  Between a BMI of 25 and 35 
kg/m², the differences in risk ratio were smaller. A BMI of 30kg/m² when compared with a 
BMI of 25kg/m² was associated with a 17% reduction in hip fracture risk (RR =0.83) (De Laet 
et al., 2005).  
 
Although the participants were not representative of residents with dementia, because it was 
only possible to get consent from few individuals in this resident group, 40% of the incident 
fractures observed was in participants with dementia. Also the incidence of falls and fractures 
was over 10 times higher in residents not included in the study than in the participants with 
lack of capacity being the main reason for non-enrolment. This suggests that dementia is an 
important predictor of falls and fractures in this cohort.  
 
While this should ideally be confirmed in a prospective study, it is very common in care home 
residents and it is easy to assess compared to the other risk factors identified and I would 
therefore recommend it as an important risk factor to be included in an algorithm for fracture 
risk assessment in care homes. Estimating BMI is easy and nomograms for calculation are 
widely available, indeed it is already been assessed routinely in many care homes both during 
admission and follow up and including the history of dementia in the screening process is 
likely to increase the pick-up rate.  
 
This study also identified a high mortality of 25% in the care home population enrolled. While 
it is important to prevent fractures in individuals with a reasonable prognosis, such treatment 
would be futile in residents with only a few months to live. It is therefore reasonable to include 
a predictor of mortality into the screening algorithm.  The Charlson Co-morbidity Index (CCI) 
is a validated predictor of mortality and was included in this study. The mean CCI for 
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participants who died before 1 year was 36%.  A cut-off of 36% and above was therefore used 
as threshold for non-intervention. There were no publications available for comparison.   
A screening algorithm to identify care home residents who should be considered for 
preventative treatment was then designed based on BMI, presence of dementia and the CCI 
(Figure 8).  
 
If the BMI is 21.2 kg/m² or less or the resident has dementia or both, the CCI should be  
assessed. If it is below 36%, the resident should be offered treatment following recommended  
guidelines (NOGG 2018 NICE 2016, SIGN 2015).  This algorithm has been designed based 
on the results obtained from the analysis. Although it was a pilot study, the size (217) of the 
participants was large. Obtaining representative sample of residents without mental capacity 
for a fully powered study may not be feasible given the ethical requirement for recruitment of 
residents without mental capacity. This algorithm is practicable and attracts no cost, therefore 
I would recommend it to manage appropriate residents  along the recommended guidelines. 
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Figure 8: Algorithm for the management of fragility fractures in care home residents 
 
Interpretation 
Figure 8 shows that only three variables were used in the design. Low BMI and dementia or 
both are used in the identification of people at high risk of falls and fractures. The Charlson 
Comorbidity Index is then used for the selection of people for treatment following established 
guidelines. 
 
A range of pharmaceutical interventions has been shown to be effective in reducing fracture  
 risk in postmenopausal women with osteoporosis (Crandall et al 2014). Recommendations 
concerning the major interventions are based on high levels of evidence (Evidence level 1a 
and 1b) and the grade of these recommendations is summarised in table 39 (NOGG 2017).  
 
 
 
 
 
Treat along established guidelines 
(NOGG 2018, NICE 2016, SIGN 2015) 
 
Charlson Comorbidity Index < 36% 
        Low BMI (≤ 21.2 kg/m²) or        
Dementia or both 
Do nothing 
Do nothing 
Yes
No 
Yes 
No 
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Table 39. Anti-fracture efficacy of approved treatments for postmenopausal women with 
osteoporosis when given with calcium and vitamin D. 
 
Intervention Vertebral fracture Non-vertebral fracture Hip fracture 
Alendronate A A A 
Ibandronate A A* NAE 
Risedronate A A A 
Zoledronic acid A A A 
Calcitriol A NAE NAE 
Denosumab A A A 
HRT A A A 
Raloxifene A NAE NAE 
Teriparatide A A NAE 
         Source: NOGG 2017 
        A: grade A recommendation 
       NAE: not adequately evaluated 
       *in subsets of patients only (post-hoc analysis) 
        HRT: hormone replacement therapy 
 
HRT and raloxifene are not useful for care home residents because the majority of them aretoo 
old. 
Pharmacological intervention should be supplemented with lifestyle and dietary measures. The 
National Institute for Health and Care Excellence (2016) recommends calcium and vitamin D 
intake as follows: 
 If the person`s calcium intake is adequate (700mg/day), prescribe 10 micrograms (400 
international units) of vitamin D (without calcium) for people not exposed to much 
sunlight. 
 If calcium intake is inadequate: prescribe 10 micrograms (400 international units of 
vitamin D with at least 1000 mg of calcium daily; prescribe 20 micrograms (800 
international units) of vitamin D with at least 1000 mg of calcium daily for elderly 
people who are housebound or living in a nursing home. 
These interventions should be supplemented with regular weight-bearing exercises which are 
tailored according to needs and abilities of the individual patient. Smoking and alcohol intake 
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of 3 or more units daily are associated with increase in fracture risk and should be avoided 
(Kanis et al 2005a, Kanis et al 2005b) 
  
 
6.6.2 Screening for Falls 
 
My results suggest that screening for falls is possible in care home residents. The majority of 
the participants were able to complete the tests. The duration of the assessment was between 1 
and 2 minutes. NICE (National Institute for Health and Care Excellence, 2014) recommends 
using either the TUGT (Podsiadlo, Richardson, 1991) or Turn 180º (Simpson et al., 2002) as 
falls risk assessment tool in primary care setting.  The TUGT poses logistic problems 
particularly for the care home residents who lack mental capacity. In this observational study, 
93 (43%) could not perform the TUGT but there were no published data for comparison.  The 
TUGT requires adequate space, stop watch and the undivided attention of the assessor. The 
Turn 180º, another test suggested by NICE, is simple to perform but it cannot be used in older 
people who use walking aids, who are not able to fully weight bear and who cannot follow 
instructions.  In this study, 83 (38%) participants needed walking aids and 70 (32%) could not 
follow instructions because of dementia. Thus both the TUGT and Turn 180º are not 
pragmatic assessment tools for this cohort. Furthermore, while TUGT predicted falls in this 
population, the predictive value was poor with an odds ratio of 0.99 for falls in participants 
with lower TUGT times. Given these data TUG T cannot be considered an effective screening 
tool for day to day practice in this frail cohort.  
 
 
Fall prevention through multidisciplinary assessment and intervention has the strongest 
evidence base with data supporting this approach both in primary and secondary prevention. 
Risk assessment and falls prevention (multifactorial) reduces falls by 24% (NHS RightCare 
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2019). The Prevention of Falls in the Elderly Trial (PROFET) has shown the benefits of 
assessing older people presenting to the Accident and Emergency Department with a fall 
(Close et al 1999).  These assessments allow the implementation of person-specific 
interventions, designed to reduce the chances of a fall. Such interventions have been identified 
as a higher value intervention in the NHS RightCare pathway. It includes strength and balance 
training for those at low to moderate risk of falls,  multi-factorial intervention for those at 
higher risk of falls and life course approach to lifestyle risk factors including smoking 
cessation, reduced use of alcohol and exercise (NHS RightCare 2019). 
 
6.7 The Need for Research in Care Home Residents and the Challenges 
 
This project shows that the majority of fracture risk assessment tools developed in the 
community are not useful in care home residents. This emphasizes the need for research in this 
vulnerable cohort.  Establishing effective assessments and interventions in this population is 
particularly important in view of the increasing number of older people worldwide which 
means that a greater number are likely to be managed in long term care facilities.  Care home 
residents are usually frail and physically and mentally challenged due to multi-morbidities. 
Many residents are female, in their mid-eighties and with an average life expectancy of 
between two and three years in residential care and one and two years in nursing homes 
(Bebbington, Darton & Netten, 2001, Froggatt, Davies, 2009). Therefore, the results of 
research in the relatively healthy community dwelling older persons should not be 
extrapolated to care home residents (Katz, Karuza & Counsell, 1995, Katz, 2011). 
 
Three systematic reviews have highlighted the need for exclusive research in this setting 
(Cartwright, 2002, Froggatt et al., 2006, Oliver, Porock & Zweig, 2005). However, research in 
this population poses a number of ethical and methodological challenges. These include equity 
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of participant selection, informed consent, confidentiality, risk/benefit considerations, and 
preservation of the resident’s rights and dignity (Maas et al., 2002, Addington-Hall, 2002, 
Pleschberger, 2007).  
 
The difficulties which were encountered in this study were: 
 Consent 
 Dementia 
 Mortality 
 Gaining access 
 Staff too busy to accommodate research into work schedules 
 Families not always available 
 
Only 35% of the entire local care home population were recruited. Zermansky and colleagues 
reported a recruitment rate of 41%, but it was unclear from the publication what the 
proportions of mentally competent and incompetent participants in the study were (Zermansky 
et al., 2007). Most of the participants in this observational study were assessed between 14:30 
h and 17:00 h, but Hall and colleagues found that it was best not to interview residents after 
lunch, as they may too tired and lethargic (Hall, Longhurst & Higginson, 2009). In this study I 
did not formally monitor tiredness, but had no problems conducting interviews in the early 
afternoon.  
 
Undertaking research in a care home is challenging but important. It requires resilience, good 
communication, anticipatory skills, planning, seizing opportunities and a good knowledge of 
who, when and how people can be approached. The importance of research in care homes is 
recognized by the National Institute for Health Research, who funded the Enabling Research 
in Care Homes (ENRICH) Programme to support research in this challenging environment 
 289 
 
(NIHR 2012). . It is co-ordinated through the office of the National Institute for Health 
Research in the Office of the National Director for Dementia Research. This programme 
started in 2012 but none of the care homes in Boston participated.  
 
 The ENRICH project is a relatively new initiative with the overarching aim of to encourage 
research in care home residents. It is currently active in England, Scotland and Wales. Other 
networks are being established in parts of the USA and Australia, modelled around ENRICH. 
This network brings together care home staff, residents and researchers to facilitate the design 
and delivery of research. Hopefully, this will lead to improvement in the quality of life, 
treatment and care for all residents. Getting involved in research can potentially lead to 
benefits to care home residents and staff and can provide stimulation as residents take part in 
new activities or have someone new to talk to, give back control to residents, allowing them to 
feel like they are contributing to the future, stimulate residents to take an increased interest in 
their own health and well being, lead to professional development opportunities, enable care 
home staff to learn of new developments which can contribute to their business and marketing 
plans, encourage researchers and funders to address issues that are of interest to care home 
such as symptom management, or end-of-life-care, improve contact between care homes and 
other local health and care services, and, lastly, provide an effective voice for residents, 
families and staff whose views may have been previously unheard. In the short term, the 
network provides opportunities for care homes and residents to become involved in local and 
national studies. In the long term, it will help researchers understand the challenges and 
solutions around increasing research activity in care homes and identify better ways of 
working with existing care home systems to ease study delivery. Such support would have 
helped overcome some of the problems with recruitment identified in this study. 
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6.8 Strengths and Weaknesses of the Study 
 
6.8.1 Strengths 
 
 The first assessment of these tools in a care home population  
 Preparation with consultation visit 
 Single assessor allowed consistency 
 High completion rate and few drop outs 
 
6.8.2 Weaknesses  
 Only conducted in Lincolnshire therefore the results may not be representative of the 
UK, Europe or the rest of the world 
 All the participants were Caucasians; therefore the results may not be applicable to 
other ethnic groups. 
 Skewed population with under-representation of individuals who lacked competence to 
consent.  
 Only one reviewer, therefore it is unclear whether the same results would be seen by 
another person. However, all of the tests conducted were objective, and it is unlikely 
that this would have affected the results.  
 The study duration was only 1 year and the fracture rates would have been higher with 
longer follow-up. However, in a population with 25% mortality this time frame might 
be considered appropriate.  
 The algorithm designed has not been field-tested for efficacy and clinical effectiveness. 
 
6.9 Recommendations for Future Research  
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1. The results of this project suggest that BMI and the presence of dementia are strong 
predictors of fragility fractures in a care home population. This should be confirmed in 
a large fully powered study.  
 
2. The study also highlighted the difficulty of obtaining consent in residents lacking 
competence and the adverse impact on representation of the results.   
 
3. The possibility of widening the criteria for consultee consent could be explored to 
include the care home manager, deputy or senior nurse on duty. It is also possible to 
obtain assent for future research during admission if it is observational. Applicants for 
the Lasting Power of Attorney (LPA) should be asked to state their wish about 
participation in future research. 
 
4. Using different research methods, BMI and the presence or absence of dementia, as 
well as comorbidities which are available from General Practice registries, as are 
fractures, it may be possible to conduct such research from existing primary care 
databases.  
 
5. The algorithm designed should be tested in future fully powered studies to include 
representative samples of other ethnic groups and residents who lack mental capacity. 
 
 
6.10 Conclusions 
Only 4 out of 33 fragility fracture assessment tools identified in the systematic review were 
potentially suitable in a care home population. Of these, only BMI was shown to have 
acceptable discriminatory and screening performance. A major problem with the conduct of 
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the study was obtaining consent form mentally incompetent individuals. This resulted in 
underrepresentation of this group. This was particularly important as 40% of participants who 
had fractures suffered from dementia, suggesting this as another important predictor of 
fractures. The results of this study indicate that combining low BMI and dementia as a 
screening tool could be  reliable and easy to implement in a care home population. This should 
be assessed formally in a larger, representative and fully powered study. 
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Appendices 
Appendix A IRAS approval 
  
 
 
 
NRES Committee East Midlands - Nottingham 1 
 
 
 
 
  Telephone: 0115 8839428 
 
09 January 2015 
 
Dr Felix Ihama 
Department of Medicine 
Pilgrim Hospital, Sibsey Road, Boston 
PE21 9QS 
 
Dear Dr Ihama 
 
Study title: A feasibility study evaluating the performance of three fragility 
risk assessment tools in predicting falls in older people; A 
prospective study of older care home 
residents in the UK 
REC reference: 14/EM/1225 
Protocol number: 1 
IRAS project ID: 59238 
 
Thank you for your letter of 06 January 2015, responding to the Committee’s request for further 
information on the above research and submitting revised documentation. The further information has been considered on 
behalf of the Committee by the Vice-Chair. We plan to publish your research summary wording for the above study on the 
HRA website, together with your contact details. Publication will be no earlier than three months from the date of this 
favourable opinion letter.  The expectation is that this information will be published for all studies that receive an ethical 
opinion but should you wish to provide a substitute contact point, wish to make a request to defer, or require further 
information, please contact the REC Manager, Ms Penelope Gregory, NRESCommittee.EastMidlands-
Nottingham1@nhs.net. Under very limited circumstances (e.g. for student research which has received an unfavourable 
opinion), it may be possible to grant an exemption to the publication of the study. 
 
Confirmation of ethical opinion 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above research on the 
basis described in the application form, protocol and supporting documentation as revised, subject to the conditions 
specified below. 
 
Mental Capacity Act 2005 
I confirm that the committee has approved this research project for the purposes of the Mental Capacity Act 2005. The 
committee is satisfied that the requirements of section 31 of the Act will be met in relation to research carried out   as part 
of this project on, or in relation to, a person who lacks capacity to consent to taking part in the project. 
 
 
 
Conditions of the favourable opinion 
The favourable opinion is subject to the following conditions being met prior to the start of the study. 
 
Management permission or approval must be obtained from each host organisation prior to the  
start of the study at the site concerned. 
Royal Standard Place 
Nottingham  
NG1 6FS 
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Management permission ("R&D approval") should be sought from all NHS organisations involved in the study in 
accordance with NHS research governance arrangements. 
 
Guidance on applying for NHS permission for research is available in the Integrated Research 
Application System or at  http://www.rdforum.nhs.uk. 
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential participants to research 
sites ("participant identification centre"), guidance should be sought from the R&D office on the information it 
requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the procedures of the 
relevant host organisation. 
 
Sponsors are not required to notify the Committee of approvals from host organisations 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered on a publically accessible 
database. This should be before the first participant is recruited but no later than 6 weeks after recruitment of the first 
participant. 
 
There is no requirement to separately notify the REC but you should do so at the earliest opportunity e.g. when submitting 
an amendment.  We will audit the registration details as part of the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered but for non-clinical trials this 
is not currently mandatory. 
 
If a sponsor wishes to request a deferral for study registration within the required timeframe, they should contact 
hra.studyregistration@nhs.net. The expectation is that all clinical trials will be registered, however, in exceptional 
circumstances non registration may be permissible with prior agreement from NRES. Guidance on where to register is 
provided on the HRA website. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with before the start of the 
study or its initiation at a particular site (as applicable). 
 
 
Ethical review of research sites 
NHS sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to management permission being obtained 
from the NHS/HSC R&D office prior to the start of the study (see "Conditions of the favourable opinion" below). 
 
Non-NHS sites 
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Document Version Date 
Other – Individual research recommendation details document   
Covering letter on headed paper  20 September 
2014 GP/consultant information sheets or letters   
Other – Introduction to Good Clinical Practice certificate – 
Felix 
Ihama 
 24 June 2011 
Other – Certificate – e-learning course – Manual Handling – 
Felix 
Ihama 
 17 October 2013 
IRAS Checklist XML [Checklist_06012015]  06 January 2015 
IRAS Checklist XML [Checklist_08012015]  08 January 2015 
Letter from sponsor   
Letter from statistician   
Non-validated questionnaire   
Non-validated questionnaire   
Other [CV - Anand D Pandyan]   
Other [CV - Dr F Lally]   
Other [CV - Christine Roffe]   
Other [Consent form ] 2.0 06 January 2015 
Other [Consultee form] 2.0 06 January 2015 
Other [Consultee information sheet] 1.0 05 January 2015 
Other [Letter of invitation] 2.0 05 January 2015 
Other [Consultee invitation letter] 2.0 05 January 2015 
Other [Participant information sheet] 3.0 08 January 2015 
REC Application Form [REC_Form_22102014]  22 October 2014 
Referee's report or other scientific critique report   
Research protocol or project proposal   
Response to Request for Further Information [Documents 
uploaded to HARP] 
 06 January 2015 
Summary CV for Chief Investigator (CI)   
Summary CV for student   
Validated questionnaire   
Validated questionnaire   
 
Approved documents 
The final list of documents reviewed and approved by the Committee is as follows:
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Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements for Research Ethics Committees and 
complies fully with the Standard Operating Procedures for Research Ethics Committees in the UK. 
 
After ethical review 
Reporting requirements 
 
The attached document “After ethical review – guidance for researchers” gives detailed guidance on reporting 
requirements for studies with a favourable opinion, including: 
 
    Notifying substantial amendments 
    Adding new sites and investigators 
    Notification of serious breaches of the protocol 
    Progress and safety reports 
    Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of changes in reporting 
requirements or procedures. 
 
User Feedback 
The Health Research Authority is continually striving to provide a high quality service to all applicants and sponsors. You 
are invited to give your view of the service you have received and the application procedure. If you wish to make your 
views known please use the feedback form available on the HRA website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/ 
 
HRA Training 
We are pleased to welcome researchers and R&D staff at our training days – see details at http://www.hra.nhs.uk/hra-
training/ 
 
14/EM/1225                                         Please quote this number on all correspondence 
 
With the Committee’s best wishes for the success of this project. Yours sincerely 
 
 
 
Dr Carl Edwards 
Chair 
 
Email:NRESCommittee.EastMidlands-Nottingham1@nhs.net 
 
Enclosures:               “After ethical review – guidance for 
researchers” [SL-AR2] 
 
Copy to:                      Professor Christine Roffe 
Dr T Ahmed, United Lincolnshire NHS Trust 
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Appendix B IRAS approval for minor amendments 
 
 
NRES Committee East Midlands - Nottingham 1 
Royal Standard Place Nottingham NG1 
6FS 
10 March 2015 
 
Professor Christine Roffe 
Stroke Research Network 
North Staffs Combined Healthcare NHS Trust, Holly 
Lodge, 62 Queens Road 
Hartshill, Stoke-on-Trent 
ST4 7LH 
 
 
 
Dear Professor Roffe 
Tel: 0115 883 9428
 
Study title: A feasibility study evaluating the performance of three 
fragility risk assessment tools in predicting falls in older people; 
A prospective study of older care home residents in the UK 
REC reference: 14/EM/1225 
Protocol number: 1 
Amendment number: SA1 
Amendment date: 06 February 2015 
IRAS project ID: 59238 
 
The above amendment was reviewed by the Sub-Committee in correspondence. 
 
Ethical opinion 
 
The members of the Committee taking part in the review gave a favourable ethical opinion of the amendment on 
the basis described in the notice of amendment form and supporting documentation. 
 
Approved documents 
 
The documents reviewed and approved at the meeting were: 
 
Document Version Date 
Notice of Substantial Amendment (non-CTIMP)  06 February 2015 
 
Membership of the Committee 
 
The members of the Committee who took part in the review are listed on the attached sheet. 
 
R&D approval 
ll investigators and research collaborators in the NHS should notify the R&D office for the relevant NHS care 
organisation of this amendment and check whether it affects R&D approval of the research.
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Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research Ethics Committees and 
complies fully with the Standard Operating Procedures for Research Ethics Committees in the UK. 
 
We are pleased to welcome researchers and R & D staff at our NRES committee members’ 
training days – see details at  http://www.hra.nhs.uk/hra-training/ 
 
14/EM/1225:                  Please quote this number on all correspondence 
 
Yours sincerely 
 
 
 
 
 
Reverend Keith Lackenby 
Chair 
 
E-mail:                        NRESCommittee.EastMidlands-Nottingham1@nhs.net 
 
 
Enclosures:                  List of names and professions of members who took part in the review 
 
Copy to:                        Dr T Ahmed, United Lincolnshire NHS Trust 
 
Dr Felix IhamaNRES Committee East Midlands - Nottingham 1 
 
Attendance at Sub-Committee of the REC meeting on 10 March 2015 
 
 
 
Committee Members: 
 
Name Profession Present Notes 
Professor Cris Constantinescu Professor of 
Clinical 
Neurology 
Yes  
Reverend Keith Lackenby (Chairing) Lay member Yes  
 
Also in attendance: 
 
Name Position (or reason for attending) 
Nicola Kohut REC Assistant 
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Appendix D Letter of invitation to participants 
 
 
 
 
 
 
Dr F Ihama, Consultant Physician Care of the Elderly 
Department of Care of the Elderly 
Secretary :  01205 445305 
Office:  01205 445477 
Email:  felix.ihama@ulh.nhs.uk 
 
 
 
 
 
 
Monday, 05 January 2015 
Version 2.0 
 
 
 
Dear Sir/Madam, 
 
Invitation to participate in a research 
 
You are invited to take part in a study which is seeking to evaluate the performance of three common fracture risk 
assessment tools in care home residents in Boston. Before you decide to join, it is important to understand why the 
research is being done and what it will involve for you. Dr Ihama, the Chief Investigator will go through the 
information sheet with you and answer any questions you have. This will take about 10 minutes.   
 
 
So please consider the information leaflet carefully. Talk to your family, friends, GP or Nurse if you want to. If any 
information is unclear or if you would like more information, please contact Dr F E Ihama. Contact details can be 
found at the bottom of the participant information sheet. If you do not want to take part, I would like to assure you 
that your current medical care will not be compromised in any way and would like to thank you for giving me 
some of your time. 
 
The purpose of this study and the details of how the study will be carried out has been presented in summary (part 
1) and more detailed versions (part 2). Many thanks. 
 
Yours sincerely, 
 
 
Dr F Ihama 
Principal Investigator 
 
Pilgrim Hospital 
Sibsey Road 
Boston 
Lincolnshire 
PE21 9QS 
 
Tel: 01205 364801 
Fax: 01205 354395 
 
www.ulh.nhs.uk 
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Pilgrim Hospital 
Sibsey Road 
Boston 
Lincolnshire 
LN2 5QY 
 
 
 
Department of Medicine, Elderly Care Unit, Pilgrim Hospital, Boston. Lincolnshire. 
PE21 9QS 
 
Title of study; A feasibility study evaluating three fragility risk tools  
 
Participant Information sheet 
Version 3.0 
 
You are invited to take part in the above study which is seeking to evaluate the 
performance of three common fracture risk assessment tools in care home residents in 
Boston. Before you decide, it is important to understand why the research is being 
done and what it will involve for you. So please consider this leaflet carefully, talk to 
your family, friends, GP or Nurse if you want to. 
 
If any information is unclear or if you would like more information, please contact Dr 
F E Ihama who will go through it with you, it will take about 10 minutes. Contact 
details can be found at the bottom of this document. If you do not want to take part, I 
would like to assure you that your current medical care will not be compromised in 
any way and will like to thank you for giving me some of your time. Part 1 is a 
summary of the information; Part 2 is the more detailed version. 
Part 1 
 
Aim; A feasibility study evaluating the performance of three fracture risk 
assessment tools in Boston. 
Tel: 01205 364801 
   www.ulhnhs.uk 
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WHY; Fractures are very common in care home residents. Some of these 
can be prevented if high risk care home residents are identified early enough. 
 
WHY HAVE I BEEN INVITED: Because you are a care home resident and 
meet the requirements for this study. 200 care home residents including yourself will 
be needed for this research. 
 
DO I HAVE TO TAKE PART; No, this is entirely voluntary. 
 
WHAT WILL HAPPEN IF I DO DECIDE TO TAKE PART; 
1. You will be requested to sign a consent form. 
2. The nursing staff and myself will weigh you. 
3.  I will take measurement of your forearm with a tape measure. 
4.  I will request you to walk a distance of 10 feet in-doors (if you can), turn around 
and sit down. This will happen thrice after a test run. 
5. I will access your medical noted for relevant details. 
 
WHAT WILL I HAVE TO DO; 
1. Answer a few questions for about 20 minutes relating to fractures and falls. 
2. You will be weighed 
3. I will take measurement of your forearm with a tape measure. 
4. I will request you to walk a distance of 10 feet in-doors (if you can), turn around 
and sit down. This will happen thrice after a test run. 
WHAT ARE THE POSSIBLE DISADVANTAGES; None apart from the 
inconveniences of answering a few questions, been weighed, your forearm measured 
and walking.  
 
WHAT ARE THE POSSIBLE BENEFITS; None to you but this research may help 
others like yourself in future. 
 
WILL ANYONE ELSE KNOW I AM DOING THIS: Your identity will be kept 
secret and only those who need to know will be informed for example, your GP who 
you could contact for an independent opinion whether to participate in this study or 
not. 
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WHO IS ORGANISING AND FUNDING THIS RESEARCH  
I am doing this as my research project in the University of Keele. This research is 
privately funded entirely and there is no incentive. 
 
WHO HAS REVIEWED THE STUDY: The appointed Agency of the Government of 
the UK, `Nottingham 1 REC` and the University of Keele Research Authority. 
 
WHAT HAPPENS IF I DON`T WANT TO PARTICIPATE IN THE RESEARCH 
ANYMORE. Fine but please inform your nurse or GP who will contact me. 
 
WHAT WILL HAPPEN TO THE RESULTS OF THE STUDY? 
The results will be published but your identity will not be revealed. 
 
 Thank you very much for your time. 
 
 
Part 2 
 
Aim; A feasibility study evaluating the performance of three fragility risk assessment 
risk tools to predict falls in care home residents in Boston. 
 
Why is this research important? 
Fractures due to brittle bone disease are common in the elderly. They are even more 
common in care home residents many of whom are very frail due to various diseases. 
Risk assessment can be used to identify those residents who are likely to fall and 
sustain these fractures. Risk assessment tools consist of some questions. For fractures, 
I have identified three from review of previous studies but these were developed from 
research which involved healthy elderly in the community. Secondly, these three tools 
I have identified assess the risk of fractures over a 5 year or 10 year period. It is 
therefore not clear if these same tools can be useful in care home residents. The aim of 
this study is to compare the performance of these three tools in care home residents 
and determine the best which can predict fracture risk over a shorter period of 12 
months. 
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Why have I been invited to take part? 
You have been invited to take part because you are a care home resident and you meet 
with the requirements for this study. This project will involve 200 care home residents 
including you. This study has not been done before.  
 
Do I have to take part? 
Participation in this study is entirely voluntary therefore you are not obliged to support 
or participate in this study. If you do decide to take part, you will be requested to sign 
a consent form. If you decide to take part, you are still free to withdraw from the study 
at any time without giving any reasons. Your decision to withdraw will not affect the 
standard of care which you receive. You may have someone present with you if you 
wish during the interview and measurements required for this study and your nurse 
will always be present. 
 
What will happen if I decide to take part? 
If you decide to take part, I will need access to your medical records and it may be 
necessary to contact your GP for some clarifications. I will then enter the relevant 
details of your records into my computer which is secured as I alone have the 
password to it. Dr F E Ihama will ask the questions and record them on a sheet of 
paper. The questions that I shall be asking will relate to falls, brittle bones and 
fractures.  You will also need to be weighed by the nursing staff and myself on the 
usual electronic weighing scale with you wearing light clothing and usual shoes. I will 
take a measurement of your arm with a tape measure using the left forearm preferably. 
From these measurements I will be able to estimate your height and body mass index.  
I will request you to walk a distance of 10 feet in-doors (if you can) turn around then 
sit down. This will happen thrice after a test run. These done, I will telephone the care 
staffs from time to time to see if you have had any falls or sustained any fractures.  
This research will not affect your usual treatment in any way. 
 
What will I have to do? 
You will be required to answer some questions regarding your fall and fracture 
condition then you will be weighed on the usual electronic weighing scale and I will 
take measurement of your forearm with a tape measure and request you to walk 
indoors. 
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What are the possible disadvantages? 
The questions may take about 20 minutes of your time, the weighing will take a few 
minutes and the measurement of your forearm will take a couple of minutes and the 
walking test will take a few minutes. 
 
What are the possible benefits of taking part? 
You may not benefit from this study but the result may enable me identify the best 
risk assessment tool to recommend for use in care home residents to prevent falls and 
fractures in future. 
 
Will anyone else know I am taking part in this Research Project? 
If you decide to take part in this study, your identity will be kept secret and will not be 
given to any person except only those who have the need to know. I will only send out 
information that has your name and address removed. All information collected 
during the study will be stored in a computer secured by a password. I will however 
need to inform your GP about your participation in this study. You may wish to 
contact your GP for an independent opinion about whether to take part or not. 
 
Who is organising and funding the research project 
I am doing this as my research project in the University of Keele where I am a 
student. The research is entirely privately funded and there is no incentive. 
 
Who has reviewed the research project 
Before any research like this is conducted, it has to be reviewed by the Research 
Ethics Committee, the designated arm of the Government of the UK, they make sure 
that the research is appropriate.  
 
What happens if I don`t want to do the research anymore 
If at any time you don`t want to continue with the research, please inform the nurse or 
GP. They will inform me and I will not be offended.  
 
What will happen to the results of the study 
At the end of the study, I will analyse the result to determine the best of the three 
fracture risk tools and then recommend it for use in care home residents. This will 
then form part of the initial assessment when anybody is admitted to the care home in 
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much the same way blood pressure, pulse rate and temperature are assessed on 
admission. 
 
I will also publish my result in medical journals as well as presenting it in conferences 
so that others might benefit from my study. If you are interested and want to be 
informed of the results, do let me know by ticking the relevant section in the consent 
form and I will make a simplified summary available to you by post. 
 
The result from this research may be used to support other research in this area in 
future but it will not be possible to specifically identify you as one of the participants.  
 
What if there is a problem in the Research process 
If you have any concerns about any aspect of this study, you should ask to speak to Dr 
Ihama who will do his best to answer your questions. If you remain unhappy and wish 
to complain formally, you can do so by contacting the Complaint Department through 
the Research and Development Department, ULHT. 
 
I will like to thank you for taking time to read this information about this study. If you 
have further questions, please contact me through the details giving below and I will 
be happy to answer them. If you wish to support this study could you please sign the 
consent form. If however you have decided not to participate, I will like to thank you 
for taking the time to find out about this study.  
 
Thank you very much. 
 
 
Dr F E Ihama 
Department of Medicine, Pilgrim Hospital, 
Boston. Lincolnshire. PE219QS 
Telephone; 01205 364 801 bleep 506 
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Appendix F Letter of invitation to Consultee 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tuesday, 06 January 2015 
Version 2.0 
 
 
Dear Sir/Madam, 
 
Invitation to participate in a research 
 
Your relative/friend is invited in a study which is seeking to evaluate the performance of three common fracture risk 
assessment tools in care home residents in Boston. I feel your relative/friend is unable to decide for himself/herself 
whether to participate in this research. 
 
To help decide if he/she should participate in this study, I wish to ask your opinion whether or not they would want to be 
involved. I will like you to consider what you know of his/her wishes and feelings, and to consider his/her interests. Please 
let me know of any advance decisions he/she may have made about participating in research. These should take 
precedence. The information sheet is enclosed and is similar to what would have been provided to your relative/friend. 
 
If you decide your relative/friend would have no objection to taking part, may I request you to read and sign the consultee 
declaration form enclosed. I will then give you a copy to keep. I will keep you fully informed during the study so that you can 
let me know if you have any concerns or you think your relative/friend should be withdrawn. 
 
If you decide that your relative/friend would not wish to take part, it will not affect the standard of care he/she receives in 
any way. If you are unsure about taking the role of consultee you may seek independent advice. I will understand if you do 
not want to take on the responsibility. Many thanks 
 
Yours Sincerely, 
 
Dr F E Ihama 
Principal Investigator 
Pilgrim Hospital 
Sibsey Road 
Boston 
Lincolnshire 
PE21 9QS 
 
Tel: 01205 364801 
Fax: 01205 354395 
 
www.ulh.nhs.uk 
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Appendix G Consultee information sheet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Title of study; A feasibility study evaluating three fragility risk assessment tools  
 
Consultee Information sheet 
Version 1.0 
 
Your relative/friend is being invited to take part in the above study which is seeking to evaluate 
the performance of three common fracture risk assessment tools in care home residents in 
Boston. As his/her consultee, before you decide, it is important to understand why the research 
is being undertaken and what it will involve so please read this leaflet carefully, talk to your 
family, friends, his/her GP or nurse if you want to. If any information is unclear or if you would 
like more information, please contact Dr F E Ihama through the contact details at the bottom of 
this document. If you do not want him/her to take part , I would like to assure your that his/her 
current medical care will not be compromised in any way and would like to thank you for giving 
me some of your time. The document has been presented in two parts; the summary version 
(part 1) and a more detailed version (part 2). 
 
Part 1 
 
Aim; A feasibility study evaluating the performance of three fracture risk assessment tools in 
Boston 
 
Why?; Fractures are very common in care home residents. Some of these fractures can be 
prevented if high risk care home residents are identified early enough. 
Pilgrim Hospital 
Sibsey Road 
Boston 
Lincolnshire 
PE21 9QS 
 
Tel: 01205 364801 
Fax: 01205 354395 
 
www.ulh.nhs.uk 
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Why has your relative/friend been invited? Your relative/friend is a care home resident and 
meet the requirements for enrolment in the study. 200 care home residents including him/her 
will be needed for this research. 
 
Does he/she need to take part? No, this is entirely voluntary. 
 
What will happen if he/she decides to take part?  
1. The nursing staff/Dr Ihama will take his/her weight 
2. Dr Ihama will take measurement of his/her forearm using a tape measure 
3. Dr Ihama will request him/her to walk (if he/she can) 10 feet indoors, turn around walk 
back to an armed chair then sit down. This will happen thrice after a test run. This is the walking 
test 
4. I will request access to his/her medical case file for relevant information 
5. I will request you to sign a consultee form; one copy will be put in her file, you will have a 
copy and I will have a copy  
6. Periodically, I will contact his/her care home to find out if he/she has had a fall or fracture 
 
What will your relative/friend need to do? 
1. Answer a few questions for about 20 minutes 
2. Your relative/friend will be weighed 
3. Dr Ihama will take measurement of her forearm 
4. He/she will be requested to do the walking test if he/she can 
 
What are the possible disadvantages?;   None apart from the inconveniences of answering a 
few questions, being weighed, taking the forearm measurement and doing the walking test. 
 
What are the possible benefits? 
None to your relative/friend but this research may benefit others in future. 
 
Will anyone else know about the identity of your relative/friend? 
His/her identity will be kept secret and only those who need to know will be informed; for 
example his/her GP who you could contact for an independent opinion. 
 
Who is organising and funding this research? 
It is a research project in the University of Keele. It is privately funded and there are no 
incentives 
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Who has revised this study? 
It has been reviewed and approved by the UK Government appointed Agency; IRAS and the 
University of Keele. 
 
What happens if you wish to withdraw assent?; Fine but please inform his/her nurse and GP or 
you may wish to contact me. 
 
What will happen to the results of the research? 
The results will be published but the identity of your relative/friend will not be revealed. 
 
Part 2 
 
Aim; A feasibility study to evaluate the performance of three fragility risk assessment tools in 
predicting falls in care home residents in Boston 
 
Why? 
Fractures due to brittle bone disease are common in the elderly. They are especially common 
in care home residents many of whom are frail due to various diseases. Risk assessment can 
be used to identify those residents who are likely to fall and sustain fractures. Risk assessment 
tools consist of some questions. For fractures, I have identified three but these were developed 
from research which involved healthy elderly in the community. 
 
Secondly, these tools I have identified assess the fracture risk over a 5-year or 10-year period. 
It is therefore not clear if these same tools can be useful in care home residents. The aim of this 
study is to compare the performances of these three tools in care home residents and 
determine the best which can predict fracture risk over a shorter period of 12 months. 
 
Why has your relative/friend been invited to take part?  
He/she has been invited to take part in this study because he/she meets with the requirements. 
This research will enrol 200 participants including your relative/friend. 
 
Does he/she need to take part? 
Participation in this study is entirely voluntary. If you decide to give assent, you will be 
requested to sign a consultee form and you are free to withdraw it at any time without giving 
any reason, this will not affect the standard of care he/she receives. You may wish to be 
present during the interview and the measurements required and her care nurse will always be 
present. 
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What will happen if he/she takes part? 
If you give assent, by signing the consultee form, I will need to assess his/her medical notes 
and it may be necessary to contact his/her GP for some clarification. The information obtained 
will be entered into my computer which is secured as it is password protected. I will then ask 
him/her some questions relating to falls and fractures; this will take about 20 minutes.  
 
He/she will be weighed on the usual electronic scale with the resident wearing light clothing and 
usual shoes. I will take measurement of the forearm with a tape measure and from the weight 
and forearm length I will be able to estimate the body mass index which is a measure of the 
state of nutrition. I will request him/her to walk (if he/she can) 10-feet indoors, turn around, walk 
back to an armed chair and sit down. This will happen three times after a test run. This is the 
walking test. These done, I will telephone the care home nurse periodically to find out if a fall or 
fracture has occurred. This research will not affect his/her usual treatment in any way. 
 
What will he/she need to do? 
He/she will be requested to answer some questions regarding fall and fractures. He/she will be 
weighed on the usual weighing scale, measurement of the forearm will be taken using a tape 
measure and she will be requested to undertake the walking test if he/she can. 
 
What are the possible disadvantages of taking part? 
The questioning takes about 20 minutes, the weighing, forearm measurement and walking test 
take a few minutes. 
 
What are the possible benefits in taking part? 
He/she will not benefit from this study but the result may enable me to identify the best fracture 
risk assessment tool to recommend for use in care home residents. 
 
Will anyone else know he/she is taking part in the study? 
His/her identity will be kept secret and will not be given to any person except those who need to 
know. I will only send out information that has his/her name, and address removed. All 
information collected will be stored in a computer which is secured as it is password protected. I 
will inform his/her GP of participation. You may wish to contact his/her GP for an independent 
opinion about participation in this study. 
 
Who is organising and funding this research? 
This research is part of my project in the University of Keele. It is entirely privately funded and 
there is no incentive. 
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Who has reviewed this research project? 
Before any research of this type is conducted in the UK, it must be reviewed by the 
Government Agency called IRAS to determine if the project is appropriate. This study has been 
approved by IRAS as well as the University of Keele. 
 
What happens if you do wish to withdraw assent? 
If at any time you do not want him/her to continue with the study, please you can contact me, 
the nurse or GP, I will not be offended. 
 
What will happen to the results of this study? 
At the end of the study, I will analyse the information and determine the best of the three tools 
to recommend for use in care homes. This will then form part of the initial assessment when 
anybody is admitted to a care home in much the same way blood pressure, temperature, pulse 
rate are assessed on admission. 
 
I will publish my findings as well as presenting it in conferences so that others might benefit 
from my study. If you are interested and want to be informed of the results do let me know by 
ticking the relevant box in the consultee form and I will make a simplified summary available to 
you by post. The result from this study may be used to support other research of this type in 
future but it will not be possible to specifically identify him/her as one of the participants. 
 
What if there is a problem in the research process? 
If you have any concerns about any aspect of this research, you may request to speak to me 
and I will do my best to answer your questions. If you are not satisfied and wish to complain 
formally, you can do so by contacting the Compliant Department through the Research and 
Development Department, ULHT. 
 
I will like to thank you for taking time to read this information leaflet. If you have further 
questions, please contact me through the details at the bottom of this document. If you wish to 
support this study, could you please sign the consultee form enclosed. If you have decided not 
to sign I will like to thank you for taking the time to find out about this study.  
 
Thank you very much 
 
Dr F E Ihama 
Department of Medicine, 
Pilgrim Hospital, 
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Boston. 
Lincolnshire  
PE21 9QS 
Telephone; 01205 364 801, bleep 506 
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Appendix H Consent form 
 
 
 
 
 
 
                                                                                                                  
 
 
  
Pilgrim Hospital 
Sibsey Road 
Boston 
Lincolnshire 
LN2 5QY 
 
Study Number: 
 
Patient Identification Number for this study: 
 
CONSENT FORM 
VERSION 2.0 
 
Title of Project: A feasibility study evaluating the efficacy of three fragility risk assessment tools to predict 
falls and fractures in care home residents 
 
Name of Researcher: Dr F E Ihama 
 
                             Please initial all boxes 
 
I confirm that I have read and understand the information 
sheet dated (DATE) version number X for the above study. 
I have had the opportunity to consider the information, ask 
questions and have had these questions answered  
satisfactorily. 
 
 
 
I understand that my participation is voluntary and that I am  
free to withdraw at any time without giving any reason, 
without my care or legal rights being affected. 
 
 
 
I understand that relevant sections of my medical notes and 
data collected during the study, may be looked at by individuals 
from the University of Keele, from regulatory authorities or 
from the NHS Trust, where it is relevant to my taking part in 
this research. I give permission for these individuals and Dr Ihama to have 
Tel: 01205 364801 
   www.ulhnhs.uk 
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access to my medical records for research purposes 
 
 
 
I agree to my GP being informed of my participation in the  
study. 
 
 
 
I agree to take part in the above study. 
 
 
 
I will like to be informed of the outcome of this research 
 
 
 
I agree to my data being used in future research if it is necessary 
 
    __________________             ________________      ______________ 
    Name of Participant               Date                              Signature 
 
 
   __________________            _________________     ________________ 
Name of Witness                  Date                                   Signature 
 
 __________________             ________________       ________________ 
  Name of Person                     Date                               Signature 
Taking consent 
 
 
 
When completed 1 for participant, 1 for researcher site file, 1 (original) to be kept in medical notes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 367 
 
Appendix I Consultee form 
 
 
 
 
 
 
                                                                                                                  
 
 
  
Pilgrim Hospital 
Sibsey Road 
Boston 
Lincolnshire 
LN2 5QY 
 
Study Number: 
 
Patient Identification Number for this study: 
 
CONSULTEE DECLARATION FORM 
(Participant`s representative) 
Version 2.0 
 
Title of Project: A feasibility study evaluating the efficacy of three fragility fracture risk tools to predict falls 
and fractures in care home residents 
 
Name of Researcher: Dr F E Ihama 
 
 
                                                       Please initial all boxes 
 
 
I (name of consultee) have been consulted about (name of 
 potential participant)`s participation in this research project. I have 
had the opportunity to ask questions about the study and  
understand what is involved. 
 
 
 
In my opinion he/she would have no objection to taking part in the  
study 
 
 
 
I understand that I can request he/she is withdrawn from the study  
at any time without giving any reason and without his/her care or 
legal rights being affected. 
 
Tel: 01205 364801 
   www.ulhnhs.uk 
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I understand that the relevant sections of his/her care record and 
data collected during the study may be looked at by responsible 
individuals from the University of Keele and the United Lincolnshire  
Hospital NHS Trust or from regulatory authorities, where it is  
relevant to their taking part in this research. 
 
 
I agree to his/her GP being informed of 
 participation in the study.  
 
 
 
I will like to be informed of the outcome of this research    
 
 
 
I agree to his/her data being used in future research if it is necessary 
 
 
 
 _______________           ________________        _______________ 
 Name of Consultee              Date                                Signature 
 
 
Relationship to participant:    
 
 
________________        ________________      _____________ 
Researcher                                        Date            Signature 
 
 
 
When completed: 1 (original) to be kept in care record, 1 for consultee; 1 for researcher site file 
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Appendix J Letter to the General Practitioner 
 
 
 
 
 
 
                                                                                                                  
 
 
  
Pilgrim Hospital 
Sibsey Road 
Boston 
Lincolnshire 
LN2 5QY 
 
 
 
 
Department of Medicine, Elderly Care Unit, Pilgrim Hospital, Boston. Lincolnshire. PE21 9QS 
 
Letter to the General Practitioner 
Version; 1.0 
 
Title of Study; A feasibility study evaluating the efficacy of three fragility risk assessment tools to predict falls and 
fractures in care home residents 
 
Date; 
 
 
 
 
Dear Dr  
 
I am conducting a research on the above subject. It is a prospective observational cohort study. I have the written 
signed informed consent of your patient (name of patient, NHS number;) to contact you for clarification of some 
details.  I have enclosed a photo copy of the signed consent form and the participant information sheets. 
 
 Many thanks. 
 
 
 
Yours Sincerely, 
 
Dr F E Ihama 
 
 
 
Tel: 01205 364801 
   www.ulhnhs.uk 
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Appendix K Research pathway 
Research pathway 
 
OPTION A - Identified by Care home manager as having mental capacity 
 
(VISIT 1) To be completed by Care Home Manager: 
Care home ____________________________ 
Telephone number of care home ___________________________ 
Principal investigator ____________________________ 
 
Information Sheet given? Y / N (Date________________) 
Permission given for contact by Dr Ihama? Y / N (If ‘no’ record initials/DOB only) 
Name / Initials ________________________ 
Date of birth _____________________ (Dr Ihama to record pt on screening log) 
 
(VISIT 2) To be completed by Dr Ihama: 
Date referral received: ________________________ 
Date of first approach: _________________________ 
Time of first approach: _________________________ 
Information sheet received previously?  Yes / No 
Discussion of study?    Yes / No 
Witness (name) ___________________________ 
Any questions following discussion?  Yes / No Outcome of first visit:  
 Written Consent Yes / No (Only applicable if PIL given >24 hours previously) 
 Will consider participating 
 Not interested in participating (record on screening log) 
 
(VISIT 3) To be completed by Dr Ihama: 
Date __________________ 
Time __________________ 
Remains happy to participate?  Yes / No 
Witness present? (Name) ______________________________ 
Continuing Mental capacity? Yes / No (if no for consultee: see pathway 2 below)  
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Written Consent obtained? Yes / No (Only if not previously obtained) 
Activity checklist (See completed questionnaire for full detail): 
 Questionnaire  
 Weight 
 Ulnar Length 
 Timed Get up and Go Test  
 
 
OPTION B - Identified by Care home manager as not having full  mental capacity 
(VISIT 1) - To be completed by Care Home Manager: 
Care home _________________ 
Telephone number of care home __________________ 
Principal investigator _____________________ 
 
Name __________________________________ 
Date of birth _____________________________ 
Consultee name __________________________ 
Relationship _____________________________ 
Telephone number ________________________ 
Contact address _____________________________________________ 
___________________________________________________________ 
Date information leaflet and contact detail form given/posted to consultee 
__________________________________ 
 
Date consultee form returned ____________________________ (Please forward completed form to Dr Ihama) 
 
(VISIT 2) – To be completed by Dr Ihama 
Date of notification from care home manager / referral received: ______________ 
Date of discussion with consultee _____________________ 
Information sheet received previously?  Yes / No 
Discussion of study?    Yes / No 
Any questions following discussion?  Yes / No 
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Outcome of first visit:  
 Written assent given?  Yes / No (Only applicable if Information Leaflet given >24 hours previously) 
 Will consider  
 Not interested in participating (record on screening log) 
 
(VISIT 3) To be completed by Dr Ihama: 
Date __________________ 
Time __________________ 
Remains happy to provide assent for participation?  Yes / No 
Written Assent obtained?  Yes / No (Only if not previously obtained) 
Activity checklist (See completed questionnaire for full detail): 
 Questionnaire  
 Weight 
 Ulnar Length 
 Timed Get up and Go Test  
 
NOTES 
 
Incidents Yes/No 
 
Type 
 
End of study date 
 
Total duration of recruitment process 
 
Any other comments 
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 Appendix L Screening log template 
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Appendix M Scoring in the composite questionnaire  
 
The table shows the scoring system of the composite questionnaire. Categorical variables were assigned numerical 
values and the actual values were recorded for the continuous variables. 
FRAX 
Identity     
Variable  Participant`s 
response 
Scoring system for 
EXCEL 
Score 
Age (ys.) Actual age 
record 
  
Date of Birth (Year Month 
Day) 
Actual record   
Sex (Male, Female)  Male=1, Female=0  
Weight (kg) Actual weight 
record 
Actual weight record  
Height (cm) Actual height 
record 
Actual height record  
Previous fracture (No, Yes)  No=0, Yes=1  
Parental Fractures Hip 
(No, Yes) 
 No=0, Yes=1  
Current smoking 
(No, Yes) 
 No=0, Yes=1  
Glucocorticoids 
(No, Yes) 
 No=0, Yes=1  
Rheumatoid arthritis 
(No,, Yes) 
 No=0, Yes=1  
Secondary osteoporosis 
(No, yes) 
 No=0, Yes=1  
Alcohol 3 or more 
units/day 
(No, Yes) 
 No=0, Yes=1  
10 year absolute fracture 
probability 
Actual score Actual score record  
Time to complete FRAX in 
minutes 
Actual record Actual record  
 
  
 375 
 
Appendix M Scoring system of the composite questionnaire (continued) 
 
QFractureScores 
Variable  Participant`s 
response 
Scoring system for 
EXCEL 
Score 
Age (30-99 ys.) Actual age 
record 
  
Sex (Male, Female)  Male=1,  
Female=0 
 
Ethnicity 
(White, Indian, Pakistani,  
Bangladeshi, Other Asian, 
Black Caribbean, Black 
African, Chinese, Other 
Ethnic group) 
 White=0, Indian=1, 
Pakistani=2, 
Bangladeshi=3, Other 
Asian=4, Black 
Caribbean=5, Black 
African=6, 
Chinese=7,Other Ethnic 
group=8) 
 
Smoking 
(non-smoker, ex-smoker, 
light smoker ;less than 10), 
moderate smoker;10-19), 
heavy smoker;20 or over) 
 Non-smoker=0, Ex-
smoker=1, Light smoker; 
less than 10=2, Moderate 
smoker;10-19=3, Heavy 
smoker ;20 or over=4 
 
Alcohol status 
(None, <1 unit per day, 1-2 
units per day, 3-6 units per 
day, 7-9 units per day, >9 
units per day) 
 None=0,<1 unit/day=1, 
 1-2 units/day=2,  
3-6 units/day=3,  
7-9 units/day=4,  
>9units/day=5 
 
Diabetes 
(None, Type1, Type 2) 
 None=0,  
Type 1=1,  
Type2=2 
 
Do either your parents 
have osteoporosis/hip 
fracture? 
(No, Yes) 
 No=0 
Yes=1 
 
Do you live in a nursing or 
care home? 
(No, Yes) 
 No=0 
Yes=1 
 
Have you had a wrist, 
spine, hip or shoulder 
fracture? 
(No, Yes) 
 No=0 
Yes=1 
 
History of fall/ 
(No, Yes) 
 No=0 
Yes=1 
 
Dementia? 
(No, Yes) 
 No=0 
Yes=1 
 
Cancer  
(No, Yes) 
 No=0 
Yes=1 
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Appendix M Scoring system of the composite questionnaire (continued) 
 
Asthma? 
(No, Yes) 
 No=0 
Yes=1 
 
Heart attack, angina, stroke 
or TIA? 
(No, Yes) 
 No=0 
Yes=1 
 
Chronic liver disease? 
(No, Yes) 
 No=0 
Yes=1 
 
Chronic kidney disease? 
(No, Yes) 
 No=0 
Yes=1 
 
Parkinson`s disease? 
(No, Yes) 
 No=0 
Yes=1 
 
Rheumatoid disease? 
(No, Yes) 
 No=0 
Yes=1 
 
Malabsorption e.g. Crohn`s 
disease, ulcerative colitis, 
Coeliac disease, 
steatorrhoea or blind loop 
syndrome? 
(No, Yes) 
 No=0 
Yes=1 
 
Endocrine problems e.g. 
Thyrotoxicosis, 
hyperthyroidism, 
Cushing`s syndrome? 
 No=0 
Yes=1 
 
Epilepsy or taking 
anticonvulsants? 
(No, Yes) 
 No=0 
Yes=1 
 
Taking antidepressants? 
(No, Yes) 
 No=0 
Yes=1 
 
Taking steroid tablets 
regularly? 
(No, Yes) 
 No=0 
Yes=1 
 
Taking oestrogen only 
HRT? 
(No, Yes) 
 No=0 
Yes=1 
 
Body mass index Actual record Actual record  
Height (cm) Actual record Actual record  
Weight (kg) Actual record Actual record  
10 year absolute fracture 
probability 
Actual record Actual record  
Time to complete 
QFractureScore in minutes 
Actual record Actual record  
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Appendix M Scoring system of the composite questionnaire (continued) 
Garvan nomogram 
 
Variable  Participant`s 
response 
Scoring system for 
EXCEL 
Score 
Sex (Male, Female)  Male=1, Female-0  
Age Actual age 
record 
  
Fracture since age of 50 
years 
(Excluding major trauma 
e.g. car accidents) 
(0, 1, 2, 3 or more) 
 0=0 
1=1 
2=2 
3 or more =3 
 
Falls over last 12 months 
(0, 1, 2 3 or more) 
 0=0 
1=1 
2=2 
3 or more=3 
 
Weight (kg) Actual record Actual record  
10 year absolute fracture 
probability 
Actual record Actual record  
Time to complete Garvan 
nomogram in minutes 
Actual record Actual record  
 
Timed Up & Go Test (TUGT) 
Variable  Participant`s 
response 
Scoring system for 
EXCEL 
Score 
Time to complete TUGT 
(< 10 seconds= freely 
mobile, <20 seconds 
Mostly independent, 20-29 
seconds  variable mobility, 
> 30 seconds impaired 
mobility) 
Actual record 
First attempt 
Second attempt 
Third attempt 
Average=  
≤ 10 seconds=0 
11- 19 seconds=1 
20-29 seconds=2 
≥30 seconds= 3 
 
 
Participant unable to 
undertake task 
Participant unable 
to undertake task 
4  
TUGT With walking 
aids=1 
Without walking 
aids=0 
  
Time to complete TUGT in 
minutes(including 
preparation) 
Actual record   
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Appendix M Scoring system of the composite questionnaire (continued) 
Other variables 
 
Variables  Participant`s 
response 
Scoring system for 
EXCEL 
Score 
Number of comorbidities Actual number 
record 
  
Charlson`s comorbidity 
index in 1yr 
Actual record   
Duration in days to 
complete questionnaire 
including consenting 
Actual record   
Falls in study 
(No, Yes) 
 No=0 
Yes=1 
 
Fractures in study 
(No, Yes) 
 No=0 
Yes=1 
 
Radiologically verified 
fractures 
 No=0 
Yes=1 
 
Falls and Fractures in study 
(No, Yes) 
 No=0 
Yes=1 
 
Outcome of participant at 
end of study 
(Alive, Dead) 
 Alive =0 
Dead=1 
 
Name of Care Home Actual record Actual record  
Type of Care Home 
(RH, NH, MIH) 
 RH=0 
NH=1 
MIH=2 
 
Telephone number of Care 
Home 
Actual record Actual record  
GP of Participant Actual record Actual record  
Telephone number of 
Participant`s GP 
Actual record Actual record  
Next of Kin (NOK) Actual record Actual record  
Telephone number of NOK Actual record Actual record  
Date of recruitment of 
participant 
Actual record Actual record  
Proposed termination date Actual record Actual record  
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Appendix N Definitions of terms 
 
For this research, the following terms were defined thus: 
 
Age: Defined as the number of years since the last birthday. 
 
Date of birth: Defined as the date of birth in the participant`s case file. 
 
Adult: A person who has attained the age of legal majority (18 years for most purposes). 
 
Older person: In high resourced countries older age is defined in relation to retirement from paid employment and 
receipt of a pension at 60 or 65 year (WHO 2012). 
 
Sex: Defined as the sex recorded in the participants care home case file. 
 
Ethnicity: Defined as the state of belonging to a social group that has a common natural or cultural tradition and 
recorded in the casefile. 
 
Body weight: Defined as the weight in kilograms measured by SECA sit-in electronic weighing scale with the 
participant weighed sitting in the scale, wearing normal clothing, light shoes and feet off the ground. 
 
Body mass index (BMI): Calculated from baseline objective weight and height measurements, as weight in 
kilograms divided by height in squared meters (kg/m²). 
 
Smoking status: Defined as smoking status recorded in the participant`s case file. 
 
Alcohol status: Defined as alcohol consumption recorded in the participant`s case file. 
 
Co-morbidities: Defined as the past medical history recorded in the participant`s case file. 
 
Medications: Defined as medications recorded on the participant’s treatment sheet. 
 
Use of walking aid: Defined as the current use of a walking frame, stick, crutches or wheelchair irrespective of the 
frequency of use. 
 
History of previous fall: Defined as history of fall prior to recruitment. 
 
Number of previous falls: Defined as the number of previous falls prior to recruitment. 
 
Previous Fragility Fractures: Defined as any previous fragility fractures in the past. 
 
Parental history of hip fractures/osteoporosis: Defined as a history of hip fractures and osteoporosis obtained from 
the participant, Next of kin (NOK) or GP. 
 
Secondary osteoporosis: Defined as osteoporosis with identified causes. 
 
Outcome at the end of 12 months of study: Defined as the status of the participant at the end study, dead or alive. 
 
Date of recruitment of participant: Defined as the date the participant was enrolled in this study. 
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Termination date: Defined as the date of termination of follow-up (12 months after recruitment). 
 
Crude incidence rate: The number of new cases occurring in a specified population in a year. 
 
Person-centred care; the experience (to the extent the informed individual patient desires it) of transparency, 
individualization, recognition, respect, dignity, and choice in all matters, without exception, related to one`s 
person, circumstances, and relationships in health care (Berwick DM et al 2009). 
Statistical power: Defined as the probability that the test will reject a false null hypothesis. In plain English, 
statistical power is the likelihood that a study will detect an effect when there is an effect there to be detected (Ellis 
P.D 2010). 
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Appendix O The QUADAS tool 
The tool is structured as a list of 14 questions which should each be answered "yes", "no", or "unclear". 
 
Item 
 
Yes No Unclear 
    
1. 
Was the spectrum of patients representative of the patients 
who will receive the test in practice? 
( ) ( ) ( ) 
2. Were selection criteria clearly described? ( ) ( ) ( ) 
3. 
Is the reference standard likely to correctly classify the target 
condition? 
( ) ( ) ( ) 
4. 
Is the time period between reference standard and index test 
short enough to be reasonably sure that the target condition did 
not change between the two tests? 
( ) ( ) ( ) 
5. 
Did the whole sample or a random selection of the sample, 
receive verification using a reference standard of diagnosis? 
( ) ( ) ( ) 
6. 
Did patients receive the same reference standard regardless of 
the index test result? 
( ) ( ) ( ) 
7. 
Was the reference standard independent of the index test (i.e. 
the index test did not form part of the reference standard)? 
( ) ( ) ( ) 
8. 
Was the execution of the index test described in sufficient 
detail to permit replication of the test? 
( ) ( ) ( ) 
9. 
Was the execution of the reference standard described in 
sufficient detail to permit its replication? 
( ) ( ) ( ) 
10. 
Were the index test results interpreted without knowledge of 
the results of the reference standard? 
( ) ( ) ( ) 
11. 
Were the reference standard results interpreted without 
knowledge of the results of the index test? 
( ) ( ) ( ) 
12. 
Were the same clinical data available when test results were 
interpreted as would be available when the test is used in 
practice? 
( ) ( ) ( ) 
13. Were uninterpretable/ intermediate test results reported? ( ) ( ) ( ) 
14. Were withdrawals from the study explained? ( ) ( ) ( ) 
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Appendix P Order of selection of the care homes 
 
1. Log on google using www.google.co.uk then 
2. Enter online random generation then 
3. Assess random org-true random number services then 
4. Locate number selection section and locate sequence generator then 
5. Enter the number 1 for smallest and the number 18 (number of care homes in Boston) for largest and the 
number 1 for format then 
            enter the `Get sequence` button. 
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Appendix Q Power calculation 
 
 
Contents from the abstract  
In the observational study, 217 (35%) participants out of 618 residents in the 18 care homes were enrolled. Out of 
the 217 participants, 147 (68%) had mental capacity and only 70 (32%) did not. This was because there was 
difficulty in obtaining informed consent from the consultees in residents without mental capacity. The odds ratios 
for the prediction of the outcomes were as follows: FRAX falls 1.003 (p=0.813), fractures 1.027 (p=0.267), 
combined falls and fractures 1.027 (p=0.267); QFractureScores falls  1.007 (p=.160), fractures  1.024 (p=0.036), 
combined falls and fractures  1.024 (p=0.036); Garvan nomogram fall, 1.010 (p=0.054), fractures 1.021 
(p=0.0620, combined falls and fractures 1.021 (p=0.062); BMI falls 0.952 (p=0.015), fractures  0.868 (p=0.024), 
combined falls and fractures 0.868 (p=0.024); TUGT:  falls  0.999 (p=0.013), fractures  1.000 (p=0.829), 
combined falls and fractures  1.000 (p=0.829).  
 
Power analysis and sample size computations  
The purpose of this project was to determine the minimum sample size needed for each tool (FRAX, 
QFractureScore, Garvan, BMI, and TUGT) under each circumstance (fall, fractures, and combined falls and 
fractures), based on a two-tailed test and an alpha level of 0.05, to give 80% power to detect an odd ratio of 2 
(small to medium effect) for each tool in the prediction of falls and fractures. 
 
A priori power analysis was conducted based on binary logistic regression (for binary response variable, i.e., falls 
vs. no falls; fractures vs. no fractures; combined falls and fractures vs. neither) to determine the minimum sample 
size required for this study for each tool (FRAX, QFractureScore, Garyan, BMI, and TUGT) under each 
circumstance (fall, fractures, and combined falls and fractures) using Gpower version 3.1.9.2 (Faul, Erdfelder, 
Buchner, and Lang, 2009). During the process of sample size computation for each tool, the following assumptions 
were made: 1) the predictor of interest is a categorical variable with two levels (above the threshold vs. not above 
the threshold), and 2) a medium effect size (odds ratio = 2) (Haddock, Rindskopf, & Shadish, 1998). Additionally, 
the probability of event happening if the score of a tool is above the threshold (ex: probability of falls given FRAX 
score above a threshold) is computed based on the observed odds in the pilot study (see Table 1).  
 
The results of the power analysis are presented in Table 1. For a two-sided test with a significance level of 0.05, 
medium effect size (odds ratio = 2), and a power of 0.8 to show a significant effect of the predictor, the minimum 
sample size needed (Ntotal) for each tool under each circumstance in the study ranged from 271 (for BMI) to 277 
(for FRAX).  
 
Furthermore, in the pilot study, 68% of the participants had mental capacity and 32% did not. Hence, we assumed 
the sample would contain 70% patients with mental capacity and 30% patients without metal capacity. The 
required number of samples from each group (with mental capacity vs. without mental capacity) for each tool 
under each circumstance is presented in Table 1.  
 
Also from the pilot study, we learned that only 21% of patients without mental capacity would give consents and 
57% of patients with mental capacity would give consents for the study.  
 
To obtain enough patients without mental capacity (Ntotal_nm), the researcher would need to sample Nnm (= Ntotal_nm 
/0.21) residents without mental capacity; to obtain enough patients with mental capacity (Ntotal_m), the researcher 
would need to sample Nm (= Ntotal_m /0.57) residents with mental capacity, see Table 1. 
 
For example, according to the results presented in Table 1, for tool = “FRAX” and circumstance = “Falls”, the 
minimum sample required (Ntotal) is 276, in which, 193 (Ntotal_m) is expected to have mental capacity and 83 
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(Ntotal_nm) is expected to have no mental capacity. Furthermore, based on the consent rate of the pilot study, to 
ensure enough residents would participate in the study, 339 patients with mental capacity (Nm) should be sampled 
and 395 patients without mental capacity (Nnm) should be sampled. 
 
Table 1: Results of Power Analysis 
 
Tool Outcome Observed 
odds ratio 
Observed 
probability = 
odds 
ratio/(1+odds 
ratio) 
Ntotal Ntotal_m  Ntotal_nm  Nm Nnm 
FRAX Falls 1.003 0.501 276 193 83 339 395 
 Fractures 1.027 0.507 277 194 83 340 395 
 Combined falls 
and fractures 
1.027 0.507 277 194 83 340 395 
QFractureScores Falls 1.007 0.502 276 193 83 339 395 
 Fractures 1.024 0.506 277 194 83 340 395 
 Combined falls 
and fractures 
1.024 0.506 277 194 83 340 395 
Garvan Falls 1.010 0.502 276 193 83 339 395 
 Fractures 1.021 0.505 277 194 83 340 395 
 Combined falls 
and fractures 
1.021 0.505 277 194 83 340 395 
BMI Falls 0.952 0.488 274 192 82 337 390 
 Fractures 0.868 0.465 271 190 81 333 386 
 Combined falls 
and fractures 
0.868 0.465 271 190 81 333 386 
TUGT Falls 0.999 0.500 276 193 83 339 395 
 Fractures 1.000 0.500 276 193 83 339 395 
 Combined falls 
and fractures 
1.000 0.500 276 193 83 339 395 
Note: Ntotal = minimum sample size required. Ntotal_m = minimum sample size required for patients with mental 
capacity = 70% of total N. Ntotal_nm = minimum sample size required for patients without mental capacity = 30% of 
total N. Nm = Ntotal_m /0.57 = number of residents with mental capacity that need to be sampled. Nnm = Ntotal_nm 
/0.21 = number of residents without mental capacity that need to be sampled. 
 
This power calculation was done by Dr Y Su, Consultant Statistician in Hawaii, USA. 
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Appendix R Data extraction template of the systematic literature review 
 
1. Number of authors 
2. Year of publication 
3. Type of study; Review/meta-analysis/original 
4. Title of article 
5. Country of study 
6. Mean age in years of the participants 
7. Sex; male/female 
8. Ethnicity 
9. Setting; community/care home/mixed 
10. Design of the study 
11. Number of participants 
12. Type of assessment 
13. Site of primary outcome measure 
14. Method of fracture verification; self-report/radiologist/case note review 
15. Duration of follow-up 
16. Method of statistical analysis 
17. Conflict of interest declared; yes/no 
18. Ethical approval; yes/no 
19. Performance characteristics 
20. Internal validation; yes/no 
21. External validation; yes/no 
22. Internal and external validation; yes/no 
23. Tool calibration; yes/no 
24. Authors involved in calibration; yes/no 
25. Output of tools 
26. No of risk factors 
27. Missing data reported; yes/no 
28. Loss to follow-up reported; yes/no 
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Appendix S Pilgrim Hospital named best hospital in the UK for Hip Fracture management 
 
